NH³óÇù¼ÕÇØº¸Çè
¹ßÇàÀÏÀÚ: 2025³â03¿ù24ÀÏ 13½Ã27ºĞ
¹ß±ŞÀÚ: ¹é¼±°æ
¡Ø¾÷¹«¸ñÀû¿Ü »ç¿ë ¹× À¯Ãâ±İÁö
Áõ±Ç¹øÈ£: 319-1472-7663-13
Çì¾Æ¸²
°è¾à³»¿ëÁ¶È¸
»óÇ°¸í
(¹«) °£Æí°¡ÀÔÇì¾Æ¸²½Ç¼ÕÀÇ·áºñº¸Çè
2404
º¸Çè±â°£
2024-10-08 ~
2054-10-08
Åë½Å¼ö´ÜÇØÁö¿©ºÎ
N
Á¤»ó/À¯È¿
°è¾àÀÚ
ÀÌÁ¶ÈÆ
½Ç¸í¹øÈ£
850224-1******
°è¾à»óÅÂ
(2025-03-10)
³³ÀÔ±â°£ 1³â³³/100¼¼
ÃÖÁ¾³³ÀÔÀÏ 2025-03-10
³³ÀÔÁÖ±â ¿ù³³
¼Òµæ°øÁ¦
Y
°¡ÀÔ±¸ºĞ ÀÏ¹İÃßÁø
¼¼Á¦ÇıÅÃ
ÀÏ¹İ°ú¼¼
Áú±Ç/Áö±ŞÁ¦ÇÑÀ¯¹« ¹«/¹«
ÁÖ°è¾à°¡ÀÔ±İ¾×
ÃÖÁ¾³³ÀÔ¿ù(È½¼ö) 2025-03/6 È¸
º¸Çè°è¾à´ëÃâ
¹«
Ãë±ŞÀÚ ±İÃÌ³óÇù±è¼±Çü(B0007654)
0¿ø
[º¸Çè°ü·Ã»çÇ×]
1È¸º¸Çè·á
57,521¿ø º¸Àåº¸Çè·á
57,521¿ø ½Ç³³ÀÔº¸Çè·á
57,521¿ø Àû¸³º¸Çè·á
0¿ø
Ä«µåÀÌÃ¼/ÀÏ
³³ÀÔ¹æ¹ı
ÀºÇà(Ä«µå»ç) ±¹¹ÎÄ«µå
¿¹±İÁÖ
ÀÌÁ¶ÈÆ
°èÁÂ(Ä«µå)¹øÈ£ 554959********
ÀÚ: 10ÀÏ
[°è¾à±âº»Á¤º¸]
¿ìÆí¹°¼ö·ÉÁö ÀÚÅÃ
±¸ºĞ
¿ìÆí¹øÈ£
ÀÚÅÃ
10869
Á÷Àå
±âÅ¸
[°è¾à°ü°èÀÚÁ¤º¸]
±¸ºĞ(°í°´¿ªÇÒ)
¸¸±â¼öÀÍÀÚ
¸ñÀû¹°¼ÒÀ¯ÀÚ
ÁÖ¼Ò
(10869)°æ±âµµ ÆÄÁÖ½Ã °¡¶÷·Î 109 311µ¿ 1701È£ (¿Íµ¿µ¿, º°ÇÏ¶÷¸¶À»3´ÜÁö ¼­Èñ½ºÅ¸Èú½ºNHF)
¼º¸í
½Ç¸í¹øÈ£
°è¾àÀÚ¿ÍÀÇ °ü°è
001 / 002

NH³óÇù¼ÕÇØº¸Çè
Çì¾Æ¸²
°è¾à³»¿ëÁ¶È¸
[ÇÇº¸ÇèÀÚ Á¤º¸]
±¸ºĞ ÇÇº¸ÇèÀÚ¸í
½Ç¸í¹øÈ£
°¡ÀÔ¿¬·É Á÷¾÷ÄÚµå »óÇØ±Ş¼ö
Á÷¾÷¸í
º¸Çè·á(¿ø) ÀÌ·ûÂ÷ºÎ´ã
ÁÖÇÇ
ÀÌ±¤¿í
550112-1****
70||
61110
1±Ş
ÀÛ¹°Àç¹è¿ø(°î½Ä, Ã¤¼Ò, °ú
57,521
¹Ì°¡ÀÔ
»ç¸Á¼öÀÍÀÚ
ÇÇº¸ÇèÀÚ¿ÍÀÇ °ü°è:
»ıÁ¸/ÀÔ¿ø¼öÀÍÀÚ ÀÌÁ¶ÈÆ 850224-1******
ÁöÁ¤´ë¸®ÀÎ
ÇÇº¸ÇèÀÚ¿ÍÀÇ °ü°è: ÀÚ³à
ÇÇº¸ÇèÀÚ¿ÍÀÇ °ü°è:
[ÇÇº¸ÇèÀÚº° °¡ÀÔ´ãº¸]
°¡ÀÔ´ãº¸¸í
³³ÀÔÀ¯Çü
ÇÇº¸ÇèÀÚ¸í
±¸ºĞ
´ãº¸»óÅÂ
(±âº»°è¾à)°»½ÅÇü ½Ç¼Õ»óÇØÀÔ¿øÀÇ·áºñ(°£Æí°¡ÀÔ)
¼±ÅÃ´ãº¸
º¸Àå±â°£
Ãß°¡³³ÀÔÇü
1³â
º¸Çè½Ã±â
º¸ÇèÁ¾±â
2024-10-08
°¡ÀÔ±İ¾×(¿ø)
º¸Çè·á(¿ø)
50,000,000¿ø
6,135
2025-10-08
(±âº»°è¾à)°»½ÅÇü ½Ç¼Õ»óÇØÅë¿øÀÇ·áºñ(°£Æí°¡ÀÔ)
¼±ÅÃ´ãº¸
ÀÌ±¤¿í
(±âº»°è¾à)°»½ÅÇü ½Ç¼ÕÁúº´ÀÔ¿øÀÇ·áºñ(°£Æí°¡ÀÔ)
¼±ÅÃ´ãº¸
Ãß°¡³³ÀÔÇü
1³â
Ãß°¡³³ÀÔÇü
1³â
2024-10-08
200,000¿ø
450¿ø
2025-10-08
2024-10-08
50,000,000¿ø
39,368
(±âº»°è¾à)°»½ÅÇü ½Ç¼ÕÁúº´Åë¿øÀÇ·áºñ(°£Æí°¡ÀÔ)
¼±ÅÃ´ãº¸
Ãß°¡³³ÀÔÇü
1³â
2025-10-08
2024-10-08
200,000¿ø
11,568¿ø
2025-10-08
[±âÅ¸Æ¯¾à ´ãº¸]
°¡ÀÔ´ãº¸¸í
±¸ºĞ 1
±¸ºĞ
´ãº¸»óÅÂ
º¸Çè·áÀÚµ¿³³ÀÔ
³³ÀÔÀ¯Çü
º¸Àå±â°£
ÇØ´ç¾øÀ½
º¸Çè½Ã±â
°¡ÀÔ±İ¾×(¿ø)
º¸Çè·á(¿ø)
º¸ÇèÁ¾±â
2024-10-08
Á¦µµ¼º
0¿ø
0¿ø
¼±ÅÃ´ãº¸
100¼¼
2054-10-08
Á¦µµ¼º
ÀÚµ¿°»½ÅÀû¿ë´ë»ó
¼±ÅÃ´ãº¸
ÇØ´ç¾øÀ½
2024-10-08
0¿ø
0¿ø
100¼¼
2054-10-08
002 / 002

(¹«) °£Æí°¡ÀÔÇì¾Æ¸²½Ç¼ÕÀÇ·áºñº¸Çè 2404
°è¾àÀÚ
ÀÌÁ¶ÈÆ
Áõ±Ç¹øÈ£
319-1472-7663-13
ÇÇº¸ÇèÀÚ
ÀÌ±¤¿í
³ªÀÌ/±Ş¼ö
70¼¼/1±Ş
ÁÖ¹Îµî·Ï¹øÈ£ 550112-1******
¿îÀüÇüÅÂ
Á÷¾÷ ÀÛ¹°Àç¹è¿ø(°î½Ä, Ã¤¼Ò, °ú¼ö, ¿ø¿¹)
ÀÇ·á±Ş¿©¼ö±Ş±ÇÀÚ N
ÁÖ¼Ò
(ÀÚÅÃ)(10446) °æ±âµµ °í¾ç½Ã ÀÏ»êµ¿±¸ ¹é¼®·Î86¹ø±æ 60-10 (¹é¼®µ¿)
ÀÌÁ¶ÈÆ(850224-1******)/ÀÚ³à
»ç¸Á¼öÀÍÀÚ
»ıÁ¸/ÀÔ¿ø¼öÀÍÀÚ
(ÀÚÅÃ)(10869) °æ±âµµ ÆÄÁÖ½Ã °¡¶÷·Î 109 311µ¿
1701È£ (¿Íµ¿µ¿, º°ÇÏ¶÷¸¶À»3´ÜÁö ¼­Èñ½ºÅ¸Èú½º
NHF)
¡¼º¸Àå³»¿ª¡½ ¼±ÅÃ°è¾à
º¸Àå¸í
º¸Àå»ó¼¼
°¡ÀÔ±İ¾×
³³ÀÔ ¹× ¸¸±â
(¸¸¿ø)
(±âº»°è¾à)°»½ÅÇü ½Ç¼Õ»óÇØÀÔ¿øÀÇ
·áºñ(°£Æí°¡ÀÔ)
(±âº»°è¾à)°»½ÅÇü ½Ç¼Õ»óÇØÅë¿øÀÇ
·áºñ(°£Æí°¡ÀÔ)
(±âº»°è¾à)°»½ÅÇü ½Ç¼ÕÁúº´ÀÔ¿øÀÇ
[·áºñ(°£Æí°¡ÀÔ)
-
-
»óÇØ·Î ÀÔ¿øÄ¡·á½Ã ÀÔ¿ø½Ç·á, ÀÔ¿øÁ¦ºñ¿ë, ÀÔ¿ø¼ö¼úºñ º¸»ó ±¹¹Î°Ç°­
º¸Çè¹ı¿¡¼­ Á¤ÇÑ ¿ä¾ç±Ş¿© ¶Ç´Â ÀÇ·á±Ş¿©¹ı¿¡¼­ Á¤ÇÑ ÀÇ·á±Ş¿© Áß º»ÀÎ
|ºÎ´ã±İ°ú ºñ±Ş¿©(»ó±Şº´½Ç·á Â÷¾× Á¦¿Ü)¸¦ ÇÕÇÑ ±İ¾×ÀÎ º¸»ó´ë»óÀÇ·á
ºñ(º»ÀÎÀÌ ½ÇÁ¦·Î ºÎ´ãÇÑ ±İ¾×À» ¸»ÇÕ´Ï´Ù.)¿¡¼­ 10¸¸¿ø°ú º¸»ó´ë»óÀÇ
·áºñÀÇ 30% Áß Å« ±İ¾×À» »« ±İ¾×À» º¸»ó(´Ü, 10¸¸¿ø°ú º¸»ó´ë»óÀÇ·á
ºñÀÇ 30% Áß Å« ±İ¾×ÀÌ °è¾àÀÏ ¶Ç´Â ¸Å³â °è¾àÇØ´çÀÏºÎÅÍ ±â»êÇÏ¿© ¿¬
|°£ 200¸¸¿øÀ» ÃÊ°úÇÏ´Â °æ¿ì ±× ÃÊ°ú±İ¾×Àº º¸»óÇÕ´Ï´Ù.), »ó±Şº´½Ç·á
Â÷¾× ÀÔ¿ø ½Ã ½ÇÁ¦·Î »ç¿ëÇÑ º´½Ç°ú ±âÁØº´½Ç°úÀÇ º´½Ç·á Â÷¾× Áß
50%¸¦ »« ±İ¾× (´Ü, 1ÀÏ Æò±Õ±İ¾× 10¸¸¿øÀ» ÇÑµµ·Î ÇÏ¸ç, 1ÀÏ Æò±Õ±İ
¾×Àº ÀÔ¿ø±â°£ µ¿¾È »ó±Şº´½Ç·á Â÷¾× ÀüÃ¼¸¦ ÃÑ ÀÔ¿øÀÏ¼ö·Î ³ª´©¾î¼­
»êÃâÇÕ´Ï´Ù.)(´Ü, ÇÇº¸ÇèÀÚ°¡ ±¹¹Î°Ç°­º¸Çè¹ı ¶Ç´Â ÀÇ·á±Ş¿©¹ıÀ» Àû¿ë
¹ŞÁö ¸øÇÏ´Â °æ¿ì¿¡´Â ÀÔ¿øÀÇ·áºñ(±¹¹Î°Ç°­º¸Çè ¿ä¾ç±Ş¿©ÀÇ ±âÁØ¿¡ °ü
ÇÑ ±ÔÄ¢¿¡ µû¶ó Á¤ÇÑ ±Ş¿© ¹× ºñ±Ş¿© ÀÇ·áºñ Ç×¸ñ¸¸ ÇØ´ç) Áß º»ÀÎÀÌ ½Ç
Á¦·Î ºÎ´ãÇÑ ±İ¾×¿¡¼­ 10¸¸¿ø°ú º¸»ó´ë»óÀÇ·áºñÀÇ 30% Áß Å« ±İ¾×À»
|»« ±İ¾×ÀÇ 40%¸¦ ÇÏ³ªÀÇ »óÇØ´ç º¸Çè°¡ÀÔ±İ¾×ÀÇ ÇÑµµ ³» º¸»ó)
»óÇØ·Î Åë¿øÄ¡·á½Ã ¿Ü·¡Á¦ºñ¿ë, ¿Ü·¡¼ö¼úºñ º¸»ó(´Ü, Ã³¹æÁ¶Á¦ Á¦¿Ü).
¹æ¹® 1È¸´ç ±¹¹Î°Ç°­º¸Çè¹ı¿¡¼­ Á¤ÇÑ ¿ä¾ç±Ş¿© ¶Ç´Â ÀÇ·á±Ş¿©¹ı¿¡¼­
Á¤ÇÑ ÀÇ·á±Ş¿© Áß º»ÀÎºÎ´ã±İ°ú ºñ±Ş¿©¸¦ ÇÕÇÑ ±İ¾×ÀÎ º¸»ó´ë»óÀÇ·áºñ(
º»ÀÎÀÌ ½ÇÁ¦·Î ºÎ´ãÇÑ ±İ¾×À» ¸»ÇÕ´Ï´Ù.)¿¡¼­ 2¸¸¿ø°ú º¸»ó´ë»óÀÇ·áºñ
|30% Áß Å« ±İ¾×À» »« ±İ¾×À» ¿Ü·¡ÀÇ º¸Çè°¡ÀÔ±İ¾×(È¸´ç 20¸¸¿ø)ÀÇ ÇÑ
µµ ³»¿¡¼­ º¸»ó(¸Å³â °è¾àÇØ´çÀÏºÎÅÍ 1³â°£ 180È¸ ÇÑµµ·Î ÇÕ´Ï´Ù.)(´Ü,
ÇÇº¸ÇèÀÚ°¡ ±¹¹Î°Ç°­º¸Çè¹ı ¶Ç´Â ÀÇ·á±Ş¿©¹ıÀ» Àû¿ë¹ŞÁö ¸øÇÏ´Â °æ¿ì
|¿¡´Â Åë¿øÀÇ·áºñ(±¹¹Î°Ç°­º¸Çè ¿ä¾ç±Ş¿©ÀÇ ±âÁØ¿¡ °üÇÑ ±ÔÄ¢¿¡ µû¶ó Á¤
ÇÑ ±Ş¿© ¹× ºñ±Ş¿© ÀÇ·áºñ Ç×¸ñ¸¸ ÇØ´ç)Áß º»ÀÎÀÌ ½ÇÁ¦·Î ºÎ´ãÇÑ ±İ¾×¿¡
|¼­ 2¸¸¿ø°ú º¸»ó´ë»óÀÇ·áºñ 30%Áß Å« ±İ¾×À» »« ±İ¾×ÀÇ 40%¸¦ º¸Çè
°¡ÀÔ±İ¾× ÇÑµµ ³»¿¡¼­ º¸»ó)
Áúº´À¸·Î ÀÔ¿øÄ¡·á½Ã ÀÔ¿ø½Ç·á, ÀÔ¿øÁ¦ºñ¿ë, ÀÔ¿ø¼ö¼úºñ º¸»ó - ±¹¹Î°Ç
|°­º¸Çè¹ı¿¡¼­ Á¤ÇÑ ¿ä¾ç±Ş¿© ¶Ç´Â ÀÇ·á±Ş¿©¹ı¿¡¼­ Á¤ÇÑ ÀÇ·á±Ş¿© Áß º»
|ÀÎºÎ´ã±İ°ú ºñ±Ş¿©(»ó±Şº´½Ç·á Â÷¾× Á¦¿Ü)¸¦ ÇÕÇÑ ±İ¾×ÀÎ º¸»ó´ë»óÀÇ
·áºñ(º»ÀÎÀÌ ½ÇÁ¦·Î ºÎ´ãÇÑ ±İ¾×À» ¸»ÇÕ´Ï´Ù.)¿¡¼­ 10¸¸¿ø°ú º¸»ó´ë»ó
ÀÇ·áºñÀÇ 30% Áß Å« ±İ¾×À» »« ±İ¾×À» º¸»ó(´Ü, 10¸¸¿ø°ú º¸»ó´ë»óÀÇ
·áºñÀÇ 30% Áß Å« ±İ¾×ÀÌ °è¾àÀÏ ¶Ç´Â ¸Å³â °è¾àÇØ´çÀÏºÎÅÍ ±â»êÇÏ¿©
¿¬°£ 200¸¸¿øÀ» ÃÊ°úÇÏ´Â °æ¿ì ±× ÃÊ°ú±İ¾×Àº º¸»óÇÕ´Ï´Ù.), »ó±Şº´½Ç
·á Â÷¾× ÀÔ¿ø ½Ã ½ÇÁ¦·Î »ç¿ëÇÑ º´½Ç°ú ±âÁØº´½Ç°úÀÇ º´½Ç·á Â÷¾× Áß
50%¸¦ »« ±İ¾× (´Ü, 1ÀÏ Æò±Õ±İ¾× 10¸¸¿øÀ» ÇÑµµ·Î ÇÏ¸ç, 1ÀÏ Æò±Õ±İ
¾×Àº ÀÔ¿ø±â°£ µ¿¾È »ó±Şº´½Ç·á Â÷¾× ÀüÃ¼¸¦ ÃÑ ÀÔ¿øÀÏ¼ö·Î ³ª´©¾î¼­
»êÃâÇÕ´Ï´Ù.)(´Ü, ÇÇº¸ÇèÀÚ°¡ ±¹¹Î°Ç°­º¸Çè¹ı ¶Ç´Â ÀÇ·á±Ş¿©¹ıÀ» Àû¿ë
¹ŞÁö ¸øÇÏ´Â °æ¿ì¿¡´Â ÀÔ¿øÀÇ·áºñ(±¹¹Î°Ç°­º¸Çè ¿ä¾ç±Ş¿©ÀÇ ±âÁØ¿¡ °ü
ÇÑ ±ÔÄ¢¿¡ µû¶ó Á¤ÇÑ ±Ş¿© ¹× ºñ±Ş¿© ÀÇ·áºñ Ç×¸ñ¸¸ ÇØ´ç) Áß º»ÀÎÀÌ ½Ç
Á¦·Î ºÎ´ãÇÑ ±İ¾×¿¡¼­ 10¸¸¿ø°ú º¸»ó´ë»óÀÇ·áºñÀÇ 30% Áß Å« ±İ¾×À»
»« ±İ¾×ÀÇ 40%¸¦ ÇÏ³ªÀÇ Áúº´´ç º¸Çè°¡ÀÔ±İ¾×ÀÇ ÇÑµµ ³» º¸»ó)
-
1³â³³ 1³â¸¸±â
°»½ÅÁ¾·á : 100¼¼
5,000
Ãß°¡³³ÀÔÇü
2024/10/08 ~ 2025/10/08
°»½ÅÁÖ±â : 1³â
º¸Àåº¯°æÁÖ±â: 03³â
1³â³³ 1³â¸¸±â
°»½ÅÁ¾·á : 100¼¼
20
Ãß°¡³³ÀÔÇü
2024/10/08 ~ 2025/10/08
°»½ÅÁÖ±â : 1³â
5,000
º¸Àåº¯°æÁÖ±â: 03³â
1³â³³ 1³â¸¸±â
°»½ÅÁ¾·á : 100¼¼
Ãß°¡³³ÀÔÇü
2024/10/08 ~ 2025/10/08
°»½ÅÁÖ±â : 1³â
º¸Àåº¯°æÁÖ±â : 03³â
¹ß±ŞÀÚ:¹é¼±°æ(HM145151) ¹ßÇàÀÏ½Ã: 2025-03-24 13:27:52
1/2

(¹«) °£Æí°¡ÀÔÇì¾Æ¸²½Ç¼ÕÀÇ·áºñº¸Çè2404
°è¾àÀÚ ÀÌÁ¶ÈÆ
¡¼º¸Àå³»¿ª¡½ ¼±ÅÃ°è¾à
º¸Àå¸í
º¸Àå»ó¼¼
(±âº»°è¾à)°»½ÅÇü ½Ç¼ÕÁúº´Åë¿øÀÇ
·áºñ(°£Æí°¡ÀÔ)
Áúº´À¸·Î Åë¿øÄ¡·á½Ã ¿Ü·¡Á¦ºñ¿ë, ¿Ü·¡¼ö¼úºñ º¸»ó(´Ü, Ã³¹æÁ¶Á¦ Á¦¿Ü)
?¹æ¹® 1È¸´ç ±¹¹Î°Ç°­º¸Çè¹ı¿¡¼­ Á¤ÇÑ ¿ä¾ç±Ş¿© ¶Ç´Â ÀÇ·á±Ş¿©¹ı¿¡¼­
Á¤ÇÑ ÀÇ·á±Ş¿© Áß º»ÀÎºÎ´ã±İ°ú ºñ±Ş¿©¸¦ ÇÕÇÑ ±İ¾×ÀÎ º¸»ó´ë»óÀÇ·áºñ(
º»ÀÎÀÌ ½ÇÁ¦·Î ºÎ´ãÇÑ ±İ¾×À» ¸»ÇÕ´Ï´Ù.)¿¡¼­ 2¸¸¿ø°ú º¸»ó´ë»óÀÇ·áºñ
30% Áß Å« ±İ¾×À» »« ±İ¾×À» ¿Ü·¡ÀÇ º¸Çè°¡ÀÔ±İ¾×(È¸´ç 20¸¸¿ø)ÀÇ ÇÑ
µµ ³»¿¡¼­ º¸»ó(¸Å³â °è¾àÇØ´çÀÏºÎÅÍ 1³â°£ 180È¸ ÇÑµµ·Î ÇÕ´Ï´Ù.)(´Ü,
ÇÇº¸ÇèÀÚ°¡ ±¹¹Î°Ç°­º¸Çè¹ı ¶Ç´Â ÀÇ·á±Ş¿©¹ıÀ» Àû¿ë¹ŞÁö ¸øÇÏ´Â °æ¿ì
¿¡´Â Åë¿øÀÇ·áºñ(±¹¹Î°Ç°­º¸Çè ¿ä¾ç±Ş¿©ÀÇ ±âÁØ¿¡ °üÇÑ ±ÔÄ¢¿¡ µû¶ó Á¤
ÇÑ ±Ş¿© ¹× ºñ±Ş¿© ÀÇ·áºñ Ç×¸ñ¸¸ ÇØ´ç)Áß º»ÀÎÀÌ ½ÇÁ¦·Î ºÎ´ãÇÑ ±İ¾×¿¡
¼­ 2¸¸¿ø°ú º¸»ó´ë»óÀÇ·áºñ 30%Áß Å« ±İ¾×À» »« ±İ¾×ÀÇ 40%¸¦ º¸Çè
°¡ÀÔ±İ¾× ÇÑµµ ³»¿¡¼­ º¸»ó)
[Á¦µµ¼º Æ¯¾à ¹× ±âÅ¸»çÇ×¡½
º¸Çè·áÀÚµ¿³³ÀÔ
ÀÚµ¿°»½ÅÀû¿ë´ë»ó
Á¦µµ¼º Æ¯¾à ¹× ±âÅ¸»çÇ×
Áõ±Ç¹øÈ£
319-1472-7663-13
°¡ÀÔ±İ¾×
³³ÀÔ ¹× ¸¸±â
(¸¸¿ø)
1³â³³ 1³â¸¸±â
°»½ÅÁ¾·á : 100¼¼
Ãß°¡³³ÀÔÇü
20
2024/10/08 ~ 2025/10/08
°»½ÅÁÖ±â : 1³â
º¸Àåº¯°æÁÖ±â: 03³â
¡¼À¯ÀÇ»çÇ×¡½
¡Ø ÀÌ º¸ÇèÁõ±ÇÀº °è¾àÃ¼°áÀÇ Áõ°Å·Î¼­ ¹ßÇàµÇ´Â °ÍÀÌ¸ç, º¸Çè±İÀ» Áö±ŞÇÏÁö ¾Æ´ÏÇÏ´Â »çÀ¯ µî °è¾à³»¿ë ¹× ´ãº¸º° »ó¼¼³»¿ëÀº º¸Çè°è¾àÃ»¾à¼­ ¹×
º¸Çè¾à°ü¿¡ µû¸¨´Ï´Ù.
¡Ø È¸»çÀÇ º¸Àå°³½Ã´Â È¸»ç°¡ °è¾àÀÇ Ã»¾àÀ» ½Â³«ÇÏ°í Á¦1È¸ º¸Çè·á¸¦ ¹ŞÀº¶§ºÎÅÍ ½ÃÀÛµË´Ï´Ù. ±âÅ¸ ÀÚ¼¼ÇÑ ³»¿ëÀº ¾à°üÀÇ ¡¸Á¦1È¸º¸Çè·á ¹× È¸»ç
ÀÇ º¸Àå°³½Ã¡¹¸¦ ÂüÁ¶ÇÏ½Ã±â ¹Ù¶ø´Ï´Ù.
¡Ø °í°´´ÔÀÇ ¿øÈ°ÇÑ °è¾à°ü¸®¿Í º¸»óÀ» À§ÇÏ¿© ÁÖ¼Ò ¶Ç´Â ¿¬¶ôÃ³ º¯µ¿½Ã ¹İµå½Ã È¸»ç·Î Åëº¸ÇÏ¿© ÁÖ½Ã±â ¹Ù¶ø´Ï´Ù.
¡Ø Æ¯¾àº° ¸¸±â°¡ ±âº»°è¾àÀÇ ¸¸±â ÀÌÀü¿¡ Á¾·áµÉ ¼ö ÀÖÀ¸¹Ç·Î ¹İµå½Ã Æ¯¾àº° ¸¸±â¸¦ È®ÀÎÇÏ½Ã±â ¹Ù¶ø´Ï´Ù.
¡Ø ´ãº¸Á¾¸ñº° ÀÚ¼¼ÇÑ º¸»ó³»¿ëÀº ¾à°üÀ» ÂüÁ¶ÇÏ½Ã±â ¹Ù¶ø´Ï´Ù.
¡Ø Ã»¾à¼­ ÁÖ¿ä³»¿ë ÀÛ¼º½Ã »ç½Ç ±×´ë·Î¸¦ ¾Ë¸®Áö ¾Ê¾Ò°Å³ª, ÀÚÇÊ¼­¸íÀ» º»ÀÎÀÌ Á÷Á¢¼­¸í(³¯ÀÎ)ÇÏÁö ¾ÊÀº°æ¿ì´Â º¸»óµÇÁö ¾ÊÀ» ¼ö ÀÖ½À´Ï´Ù.
¡Ø »óÇØ´ãº¸°¡ÀÔ½Ã, º¸Çè±â°£ Áß¿¡ ÇÇº¸ÇèÀÚ°¡ Á÷¾÷ÀÌ³ª Á÷¹«¸¦ º¯°æÇÏ°Å³ª ÀÌ·ûÀÚµ¿Â÷¸¦ °è¼ÓÀûÀ¸·Î »ç¿ëÇÏ°Ô µÈ °æ¿ì¿¡´Â ÁöÃ¼¾øÀÌ È¸»ç¿¡ ¾Ë·Á
¾ß ÇÏ¸ç ±×·¸Áö ¾ÊÀº °æ¿ì º¸Çè±İ Áö±ŞÀÌ °ÅÀıµÇ°Å³ª °¨¾×µÉ ¼ö ÀÖ½À´Ï´Ù.
|¡Ø [°»½ÅÇü ´ãº¸ °»½Å¿¡ °üÇÑ »çÇ×]
¡Ø °»½Å½ÃÁ¡ÀÇ º¸Çè·á´Â ÃÖÃÊ(°»½ÅÀü) °è¾àº¸´Ù ¿¬·ÉÁõ°¡, º¸Çè·á »êÃâ¿¡ °üÇÑ º¸Çè·áÀ²ÀÇ º¯µ¿¿¡ ÀÇÇØ °»½Å½ÃÁ¡ ¿¬·É¿¡ ÇØ´çµÇ´Â º¸Çè·á¸¦ ³³ÀÔ
ÇÏ¹Ç·Î °»½Å½ÃÁ¡ÀÇ º¸Çè·á´Â ÃÖÃÊ(°»½ÅÀü)°è¾àº¸´Ù Áõ°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¡ØÀÚµ¿°»½ÅÆ¯¾àÀº ±âº»°è¾àÀÇ ³³ÀÔ±â°£°ú °ü°è¾øÀÌ º¸Çè·á ³³ÀÔ±â°£ÀÌ Á¾·áµÈ ÀÌÈÄ¿¡µµ ÇØ´ç Æ¯¾àÀÇ º¸Çè·á¸¦ °»½ÅÁ¾·á¿¬·É±îÁö °è¼Ó ³³ÀÔÇÏ¼Å
¾ß ÇÕ´Ï´Ù.
°»½Åº¸Çè·á´Â Àû¸³º¸Çè·á ¶Ç´Â Àû¸³ºÎºĞ °è¾àÀÚÀû¸³¾×¿¡¼­ ´ëÃ¼µÇÁö ¾ÊÀ¸¸ç, °»½Åº¸Çè·á¸¦ ¹İµå½Ã ³³ÀÔÇÏ¼Å¾ß °è¾àÀÌ Á¤»ó À¯ÁöµË´Ï´Ù. ¸¸¾à,
°»½Åº¸Çè·á¸¦ ³³ÀÔÇÏÁö ¾ÊÀ¸¸é ÇØ´ç °»½Åº¸ÀåÆ¯¾àÀº ÇØÁöµÈ °ÍÀ¸·Î º¾´Ï´Ù.
¡Ø [°»½ÅÇü ´ãº¸ ÀÚµ¿°»½Å¿¡ °üÇÑ »çÇ×]
¡ØÀÚµ¿°»½Å Àû¿ë´ë»ó °è¾àÀÌ º¸Çè±â°£ Á¾·áÀÏÀÇ ÀüÀÏ±îÁö º°µµÀÇ ÀÇ»çÇ¥½Ã°¡ ¾øÀ» ¶§¿¡´Â Á¾ÀüÀÇ ÀÚµ¿°»½Å Àû¿ë´ë»ó °è¾àÀÌ ¸¸±âµÇ´Â ³¯ÀÇ ´ÙÀ½
³¯¿¡ µ¿ÀÏÇÑ º¸Àå³»¿ëÀ¸·Î °»½ÅµÇ´Â °ÍÀ¸·Î ÇÕ´Ï´Ù.
1. °»½ÅµÈ ÀÚµ¿°»½Å Àû¿ë´ë»ó °è¾à ¸¸±âÀÏÀÌ È¸»ç°¡ Á¤ÇÑ ±â°£ ³»ÀÏ °Í
2. °»½ÅÀÏ¿¡ ÀÖ¾î¼­ ÇÇº¸ÇèÀÚÀÇ ³ªÀÌ°¡ È¸»ç°¡ Á¤ÇÑ ³ªÀÌÀÇ ¹üÀ§ ³»ÀÏ °Í
3. °»½Å Àü º¸Àå°è¾àÀÇ º¸Çè·á°¡ Á¤»óÀûÀ¸·Î ³³ÀÔ¿Ï·á µÇ¾úÀ» °Í
¡Ø°»½ÅÇü ´ãº¸ÀÇ º¸Çè±â°£Àº °»½ÅÇü ´ãº¸ º¸Àå±â°£À¸·Î ÇÕ´Ï´Ù. ´Ù¸¸, °»½Å½ÃÁ¡ÀÇ ÇÇº¸ÇèÀÚÀÇ º¸Çè³ªÀÌ·ÎºÎÅÍ °»½ÅÁ¾·áº¸Çè³ªÀÌ(ÃÖÃÊ °è¾àÀ» Ã¼
°áÇÒ ¶§ ¾àÁ¤ÇÑ °»½ÅÁ¾·áº¸Çè³ªÀÌ¸¦ ¸»ÇÕ´Ï´Ù)±îÁöÀÇ ±â°£ÀÌ °»½ÅÇü ´ãº¸ º¸Àå±â°£ ¹Ì¸¸ÀÏ °æ¿ì¿¡´Â ±× ÀÜ¿©±â°£À» º¸Çè±â°£À¸·Î ÇÕ´Ï´Ù.
¡Ø [½Ç¼ÕÀÇ·áºñ ÀÚµ¿°»½Å¿¡ °üÇÑ »çÇ×]
¡Ø °è¾àÀÚÀÇ º°µµ ÀÇ»çÇ¥½Ã°¡ ¾ø´Â ÇÑ ½Ç¼ÕÀÇ·áºñ´Â 1³â¸¶´Ù ÀÚµ¿°»½ÅÇÕ´Ï´Ù.(´Ü, ÀÚµ¿°»½Å±â°£Àº º¸Àå³»¿ëº¯°æÁÖ±â ÃÖ´ë 3³â ÀÌ³»·Î ÇÔ)
¡Ø º¸Àå³»¿ëº¯°æÁÖ±â(ÀÚµ¿°»½Å±â°£)¶õ º¸Çè°¡ÀÔ ÈÄ º¸Àå³»¿ëÀÇ º¯°æ¾øÀÌ ÀÚµ¿À¸·Î °»½ÅµÇ´Â ÃÖ´ë±â°£À» ÀÇ¹ÌÇÏ¸ç º¸Àå³»¿ë º¯°æÁÖ±â(ÀÚµ¿°»½Å±â°£
) Á¾·á ÀÌÈÄ¿¡´Â È¸»ç°¡ Á¤ÇÑ Àç°¡ÀÔÀıÂ÷¿¡ µû¶ó º¸Çè¿¡ °¡ÀÔÇÏ¿©¾ß ÇÕ´Ï´Ù.(´Ü, °è¾àÀÇ º¸Çè±â°£ÀÌ º¸Àå³»¿ëº¯°æÁÖ±âº¸´Ù ÀÛÀº °æ¿ì °è¾àÀÇ ¸¸
±â±îÁö¸¸ °»½ÅµÊ)
¡Ø ÇâÈÄ ÇØÁö(¸¸±â)È¯±Ş·üÀº ½Ç¼ÕÀÇ·áºñ °»½ÅÆ¯¾à º¸Çè·á¿¡ µû¶ó ´Ş¶óÁú ¼ö ÀÖ½À´Ï´Ù.
¹ß±ŞÀÚ:¹é¼±°æ(HM145151) ¹ßÇàÀÏ½Ã: 2025-03-24 13:27:52
2/2

»ç°íÁ¢¼ö ÇÇÇØÀÚ¹°/´ãº¸
| ¼ÒÀçÁö°è¾à¸ñ·Ï
No
1
±â»ç°í(ÇÇº¸ÇèÀÚ) ICIS
Áõ±Ç¹øÈ£
¼ÒÀçÁö
»óÇ°¸í
°è¾àÀÚ¸í
319-1472-7663-13
0
(¹«) °£Æí°¡ÀÔÇì¾Æ¸²½Ç¼ÕÀÇ·áºñº¸Çè 2404
ÀÌÁ¶ÈÆ
°è¾à½Ã±â
2024-10-08
°è¾àÁ¾±â
2054-10-08
°è¾à»óÅÂ
Á¤»ó
°è¾àº¯°æÀÏ
2024-10-08
ÇÇº¸ÇèÀÚ¸í
ÀÌ±¤¿í
ÇÇº¸ÇèÀÚ°ü°è
º»ÀÎ
ÇÇÇØÀÚ(¼ÒÀ¯ÀÚ)ÀÔ·Â
*¸ñÀû±¸ºĞ ÀÎ
ÃßÁ¤¼ÕÇØ¾×
ÇÇÇØÀÚ(¼ÒÀ¯ÀÚ)¸ñ·Ï
*Ã»±¸ÀÚ 'ÇÇº¸ÇèÀÚº»ÀÎ
°³ÀÎ
550112-1257810
ÀÌ±¤¿í
1
ÇÇÇØ¹°¸í(»ó¼¼)
*¿¬¶ôÃ³ 010
¼ø¹ø
1
Áõ±Ç¹øÈ£
319-1472-7663-13
ÇÇÇØÀÚº¯°æ
´ë ½Å¿ëÁ¤º¸
3766
2316
´ë ½Ç¼Õ»ó¼¼
¼ÒÀçÁö
°è¾àÀÚ¸í
¼ÕÇØ¸ñÀû
0
ÀÌÁ¶ÈÆ
ÀÎ
Ã»±¸ÀÚ/ÇÇÇØÀÚ
ÇÇº¸ÇèÀÚº»ÀÎ
½Ç¸í¹øÈ£
ÇÇÇØ/¼ÒÀ¯ÀÚ¸í
¼­¿­
Ãß°¡
ÇÇÇØ¹°¸í
º¯°æ
»èÁ¦
Á÷Àü¼­¿­ÀÚµ¿ÀÔ·Â
ÃßÁ¤¼ÕÇØ¾×
550112-1257810
ÀÌ±¤¿í
1
1
|º¸»ó´ãº¸¸ñ·Ï
¡à °è¾à´ãº¸Á¶È¸
No
Áõ±Ç¹øÈ£
¼ÒÀçÁö
¼ÕÇØ¸ñÀû
¼­¿­ ÅëÈ­ ÇÇÇØ¼­¿­ °è¾à¸ñÀû¹°¸í
°¡ÀÔ±İ¾× Æ¯¾à´ãº¸¸í Á¦¿Ü
º¸»ó´ãº¸¸í
°è¾à¸ñÀû¹°ÀÏ·Ã¹øÈ£
ÀÌÇ¥¹øÈ£
Æ¯¾à´ãº¸ÄÚµå
À§ÇèÄÚµå
1
319-1472-7663-13
0
ÀÎ
1
KRW
1 ÀÌ±¤¿í
200,000(±âº»°è¾à)
2
?
319-1472-7663-13 0
ÀÎ
1
KRW
1
ÀÌ±¤¿í
°£Æí°¡ÀÔÁúº´Åë¿ø (¿Ü·¡)ÀÇ·áºñ(ºñ±Ş¿©)
200,000 (±âº»°è¾à) ¡à °£Æí°¡ÀÔ Áúº´Åë¿ø (¿Ü·¡)ÀÇ·áºñ(±Ş¿©)
2
1421729
1217059
2
1421729
1217057
¡æ ÀÌ¹ÌÁö 7
¡Ú¸Ş¸ğ ¡æÀÌ¹ÌÁöÁ¢¼ö ¡æ Á¶»ç °í°´ µ¿ÀÇ
¾ß°£Á¶»çÀÇ·Ú ¼­·ùÁ¢¼öÆÑ½º ¿µ¼öÁõ
FAST
SMSÀü¼Û
ºÎ´ãº¸
°è¾àº¯°æ
ºÎÈ°À¯¹«
ÈŞ¸é¹ÌÁö±Ş
À¯ÀÇ°è¾àÀÚ¡æ³ìÃë¡æ °Çº° SMS¹ß¼Û Å¸»ç°£»ç
ºĞ¸®»ç°íÁ¢¼ö
4¼¼´ë½Ç¼ÕÇÒÁõºñ±Ş¿©
»èÁ¦
ÀúÀå

NH³óÇù¼ÕÇØº¸Çè
(¹«) °£Æí°¡ÀÔÇì¾Æ¸²½Ç¼ÕÀÇ·áºñº¸Çè2404
Çì¾Æ¸²
Ã»¾à¼­ (È¸»çº¸°ü¿ë)
°è¾àÀÚ
°¡ÀÔÀ¯Çü
ÁÖ¼Ò
ÀÌÁ¶ÈÆ
Ã»¾àÀÏÀÚ
ÀÚÀ¯¼³°è
2024-10-08
ÁÖ¹Î/»ç¾÷ÀÚ¹øÈ£ 850224-1******
Ã»¾à¹øÈ£
Áõ±Ç¹øÈ£
241008-1-066502
319-1472-7663-13
³³ÀÔ ¹× º¸Çè±â°£
³³ÀÔÁÖ±â
10869 °æ±âµµ ÆÄÁÖ½Ã °¡¶÷·Î ***
1³â³³ 1³â¸¸±â °»½ÅÁ¾·á³ªÀÌ 100¼¼
¿ù³³
Àû¸³º¸Çè·á
***µ¿ ****È£ (¿Íµ¿µ¿, º°ÇÏ¶÷¸¶À» * ´ÜÁö ¼­Èñ½ºÅ¸Èú½ºNHF)
³³ÀÔº¸Çè·á
57,521
º¸Àåº¸Çè·á
0¿ø
½Ç³³ÀÔº¸Çè·á
57,521
57,521
¸¸±â¼öÀÍÀÚ
ÁöÁ¤´ë¸®ÀÎ
°í°´°Å·¡(½ÇÁ¦¼ÒÀ¯ÀÚ)È®ÀÎ¼­(°³ÀÎ)
ÀÌ È®ÀÎ¼­´Â Æ¯Á¤ ±İÀ¶°Å·¡ÀÇ º¸°í ¹× ÀÌ¿ë µî¿¡ °üÇÑ ¹ı·ü¿¡ µû¶ó °í°´ÀÌ ½Å±Ô°è¾àÃ¼°á ¶Ç´Â..CCC ´Ü¿ø(¹ÌÈ­ 1¸¸ºÒ) ÀÌ»óÀÇ ÀÏÈ¸¼º °Å·¡ ½Ã ¾Æ·¡ÀÇ ³»¿ëÀ» ±âÀçÇÏ¼Å¾ß ÇÏ¸ç
Á¦°øÇÏ½Å Á¤º¸´Â µ¿¹ı¿¡ ÀÇ°Å ¿ëµµÀÌ¿ÜÀÇ ¸ñÀûÀ¸·Î »ç¿ëµÇÁö ¾Ê½À´Ï´Ù. ±İÀ¶±â°üÀº Á¤º¸È®ÀÎ ¹× °ËÁõÀ» À§ÇØ ¹®¼­ ¹× ÀÚ·á Á¦ÃâÀ» ¿äÃ»ÇÒ ¼ö ÀÖÀ¸¸ç,
¢º °è¾àÀÚ»çÇ× (°è¾àÀÚ°¡ ¹Ì¼º³âÀÚÀÎ °æ¿ì ´ë¸®ÀÎ(Ä£±ÇÀÚ µî)¿¡ ´ëÇÑ ½Ç¸íÈ®ÀÎÀ» ¼öÇàÇØ ÁÖ½Ê½Ã¿À.)
°è¾àÀÚ¸í ÀÌÁ¶ÈÆ
±¹Àû ´ëÇÑ¹Î±¹
Á÷¾÷/¾÷Á¾
ÁÖ¹Î¹øÈ£ 850224-1******
½Ç¸íÈ®ÀÎ
(ÅÃÀÏ)
½ÅºĞÁõ»çº» Â¡±¸¿©ºÎ [¿©/ V
¡æ ÁÖ¹Îµî·ÏÁõ(www.minwon.go.kr} ¿îÀü¸éÇãÁõ(www.safedriving.or.kr)
¤§. ¿Ü±¹ÀÎµî·ÏÁõ(www.hikorea.go.kr) ¿©±Ç [±âÅ¸
¹ß±Ş±â°ü/¸éÇã¹øÈ£/ ¹ßÇà±¹°¡ °æ±âµµ°í¾ç½ÃÀå
¹ß±ŞÀÏ
20031208
À½·á¼­ºñ½º Á¾»ç¿ø
½ÇÁ¦¼ÒÀ¯ÀÚ(´ëÃâ±İ È¯±Ş±İ µî ¼öÀÔ±İ¾×°úº¸Çè·á ³³ÀÔ, À¶ÀÚ»óÈ¯ µîÀÇ Áö±Ş±İ¾×ÀÇ ÃÖÁ¾ ´ç»çÀÚ°¡ µÇ´Â ÀÚ·Î¼­, °è¾àÀÚ¿Í º°°³·Î Á¸ÀçÇÒ¼öÀÖ´Â °è¾àÀÇ ÃÖÁ¾Áö¹èÀÚ ¹× ÅëÁ¦ÀÚ¸¦ ÀÇ¹Ì)
ÇØ´ç °Å·¡ÀÇ ½ÇÁ¦¼ÒÀ¯ÀÚ ¿©ºÎ V. ¿© / [ ºÎ (ºÎ Ã¼Å©½Ã ½ÇÁ¦¼ÒÀ¯ÀÚ Á¤º¸ ±âÀÔ)
½ÇÁ¦¼ÒÀ¯ÀÚ
Á¤º¸
¼º¸í
ÁÖ¹Î¹øÈ£
±¹Àû(¿Ü±¹ÀÎ)
) ´ë¸®ÀÎ»çÇ× (¹ıÁ¤, ÀÓÀÇ)´ë¸®ÀÎÀÌ Á¸ÀçÇÒ °æ¿ì, ´ë¸®ÀÎÀÇ ½Ç¸íÈ®ÀÎÀÌ ÇÊ¿äÇÕ´Ï´Ù.
ÇØ´ç °Å·¡ÀÇ º»ÀÎ ¿©ºÎ ¡î ¿©/ [ºÎ(ºÎ Ã¼Å©½Ã ´ë¸®ÀÎ Á¤º¸ ±âÀÔ)
¼º¸í
´ë¸®ÀÎ
ÁÖ¼Ò
Á¤º¸
±¹Àû
Á÷¾÷/¾÷Á¾
ÁÖ¹Î¹øÈ£
°í°´°úÀÇ °ü°è
½ÅºĞÁõ»çº» Â¡±¸¿©ºÎ
¿¬¶ôÃ³
[ ¿©/
ºÎ
½Ç¸íÈ®ÀÎ
(ÅÃÀÏ)
¿ù
ÁÖ¹Îµî·ÏÁõ(www.minwon.go.kr)
¤§ ¿Ü±¹ÀÎµî·ÏÁõ(www.hikorea.go.kr)
¹ß±Ş±â°ü/¸éÇã¹øÈ£/ ¹ßÇà±¹°¡
³â
¿îÀü¸éÇãÁõ(www.safedriving.or.kr)
¡¸¿©±Ç [ ±âÅ¸[
]
¹ß±ŞÀÏ
ÀÏ
¸ğÁıÀÎ(¸é´ãÀÚ):
±è¼±Çü
Ãâ±İ±İÀ¶±â°ü¸í
±¹¹ÎÄ«µå
Ãâ±İ°èÁÂ(Ä«µå)¹øÈ£
5549590157259091
¿¹±İ(Ä«µå)ÁÖ
ÀÌÁ¶ÈÆ
V
Ãâ±İ±İÀ¶±â°ü¸í
Ãâ±İ°èÁÂ(Ä«µå)¹øÈ£
ÀÌÃ¼ÀÏÀÚ
¿¹±İ(Ä«µå)ÁÖ
ÁÖ¹Î¹øÈ£
?
°è¾àÀÚ
°è¾à³»¿ë ¹× ¾à°üÀÇ ÁÖ¿ä³»¿ë(º¸Çè±İ Áö±Ş»çÀ¯. º¸Çè±İÀ» Áö±ŞÇÏÁö ¾ÊÀº »çÀ¯)À» ¼³¸í µé¾ú½À´Ï±î?
º¸Çè¾à°ü, °è¾àÀÚ º¸°ü¿ë Ã»¾à¼­ ¹× ¼³¸í¼­¸¦ Àü´Ş¹Ş¾Ò½À´Ï±î?
¿¹
¾Æ´Ï¿À
¿¹
¾Æ´Ï¿À
È®ÀÎ»çÇ×
º¸Çè»ç±â(°íÀÇ»ç°í ÇãÀ§»ç°í, ÇãÀ§ÀÔ¿ø. Áø´Ü. ÀåÇØ, »ç°í ÈÄ º¸Çè°¡ÀÔ µî)´Â Çü¹ı»ó ±İÁöµÈ ¹üÁËÀÔ´Ï´Ù.
±¸ºĞ!
°è¾àÀÚ
ÀÚ
i
ÇÊ¼­¸í
ÇÊ: ¼º¸í
ÀÌÁ¶ÈÆ
ÁÖÇÇº¸ÇèÀÚ Á¾ÇÇº¸ÇèÀÚ 1 Á¾ÇÇº¸ÇèÀÚ2 Á¾ÇÇº¸ÇèÀÚ3 Á¾ÇÇº¸ÇèÀÚ4 Á¾ÇÇº¸ÇèÀÚ5
ÀÌ±¤¿í
¹ıÁ¤´ë¸®ÀÎ(Ä£±ÇÀÚ)
°ü
¼­¸í ÀÌÁ¶ÈÆ
ÀÌ±¤¿í
* °¡ÀÔÀÚº¸°ü¿ë Ã»¾à¼­»ó¿¡ ÀÚÇÊ¼­¸íÇÏ¼Ì½À´Ï±î?
¿¹
= ¾Æ´Ï¿À
* º¸Çè°è¾àÀÚ ¶Ç´Â ÇÇº¸ÇèÀÚ°¡ ¹Ì¼º³âÀÚÀÎ °æ¿ì ¹ıÁ¤´ë¸®ÀÎÀÌ ¼­¸íÇÏ¿© ÁÖ½Ã±â ¹Ù¶ø´Ï´Ù.
*ÇÇº¸ÇèÀÚ(º¸Çè´ë»óÀÚ º»ÀÎÀÌ ÀÚÇÊ¼­¸íÀ» ÇÏÁö ¾ÊÀ¸½Å °æ¿ì¿¡´Â º¸Çè°è¾àÀÌ ¹«È¿°¡ µÇ¾î º¸ÀåÀ» ¹ŞÁö ¸øÇÒ ¼öµµ ÀÖ½À´Ï´Ù
*°è¾àÀÇ º¸Àå°³½Ã È¿·ÂÀº 1È¸ º¸Çè·á¸¦ ³³ÀÔÇÏ½Å ¶§ºÎÅÍÀÔ´Ï´Ù. µŞ¸éÀÇ ²À ¾Æ¼Å¾ß ÇÒ »çÇ×À» ¹İµå½Ã È®ÀÎÇÏ½Ã±â ¹Ù¶ø´Ï´Ù.
¡Ø¾È³»Àå ¹ß¼Û(7 µ¿ÀÇ µ¿ÀÇ¾ÈÇÔ * ¾È³»Àå ¹ß¼ÛÇüÅÂ(¤§ ¸ğ¹ÙÀÏ ¾È³»Àå
E-Mail/E-MaÁÖ¼Ò
¡Ø¾à°üÀ» ¸ğ¹ÙÀÏ(¹®ÀÚ)¸¦ ÅëÇØ ¼ö·ÃÇÏ´Â °Í¿¡ ´ëÇÑ µ¿ÀÇ¿©ºÎ{V µ¿ÀÇ
[µ¿ÀÇ¾ÈÇÔ)
¡Øº»ÀÎ¼öÀÇÀÚ ÁöÁ¤ º¯°æ °ü·Ã Ãß°¡¾àÁ¤( 5 ¾àÁ¤ÇÔ
ÀÌÁ¶ÈÆ
(¼­¸í)
¾àÁ¤ÇÏÁö ¾Æ´ÏÇÔ
(¾àÁ¤ÇÔÀ» ¼±ÅÃÇÑ °æ¿ì) º»ÀÎ(º¸Çè°è¾àÀÚ)ÀÌ »ç¸ÁÇÑ °æ¿ì¿¡´Â »ó¼ÓÀÎ µî ½Â°èÀÎÀÌ º¸Çè¼öÀÍÀÚ ÁöÁ¤¡¤º¯°æ±ÇÀ» Çà»çÇÕ´Ï´Ù
ºÎ)
¡Ø(´ë»ó: ÇÇº¸ÇèÀÚ) ÀÇ·á±Ş¿© ¼ö±Ş±ÇÀÚ º¸Çè·á ÇÒÀÎ ½ÅÃ» (
= ¿©
-ÀÚ°İÃëµæÀÏ·ÎºÎÅÍ ½Ç¼ÕÀÇ·áºñ º¸Àå º¸Çè°è¾àÀÇ ¸ÅÈ¸ ³³ÀÔÇÒ º¸ÀåÁ¾¸ñº° º¸Àåº¸Çè·áÀÇ 5%¸¦ ÇÒÀÎÇÏ¿© µå¸³´Ï´Ù.
¡ØÃ»¾àÀ¯È¿ÀÏÀÚ: 2024 10-31 ±îÁö
LW00241008106650201
(Ãâ·Â¹° ¹öÀü:01)
¡Ù ¿ìÆí:
º»ÀÎÀº ´Ù¸¥ ¹ıÁ¤´ë¸®ÀÎ(Ä£±ÇÀÚ) 1ÀÎ
°ú ÇÕÀÇÇÏ¿¡ °øµ¿À¸·Î Ä£±ÇÀ» Çà»çÇÕ
´Ï´Ù.
°áÀç
¼­¸í
ÆÀ¿ø
Ã¥ÀÓÀÚ
¸ğÁıÁ¡
±İÃÌ³óÇù
¸ğÁıÀÚ
±è¼±Çü
¿¬¶ôÃ³
(20120384110104)
031-941 3661
¼³°è¹øÈ£ 241008-1-063096
¼³°èÀÏÀÚ 2024-10.08
¹ßÇàÀÏ½Ã 2024 10 08 16:20:03
1/7

NH³óÇù¼ÕÇØº¸Çè
(¹«) °£Æí°¡ÀÔÇì¾Æ¸²½Ç¼ÕÀÇ·áºñº¸Çè2404
Çì¾Æ¸² |
Ã»¾à¼­ (È¸»çº¸°ü¿ë)
°è¾àÀÚ
ÀÌÁ¶ÈÆ
Ã»¾àÀÏÀÚ
2024-10-08
Ã»¾à¹øÈ£
241008-1-066502
ÇÇº¸ÇèÀÚ ÀÌ±¤¿í(70¼¼) »ó·ÉÀÏ 2025-07-12 ÁÖ¹Îµî·Ï¹øÈ£ 550112-1 ******
ÁÖ¼Ò 10446 °æ±âµµ °í¾ç½Ã ÀÏ»êµ¿±¸ ¹é¼®·Î**¹ø±æ **-** (¹é¼®µ¿)
ÀÇ·á±Ş¿©¼ö±Ş±ÇÀÚ ºÎ
Á÷¾÷ ÀÛ¹°Àç¹è¿ø(°î½Ä, Ã¤¼Ò, °ú¼ö, ¿ø¿¹)
¿îÀüÇüÅÂ
±Ş¼ö
ÀÌÁ¶ÈÆ(850224-1******)/ÀÚ³à
»ç¸Á¼öÀÍÀÚ
»ıÁ¸/ÀÔ¿ø¼öÀÍÀÚ 10869 °æ±âµµ ÆÄÁÖ½Ã °¡¶÷·Î 109***µ¿ ****È£ (¿Íµ¿µ¿,
º°ÇÏ¶÷¸¶À» * ´ÜÁö ¼­Èñ½ºÅ¸Èú½º NHF)
º¸Àå³»¿ª(¼±ÅÃ°è¾à)
º¸Àå¸í
º¸Àå»ó¼¼
°¡ÀÔ±İ¾×(¸¸¿ø)
º¸Àåº¸Çè·á(¿ø)
³³ÀÔ±â°£ ¹× ¸¸±â
(±âº»°è¾à)°»½ÅÇü ½Ç¼Õ»ó
ÇØÀÔ¿øÀÇ·áºñ(°£Æí°¡ÀÔ)
»óÇØ·Î ÀÔ¿øÄ¡·á½Ã ÀÔ¿ø½Ç·á, ÀÔ¿øÁ¦ºñ¿ë, ÀÔ¿ø¼ö¼úºñ º¸»ó
±¹¹Î°Ç°­º¸Çè¹ı¿¡¼­ Á¤ÇÑ ¿ä¾ç±Ş¿© ¶Ç´Â ÀÇ·á±Ş¿©¹ı¿¡¼­ Á¤
ÇÑ ÀÇ·á±Ş¿© Áß º»ÀÎºÎ´ã±İ°ú ºñ±Ş¿©(»ó±Şº´½Ç·á Â÷¾× Á¦¿Ü)
¸¦ ÇÕÇÑ ±İ¾×ÀÎ º¸»ó´ë»óÀÇ·áºñ(º»ÀÎÀÌ ½ÇÁ¦·Î ºÎ´ãÇÑ ±İ¾×À»
¸»ÇÕ´Ï´Ù.)¿¡¼­ 10¸¸¿ø°ú º¸»ó´ë»óÀÇ·áºñÀÇ 30% Áß Å« ±İ¾×
À» »« ±İ¾×À» º¸»ó(´Ü, 10¸¸¿ø°ú º¸»ó´ë»óÀÇ·áºñÀÇ 30% Áß
Å« ±İ¾×ÀÌ °è¾àÀÏ ¶Ç´Â ¸Å³â °è¾àÇØ´çÀÏºÎÅÍ ±â»êÇÏ¿© ¿¬°£
200¸¸¿øÀ» ÃÊ°úÇÏ´Â °æ¿ì ±× ÃÊ°ú±İ¾×Àº º¸»óÇÕ´Ï´Ù.), »ó±Ş
º´½Ç·á Â÷¾× - ÀÔ¿ø ½Ã ½ÇÁ¦·Î »ç¿ëÇÑ º´½Ç°ú ±âÁØº´½Ç°úÀÇ º´
½Ç·á Â÷¾× Áß 50% µÑ »« ±İ¾× (´Ü, 1ÀÏ Æò±Õ±İ¾× 10¸¸¿øÀ» ÇÑ
µµ·Î ÇÏ¸ç, 1ÀÏ Æò±Õ±İ¾×Àº ÀÔ¿ø±â°£ µ¿¾È »ó±Şº´½Ç·á Â÷¾× Àü
Ã¼¸¦ ÃÑ ÀÔ¿øÀÏ¼ö·Î ³ª´©¾î¼­ »êÃâÇÕ´Ï´Ù.) (´Ü, ÇÇº¸ÇèÀÚ°¡ ±¹
¹Î°Ç°­º¸Çè¹ı ¶Ç´Â ÀÇ·á±Ş¿©¹ıÀ» Àû¿ë¹ŞÁö ¸øÇÏ´Â °æ¿ì¿¡´Â
ÀÔ¿øÀÇ·áºñ(±¹¹Î°Ç°­º¸Çè ¿ä¾ç±Ş¿©ÀÇ ±âÁØ¿¡ °üÇÑ ±ÔÄ¢¿¡ µû
¶ó Á¤ÇÑ ±Ş¿© ¹× ºñ±Ş¿© ÀÇ·áºñ Ç×¸ñ¸¸ ÇØ´ç) Áß º»ÀÎÀÌ ½ÇÁ¦
·Î ºÎ´ãÇÑ ±İ¾×¿¡¼­ 10¸¸¿ø°ú º¸»ó´ë»óÀÇ·áºñÀÇ 30% Áß Å«
±İ¾×À» »« ±İ¾×ÀÇ 40%¸¦ ÇÏ³ªÀÇ »óÇØ´ç º¸Çè°¡ÀÔ±İ¾×ÀÇ ÇÑµµ
³» º¸»ó)
[º¸Çè±İÀ» Áö±ŞÇÏÁö ¾Ê´Â »çÀ¯]
1Ç× ´ÙÀ½ÀÇ »çÀ¯·Î ÀÎÇÏ¿© »ı±ä ÀÔ¿øÀÇ·áºñ´Â º¸»óÇÏÁö ¾Ê½À´Ï´Ù.
1³â³³ 1³â¸¸±â
°»½ÅÁ¾·á: 100¼¼
5,000
6.135
Ãß°¡³³ÀÔÇü
°»½ÅÁÖ±â : 1³â
º¸Àåº¯°æÁÖ±â : 3³â
1. ÇÇº¸ÇèÀÚ°¡ °íÀÇ·Î ÀÚ½ÅÀ» ÇØÄ£ °æ¿ì 2. º¸Çè¼öÀÍÀÚ°¡ °íÀÇ·Î ÇÇº¸ÇèÀÚ¸¦ ÇØÄ£ °æ¿ì 3. °è¾àÀÚ°¡ °íÀÇ·Î ÇÇº¸ÇèÀÚ¸¦ ÇØÄ£ °æ¿ì 4 ÇÇº¸ÇèÀÚ°¡ ÀÓ½Å, Ãâ»ê, »êÈÄ±â
·Î ÀÔ¿ø ¶Ç´Â Åë¿øÇÑ °æ¿ì 5 ÀüÀï, ¿Ü±¹ÀÇ ¹«·ÂÇà»ç, Çõ¸í, ³»¶õ, »çº¯, Æøµ¿ 6 ÇÇº¸ÇèÀÚ°¡ Á¤´çÇÑ ÀÌÀ¯¾øÀÌ ÀÔ¿ø±â°£ Áß ÀÇ»çÀÇ Áö½Ã¸¦ µû¸£Áö ¾Ê°Å³ª ÀÇ»ç°¡ Åë¿ø
Ä¡·á°¡ °¡´ÉÇÏ´Ù°í ÀÎÁ¤ÇÔ¿¡µµ ÇÇº¸ÇèÀÚ º»ÀÎÀÌ ÀÚÀÇÀûÀ¸·Î ÀÔ¿øÇÏ¿© ¹ß»ıÇÑ ÀÔ¿øÀÇ·áºñ
2Ç× ´Ù¸¥ ¾àÁ¤ÀÌ ¾øÀ¸¸é ÇÇº¸ÇèÀÚ°¡ Á÷¾÷, Á÷¹« ¶Ç´Â µ¿È£È¸ È°µ¿¸ñÀûÀ¸·Î ÇÑ ´ÙÀ½ÀÇ ¾î´À ÇÏ³ª¿¡ ÇØ´çÇÏ´Â ÇàÀ§·Î »ı±ä »óÇØ´Â º¸»óÇÏÁö ¾Ê½À´Ï´Ù.
1 Àü¹®µî¹İ, ±Û¶óÀÌ´õ Á¶Á¾ ½ºÄ«ÀÌ´ÙÀÌºù µî 2 ¸ğÅÍº¸Æ® ÀÚµ¿Â÷ ¶Ç´Â ¿ÀÅä¹ÙÀÌ¿¡ ÀÇÇÑ °æ±â. ½Ã¹ü. Çà»ç(ÀÌ¸¦ À§ÇÑ ¿¬½À Æ÷ÇÔ) ¶Ç´Â ½Ã¿îÀü 3 Á÷¹«»ó ¼±¹Ú¿¡ Å¾½Â
ÇÏ°í ÀÖ´Â µ¿¾È »ç°í
3Ç× ´ÙÀ½ÀÇ ÀÔ¿øÀÇ·áºñ¿¡ ´ëÇØ¼­´Â º¸»óÇÏÁö ¾Ê½À´Ï´Ù
Ä¡°úÄ¡·á (KOC-KCB) ¹× ÇÑ¹æÄ¡·á¿¡¼­ ¹ß»ıÇÑ ¡¸±¹¹Î°Ç°­º¸Çè¹ı¡¹¿¡ µû¸¥ ¿ä¾ç±Ş¿©¿¡ ÇØ´çÇÏÁö ¾Ê´Â ºñ±Ş¿© ÀÇ·áºñ 2 "±¹¹Î°Ç°­º¸Çè¹ı¿¡ µû¸¥ ¿ä¾ç±Ş¿© Áß
º»ÀÎºÎ´ã±İÀÇ °æ¿ì ±¹¹Î°Ç°­º¸Çè °ü·Ã ¹ı·É¿¡ µû¶ó ±¹¹Î°Ç°­º¸Çè°ø´ÜÀ¸·ÎºÎÅÍ »çÀü ¶Ç´Â »çÈÄ È¯±ŞÀÌ °¡´ÉÇÑ ±İ¾×(º»ÀÎºÎ´ã±İ »óÇÑÁ¦ 3 ÀÇ·á±Ş¿©¹ı¡¹¿¡ µû¸¥
ÀÇ·á±Ş¿© Áß º»ÀÎºÎ´ã±İÀÇ °æ¿ì ÀÇ·á±Ş¿© °ü·Ã ¹ı·ü¿¡ µû¶ó ÀÇ·á±Ş¿©±â±İ µîÀ¸·ÎºÎÅÍ »çÀü ¶Ç´Â »çÈÄ È¯±ŞÀÌ °¡´ÉÇÑ ±İ¾×(ÀÇ·á±Ş¿©¹ı¿¡ µû¸¥ º»ÀÎºÎ´ã±İ º¸»ó
Á¦ ¹× º»ÀÎºÎ´ã±İ »óÇÑÁ¦ 4 °Ç°­°ËÁø ¿¹¹æÁ¢Á¾ ÀÎ°øÀ¯»ê¿¡ µç ºñ¿ë 5. ¿µ¾çÁ¦ ºñÅ¸¹ÎÁ¦ µîÀÇ ¾àÁ¦¿Í °ü·ÃÇÏ¿© ¼Ò¿äµÈ ºñ¿ë 6 ÀÍÄ¡ ÀÇ¼öÁ· ÀÇ¾È, ¾È°æ, ÄÜÅÃÆ®
·»Áî, º¸Ã»¤¡. ¸ñ¹ß, ÆÈ°ÉÀÌ º¸Á¶±â µî Áø·á Àç·áÀÇ ±¸ÀÔ ¹× ´ëÃ¼ ºñ¿ë 7 ´ÙÀ½ÀÇ ±¹¹Î°Ç°­º¸Çè ºñ±Ş¿© ´ë»óÀ¸·Î ½ÅÃ¼ÀÇ ÇÊ¼ö ±â´É°³¼± ¸ñÀûÀÌ ¾Æ´Ñ ¿Ü¸ğ°³¼± ¸ñÀûÀÇ
Ä¡·á·Î ÀÎÇÏ¿© ¹ß»ıÇÑ ÀÇ·áºñ °¡ ½Ö²¨Ç®¼ö¼ú ÄÚ¼ºÇü¼ö¼ú, À¯¹æÈ®´ë Ãà¼Ò¼ú, Áö¹æÈíÀÔ¼ú, ÁÖ¸§»ìÁ¦°Å¼ú µî ³ª »ç½Ã±³Á¤, ¾È¿Í°İ¸®ÁßÀÇ ±³Á¤ µî ½Ã°¢°è ¼ö¼ú·Î¼­
½Ã·Â°³¼± ¸ñÀûÀÌ ¾Æ´Ñ ¿Ü¸ğ°³¼± ¸ñÀûÀÇ ¼ö¼ú ´Ù ¾È°æ, ÄÜÅÃÆ®·»Áî µîÀ» ´ëÃ¼ÇÏ±â À§ÇÑ ½Ã·Â±³Á¤¼ú (±¹¹Î°Ç°­º¸Çè ¿ä¾ç±Ş¿© ´ë»ó ¼ö¼ú¹æ¹ı ¶Ç´Â Ä¡·áÀç·á°¡ »ç¿ëµÇÁö
¾ÊÀº ºÎºĞÀº ½Ã·Â±³Á¤¼ú·Î ÇÅ´Ï´Ù)¶ó ¿Ü¸ğ°³¼± ¸ñÀûÀÇ ´Ù¸® Á¤¸Æ·ù ¼ö¼ú ¸¶ ±× ¹Û¿¡ ¿Ü¸ğ°³¼± ¸ñÀûÀÇ Ä¡·á·Î ±¹¹Î°Ç°­º¸Çè ºñ±Ş¿©´ë»ó¿¡ ÇØ´çÇÏ´Â Ä¡·á 8 Áø·á¿Í
¹«°üÇÑ °¢Á¾ ºñ¿ë À¯»çÀÇ ÀÓ»óÀû ¼Ò°ß°ú °ü·ÃÀÌ ¾ø´Â °Ë»çºñ¿ë °£º°ºñ 9 ÀÚµ¿Â÷º¸Çè(°øÁ¦ Æ÷ÇÔ)¿¡¼­ º¸»ó¹Ş´Â Ä¡·á°ü°èºñ(°ú½Ç»ó°è ÈÄ ±İ¾× ±âÁØ) ¶Ç´Â »êÀçº¸Çè
¿¡¼­ º¸»ó¹Ş´Â ÀÇ·áºñ 'C ¡¸±¹¹Î°Ç°­º¸Çè¹ı Á¦42Á¶ÀÇ ¿ä¾ç±â°üÀÌ ¾Æ´Ñ ¿Ü±¹¿¡ ÀÖ´Â ÀÇ·á±â°ü¿¡¼­ ¹ß»ıÇÑ ÀÇ·áºñ 11 µµ¼öÄ¡·á Ã¼¿ÜÃæ°İÆÄÄ¡·á Áõ½ÄÄ¡·á·Î
ÀÎÇÏ¿© ¹ß»ıÇÑ ºñ±Ş¿© ÀÇ·áºñ '2 ºñ±Ş¿© ÁÖ»ç·á.3 ÀÚ±â°ø¸í¿µ»óÁø´Ü(MR/MRA)À¸·Î ÀÎÇÏ¿© ¹ß»ıÇÑ ºñ±Ş¿© ÀÇ·áºñ(Á¶¿µÁ¦ ÆÇµ¶·á¸¦ Æ÷ÇÔÇÕ´Ï´Ù). 4. Á¦11È£. Á¦
-2È£, Á¦3È£¿Í °ü·ÃÇÏ¿© ÀÚµ¿Â÷º¸Çè(°øÁ¦ Æ÷ÇÔ) ¶Ç´Â »êÀçº¸Çè¿¡¼­ ¹ß»ıÇÑ º»ÀÎºÎ´ãÀÇ·áºñ
¸ğÁıÁ¡
±İÃÌ³óÇù
¸ğÁıÀÚ
±è¼±Çü
(20120384110104)
¿¬¶ôÃ³ 031-941 3661
¼³°è¹øÈ£ 241008-.-063096
¼³°èÀÏÀÚ 2024-10-08
¹ßÇàÀÏ½Ã 2024-10-08 16:20:03
2/7

NH³óÇù¼ÕÇØº¸Çè
(¹«) °£Æí°¡ÀÔÇì¾Æ¸²½Ç¼ÕÀÇ·áºñº¸Çè2404
°è¾àÀÚ
ÀÌÁ¶ÈÆ
º¸Àå³»¿ª(¼±ÅÃ°è¾à)
º¸Àå¸í
Ã»¾àÀÏÀÚ 2024-10-08
º¸Àå»ó¼¼
Çì¾Æ¸²
Ã»¾à¼­ (È¸»çº¸°ü¿ë)
Ã»¾à¹øÈ£ 241008-1-066502
°¡ÀÔ±İ¾×(¸¸¿ø)
º¸Àåº¸Çè·á(¿ø)
³³ÀÔ±â°£ ¹× ¸¸±â
(±âº»°è¾à)°»½ÅÇü ½Ç¼Õ»ó
ÇØÅë¿øÀÇ·áºñ(°£Æí°¡ÀÔ)
»óÇØ·Î Åë¿øÄ¡·á½Ã ¿Ü·¡Á¦ºñ¿ë, ¿Ü·¡¼ö¼úºñ º¸»ó(´Ü, Ã³¹æÁ¶
Á¦ Á¦¿Ü) - ¹æ¹® 1È¸´ç ±¹¹Î°Ç°­º¸Çè¹ı¿¡¼­ Á¤ÇÑ ¿ä¾ç±Ş¿© ¶Ç
´Â ÀÇ·á±Ş¿©¹ı¿¡¼­ Á¤ÇÑ ÀÇ·á±Ş¿© Áß º»ÀÎºÎ´ã±İ°ú ºñ±Ş¿©¸¦
ÇÕÇÑ ±İ¾×ÀÎ º¸»ó´ë»óÀÇ·áºñ(º»ÀÎÀÌ ½ÇÁ¦·Î ºÎ´ãÇÑ ±İ¾×À» ¸»
ÇÕ´Ï´Ù.)¿¡¼­ 2¸¸¿ø°ú º¸»ó´ë»óÀÇ·áºñ 30% Áß Å« ±İ¾×À» »«
±İ¾×À» ¿Ü·¡ÀÇ º¸Çè°¡ÀÔ±İ¾× (È¸´ç 20¸¸¿ø)ÀÇ ÇÑµµ ³»¿¡¼­ º¸
»ó(¸Å³â °è¾àÇØ´çÀÏºÎÅÍ 1³â°£ 180È¸ ÇÑµµ·Î ÇÕ´Ï´Ù.) (´Ü, ÇÇ
º¸ÇèÀÚ°¡ ±¹¹Î°Ç°­º¸Çè¹ı ¶Ç´Â ÀÇ·á±Ş¿©¹ıÀ» Àû¿ë¹ŞÁö ¸øÇÏ
?´Â °æ¿ì¿¡´Â Åë¿øÀÇ·áºñ(±¹¹Î°Ç°­º¸Çè ¿ä¾ç±Ş¿©ÀÇ ±âÁØ¿¡ °ü
ÇÑ ±ÔÄ¢¿¡ µû¶ó Á¤ÇÑ ±Ş¿© ¹× ºñ±Ş¿© ÀÇ·áºñ Ç×¸ñ¸¸ ÇØ´ç)Áß º»
¿¬ÀÌ ½ÇÁ¦·Î ºÎ´ãÇÑ ±İ¾×¿¡¼­ 2¸¸¿ø°ú º¸»ó´ë»óÀÇ·áºñ 30%
Áß Å« ±İ¾×À» »« ±İ¾×ÀÇ 40%¸¦ º¸Çè°¡ÀÔ±İ¾× ÇÑµµ ³»¿¡¼­ º¸
»ó)
[º¸Çè±İÀ» Áö±ŞÇÏÁö ¾Ê´Â »çÀ¯]
'Ç× ´ÙÀ½ÀÇ »çÀ¯·Î ÀÎÇÏ¿© »ı±ä Åë¿øÀÇ·áºñ´Â º¸»óÇÏÁö ¾Ê½À´Ï´Ù.
1³â³³ 1³â¸¸±â
20
450
°»½ÅÁ¾·á: 100¼¼
Ãß°¡³³ÀÔÇü
°»½ÅÁÖ±â : 1³â
º¸Àåº¯°æÁÖ±â : 3³â
ÇÇº¸ÇèÀÚ°¡ °íÀÇ·Î ÀÚ½ÅÀ» ÇØÄ£ °æ¿ì 2 º¸Çè¼öÀÍÀÚ°¡ °íÀÇ·Î ÇÇº¸ÇèÀÚ¸¦ ÇØÄ£ °æ¿ì 3 °è¾àÀÚ°¡ °íÀÇ·Î ÇÇº¸ÇèÀÚ¸¦ ÇØÄ£ °æ¿ì 4. ÇÇº¸ÇèÀÚ°¡ ÀÓ½Å, Ãâ»ê, »êÈÄ±â
·Î ÀÔ¿ø ¶Ç´Â Åë¿øÇÑ °æ¿ì 5 ÀüÀï ¿Ü±¹ÀÇ ¹«·ÂÇà»ç, Çõ¸í, ³»¶õ, »çº¯, Æøµ¿ 6 ÇÇº¸ÇèÀÚ°¡ Á¤´çÇÑ ÀÌÀ¯¾øÀÌ ÀÔ¿ø±â°£ Áß ÀÇ»çÀÇ Áö½Ã¸¦ µû¸£Áö ¾Ê°Å³ª ÀÇ»ç°¡ ¿ø
Ä¡·á°¡ °¡´ÉÇÏ´Ù°í ÀÎÁ¤ÇÔ¿¡µµ ÇÇº¸ÇèÀÚ º»ÀÎÀÌ ÀÚÀÇÀûÀ¸·Î ÀÔ¿øÇÏ¿© ¹ß»ıÇÑ ÀÔ¿øÀÇ·áºñ
2Ç×. ´Ù¸¥ ¾àÁ¤ÀÌ ¾øÀ¸¸é ÇÇº¸ÇèÀÚ°¡ Á÷¾÷ Á÷¹« ¶Ç´Â µ¿È£È¸ È°µ¿¸ñÀûÀ¸·Î ÇÑ ´ÙÀ½ÀÇ ¾î´À ÇÏ³ª¿¡ ÇØ´çÇÏ´Â ÇàÀ§·Î »ı±ä »óÇØ´Â º¸»óÇÏÁö ¾Ê½À´Ï´Ù.
Àü¹®µî¹İ, ±Û¶óÀÌ´õ Á¶Á¾ ½ºÄ«ÀÌ´ÙÀÌºù µî 2 ¸ğÅÍº¸Æ® ÀÚµ¿Â÷ ¶Ç´Â ¿ÀÅä¹ÙÀÌ¿¡ ÀÇÇÑ °æ±â ½Ã¹ü Çà»ç(ÀÌ¸¦ À§ÇÑ ¿¬½À Æ÷ÇÔ) ¶Ç´Â ½Ã¿îÀü 3 Á÷¹«»ó ¼±¹Ú¿¡ Å¾½Â
ÇÏ°í ÀÖ´Â µ¿¾È »ç°í
3Ç×. ´ÙÀ½ÀÇ Åë¿øÀÇ·áºñ¿¡ ´ëÇØ¼­´Â º¸»óÇÏÁö ¾Ê½À´Ï´Ù
Ä¡°úÄ¡·á ÇÑ¹æÄ¡·á¿¡¼­ ¹ß»ıÇÑ ¡¸±¹¹Î°Ç°­º¸Çè¹ı¡¹¿¡ µû¸¥ ¿ä¾ç±Ş¿©¿¡ ÇØ´çÇÏÁö ¾Ê´Â ºñ±Ş¿© ÀÇ·áºñ 2 ¡¸±¹¹Î°Ç°­º¸Çè¹ı¡¹¿¡ µû¸¥ ¿ä¾ç±Ş¿© Áß º»ÀÎºÎ´ã±İÀÇ
°æ¿ì ±¹¹Î°Ç°­º¸Çè °ü·Ã ¹ı·É¿¡ µû¶ó ±¹¹Î°Ç°­º¸Çè°ø´ÜÀ¸·ÎºÎÅÍ »çÀü ¶Ç´Â »çÈÄ È¯±ŞÀÌ °¡´ÉÇÑ ±İ¾×(º»ÀÎºÎ´ã±İ »óÇÑÁ¦] 3. ¡¸ÀÇ·á±Ş¿©¹ı¿¡ µû¸¥ ÀÇ·á±Ş¿© Áß º»
ÀÎºÎ´ã±İÀÇ °æ¿ì ÀÇ·á±Ş¿© °ü·Ã ¹ı·É¿¡ µû¶ó ÀÇ·á±Ş¿©±â±İ µîÀ¸·ÎºÎÅÍ »çÀü ¶Ç´Â »çÈÄ È¯±ŞÀÌ °¡´ÉÇÑ ±İ¾×(¡¸ÀÇ·á±Ş¿©¹ı¡¹¿¡ µû¸¥ º»ÀÎºÎ´ã±İ º¸»óÁ¦ ¹× º»ÀÎºÎ´ã
±İ »óÇÑÁ¦ 4 °Ç°­°ËÁø, ¿¹¹æÁ¢Á¾, ÀÎ°øÀ¯»ê¿¡ µç ºñ¿ë 5. ¿µ¾çÁ¦, ºñÅ¸¹ÎÁ¦ µîÀÇ ¾àÁ¦¿Í °ü·ÃÇÏ¿© ¼Ò¿äµÈ ºñ¿ë 6. ÀÇÄ¡, ÀÇ¼öÁ·, ÀÇ¾È, ¾È°æ, ÄÜÅÃÆ®·»Áî, º¸Ã»±â,
¸ñ¹ß, ÆÈ°ÉÀÌ, º¸Á¶±â µÕ Áø·á Àç·áÀÇ ±¸ÀÔ ¹× ´ëÃ¼ ºñ¿ë 7. ´ÙÀ½ÀÇ ±¹¹Î°Ç°­º¸Çè ºñ±Ş¿© ´ë»óÀ¸·Î ½ÅÃ¼ÀÇ ÇÊ¼ö ±â´É°³¼± ¸ñÀûÀÌ ¾Æ´Ñ ¿Ü¸ğ°³¼± ¸ñÀûÀÇ Ä¡·á·Î ÀÎÇÏ
¿© ¹ß»ıÇÑ ÀÇ·áºñ °¡ ½Ö²¨Ç®¼ö¼ú ÄÚ¼ºÇü¼ö¼ú, À¯¹æÈ®´ë Ãà¼Ò¼ú, Áö¹æÈíÀÔ¼ú, ÁÖ¸§»ìÁ¦°Å½½ µ¿ ³ª. »ç½Ã±³Á¤, ¸¸¿Í°İ¸®ÁòÀÇ ±³Á¤ µî ½Ã°¢°è ¼ö¼ú·Î¼­ ½Ã·Â°³¼± ¸ñ
ÀûÀÌ ¾Æ´Ñ ¿Ü¸ğ°³¼± ¸ñÀûÀÇ ¼ö¼ú ´Ù. ¾È°æ, ÄÜÅÃÆ®·»Áî µîÀ» ´ëÃ¼ÇÏ±â À§ÇÑ ½Ã·Â±³Á¤¼ú(±¹¹Î°Ç°­º¸Çè ¿ä¾ç±Ş¿© ´ë»ó ¼ö¼ú¹æ¹ı ¶Ç´Â Ä¡·áÀç·á°¡ »ç¿ëµÇÁö ¾ÊÀº ºÎºĞ
Àº ½Ã·Â±³Á¤¼ú·Î º¾´Ï´Ù)¶ó ¿Ü¸ğ°³¼± ¸ñÀûÀÇ ´Ù¸® Á¤¸Æ·ù ¼ö¼ú ¸¶ ±× ¹Û¿¡ ¿Ü¸ğ°³¼± ¸ñÀûÀÇ Ä¡·á·Î ±¹¹Î°Ç°­º¸Çè ºñ±Ş¿©´ë»ó¿¡ ÇØ´çÇÏ´Â Ä¡·á 8. ÀÜ·á¿Í ¹«°üÇÑ °¢
Á¾ ºñ¿ë, ÀÇ»çÀÇ ÀÓ»óÀû ¼Ò°ß°ú °ü·ÃÀÌ ¾ø´Â °Ë»çºñ¿ë. °£º´ºñ 9. ÀÚµ¿Â÷º¸Çè(°øÁ¦ Æ÷ÇÔ)¿¡¼­ º¸»ó¹Ş´Â Ä¡·á°ü°èºñ(°ú½Ç»ó°è ÈÄ ±İ¾× ±âÁØ) ¶Ç´Â »êÀçº¸Çè¿¡¼­ º¸»ó
¹Ş´Â ÀÇ·áºñ 10 ¡¸±¹¹Î°Ç°­º¸Çè¹ı Á¦42Á¶ÀÇ ¿ä¾ç±â°üÀÌ ¾Æ´Ñ ¿Ü±¹¿¡ ÀÖ´Â ÀÇ·á±â°ü¿¡¼­ ¹ß»ıÇÑ ÀÇ·áºñ 11 ¡¸ÀÀ±ŞÀÇ·á¿¡ °üÇÑ ¹ı·ü ¹× µ¿ ½ÃÇà±ÔÄ¢¿¡¼­ Á¤ÇÑ
ÀÀ±ŞÈ¯ÀÚ¿¡ ÇØ´çÇÏÁö ¾Ê´Â ÀÚ°¡ ¡¸ÀÇ·á¹ı Á¦3Á¶ÀÇ4¿¡ µû¸¥ »ó±ŞÁ¾ÇÕº´¿ø ÀÀ±Ş½ÇÀ» ÀÌ¿ëÇÏ¸é¼­ ¹ß»ıÇÑ ÀÀ±ŞÀÇ·á°ü¸®·á 12. µµ¼öÄ¡·á Ã¼¿ÜÃæ°İÆÄÄ¡·á Áõ½ÄÄ¡·á
·Î ÀÎÇÏ¿© ¹ß»ıÇÑ ºñ±Ş¿© ÀÇ·áºñ 13 ºñ±Ş¿© ÁÖ»ç·á 14 ÀÚ±â°ø¸í¿µ»óÁø´Ü(MRI/MRA)À¸·Î ÀÎÇÏ¿© ¹ß»ıÇÑ ºñ±Ş¿© ÀÇ·áºñ(Á¶¿µÁ¦, ÆÇµ¶·á¸¦ Æ÷ÇÔÇÕ´Ï´Ù) 15 Á¦2È£
Á¦: 3È£, Á¦4È£¿Í °ü·ÃÇÏ¿© ÀÚµ¿Â÷º¸Çè(°øÁ¦ Æ÷ÇÔ) ¶Ç´Â »êÀçº¸Çè¿¡¼­ ¹ß»ıÇÑ º»ÀÎºÎ´ãÀÇ·áºñ
¸ğÁıÁ¡
±İÃÌ³óÇù
¸ğÁıÀÚ
±è¼±Çü
(20120384110104)
¿¬¶ôÃ³ 031-941-3661
¼³°è¹øÈ£ 2410C8-1-063096
¹ßÇàÀÏ½Ã 2024-C-C8 16:20:03
¼³°èÀÏÀÚ 2024-10-08
3/7

NH³óÇù¼ÕÇØº¸Çè
(¹«) °£Æí°¡ÀÔÇì¾Æ¸²½Ç¼ÕÀÇ·áºñº¸Çè 2404
°è¾àÀÚ
ÀÌÁ¶ÈÆ
º¸Àå³»¿ª(¼±ÅÃ°è¾à)
º¸Àå¸í
Ã»¾àÀÏÀÚ 2024-10-08
º¸Àå»ó¼¼
-
Áúº´À¸·Î ÀÔ¿øÄ¡·á½Ã ÀÔ¿ø½Ç·á, ÀÔ¿øÁ¦ºñ¿ë, ÀÔ¿ø¼ö¼úºñ º¸»ó
?±¹¹Î°Ç°­º¸Çè¹ı¿¡¼­ Á¤ÇÑ ¿ä¾ç±Ş¿© ¶Ç´Â ÀÇ·á±Ş¿©¹ı¿¡¼­ Á¤
ÇÑ ÀÇ·á±Ş¿© Áß º»ÀÎºÎ´ã±İ°ú ºñ±Ş¿©(»ó±Şº´½Ç·á Â÷¾× Á¦¿Ü)
¸¦ ÇÕÇÑ ±İ¾×ÀÎ º¸»ó´ë»óÀÇ·áºñ(º»ÀÎÀÌ ½ÇÁ¦·Î ºÎ´ãÇÑ ±İ¾×À»
¸»ÇÕ´Ï´Ù.)¿¡¼­ 10¸¸¿ø°ú º¸»ó´ë»óÀÇ·áºñÀÇ 30%Áß Å« ±İ¾×
¿Ã»« ±İ¾×À» º¸»ó(´Ü, 10¸¸¿ø°ú º¸»ó´ë»óÀÇ·áºñÀÇ 30% Áß
Å« ±İ¾×ÀÌ °è¾àÀÏ ¶Ç´Â ¸Å³â °è¾àÇØ´çÀÏºÎÅÍ ±â»êÇÏ¿© ¿¬°£
200¸¸¿øÀ» ÃÊ°úÇÏ´Â °æ¿ì ±× ÃÊ°ú±İ¾×Àº º¸»óÇÕ´Ï´Ù.). »ó±Ş
º´½Ç·á Â÷¾× - ÀÔ¿ø ½Ã ½ÇÁ¦·Î »ç¿ëÇÑ º´½Ç°ú ±âÁØº´½Ç°úÀÇ º´
½Ç·á Â÷¾× Áß 50%¸¦ »« ±İ¾× (´Ü, 1ÀÏ Æò±Õ±İ¾× 10¸¸¿øÀ» ÇÑ
µµ·Î ÇÏ¸ç, 1ÀÏ Æò±Õ±İ¾×Àº ÀÔ¿ø±â°£ µ¿¾È »ó±Şº´½Ç·á Â÷¾× Àü
Ã¼¸¦ ÃÑ ÀÔ¿øÀÏ¼ö·Î ³ª´©¾î¼­ »êÃâÇÕ´Ï´Ù.) (´Ü, ÇÇº¸ÇèÀÚ°¡ ±¹
'¹Î°Ç°­º¸Çè¹ı ¶Ç´Â ÀÇ·á±Ş¿©¹ıÀ» Àû¿ë¹ŞÁö ¸øÇÏ´Â °æ¿ì¿¡´Â
ÀÔ¿øÀÇ·áºñ(±¹¹Î°Ç°­º¸Çè ¿ä¾ç±Ş¿©ÀÇ ±âÁØ¿¡ °üÇÑ ±ÔÄ¢¿¡ µû
¶ó Á¤ÇÑ ±Ş¿© ¹× ºñ±Ş¿© ÀÇ·áºñ Ç×¸ñ¸¸ ÇØ´ç) Áß º»ÀÎÀÌ ½ÇÁ¦
·Î ºÎ´ãÇÑ ±İ¾×¿¡¼­ 10¸¸¿ø°ú º¸»ó´ë»óÀÇ·áºñÀÇ 30% ÁßÅ«
±İ¾×À» »« ±İ¾×ÀÇ 40%¸¦ ÇÏ³ªÀÇ Áúº´´ç º¸Çè°¡ÀÔ±İ¾×ÀÇ ÇÑµµ
(±âº»°è¾à)°»½ÅÇü ½Ç¼ÕÁú
³» º¸»ó)
º´ÀÔ¿øÀÇ·áºñ(°£Æí°¡ÀÔ)
[º¸Çè±İÀ» Áö±ŞÇÏÁö ¾Ê´Â »ç¿î
Çì¾Æ¸² |
Ã»¾à¼­ (È¸»çº¸°ü¿ë)
Ã»¾à¹øÈ£
241008-1-066502
°¡ÀÔ±İ¾×(¸¸¿ø)
º¸Àåº¸Çè·á(¿ø)
³³ÀÔ±â°£ ¹× ¸¸±â
1³â³³ 1³â¸¸±â
5,000
39,368
°»½ÅÁ¾·á: 100¼¼
Ãß°¡³³ÀÔÇü
°»½ÅÁÖ±â : 1³â
º¸Àåº¯°æÁÖ±â : 3³â
1Ç× ´ÙÀ½ÀÇ »çÀ¯·Î ÀÎÇÏ¿© »ı±ä ÀÔ¿øÀÇ·áºñ´Â º¸»óÇÏÁö ¾Ê½À´Ï´Ù
?ÇÇº¸ÇèÀÚ°¡ °íÀÇ·Î ÀÚ½ÅÀ» ÇØÄ£ °æ¿ì 2 º¸Çè¼öÀÍÀÚ°¡ °íÀÇ·Î ÇÇº¸ÇèÀÚ¸¦ ÇØÄ£ °æ¿ì °è¾àÀÚ°¡ °íÀÇ·Î ÇÇº¸ÇèÀÚ¸¦ ÇØÄ£ °æ¿ì 4. ÇÇº¸ÇèÀÚ°¡ Á¤´çÇÑ ÀÌÀ¯ ¾øÀÌ
ÀÔ¿ø±â°£ Áß ÀÇ»çÀÇ Áö½Ã¸¦ µû¸£Áö ¾Ê°Å³ª ÀÇ»ç°¡ Åë¿øÄ¡·á°¡ °¡´ÉÇÏ´Ù°í ÀÎÁ¤ÇÔ¿¡µµ ÇÇº¸ÇèÀÚ º»ÀÎÀÌ ÀÚÀÇÀûÀ¸·Î ÀÔ¿øÇÏ¿© ¹ß»ıÇÑ ÀÔ¿øÀÇ·áºñ
2Ç× ÇÑ±¹Ç¥ÁØÁúº´»çÀÎºĞ·ù¿¡ µû¸¥ ´ÙÀ½ÀÇ ÀÇ·áºñ¿¡ ´ëÇØ¼­´Â º¸»óÇÏÁö ¾Ê½À´Ï´Ù.
1 Á¤½Å ¹× Çàµ¿Àå¾Ö (F04-F99). 2 ¿©¼º»ı½Ä±âÀÇ ºñ¿°Áõ¼º Àå¾Ö·Î ÀÎÇÑ ½À°ü¼º À¯»ê ºÒÀÓ ¹× ÀÎ°ø¼öÁ¤ °ü·Ã ÇÕº´Áõ(N96-N98)À¸·Î ¹ß»ıÇÑ ÀÇ·áºñ 3. ÇÇº¸ÇèÀÚ°¡
ÀÓ½Å, Ãâ»ê, »êÈÄ (000-099) 4. ¼±Ãµ¼º ³úÁúÈ¯(200-Q04) 5. ¿ä½Ç±İ(N39 3. N39.4. R32) 7 Á÷Àå ¶Ç´Â Ç×¹® ÁúÈ¯ Áß ¡¸±¹¹Î°Ç°­º¸Çè¹ı¿¡ µû¸¥ ¿ä¾ç±Ş¿©¿¡ ÇØ
|´çÇÏÁö ¾Ê´Â ºÎºĞ(184, K60-K62. K64)
3Ç× ´ÙÀ½ÀÇ ÀÔ¿øÀÇ·áºñ¿¡ ´ëÇØ¼­´Â º¸»óÇÏÁö ¾Ê½À´Ï´Ù
1 Ä¡°úÄ¡·á (KOO-K08) ¹× ÇÑ¹æÄ¡·á¿¡¼­ ¹ß»ıÇÑ ¡¸±¹¹Î°Ç°­º¸Çè¹ı¿¡ µû¸¥ ¿ä¾ç±Ş¿©¿¡ ÇØ´çÇÏÁö ¾Ê´Â ºñ±Ş¿© ÀÇ·áºñ 2. ¡¸±¹¹Î°Ç°­º¸Çè¹ı¿¡ µû¸¥ ¿ä¾ç±Ş¿© Áß
º»ÀÎºÎ´ã±İÀÇ °æ¿ì ±¹¹Î°Ç°­º¸Çè °ü·Ã ¹ı·É¿¡ µû¶ó ±¹¹Î°Ç°­º¸Çè°ø´ÜÀ¸·ÎºÎÅÍ »çÀü ¶Ç´Â »çÈÄ È¯±ŞÀÌ °¡´ÉÇÑ ±İ¾×(º»ÀÎºÎ´ã±İ »óÇÑÁ¦) 3 ¡¸ÀÇ·á±Ş¿©¹ı¡¹¿¡ µû¸¥
ÀÇ·á±Ş¿© Áß º»ÀÎºÎ´ã±İÀÇ °æ¿ì ÀÇ·á±Ş¿© °ü·Ã ¹ı·É¿¡ µû¶ó ÀÇ·á±Ş¿©±â±İ µîÀ¸·ÎºÎÅÍ »çÀü ¶Ç´Â »çÈÄ È¯±ŞÀÌ °¡´ÉÇÑ ±İ¾×(ÀÇ·á±Ş¿©¹ı ¿¡ µû¸¥ º»ÀÎºÎ´ã±İ º¸»ó
Á¦ ¹× º»ÀÎºÎ´ã±İ »óÇÑÁ¦) 4 °Ç°­°ËÁø ¿¹¹æÁ¢Á¾, ÀÎ°øÀ¯»ê¿¡ µç ºñ¿ë 5 ¿µ¾çÁ¦, ºñÅ¸¹ÎÁ¦ µîÀÇ ¾àÁ¦¿Í °ü·ÃÇÏ¿© ¼Ò¿äµÈ ºñ¿ë 6 ´ÙÀ½ÀÇ ¾î´À ÇÏ³ª¿¡ ÇØ´çÇÏ´Â Ä¡·á
·Î ÀÎÇÏ¿© ¹ß»ıÇÑ ÀÇ·áºñ °¡. ´Ü¼øÇÑ ÇÇ·Î ¶Ç´Â ±ÇÅÂ³ª ÁÖ±Ù±ú, ´Ù¸ğ, ¹«¸ğ, ¹é¸ğÁõ µş±â, ÄÚ (ÁÖ»çºñ). Á¡, ¸ğ¹İ, »ç¸¶±Í, ¿©µå¸§ ³ëÈ­Çö»óÀ¸·Î ÀÎÇÑ Å»¸ğ µî ÇÇºÎÁú
È¯´Ù ¹ß±â ºÎÀü ºÒ°¨Áõ. ´Ü¼ø ÄÚ°ñ¿È. Ä¡·á¸¦ µ¿¹İÇÏÁö ¾Ê´Â ´Ü¼øÆ÷°æ "±¹¹Î°Ç°­º¸Çè ¿ä¾ç±Ş¿©ÀÇ ±âÁØ¿¡ °üÇÑ ±ÔÄ¢. Á¦9Á¶ Á¦1Ç× [º°Ç¥2] ºñ±Ş¿©´ë»ó)¿¡ µû¸¥
¾÷¹« ¶Ç´Â ÀÏ»ó»ıÈ°¿¡ ÁöÀåÀÌ ¾ø´Â °Ë¿­¹İ µ¿ ¾È°úÁúÈ¯ 7 ÀÇÄ¡. ÀÇ¼öÁ·. ÀÇ¾È ¾È°æ ÄÜÅÃÆ®·»Áî, º¸Ã»¤¡ ¸ñ¹ß, ÆÈ°ÉÀÌ. º¸Á¶: µ¿ Áø·á Àç·áÀÇ ±¸ÀÔ ¹× ´ëÃ¼ ºñ¿ë
8 ´ÙÀ½ÀÇ ±¹¹Î°Ç°­º¸Çè ºñ±Ş¿© ´ë»óÀ¸·Î ½ÅÃ¼ÀÇ ÇÊ¼ö ¤¡ ´É°³¼± ¸ñÀûÀÌ ¾Æ´Ñ ¿Ü¸ğ°³¼± ¸ñÀûÀÇ Ä¡·á·Î ÀÎÇÏ¿© ¹ß»ıÇÑ ÀÇ·áºñ°¡ ½Ö²¨Ç®¼ö¼ú ÄÚ¼ºÇü¼ö¼ú, À¯¹æÈ®´ë
Ãà¼Ò¼ú Áö¹æÈíÀÔ¼ú, ÁÖ¸§»ìÁ¦°Å¼ú µî ³ª »ç½Ã±³Á¤ ¾È¿Í°İ¸®ÁòÀÇ ±³Á¤ µî ½Ã°¢°è ¼ö¼ú·Î¼­ ½Ã·Â°³¼± ¸ñÀûÀÌ ¾Æ´Ñ ¿Ü¸ğ°³¼± ¸ñÀûÀÇ ¼ö¼ú ´Ù. ¾È°æ, ÄÜÅÃÆ®·»Áî µî
À» ´ëÃ¼ÇÏ±â À§ÇÑ ½Ã·Â±³Á¤¼ú(±¹¹Î°Ç°­º¸Çè ¿ä¾ç±Ş¿© ´ë»ó ¼ö¼ú¹æ¹ı ¶Ç´Â Ä¡·á Àç·á°¡ »ç¿ëµÇÁö ¾ÊÀº ºÎºĞÀº ½Ã·Â±³Á¤¼ú·Î º¾´Ï´Ù)¶ó ¿Ü¸ğ°³¼± ¸ñÀûÀÇ ´Ù¸® Á¤¸Æ·ù
¼ö¼ú¸¶ ±× ¹Û¿¡ ¿Ü¸ğ°³¼± ¸ñÀûÀÇ Ä¡·á·Î ±¹¹Î°Ç°­º¸Çè ºñ±Ş¿©´ë»ó¿¡ ÇØ´çÇÏ´Â Ä¡·á 9 Áø·á¿Í ¹«°üÇÑ °¢Á¾ ºñ¿ë. ÀÇ»çÀÇ ÀÓ»óÀû ¼Ò°ß°ú °ü·ÃÀÌ ¾ø´Â °Ë»çºñ¿ë, °£
?º´ºñ 10 »êÀçº¸Çè¿¡¼­ º¸»ó¹Ş´Â ÀÇ·áºñ 11. »ç¶÷¸é¿ª°áÇÌ¹ÙÀÌ·¯½º(HIV) °¨¿°À¸·Î ÀÎÇÑ Ä¡·áºñ 2 ¡¸±¹¹Î°Ç°­º¸Çè¹ı¡¹ Á¦42Á¶ÀÇ ¿ä¾ç±â°üÀÌ ¾Æ´Ñ ¿Ü±¹¿¡ ÀÖ´Â ¿Í
·á±â°ü¿¡¼­ ¹ß»ıÇÑ ÀÇ·áºñ 13. µµ¼öÄ¡·á Ã¼¿ÜÃæ°İÆÄÄ¡·á Áß½ÄÄ¡·á·Î ÀÎÇÏ¿© ¹ß»ıÇÑ ºñ±Ş¿© ÀÇ·áºñ 14. ºñ±Ş¿© ÁÖ»ç·á 15 ÀÚ±â°ø¸í¿µ»óÁø´Ü(MRI/MRA)À¸·Î ÀÎÇÏ
¿© ¹ß»ıÇÑ ºñ±Ş¿© ÀÇ·áºñ(Á¶¿µÁ¦, ÆÇµ¶·á¸¦ Æ÷ÇÔÇÕ´Ï´Ù) 16. Á¦13È£, Á¦14È£, Á¦15È£¿Í °ü·ÃÇÏ¿© ÀÚµ¿Â÷º¸Çè(°øÁ¦ Æ÷ÇÔ) ¶Ç´Â »êÀçº¸Çè¿¡¼­ ¹ß»ıÇÑ º»ÀÎºÎ´ãÀÇ·áºñ
¸ğÁıÁ¡
¸ğÁıÀÚ
±İÃÌ³óÇù
±è¼±Çü
(20120384 10104)
¿¬¶ôÃ³ 031-941-366*
¼³°è¹øÈ£ 241008-1-063096
¼³°èÀÏÀÚ 2024--C-08
¹ßÇàÀÏ½Ã 2024-10-08 - 6:20.03
4/7

NH³óÇù¼ÕÇØº¸Çè
(¹«) °£Æí°¡ÀÔÇì¾Æ¸²½Ç¼ÕÀÇ·áºñº¸Çè2404
°è¾àÀÚ
ÀÌÁ¶ÈÆ
º¸Àå³»¿ª(¼±ÅÃ°è¾à)
º¸Àå¸í
Ã»¾àÀÏÀÚ 2024-10-08
º¸Àå»ó¼¼
Çì¾Æ¸²
Ã»¾à¼­ (È¸»çº¸°ü¿ë)
Ã»¾à¹øÈ£
241008-1-066502
°¡ÀÔ±İ¾×(¸¸¿ø)
º¸Àåº¸Çè·á(¿ø)
³³ÀÔ±â°£ ¹× ¸¸±â
(±âº»°è¾à)°»½ÅÇü ½Ç¼ÕÁú
º´Åë¿øÀÇ·áºñ(°£Æí°¡ÀÔ)
Áúº´À¸·Î Åë¿øÄ¡·á½Ã ¿Ü·¡Á¦ºñ¿ë, ¿Ü·¡¼ö¼úºñ º¸»ó(´Ü, Ã³¹æ
Á¶Á¦ Á¦¿Ü) - ¹æ¹® 1È¸´ç ±¹¹Î°Ç°­º¸Çè¹ı¿¡¼­ Á¤ÇÑ ¿ä¾ç±Ş¿©
¶Ç´Â ÀÇ·á±Ş¿©¹ı¿¡¼­ Á¤ÇÑ ÀÇ·á±Ş¿© Áß º»ÀÎºÎ´ã±İ°ú ºñ±Ş¿©
¸¦ ÇÕÇÑ ±İ¾×ÀÎ º¸»ó´ë»óÀÇ·áºñ(º»ÀÎÀÌ ½ÇÁ¦·Î ºÎ´ãÇÑ ±İ¾×À»
¸»ÇÕ´Ï´Ù.)¿¡¼­ 2¸¸¿ø°ú º¸»ó´ë»óÀÇ·áºñ 30% Áß Å« ±İ¾×À»
»« ±İ¾×À» ¿Ü·¡ÀÇ º¸Çè°¡ÀÔ±İ¾×(È¸´ç 20¸¸¿ø)ÀÇ ÇÑµµ ³»¿¡¼­
º¸»ó(¸Å³â °è¾àÇØ´çÀÏºÎÅÍ 1³â°£ 180È¸ ÇÑµµ·Î ÇÕ´Ï´Ù.) (´Ü,
ÇÇº¸ÇèÀÚ°¡ ±¹¹Î°Ç°­º¸Çè¹ı ¶Ç´Â ÀÇ·á±Ş¿©¹ıÀ» Àû¿ë¹ŞÁö ¸ø
ÇÏ´Â °æ¿ì¿¡´Â Åë¿øÀÇ·áºñ(±¹¹Î°Ç°­º¸Çè ¿ä¾ç±Ş¿©ÀÇ ±âÁØ¿¡
°üÇÑ ±ÔÄ¢¿¡ µû¶ó Á¤ÇÑ ±Ş¿© ¹× ºñ±Ş¿© ÀÇ·áºñ Ç×¸ñ¸¸ ÇØ´ç)Áß
º»ÀÎÀÌ ½ÇÁ¦·Î ºÎ´ãÇÑ ±İ¾×¿¡¼­ 2¸¸¿ø°ú º¸»ó´ë»óÀÇ·áºñ
30%Áß Å« ±İ¾×À» »« ±İ¾×ÀÇ 40%¸¦ º¸Çè°¡ÀÔ±İ¾× ÇÑµµ ³»¿¡
¼­ º¸»ó)
[º¸Çè±İÀ» Áö±ŞÇÏÁö ¾Ê´Â »ç¿ø]
¡°Ç× ´ÙÀ½ÀÇ »çÀ¯·Î ÀÎÇÏ¿© »ı°£ Åë¿øÀÇ·áºñ´Â º¸»óÇÏÁö ¾Ê½À´Ï´Ù.
1³â³³ 1³â¸¸±â
°»½ÅÁ¾·á: 100¼¼
Ãß°¡³³ÀÔÇü
20
11.568
°»½ÅÁÖ±â : 1³â
º¸Àåº¯°æÁÖ±â : 3³â
ÇÇº¸ÇèÀÚ°¡ °íÀÇ·Î ÀÚ½ÅÀ» ÇØÄ£ °æ¿ì 2. º¸Çè¼öÀÍÀÚ°¡ °íÀÇ·Î ÇÇº¸ÇèÀÚ¸¦ ÇØÄ£ °æ¿ì 3 °è¾àÀÚ°¡ °íÀÇ·Î ÇÇº¸ÇèÀÚ¸¦ ÇØÄ£ °æ¿ì 4 ÇÇº¸ÇèÀÚ°¡ Á¤´çÇÑ ÀÌÀ¯ ¾øÀÌ
ÀÔ¿ø±â°£ Áß ÀÇ»çÀÇ Áö½Ã¸¦ µû¸£Áö ¾Ê°Å³ª ÀÇ»ç°¡ Åë¿øÄ¡·á°¡ °¡´ÉÇÏ´Ù°í ÀÎÁ¤ÇÔ¿¡µµ ÇÇº¸ÇèÀÚ º»ÀÎÀÌ ÀÚÀÇÀûÀ¸·Î ÀÔ¿øÇÏ¿© ¹ß»ıÇÑ ÀÔ¿øÀÇ·áºñ
2Ç× ÇÑ±¹Ç¥ÁØÁúº´»çÀÎºĞ·ù¿¡ µû¸¥ ´ÙÀ½ÀÇ ÀÇ·áºñ¿¡ ´ëÇØ¼­´Â º¸»óÇÏÁö ¾Ê½À´Ï´Ù.
Á¤½Å ¹× Çàµ¿Àå¾Ö(F04-F99) 2 ¿©¼º»ı½Ä±âÀÇ ºñ¿°Áõ¼º Àå¾Ö·Î ÀÎÇÑ ½À°ü¼º À¯»ê, ºÒÀÓ ¹× ÀÎ°ø¼öÁ¤°ü·Ã ÇÕº´Áõ(N96-N98) À¸·Î ¹ß»ıÇÑ ÀÇ·áºñ 3 ÇÇº¸ÇèÀÚ°¡
Àº»ê, Ãâ»ê, »êÈÄ±â(C00-099)·Î Åë¿øÇÑ °æ¿ì 4. ¼±Ãµ¼º ³úÁúÈ¯ (200-Q04) 5 ºñ¸¸(E66) 6 ¿ä½Ç±İ(N39 3. N39 4 R32) 7 Á÷Àå ¶Ç´Â Ç×¹®ÁúÈ¯ Áß ¡¸±¹¹Î°Ç°­º¸
Çè¹ı ¿¡ µû¸¥ ¿ä¾ç±Ş¿©¿¡ ÇØ´çÇÏÁö ¾Ê´Â ºÎºĞ(184, K60-K62 K64)
3Ç× ´ÙÀ½ÀÇ Åë¿øÀÇ·áºñ¿¡ ´ëÇØ¼­´Â º¸»óÇÏÁö ¾Ê½À´Ï´Ù.
? Ä¡°úÄ¡·á [KOD-K08) ¹× ÇÑ¹æÄ¡·á¿¡¼­ ¹ß»ıÇÑ ¡¸±¹¹Î°Ç°­º¸Çè¹ı¿¡ µû¸¥ ¿ä¾ç±Ş¿©¿¡ ÇØ´çÇÏÁö ¾Ê´Â ºñ±Ş¿© ÀÇ·áºñ 2 ¡¸±¹¹Î°Ç°­º¸Çè¹ı¡¹¿¡ µû¸¥ ¿ä¾ç±Ş¿© Áß
º»ÀÎºÎ´ã±İÀÇ °æ¿ì ±¹¹Î°Ç°­º¸Çè °ü·Ã ¹ı·É¿¡ µû¶ó ±¹¹Î°Ç°­º¸Çè°ø´ÜÀ¸·ÎºÎÅÍ »çÀü ¶Ç´Â »çÈÄ È¯±ŞÀÌ °¡´ÉÇÑ ±İ¾×(º»ÀÎºÎ´ã±İ »óÇÑÁ¦) 3 ¡¸ÀÇ·á±Ş¿©¹ı¡¹¿¡ µû¸¥
ÀÇ·á±Ş¿© Áß º»ÀÎºÎ´ã±İÀÇ °æ¿ì ÀÇ·á±Ş¿© °ü·Ã ¹ı·É¿¡ µû¶ó ÀÇ·á±Ş¿©±â±İ µîÀ¸·ÎºÎÅÍ »çÀü ¶Ç´Â »çÈÄ È¯±ŞÀÌ °¡´ÉÇÑ ±İ¾×(¡¸ÀÇ·á±Ş¿©¹ı¡¹¿¡ µû¸¥ º»ÀÎºÎ´ã±İ º¸»ó
Á¦ ¹× º»ÀÎºÎ´ã±İ »óÇÑÁ¦) 4 °Ç°­°ËÁø, ¿¹¹æÁ¢Á¾, ÀÎ°øÀ¯»ê¿¡ µç ºñ¿ë 5. ¿µ¾çÁ¦, ºñÅ¸¹ÎÁ¦ µîÀÇ ¾àÁ¦¿Í °ü·ÃÇÏ¿© ¼Ò¿äµÈ ºñ¿ë 6 ´ÙÀ½ÀÇ ¾î´À ÇÏ³ª¿¡ ÇØ´çÇÏ´Â Ä¡·á
·Î ÀÎÇÏ¿© ¹ß»ıÇÑ ÀÇ·áºñ °¡. ´Ü¼øÇÑ ÇÇ·Î ¶Ç´Â ±ÇÅÂ ³ª ÁÖ±Ù±ú, ´Ù¸ğ, ¹«¸ğ, ¹é¸ğÁõ, µş±âÄÚ (ÁÖ»çºñ), Á¡, ¸ğ¹İ, »ç¸¶±Í, ¿©µå¸§, ³ëÈ­Çö»óÀ¸·Î ÀÎÇÑ Å»¸ğ µî ÇÇºÎÁú
È¯ ´Ù. ¹ß±âºÎÀü¡¤ºÒ°¨Á¾, ´Ü¼ø ÄÚ°ñÀ½, Ä¡·á¸¦ µ¿¹İÇÏÁö ¾Ê´Â ´Ü¼øÆ÷°æ, ¡¸±¹¹Î°Ç°­º¸Çè ¿ä¾ç±Ş¿©ÀÇ ±âÁØ¿¡ °üÇÑ ±ÔÄ¢ Á¦9Á¶ Á¦1Ç×([º°Ç¥2] ºñ±Ş¿©´ë»ó)¿¡ µû¸¥
|¾÷¹« ¶Ç´Â ÀÏ»ó»ıÈ°¿¡ ÁöÀåÀÌ ¾ø´Â °Ë¿­¹İ µ¿ ¾È°úÁúÈ¯ 7. ÀÇÄ¡, ÀÇ¼öÁ·, ÀÇ¾È, ¾È°æ, ÄÜÅÃÆ®·»Áî, º¸Ã»±â, ¸ñ¹ß, ÆÈ°ÉÀÌ, º¸Á¶±â µî Áø·á Àç·áÀÇ ±¸ÀÔ ¹× ´ëÃ¼ ºñ¿ë
8 ´ÙÀ½ÀÇ ±¹¹Î°Ç°­º¸Çè ºñ±Ş¿© ´ë»óÀ¸·Î ½ÅÃ¼ÀÇ ÇÊ¼ö ±â´É°³¼± ¸ñÀûÀÌ ¾Æ´Ñ ¿Ü¸ğ°³¼± ¸ñÀûÀÇ Ä¡·á·Î ÀÎÇÏ¿© ¹ß»ıÇÑ ÀÇ·áºñ°¡ ½Ö²¨Ç®¼ö¼ú, ÄÚ¼ºÇü¼ö¼ú, À¯¹æÈ®´ë
Ãà¼Ò¼ú, Áö¹æÈíÀÔ¼ú, ÁÖ¸§»ìÁ¦°Å¼ú µî ³ª »ç½Ã±³Á¤, ¾È¿Í°İ¸®ÁòÀÇ ±³Á¤ µî ½Ã°¢°è ¼ö¼ú·Î¼­ ½Ã·Â°³¼± ¸ñÀûÀÌ ¾Æ´Ñ ¿Ü¸ğ°³¼± ¸ñÀûÀÇ ¼ö¼ú ´Ù. ¾È°æ, ÄÜÅÃÆ®·»Áî µî
À» ´ëÃ¼ÇÏ±â À§ÇÑ ½Ã·Â±³Á¤¼ú(±¹¹Î°Ç°­º¸Çè ¿ä¾ç±Ş¿© ´ë»ó ¼ö¼ú¹æ¹ı ¶Ç´Â Ä¡·áÀç·á°¡ »ç¿ëµÇÁö ¾ÊÀº ºÎºĞÀº ½Ã·Â±³Á¤¼ú·Î µË´Ï´Ù)¶ó ¿Ü¸ğ°³¼± ¸ñÀûÀÇ ´Ù¸® Á¤¸Æ·ù
¼ö¼ú ¸¶ ±× ¹Û¿¡ ¿Ü¸ğ°³¼± ¸ñÀûÀÇ Ä¡·á·Î ±¹¹Î°Ç°­º¸Çè ºñ±Ş¿©´ë»ó¿¡ ÇØ´çÇÏ´Â Ä¡·á 9. Áø·á¿Í ¹«°üÇÑ °¢Á¾ ºñ¿ë, ÀÇ»çÀÇ ÀÓ»óÀû ¼Ò°ß°ú °ü·ÃÀÌ ¾ø´Â °Ë»çºñ¿ë, °£
º´ºñ 10 »êÀçº¸Çè¿¡¼­ º¸»ó¹Ş´Â ÀÇ·áºñ 11 »ç¶÷¸é¿ª°áÇÌ¹ÙÀÌ·¯½º(HIV) °¨¿°À¸·Î ÀÎÇÑ Ä¡·áºñ+2 ¡¸±¹¹Î°Ç°­º¸Çè¹ı Á¦42Á¶ÀÇ ¿ä¾ç±â°üÀÌ ¾Æ´Ñ ¿Ü±¹¿¡ ÀÖ´Â ÀÇ
'·á±â°ü¿¡¼­ ¹ß»ıÇÑ ÀÇ·áºñ 13 ¡¸¿ò±ŞÀÇ·á¿¡ °üÇÑ ¹ı·ü ¹× µ¿ ½ÃÇà±ÔÄ¢¿¡¼­ Á¤ÇÑ ÀÀ±ŞÈ¯ÀÚ¿¡ ÇØ´çÇÏÁö ¾Ê´Â ÀÚ°¡ ¡¸ÀÇ·á¹ı Á¦3Á¶ÀÇ4¿¡ µû¸¥ »ó±ŞÁ¾ÇÕº´¿ø ÀÀ±Ş½Ç
À» ÀÌ¿ëÇÏ¸é¼­ ¹ß»ıÇÑ ÀÀ±ŞÀÇ·á°ü¸®·á 14 µµ¼öÄ¡·á Ã¼¿ÜÃæ°İÆÄÄ¡·á¡¤Áõ½ÄÄ¡·á·Î ÀÎÇÏ¿© ¹ß»ıÇÑ ºñ±Ş¿©ÀÇ·áºñ 15 ºñ±Ş¿© ÁÖ»ç·á 16. ÀÚ±â°ø¸í¿µ»óÁø´Ü
{MR/MRA}À¸·Î ÀÎÇÏ¿© ¹ß»ıÇÑ ºñ±Ş¿©ÀÇ·áºñ(Á¶¿µÁ¦ ÆÇµ¶·á¸¦ Æ÷ÇÔÇÕ´Ï´Ù) 17 Á¦4È£, Á¦15È£ Á¦16È£¿Í °ü·ÃÇÏ¿© ÀÚµ¿Â÷º¸Çè(°øÁ¦ Æ÷ÇÔ) ¶Ç´Â »êÀçº¸Çè¿¡¼­ ¹ß
»ıÇÑ º»ÀÎºÎ´ãÀÇ·áºñ
|Á¦µµ¼ºÆ¯¾à ¹× ±âÅ¸»çÇ×
º¸Çè·á ÀÚµ¿³³ÀÔ
ÀÚµ¿°»½ÅÀû¿ë´ë»ó
À¯ÀÇ»çÇ×
Á¦µµ¼º Æ¯¾à ¹× ±âÅ¸»çÇ×
¨Ï »ó±â º¸Àå»çÇ×ÀÇ ¼¼ºÎÀûÀÎ ³»¿ëÀº ¾à°ü ¹× °ü°è ¹ı·ÉÀ» µû¸¨´Ï´Ù.
ºÒ¿ÏÀüÆÇ¸ÅÀ²
±¸ºĞ
±è¼±Çü ¸ğÁıÀÚ
¾÷±Ç Æò±Õ
¼Õº¸
»ıº¸
0.00 %
- %
0.02 %
0.06 %
¸ğÁıÁ¡
¸ğÁıÀÚ
±İÃÌ³óÇù
±è¼±Çü
¿¬¶ôÃ³
(201203841 C:04)
031-941-366:
¼³°è¹øÈ£
24-0081-063096
¼³°èÀÏÀÚ 2024-10-08
¹ßÇàÀÏ½Ã 2024-10-08 16:20:03
5/7

NH³óÇù¼ÕÇØº¸Çè
(¹«) °£Æí°¡ÀÔÇì¾Æ¸²½Ç¼ÕÀÇ·áºñº¸Çè2404
²À ¾Æ¼Å¾ßÇÒ »çÇ×
I º¸Çè¿¡ °¡ÀÔÇÏ½Ç ¶§
i º¸Çè°è¾à Ã»¾à¼­¿¡ ±âÀçµÈ ³»¿ëÀ» º¸Çè°è¾àÀÚ º»ÀÎÀÌ ºüÁü¾øÀÌ È®ÀÎÇÏ°í ÀÚÇÊ·Î ¼­¸íÇÏ¼Å¾ß ÇÕ´Ï´Ù.
Á¸ º¸Çè·á°¡ ³³ÀÔµÇÁö ¾ÊÀ» °æ¿ì º» º¸ÇèÀº È¿·ÂÀ» »ó½ÇÇÏ°Ô µÇ¸ç ¼ÕÇØ¹ß»ı½Ã º¸»óÀ» ¹ŞÀ» ¼ö ¾ø½À´Ï´Ù.
Çì¾Æ¸²
Ã»¾à¼­ (È¸»çº¸°ü¿ë)
3 °è¾àÀ» ¸ÎÀ» ¶§¿¡ °è¾àÀü ¾Ë¸± ÀÇ¹«»çÇ×ÀÇ ±âÀç»çÇ×¿¡ °üÇÏ¿© ¹İµå½Ã »ç½Ç´ë·Î ¾Ë·Á ÁÖ¼Å¾ß ÇÕ´Ï´Ù. ¸¸¾à »ç½Ç´ë·Î ¾Ë¸®Áö ¾Ê¾ÒÀ» °æ¿ì ¾à°ü¿¡
ÀÇ°Å ±×¿¡ »óÀÀÇÏ´Â ºÒÀÌÀÍÀ» ´çÇÏ°Ô µË´Ï´Ù.
4 °è¾àÀÚ´Â º¸ÇèÁõ±ÇÀ» ¹ŞÀº³¯ºÎÅÍ 15ÀÏÀÌ³»¿¡ Ã»¾àÀ» Ã¶È¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. ´Ù¸¸, Àü¹®±İÀ¶¼ÒºñÀÚ°¡ Ã¼°áÇÑ º¸Çè°è¾à, Ã»¾àÀÏ·ÎºÎÅÍ 30ÀÏ ÃÊ°ú,
È¸»ç°¡ °Ç°­»óÅÂ Áø´ÜÀ» Áö¿øÇÏ´Â °è¾à, º¸Çè±â°£(º¸Àå±â°£)ÀÌ 90ÀÏ ÀÌ³»ÀÎ °è¾à, ¹ı·ü¿¡ µû¶ó °¡ÀÔÀÇ¹« ºÎ°ú ¹× ÇØÁ¦¡¤ÇØÁö°¡ °¡´ÉÇÑ º¸Çè
(´Ù¸¸, °è¾àÀÚ°¡ µ¿Á¾ÀÇ ´Ù¸¥ º¸Çè¿¡ °¡ÀÔÇÑ °æ¿ì´Â Á¦¿Ü)Àº Ã»¾àÀ» Ã¶È¸ÇÒ ¼ö ¾ø½À´Ï´Ù.
5 È­Àç¼ÕÇØÆ¯¾àÀº °è¾à Ã¼°á½Ã¿¡ º¸Çè¿¡ °¡ÀÔÇÑ ¹°°ÇÀÇ °¡Ä¡(ÀÌÇÏ 'º¸Çè°¡¾×'ÀÌ¶ó ÇÕ´Ï´Ù)¸¦ Æò°¡ÇÏÁö ¾Ê°í »ç°í½Ã º¸Çè°¡¾×À» »êÁ¤ÇÏ¿© º¸Çè°¡ÀÔ
±İ¾×À» ÇÑµµ·Î º¸»óÇÏ´Â ¹ÌÆò°¡ º¸ÇèÀÔ´Ï´Ù. º¸Çè°¡ÀÔ±İ¾×Àº ½Ã°¡¿Í ¶È°°ÀÌ Á¤ÇØ¾ß ÇÕ´Ï´Ù. ¸¸¾à ½Ã°¡º¸´Ù ³·°Ô Á¤ÇÏ¸é ³³ÀÔº¸Çè·á ºÎ´ãÀº ÁÙ¾î
µéÁö¸¸ »ç°í°¡ ¹ß»ıÇÏ¿´À» ¶§ ÁÙ¾îµç ºñÀ²¸¸Å­ Àû°Ô º¸»ó¹Ş°í ³ô°Ô Á¤ÇÏ´õ¶óµµ »ç°í°¡ ¹ß»ıÇÏ¸é ½ÇÁ¦·Î ÀÔÀº ¼ÕÇØ¾×¸¸Å­ º¸»ó¹Ş°Ô µË´Ï´Ù.
6 °¡Àçµµ±¸¸¦ º¸Çè¿¡ °¡ÀÔÇÒ °æ¿ì ±Í±İ¼Ó. ±ÍÁßÇ°(¹«°Ô³ª ºÎÇÇ°¡ ÈŞ´ëÇÒ ¼ö ÀÖÀ¸¸ç Á¡´ç 300¸¸¿øÀÌ»ó). °ñµ¿Ç° µîÀº º°µµ·Î ±âÀçÇÏ¿©¾ß¸¸ º¸»óÀÇ
´ë»óÀÌ µË´Ï´Ù.
¡¤ ¾à°üÀÇ º¸»óÇÏ´Â ¼ÕÇØ¿Í º¸»óÇÏÁö ¾Æ´ÏÇÏ´Â ¼ÕÇØ¸¦ È®ÀÎÇÏ¼Å¾ß ÇÕ´Ï´Ù.
¡Ø º¸Çè±İ ¼öÀÍÀÚÀÇ ÁöÁ¤¿¡ °üÇÑ »çÇ×
°è¾àÀÚ´Â »ç¸Áº¸Çè±İ, Áßµµº¸Çè±İ, ¸¸±âº¸Çè±İ, ÀåÇØº¸Çè±İ, ÀÔ¿øº¸Çè±İ µî ¾à°ü»ó º¸Çè±İ Áö±Ş»çÀ¯°¡ ¹ß»ıÇÏ´Â ¶§¿¡ È¸»ç¿¡ º¸Çè±İÀ»
Ã»±¸ÇÏ¿© ¹ŞÀ» ¼ö ÀÖ´Â »ç¶÷(º¸Çè¼öÀÍÀÚ)À» ÁöÁ¤ÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
»ç¸Áº¸Çè±İ ¼öÀÍÀÚ¸¦ ÁöÁ¡/º¯°æÇÏ°íÀÚ ÇÒ °æ¿ì¿¡´Â »ç¸Áº¸Çè±İ Áö±Ş»çÀ¯°¡ ¹ß»ıÇÏ±â Àü¿¡ ÇÇº¸ÇèÀÚ°¡ ¼­¸éÀ¸·Î µ¿ÀÇÇØ¾ß ÇÕ´Ï´Ù.
¸¸¾à °è¾àÀÚ°¡ º¸Çè ¼öÀÍÀÚ¸¦ ÁöÁ¤ÇÏÁö ¾ÊÀº ¶§¿¡´Â ¹Î¹ı»ó ÇÇº¸ÇèÀÚÀÇ ¹ıÁ¤»ó¼ÓÀÎ ¼øÀ§·Î º¸Çè¼öÀÍÀÚ¸¦ Á¤ÇÕ´Ï´Ù.
¹Î¹ı»ó ¹ıÁ¤»ó¼ÓÀÎ ¼øÀ§ : 1. Á÷°èºñ¼Ó. 2. Á÷°èÁ¸¼Ó. 3. ÇüÁ¦ÀÚ¸Å. 4. 4ÃÌ ÀÌ³»ÀÇ ¹æ°è Ç÷Á·
¹è¿ìÀÚ´Â À§ÀÇ 1. 2¼øÀ§ »ó¼ÓÀÎÀÌ ÀÖ´Â °æ¿ì¿¡ ±× »ó¼ÓÀÎ°ú µ¿¼øÀ§·Î °øµ¿»ó¼ÓÀÎÀÌ µÇ°í, ±× »ó¼ÓÀÎÀÌ ¾ø´Â ¶§¿¡´Â ´Üµ¶»ó¼ÓÀÎÀÌ µÊ
(¼öÀÍÀÚ ÁöÁ¤/º¯°æ µî¿¡ ÇÊ¿äÇÑ}±¸ºñ¼­·ù : (°è¾àÀÚ ¹× ÇÇº¸ÇèÀÚ¿Í º¯°æ ÈÄ ¼öÀÍÀÚ) °¢ ½ÅºĞÁõ [¼ö¿ªÀÚ ÁöÁ¤ °ü·Ã ¹®ÀÇ : Äİ¼¾ÅÍ(1644-9000)]
¢Ñ º¸Çè¿¡ °¡ÀÔÇÏ½Å ÈÄ
d. º¸ÇèÁõ±ÇÀ» ¹ŞÀ¸½Ã¸é Ã»¾à¼­ ³»¿ë°ú ´Ù¸§ÀÌ ¾ø´Â Áö ¶Ç´Â ´©¶ôÀÌ ¾ø´Â Áö È®ÀÎÇÏ½Ã±â ¹Ù¶ø´Ï´Ù.
1 Ã»¾à¼­ ±âÀç»çÇ×¿¡ º¯µ¿»çÇ×(ÇÇº¸ÇèÀÚÀÇ Á÷¾÷ ¹× Á÷¹«ÀÇ º¯°æ, º¸Çè¸ñÀûÀÇ ¾çµµ, °Ç¹° ±¸Á¶ ¶Ç´Â ¿ëµµÀÇ º¯°æ, º¸Çè¸ñÀûÀ» ´Ù¸¥ Àå¼Ò·Î ¿Å±â´Â
°æ¿ì, ¼ö¸®ÇÏ´Â °æ¿ì µî)ÀÌ ÀÖ°Å³ª ´Ù¸¥ º¸Çè¿¡ °¡ÀÔÇÏ½Ç °æ¿ì È¸»ç¿¡ Áï½Ã ¿¬¶ôÇÏ½Ã±â ¹Ù¶ø´Ï´Ù.
3 º¸Çè°è¾àÀÇ ³»¿ëÀ» º¯°æÇÏ°íÀÚ ÇÒ °æ¿ì¿¡´Â È¸»çÀÇ ½Â³«À» ¾ò¾î¾ß ÇÕ´Ï´Ù.
4 ¼ÕÇØ°¡ »ı±ä °æ¿ì¿¡´Â ÁöÃ¼¾øÀÌ ÀÌ¸¦ È¸»ç¿¡ ¾Ë·Á¼­ ÇÊ¿äÇÑ ÀıÂ÷¸¦ ¾È³» ¹ŞÀ¸½Ã±â ¹Ù¶ø´Ï´Ù.
5 º¸Çè±İ Áö±Ş»çÀ¯ÀÇ Á¶»ç ¹× È®ÀÎÀ» À§ÇÏ¿© º¸Çè±İ Áö±Ş±âÀÏ ÃÊ°ú°¡ ¸í¹éÈ÷ ¿¹»óµÇ´Â °æ¿ì¿¡´Â ÇÇº¸ÇèÀÚ ¶Ç´Â ¼öÀÍÀÚÀÇ Ã»±¸¿¡ µû¶ó È¸»ç°¡ ÃßÁ¤
ÇÏ´Â º¸Çè±İÀÇ 50% »ó´ç¾×À» °¡Áö±Şº¸Çè±İÀ¸·Î Áö±ŞÇÏ¿© µå¸³´Ï´Ù.
[
½Ç¼ÕÀÇ·áºñ¸¦ °¡ÀÔÇÏ½Å °æ¿ì
ÀÌ º¸Çè°è¾à¿¡¼­ º¸ÀåÇÏ´Â ½Ç¼ÕÀÇ·áºñ´Â µ¿ ºñ¿ëÀ» ´ãº¸ÇÏ´Â ´Ù¼öÀÇ º¸Çè°è¾à¿¡ Ã¼°áµÇ¾î ÀÖ´Â °æ¿ì, ¾à°ü¿¡ µû¶ó ºñ·ÊÇÏ¿© º¸»óÇÕ´Ï´Ù.
´Ù¸¸, ÀÌ¹Ì °¡ÀÔµÈ º¸Çè °è¾à¿¡¼­ º¸»óÇÑ ±İ¾×ÀÌ º»ÀÎÀÌ ºÎ´ãÇÑ ÀÇ·áºñ¸¦ ÃÊ°úÇÏ¿´À» ¶§¿¡´Â º¸Çè±İÀÌ Áö±ŞµÇÁö ¾ÊÀ» ¼ö ÀÖ½À´Ï´Ù.
( °»½ÅÇü ½Ç¼ÕÀÇ·áºñ Æ¯º°¾à°üÀº ±âº»°è¾à º¸Çè±â°£ ÀÌ³»¿¡¼­ ¸Å 1³â¸¶´Ù ÀÚµ¿°»½ÅµÇ¸ç, °»½Å½Ã ¿¬·ÉÀÇ Áõ°¡¿Í Àû¿ë¿äÀ² µîÀÇ º¯µ¿¿¡ µû¶ó
º¸Çè·á°¡ ´Ş¶ó Áú ¼ö ÀÖÀ¸¸ç, º¸Çè·á ÀÎ»ó½Ã¿¡´Â Ãß°¡³³ÀÔ ÇÏ¿©¾ß °è¾àÀÌ À¯ÁöµË´Ï´Ù.
3 ÇÇº¸ÇèÀÚ°¡ µ¿ÀÏÇÑ È¸»ç¿¡ º¸Çè±â°£ÀÌ 3°³¿ù ÀÌ»óÀÎ ÇØ¿Ü½Ç¼ÕÀÇ·áºñ¿¡ °¡ÀÔÇÏ°í, ¿¬¼ÓÇÏ¿© 3°³¿ùÀÌ»óÀÇ ÇØ¿Ü Ã¼·ù»ç½ÇÀÌ È®ÀÎµÇ´Â °æ¿ì
½Ç¼ÕÀÇ·áº¸ÇèÀÇ º¸Çè·á³³ÀÔÀ» ÀÏÁ¤±â°£ ÁßÁöÇØÁÖ°Å³ª »çÈÄ¿¡ ÇØ´ç ±â°£ÀÇ Ç¥ÁØÈ­½Ç¼Õ»óÇ°(2009³â 10¿ù 1ÀÏ ÀÌÈÄ)ÀÇ º¸Çè·á¸¦ È¯±Ş½ÅÃ»
ÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù. È¯±Ş½ÅÃ» ÇÊ¿ä¼­·ù:ÃâÀÔ±¹¿¡ ´ëÇÑ »ç½ÇÁõ¸í. È¯±Ş½ÅÃ»¼­(´ç»ç¾ç½Ä)
Áú±Ç¼³Á¤ »çÇ×
Áú±Ç¼³Á¤ ±¸ºĞ
: »ç°íº¸Çè±İ
[È¯±Ş±İ
Áú±Ç¼³Á¤±İ¾×
±İ
¿øÁ¤
¡á Áú±Ç±â°£ :
³â
¿ù
ÀÏ
³â
ÀÏ
¡á Áú±ÇÀÚ(±İÀ¶±â°ü) :
¡á ¸ñÀû¹°¼ÒÀ¯ÀÚ ¶Ç´Â ¼öÀÍÀÚ µ¿ÀÇ :
º¸Çè°è¾àÀÚ
Ã»¾àÃ¶È¸ Ã»±¸¼­
Ã»¾àÃ¶È¸ Ã»±¸ ¾È³»
º»ÀÎÀº ±Í»ç¿¡ Ã»¾àÇÑ °è¾àÀ» Ã¶È¸ÇÏ°íÀÚ ÇÏ¿À´Ï ³³ÀÔÇÑ 1È¸º¸Çè·á¸¦
µ¹·Á ÁÖ½Ã±â ¹Ù¶ø´Ï´Ù.
½ÅÃ»ÀÏ
³â
¿ù
°è¾àÀÚ(¼º¸í) :
ÁÖ¼Ò
ÀÔ±İ°èÁÂ
ÀºÇà
¿¹±İÁÖ(°è¾àÀÚ) :
°èÁÂ¹øÈ£
1. °è¾àÀÚ´Â º¸ÇèÁõ±ÇÀ» ¹ŞÀº ³¯ ºÎÅÍ 15ÀÏÀÌ³»¿¡ Ã»¾àÀ» Ã¶È¸ÇÒ ¼ö
ÀÖ½À´Ï´Ù. ´Ù¸¸, Àü¹®±İÀ¶¼ÒºñÀÚ°¡ Ã¼°áÇÑ º¸Çè°è¾à, Ã»¾àÀÏºÎÅÍ
30ÀÏ ÃÊ°ú, È¸»ç°¡ °Ç°­»óÅÂ Áø´ÜÀ» Áö¿øÇÏ´Â °è¾à, º¸Çè±â°£(º¸Àå±â
°£)ÀÌ 90ÀÏ ÀÌ³»ÀÎ °è¾à, ¹ı·ü¿¡ µû¶ó °¡ÀÔÀÇ¹« ºÎ°ú ¹× ÇØÁ¦¡¤ÇØÁö°¡
°¡´ÉÇÑ º¸Çè(´Ù¸¸, °è¾àÀÚ°¡ µ¿Á¾ÀÇ ´Ù¸¥ º¸Çè¿¡ °¡ÀÔÇÑ °æ¿ì´Â Á¦¿Ü)
Àº Ã»¾àÀ» Ã¶È¸ÇÒ ¼ö ¾ø½À´Ï´Ù.
2. ÀúÈñ È¸»ç´Â Ã»¾àÃ¶È¸ Ã»±¸¼­¸¦ Á¢¼öÇÑ °æ¿ì ÁöÃ¼¾øÀÌ ÀÌ¹Ì ³³ÀÔÇÑ
º¸Çè·á¸¦ µ¹·Áµå¸³´Ï´Ù.
3. Ã»¾àÃ¶È¸ Ã»±¸¼­¸¦ ¹ß¼ÛÇÑ ³¯ ÀÌÈÄ(¹ß¼ÛÀÏ Æ÷ÇÔ)¿¡ ¹ß»ıÇÑ º¸Çè±İ
Áö±Ş»çÀ¯¿¡ ´ëÇØ¼­´Â È¸»ç°¡ Ã¥ÀÓÀ» ÁöÁö ¾Æ´ÏÇÏ¸ç, ÀÔ±İÃ³ÀÇ
°Å·¡ÀºÇà ¿¹±İÁÖ´Â °è¾àÀÚ¿Í µ¿ÀÏÇØ¾ß ÇÕ´Ï´Ù.
¡ØÄİ¼¾ÅÍ À¯¼±½ÅÃ», ¿ìÆí½ÅÃ» ¶Ç´Â ÀÎÅÍ³İ ½ÅÃ» µî¿¡ ÀÇÇÏ¿©µµ °¡´ÉÇÕ´Ï´Ù.
¸ğÁıÁ¡
¸ğÁıÀÚ
±İÃÌ³óÇù
±è¼±Çü
(20120384110104)
¿¬¶ôÃ³ 031-941-3661
¼³°è¹øÈ£ 241008-1-063096
¼³°èÀÏÀÚ 2024-10-08
¹ßÇàÀÏ½Ã 2024-10-08-6:20:03
6/7

NH³óÇù¼ÕÇØº¸Çè
°è¾à Àü ¾Ë¸± ÀÇ¹«»çÇ×(°£Æí°¡ÀÔ½Ç¼Õ) (È¸»ç º¸°ü¿ë)
Çì¾Æ¸²
Ã»¾à¹øÈ£ : 241008-1-066502
ÇÇº¸ÇèÀÚ : ÀÌ±¤¿í
ÇÇº¸ÇèÀÚ(º¸Çè´ë»óÀÚ)¿¡ °üÇÑ ´ÙÀ½ »çÇ×Àº È¸»ç°¡ º¸Çè°è¾àÀÇ Ã»¾àÀ» ½É»çÇÏ°í ÀÎ¼öÇÏ´Âµ¥ ÇÊ¿äÇÑ ÀÚ·áÀÌ¹Ç·Î º¸Çè°è¾àÀÚ ¹× ÇÇº¸ÇèÀÚ´Â
¾Æ·¡ Áú¹®µé¿¡ ´ëÇØ »ç½Ç´ë·Î ¾Ë·Á¾ß ÇÏ¸ç Á÷Á¢ ÀÛ¼ºÇÏ½Ã±â ¹Ù¶ø´Ï´Ù. ¸¸¾à ¾Æ·¡ Áú¹®µé¿¡ ´ëÇÏ¿© »ç½Ç´ë·Î ¾Ë¸®Áö ¾Ê°Å³ª »ç½Ç°ú ´Ù¸£°Ô ¾Ë¸°
°æ¿ì¿¡´Â º¸Çè°¡ÀÔÀÌ °ÅÀıµÉ ¼ö ÀÖÀ¸¸ç, Æ¯È÷ ±× ³»¿ëÀÌ
ÇÇº¸ÇèÀÚ¿¡°Ô °íÁöÇÒ ±âÈ¸¸¦ ÁÖÁö ¾Ê¾Ò°Å³ª »ç½Ç´ë·Î °íÁöÇÏ´Â °ÍÀ» ¹æÇØÇÏ´Â µîÀÇ °æ¿ì¿¡´Â
¡Ø ÇÇº¸ÇèÀÚ ±âÁØÀ¸·Î ÀÛ¼ºÇØÁÖ½Ã±â ¹Ù¶ø´Ï´Ù.
¹İ¸é, º¸Çè¸ğÁıÀÚ µîÀÌ º¸Çè°è¾àÀÚ ¶Ç´Â
¡¸Áß¿äÇÑ »çÇ×¡¹ ÀÌ¶õ È¸»ç°¡ ±× »ç½ÇÀ» ¾Ë¾Ò´õ¶ó¸é º¸Çè°è¾àÀÇ Ã»¾àÀ» °ÅÀıÇÏ°Å³ª º¸Çè°¡ÀÔ±İ¾× ÇÑµµ Á¦ÇÑ, ÀÏºÎ º¸Àå Á¦¿Ü, º¸Çè±İ »è°¨,
º¸Çè·á ÇÒÁõ°ú °°ÀÌ Á¶°ÇºÎ·Î ÀÎ¼öÇÏ´Â µî °è¾àÀÎ¼ö¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â »çÇ×À» ¸»ÇÕ´Ï´Ù.
¡Øº¸Çè·áÀÇ ³³ÀÔ¿¬Ã¼·Î ÀÎÇÑ ÇØÁö°è¾àÀ» ºÎÈ°(È¿·ÂÈ¸º¹)ÇÏ´Â °æ¿ì, °¢ Ç×¸ñÀÇ ¾Ë¸±ÀÇ¹« ±â°£Àº ÇØÁöÀÏÀÌÈÄ·ÎºÎÅÍ ºÎÈ°(È¿·ÂÈ¸º¹)À» Ã»¾àÇÑ ³¯±îÁöÀÇ
±â°£°ú °¢ Áú¹®º° ¾Ë¸±ÀÇ¹« ±âÁØ Áß ÂªÀº ±â°£À¸·Î ÇÕ´Ï´Ù.
°è¾à Àü ¾Ë¸± ÀÇ¹«»çÇ×
¿¹
¾Æ´Ï¿À
1
2
ÃÖ±Ù 3°³¿ù ÀÌ³»¿¡ ÀÇ»ç·ÎºÎÅÍ ÁøÂû¡¤°Ë»ç(°Ç°­°ËÁø Æ÷ÇÔ)¸¦ ¹Ş°í, ´ÙÀ½°ú °°Àº ÀÇ·áÇàÀ§¸¦ ¹ŞÀº »ç½ÇÀÌ ÀÖ½À´Ï±î?
ÀÔ¿ø ÇÊ¿ä ¼Ò°ß ¼ö¼ú ÇÊ¿ä ¼Ò°ß Ä¡·á Ãß°¡°Ë»ç(Àç°Ë»ç) ÇÊ¿ä ¼Ò°ß Áúº´È®Á¤Áø´Ü Áúº´ÀÇ½É¼Ò°ß
* ÇÊ¿ä¼Ò°ßÀÌ¶õ ÀÇ»ç·ÎºÎÅÍ Áø´Ü¼­, ¼Ò°ß¼­¸¦ ¹ß±Ş¹ŞÀº °æ¿ì ¶Ç´Â ÀÇ»ç°¡ Áø·á±â·ÏºÎµî¿¡ ±âÀçÇÏ°í ÀÌ¸¦ È¯ÀÚ¿¡
°Ô ¼³¸íÇÏ°Å³ª ±ÇÀ¯ÇÑ °æ¿ì¸¦. Áúº´ÀÇ½É¼Ò°ßÀÌ¶õ ÀÇ»ç°¡ Áø´Ü¼­, ¼Ò°ß¼­, Áø·áÀÇ·Ú¼­ µîÀ» Æ÷ÇÔÇØ ¼­¸é(ÀüÀÚ¹®¼­
Æ÷ÇÔ)À¸·Î ±³ºÎÇÑ °æ¿ì¸¦, Ãß°¡°Ë»ç(Àç°Ë»ç)¶õ °Ë»ç°á°ú ÀÌ»ó ¼Ò°ßÀÌ È®ÀÎµÇ¾î º¸´Ù Á¤È®ÇÑ Áø´ÜÀ» À§ÇØ ½ÃÇàÇÑ
°Ë»ç(º´Áõ¿¡ ´ëÇÑ Ä¡·áÇÊ¿ä¾øÀÌ À¯ÁöµÇ´Â »óÅÂ¿¡¼­ ½ÃÇàÇÑ Á¤±â°Ë»ç ¶Ç´Â ÃßÀû°üÂû ¹ÌÆ÷ÇÔ)¸¦ ¸»ÇÕ´Ï´Ù.
¡Ø Ä¡·á´Â ´Ü¼ø Ã³¹æÀ» À§ÇÏ¿© º´¿ø¿¡¼­ Áø·á¸¦ ¹Ş´Â °æ¿ì´Â Æ÷ÇÔÇÏÁö ¾Ê½À´Ï´Ù.
ÃÖ±Ù 2³â ÀÌ³»¿¡ ÀÇ»ç·ÎºÎÅÍ ÁøÂû ¶Ç´Â °Ë»ç¸¦ ¹Ş°í, ÀÌ¸¦ ÅëÇÏ¿© ´ÙÀ½°ú °°Àº ÀÇ·áÇàÀ§¸¦ ¹ŞÀº »ç½ÇÀÌ ÀÖ½À´Ï±î?
ÀÔ¿ø
¼ö¼ú(Á¦¿ÕÀı°³ Æ÷ÇÔ)
°è¼ÓÇÏ¿© 7ÀÏ ÀÌ»ó Ä¡·á
¡Ø¿©±â¼­ '°è¼ÓÇÏ¿© ¶õ °°Àº ¿øÀÎÀ¸·Î Ä¡·á ½ÃÀÛÈÄ ¿Ï·áÀÏ±îÁö ½ÇÁ¦ Ä¡·á¹ŞÀº ÀÏ¼ö¸¦ ¸»ÇÕ´Ï´Ù.
.....
3 ÃÖ±Ù 5³â ÀÌ³»¿¡ ¾Ï(¹éÇ÷º´Á¦¿Ü)À¸·Î Áø´Ü¹Ş°Å³ª ¾Ï(¹éÇ÷º´Á¦¿Ü)À¸·Î ÀÔ¿ø ¶Ç´Â ¼ö¼ú, Ä¡·á¸¦ ¹ŞÀº »ç½ÇÀÌ ÀÖ½À´Ï±î?
±ÍÇÏÀÇ Á÷¾÷Àº ¹«¾ùÀÔ´Ï±î? ±Ù¹«Ã³ (
±Ù¹«Áö¿ª (
4
¾çÆò
ÀÚÅÃ
) ¾÷Á¾ ( Ã¤¼ÒÀÛ¹°Àç¹è
ÇÏ½Ã´Â ÀÏ
Ã¤¼ÒÀÛ¹°Àç¹è
(Á÷Á¢±âÀç) (Àü»ê¿¡ ÀÔ·ÂµÈ Á÷¾÷:
Ã¤¼ÒÀÛ¹°Àç¹è
¡Øº¸Çè°è¾à Ã¼°á ´ç½Ã Á÷¾÷ ¶Ç´Â Á÷¹«¸¦ »ç½Ç´ë·Î ¾Ë¸®Áö ¾Ê°Å³ª º¸Çè°è¾à Ã¼°á ÈÄ Á÷¾÷ ¶Ç´Â Á÷¹«°¡ º¯°æµÈ »ç½Ç (¿¹:»ç¹«
°ü¸®>ÇöÀå°ü¸®)À» ÁöÃ¼¾øÀÌ È¸»ç¿¡ ¾Ë¸®Áö ¾ÊÀº °æ¿ì °è¾à ÇØÁö µî ¾Ë¸±ÀÇ¹« À§¹İ¿¡ µû¸¥ ºÒÀÌÀÍÀÌ ¹ß»ıÇÒ ¼ö ÀÖ½À´Ï´Ù.
ÇöÀç ¿îÀüÀ» ÇÏ°í ÀÖ½À´Ï±î? (¸ğµÎ Ç¥½Ã)
½Â¿ëÂ÷(¿µ¾÷¿ë) ½Â¿ëÂ÷(ÀÚ°¡¿ë)
ÀÌ·ûÀÚµ¿Â÷(50cc¹Ì¸¸ Æ÷ÇÔ)(¿µ¾÷¿ë)
±âÅ¸(
½ÂÇÕÂ÷(¿µ¾÷¿ë) - ½ÂÇÕÂ÷(ÀÚ°¡¿ë)
È­¹°Â÷(¿µ¾÷¿ë) È­¹°Â÷(ÀÚ°¡¿ë)
ÀÌ·ûÀÚµ¿Â÷(50cc¹Ì¸¸ Æ÷ÇÔ)(ÀÚ°¡¿ë) °Ç¼³±â°è(ÁßÀåºñ) - ³ó±â°è
)
5
¿øµ¿±âÀåÄ¡ ÀÚÀü°Å(Àüµ¿Å±º¸µå Àüµ¿ÈÙ µ¿À» Æ÷ÇÔÇÏ¸ç, Àå¾ÖÀÎ ¶Ç´Â ±³Åë¾àÀÚ°¡ »ç¿ëÇÏ´Â º¸Çàº¸Á¶¿ë ÀÇÀÚÂ÷ÀÎ Àüµ¿ÈÙÃ¼¾î, ÀÇ·á¿ë ½ºÄíÅÍ µîÀº Á¦¿Ü)
*±âÅ¸¿¡ ÇØ´çÇÏ´Â °æ¿ì Â÷Á¾À» ±¸Ã¼ÀûÀ¸·Î ±âÀçÇÏ°í, µÑ ÀÌ»óÀÇ Â÷·®À» ¿îÀüÇÏ°Å³ª ÇÏ³ªÀÇ Â÷·®À» µÑ ÀÌ»óÀÇ ¸ñÀûÀ¸·Î »ç¿ëÇÏ´Â °æ¿ì ÇØ´çµÇ´Â »çÇ×À» ¸ğµÎ ±âÀçÇÏ½Ê½Ã¿À.
¡ÙÀÌ·ûÀÚµ¿Â÷(¿øµ¿±âÀåÄ¡ÀÚÀü°Å Æ÷ÇÔ)¸¦ °è¼ÓÀûÀ¸·Î »ç¿ë(Á÷¾÷, Á÷¹« ¶Ç´Â µ¿È£È¸ È°µ¿°ú ÃâÅğ±Ù¿ëµµ µîÀ¸·Î ÁÖ·Î »ç¿ëÇÏ´Â °æ¿ì¿¡ ÇÑÇÔ)ÇÏ´Â °æ¿ì ±âÀç
?
ÀÌ·ûÀÚµ¿Â÷ ÀÚµ¿Â÷°ü¸®¹ı»ó ÀÌ·ûÂ÷·Î ºĞ·ùµÇ´Â »ï·û ¶Ç´Â »ç·û ÀÚµ¿Â÷¸¦Æ÷ÇÔ
*
¿øµ¿±âÀåÄ¡ÀÚÀü°Å: Àüµ¿Å±º¸µå, Àüµ¿ÀÌ·ûÆòÇàÂ÷, Àüµ¿±âÀÇ µ¿·Â¸¸À¸·Î ¿òÁ÷ÀÏ ¼ö ÀÖ´Â ÀÚÀü°Å µî °³ÀÎÇü ÀÌµ¿ÀåÄ¡¸¦ Æ÷ÇÔ
¡Øº» Áú¹®¿¡ ¾Æ´Ï¿À·Î ±âÀçÇÏ°í º¸Çè°è¾à Ã¼°á ÈÄ ÀÌ·ûÀÚµ¿Â÷ ¶Ç´Â Àüµ¿Å±º¸µå µî °³ÀÎÇüÀÌµ¿ÀåÄ¡¸¦ Æ÷ÇÔÇÑ ¿øµ¿±âÀåÄ¡ÀÚÀü°Å¸¦ »ç¿ëÇÏ°Ô µÈ »ç½ÇÀ» ÁöÃ¼¾øÀÌ
È¸»ç¿¡ ¾Ë¸®Áö ¾ÊÀº °æ¿ì °è¾àÇØÁö µî ¾Ë¸±ÀÇ¹« À§¹İ¿¡ µû¸¥ ºÒÀÌÀÍÀÌ ¹ß»ıÇÒ ¼ö ÀÖ½À´Ï´Ù.
6 ¿ùÆò±Õ¼Òµæ(°è¾àÀÚ ±âÁØ) : (
0
)¸¸¿ø ¡Ø »ç½Ç°ú ´Ù¸£°Ô ¾Ë¸± °æ¿ì º¸Çè°¡ÀÔÀÌ °ÅÀı µÉ ¼ö ÀÖ½À´Ï´Ù.
LW002410081066502
0105524471
V
1/2

NH³óÇù¼ÕÇØº¸Çè
°è¾à Àü ¾Ë¸± ÀÇ¹«»çÇ×(°£Æí°¡ÀÔ½Ç¼Õ) (È¸»ç º¸°ü¿ë)
Ã»¾à¹øÈ£ : 241008-1-066502
Çì¾Æ¸²
ÇÇº¸ÇèÀÚ : ÀÌ±¤¿í
¤±¤±
DOD
mm
º¸Çè¿¡ ¸¶À½À» ´õÇÕ´Ï´Ù Çì¾Æ¸²
|
º¸Çè¸ğÁıÀÚ´Â °è¾àÀü
´Ş¸±ÀÇ¹«
»çÇ×¿¡ ´ëÇÑ ¼ö·É±ÇÇÑÀÌ ¾øÀ¸¹Ç·Î °ú°ÅÀÇ Áø´Ü ¶Ç´Â Ä¡·á »ç½Ç µî Áß¿äÇÑ ³»¿ëÀ»
(¾Ë¸±ÀÇ¹«)
±¸µÎ
·Î¸¸ ¾Ë¸± °æ¿ì °è¾àÀü ¾Ë¸± ÀÇ¹«¸¦ ÀÌÇàÇÑ °ÍÀ¸·Î ÀÎÁ¤µÇÁö ¾Ê¾Æ ÇâÈÄ °è¾àÀÌ
ÇØÁö
µÇ°Å³ª º¸Çè±İÀ»
(±¸µÎ)
(ÇØÁö)
Áö±Ş¹ŞÁö ¸øÇÒ ¼ö ÀÖ½À´Ï´Ù.
?º¸Çè°è¾àÀÚ ÀÌÁ¶ÈÆ (Àº)´Â º¸Çè¸ğÁıÀÚ ±è¼±Çü (À¸)·ÎºÎÅÍ °è¾àÀü ¾Ë¸±ÀÇ¹« À§¹İ½ÃÀÇ È¿°ú(°è¾àÇØÁö, º¸ÀåÁ¦ÇÑ,
º¸Çè±İ ¹ÌÁö±Ş µî)¿¡ ´ëÇØ ¼³¸íÀ» µé¾úÀ¸¸ç, °è¾àÀü ¾Ë¸±ÀÇ¹« »çÇ×¿¡ ´ëÇØ Ã»¾à¼­¿¡ »ç½Ç´ë·Î ±âÀçÇÏ¿´À½À» È®ÀÎÇÕ´Ï´Ù.
À§ÀÇ °¢ °è¾à Àü ¾Ë¸± ÀÇ¹« »çÇ×¿¡ ´ëÇÑ
ÇÏ¸ç, º¸Çè°è¾àÀÚ ¹× ÇÇº¸ÇèÀÚ(º¸Çè´ë»óÀÚ) º»ÀÎÀÌ Á÷Á¢
´äº¯ ³»¿ëÀº »ç½Ç°ú ÀÏÄ¡
(´äº¯³»¿ëÀº »ç½Ç°ú ÀÏÄ¡)
ÀÛ¼ºÇÏ¿´À½À» È®ÀÎÇÕ´Ï´Ù. ¶ÇÇÑ È¸»ç°¡ À§ »çÇ×°ú °ü·ÃÇÏ¿© ÇÊ¿ä½Ã¿¡´Â º°µµÀÇ È®ÀÎÀ» ÇÒ ¼ö ÀÖÀ¸¸ç ÀÇ»ç¿¡°Ô º»ÀÎÀÇ Áúº´ µîÀÇ
°Ç°­ »óÅÂ¸¦ Á¶È¸ÇÏ°Å³ª ¿­¶÷Åä·Ï ÇÏ´Â°Í¿¡ µ¿ÀÇÇÕ´Ï´Ù.
ÀÚÇÊ¼­¸í
±¸ºĞ
º¸Çè°è¾àÀÚ
ÇÇº¸ÇèÀÚ
¼º¸í
ÀÌÁ¶ÈÆ
ÀÌ±¤¿í
¼­¸í
ÀÌÁ¶ÈÆ
¹ıÁ¤´ë¸®ÀÎ 1 (Ä£±ÇÀÚ)
°ü°è
¹ıÁ¤´ë¸®ÀÎ 2(Ä£±ÇÀÚ)
°ü°è
¹ıÁ¤´ë¸®ÀÎ(Ä£±ÇÀÚ)
1ÀÎÀÌ ¼­¸íÇÑ °æ¿ì
º»ÀÎÀº ´Ù¸¥ ¹ıÁ¤´ë¸®ÀÎ(Ä£±ÇÀÚ) 1ÀÎ°ú
ÇÕÀÇÇÏ¿¡ °øµ¿À¸·Î Ä£±ÇÀ» Çà»çÇÕ´Ï´Ù.
ÀÌ°ü¿í
ÇÇº¸ÇèÀÚ(º¸Çè´ë»óÀÚ) º»ÀÎÀÌ ÀÚÇÊ¼­¸íÀ» ÇÏÁö ¾ÊÀ¸½Å °æ¿ì¿¡´Â º¸Çè°è¾àÀÌ ¹«È¿°¡ µÇ¾î º¸ÀåÀ» ¹ŞÁö ¸øÇÒ ¼öµµ ÀÖ½À´Ï´Ù.
º¸Çè°è¾àÀÚ ¶Ç´Â ÇÇº¸ÇèÀÚ(º¸Çè´ë»óÀÚ)°¡ ¹Ì¼º³âÀÚÀÎ °æ¿ì ¹ıÁ¤´ë¸®ÀÎÀÌ ¼­¸íÇÏ¿© ÁÖ½Ã±â ¹Ù¶ø´Ï´Ù.
LW002410081066502
0105524471
Ã»¾àÀÏÀÚ:
ÀÏ
¿ù
³â
2/2

NH³óÇù¼ÕÇØº¸Çè
Á¢¼ö¹øÈ£
202503-0060596
½É»çÀÚ
±Ç¹ÌÁ¤
»ç°í Á¢¼ö³»¿ë
NH³óÇù¼ÕÇØ Àå±âº¸ÇèÁö±ŞÆÀ
»ç°íÀÏ½Ã
°è¾àÀÚ
2024³â 12¿ù 11ÀÏ
15½Ã 50ºĞ
ÀÌÁ¶ÈÆ
ÇÇº¸ÇèÀÚ
ÀÌ±¤¿í
µ¿º¸ÀÚ
ÀÌ±¤¿í
»ç°íÀ¯Çü
»ç°íÀå¼Ò
»ç°í³»¿ë
³ú°Ë»ç
Á¢¼öÀÚ
¿ÀÇÂAPI
Çì¾Æ¸²
»ç°íÁ¢¼öÁõ(È¸»çº¸°ü¿ë)
´ã´ç
Ã¥ÀÓÀÚ
Ã¥ÀÓÀÚ
Á¢¼öÀÏ½Ã
2025³â 03¿ù 19ÀÏ
ÁÖ¹Î¹øÈ£
850224-1******
ÁÖ¹Î¹øÈ£
550112-1******
¼­·ùÁ¦Ãâ½Ã±â/¹æ¹ı
Áï½Ã / ½º¸¶Æ®Ã»±¸
º¸Çè°è¾à»çÇ×
Áõ±Ç¹øÈ£
»óÇ°¸í
º¸Çè±â°£
°è¾àÀÚ¸í
ÇÇº¸ÇèÀÚ¸í
°è¾à»óÅÂ
3191472766313
(¹«)°£Æí°¡ÀÔ Çì¾Æ¸²½Ç¼ÕÀÇ·á
ºñº¸Çè2404
2024-10-08 2054-10-08
ÀÌÁ¶ÈÆ
ÀÌ±¤¿í
Á¤»ó
¡ØÁ¢¼ö³»¿ë¿¡ ´ëÇÑ ¹®ÀÇÃ³: Äİ¼¾ÅÍ 1644- 9000
¡ØÃß°¡¼­·ùÁ¦Ãâ: ½ºÄµ ¶Ç´Â ½É»çÀÚ °³ÀÎ ÆÑ½º·Î Àü¼ÛÇÏ½Ã±æ ¹Ù¶ø´Ï´Ù.
0301 0001 0101 CL002025030060596
¹ßÇàÀÏ½Ã : 2025-03-19 16:07:16
1/2

========== ÆÄÀÏ: i? i¢¥?i?¢¬e¢¬?e?€i?¢´e©ø?i??.pdf ==========

2025-04-16 19:09:54
ÇØ¿À¸§¼ÕÇØ»çÁ¤(ÁÖ)
BE SUNRISE SURVEYORS & CLAIM ADJUSTERS CO., LTD.
½ÅÃÌ¼¼ºê¶õ½ºº´¿ø
ÀÇ¹«±â·Ï»çº»
ÃÑ 1ºÎ
(Ç¥ÁöÁ¦¿Ü)
ºó°æÈ¯

UNIVER
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¹ßÇà¹øÈ£:
µî·Ï¹øÈ£:
2025-41122
8633158
È¯ÀÚ¼º¸í:
¿ëµµ:
¹ß±Ş¸Å¼ö:
ÀÌ±¤¿í
º¸ÇèÈ¸»çÁ¦Ãâ
123 ¸Å
ÀÇ¹«±â·Ï »çº» Áõ¸í¼­
ÀÌ »çº»Àº ÀÇ¹«±â·Ï ¿øº»°ú Æ²¸²ÀÌ ¾øÀ½À» Áõ¸íÇÕ´Ï´Ù.
ÀÌ »çº»Àº À§ÀÇ ¿ëµµ ¿Ü¿¡´Â »ç¿ëÇÒ ¼ö ¾ø½À´Ï´Ù.
ÀÇ¹«±â·Ï »çº» Áõ¸í¼­
2025³â 04¿ù 11ÀÏ
´ã´çÀÚ:
±è°æ¹Ì
(ÀÎ)
´ã´çÀÚÀÇ ³¯ÀÎÀÌ ¾ø´Â °ÍÀº ¹«È¿ÀÓ
¿©·¡´ëÇĞ±³
¿¬¼¼´ëÇĞ±³ ÀÇ°ú´ëÇĞ ÇĞ°ú´ëÇĞ
¼¼ºê¶õ½ºº´¿ø
º´¿ø
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/63¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2019-01-02
Áø·á°ú
½ÉÀå³»°ú
ÁÖÄ¡ÀÇ
¾ÈÃ¶¹Î
BP(S)
181 mmHg
BP(D)
95 mmHg
HR
90/min
Subjective
Objective
CT angio
Assessment
Good/No interval change
Multifocal stenosis with calcifications in both SFA and both ATA.
Diffuse atherosclerosis with calcification, infrarenal aorta.
Varicose vein, left calf.
No evidence of DVT.
Otherwise unremarkable.
CAD(2vd+ LM)
s/pCAG(2018.04, ÀÏ»ê¹é)
s/p 2018-04-09 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA)
DM
s/p carotid stenting
Plan
PTA °í·Á
SFA os, Rt contralateral approach
2¿ù 10ÀÏÀÔ¿ø, 11ÀÏ ½Ã¼ú
±â·ÏÀÚ¸í
¾ÈÃ¶¹Î
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
ÀÔ¿øÁ¤º¸
ÀÔ¿øÀÏÀÚ 2019-01-27
ÀÔ¿ø°ú
½ÉÀå³»°ú
ÀÔ¿øÁÖÄ¡ÀÇ ¾ÈÃ¶¹Î
Åğ¿øÁ¤º¸
Åğ¿øÀÏÀÚ 2019-01-29
Åğ¿ø°ú ½ÉÀå³»°ú
Åğ¿øÁÖÄ¡ÀÇ ¾ÈÃ¶¹Î
ÃÖÁ¾Áø´Ü¸í(*)
¼ø¼­
ÇÑ±¹Áúº´
±¸ºĞ
È®Áø
Áø´Ü¸í
ºĞ·ù¹øÈ£
1 ÁÖÁø´Ü
È®Áø
Peripheral arterial occlusive disease (lower extremities)
170.29
2 ±âÅ¸Áø´Ü È®Áø
Unstable angina
120.0
3
±âÅ¸Áø´Ü È®Áø
Coronary artery disease (left main)
125.1
4
±âÅ¸Áø´Ü È®Áø
Coronary artery disease (2 vessel disease)
125.1
5
±âÅ¸Áø´Ü È®Áø
S/P Coronary artery bypass graft
Z95.1
°ú°ÅÁø´Ü¸í
°ú°ÅÁø´ÜÄÚµå
ÁÖÈ£¼Ò (*)
Diabetes mellitus other, without complication; Diabetes mellitus type 2, without
complication; Diabetic polyneuropathy; Internal carotid artery stenosis;Internal
carotid artery stenosis, right;Type 2 diabetes mellitus, coronary artery disease;
E11.58;E11.9;E13.9;E14.41;165.2;
For PTA
°ú°Å·Â ¹× ÇöÀçº´·Â »ó±â 64¼¼ ³²È¯ DM, CAOD (2vd, s/p CAG), PAOD Áø´Ü ¹ŞÀº ºĞÀ¸·Î PTA ½ÃÇà À§ÇØ
±İÀÏ ÀÔ¿øÇÔ.
V/S 120/70 78 20
Current Sx: none
ÀÌ»ó ÁøÂû ¼Ò°ß (¡Ú)
n-s
Àç¿øÁß Åõ¾à³»¿ª (*) n-s
Åõ¿©µÈ ¾à¹° Áß ÀÜ·ùÈ¿°ú·Î Åğ¿ø ÈÄ ÁÖÀÇ°¡ ÇÊ¿äÇÑ ¾à¹° (*)
¾øÀ½ ÀÖÀ½
Aspirin protect->ÃâÇ÷ÀÇ À§Çè¼ºÀÌ Áõ°¡µÇ¹Ç·Î »óÃ³³ª ¸ÛÀÌ »ı±âÁö ¾Êµµ·Ï
ÁÖÀÇÇÏ½Ê½Ã¿À.; Platless-> ÃâÇ÷ÀÇ À§Çè¼ºÀÌ Áõ°¡µÇ¹Ç·Î »óÃ³³ª ¸ÛÀÌ »ı±âÁö
¾Êµµ·Ï ÁÖÀÇÇÏ½Ê½Ã¿À.;
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Åğ¿ø¿ä¾à
2019-01-29
1/3
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
°Ë»ç¼Ò°ß (*)
Ä¡·á ¹× È¿°ú (*)
@PTA(19.1.28)
Access site Lt CFA
Approach method contralateral antegrade
Peripheral angiography with JR 5F catheter revealed
total occlusion of Rt. SFA OS (TIMI 1) with diffuse irregular up to 70%
LN of p-mSFA
total occlusion of Rt. ATA (TIMI O)
Taget lesion: Rt. SFA
7F Balkin sheath c 018 command wire
The guiding wire was passed through the lesion.
Balloon angioplasty was done with 6x60 mm Mustang PTA balloon at
Rt. SFA OS~MSFA
F/U angio revealed 60% residual stenosis without dissection
Two DCB with 6x150 mm Inpact Admiral were inflated at Rt. SFA
OS~MSFA
F/U angio revealed 10 % residual stenosis without dissection or flow
limitation
conclusion>> Successful PTA C DCB at Rt. SFA
@Successful PTA c DCB at Rt. SFA(19.1.28) ½ÃÇà ÈÄ acute complication ¾øÀÌ Åğ¿øÇÔ.
@PTA(19.1.28)
ÁÖ½Ã¼ú¸í
ÁÖ½Ã¼úÄÚµå
3950
±âÅ¸½Ã¼ú¸í
±âÅ¸½Ã¼úÄÚµå
Implantable Medical Device »ç¿ë ¿©ºÎ No
Yes
Ä¡·á°á°ú (*)
¿ÏÄè
°æÄè
È£Àü¾ÈµÊ
Áø´Ü»Ó
°¡¸Á¾ø´Â Åğ¿ø
48½Ã°£ÀÌ³» »ç¸Á
¼±Çà»çÀÎ
48½Ã°£ÀÌÈÄ »ç¸Á
¼±Çà»çÀÎ
¼±Çà»çÀÎ
ºĞ·ùÄÚµå
È°·ÂÁõ»ó
Ç÷¾Ğ 120/75 mmHg
¸Æ¹Ú¼ö 70
Åğ¿øÇüÅÂ (¡Ú)
Åğ¿øÁö½ÃÈÄ
Å¸º´¿øÀü¿ø
È¸/ºĞ Ã¼¿Â 36.8
ÀÚÀÇÅğ¿ø ¤· Å»¿ø
È£Èí¼ö 20
È¸/ºĞ
ÇâÈÄ Ä¡·á°èÈ¹
¿Ü·¡ ÃßÈÄ°ü¸®
ÀçÀÔ¿ø
¾øÀ½
±âÅ¸
Åğ¿ø¿ä¾à
2019-01-29
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
2/3
Ãâ·ÂÀÏ: 2025-04-11
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Åğ¿ø¾à
¾àÇ°¸í (Name)
¿ë·®(Dose)
ÀÏ¼ö(Days)
¿ë¹ı(Direction) Ã³¹æ ºĞ·ù (Type)
È¿´É
¾Æ½ºÇÇ¸°ÇÁ·ÎÅØÆ® 1
14
Á¤100mg
¾ÆÄ§ ½ÄÈÄ 30ºĞ
º¹¿ëÇÏ½Ê½Ã¿À
Åğ¿ø¾à
Çì¸£º¥Á¤ 30mg
1
14
¾ÆÄ§,Àú³á ½ÄÈÄ 30 Åğ¿ø¾à
ºĞ º¹¿ëÇÏ½Ê½Ã¿À
¸®ÇÇÅäÁ¤ 80mg
1
14
¾ÆÄ§ ½ÄÈÄ 30ºĞ
Åğ¿ø¾à
º¹¿ëÇÏ½Ê½Ã¿À
ÇÃ·¡¸®½ºÁ¤
1
14
¾ÆÄ§ ½ÄÈÄ 30ºĞ
º¹¿ëÇÏ½Ê½Ã¿À
Åğ¿ø¾à
¶óºñ¿¡Æ®Á¤10mg 1
14
¾ÆÄ§ ½ÄÀü 30ºĞ º¹ Åğ¿ø¾à
¿ëÇÏ½Ê½Ã¿À
Áß¿Ü½Ã±×¸¶Æ®Á¤ 1
5mg
14
¾ÆÄ§, Àú³á ½ÄÈÄ 30 Åğ¿ø¾à
ºĞ º¹¿ëÇÏ½Ê½Ã¿À
ÄÚÀÚÁ¤100mg 1
14
¾ÆÄ§ ½ÄÈÄ 30ºĞ
º¹¿ëÇÏ½Ê½Ã¿À
Åğ¿ø¾à
¾Æ½ºÇÇ¸°ÇÁ·ÎÅØÆ® 1
19
Á¤100mg
¾ÆÄ§ ½ÄÈÄ 30ºĞ
º¹¿ëÇÏ½Ê½Ã¿À
Åğ¿ø¾à
Çì¸£º¥Á¤ 30mg
1
19
¾ÆÄ§,Àú³á ½ÄÈÄ 30 Åğ¿ø¾à
ºĞ º¹¿ëÇÏ½Ê½Ã¿À
¸®ÇÇÅäÁ¤ 80mg
1
19
¾ÆÄ§ ½ÄÈÄ 30ºĞ
Åğ¿ø¾à
º¹¿ëÇÏ½Ê½Ã¿À
ÇÃ·¡¸®½ºÁ¤
1
19
¾ÆÄ§ ½ÄÈÄ 30ºĞ
Åğ¿ø¾à
º¹¿ëÇÏ½Ê½Ã¿À
¶óºñ¿¡Æ®Á¤10mg 1
19
¾ÆÄ§ ½ÄÀü 30ºĞ º¹ Åğ¿ø¾à
¿ëÇÏ½Ê½Ã¿À
Áß¿Ü½Ã±×¸¶Æ®Á¤ 1
5mg
19
¾ÆÄ§,Àú³á ½ÄÈÄ 30 Åğ¿ø¾à
ºĞ º¹¿ëÇÏ½Ê½Ã¿À
ÄÚÀÚÁ¤100mg
1
19
¾ÆÄ§ ½ÄÈÄ 30ºĞ
º¹¿ëÇÏ½Ê½Ã¿À
Åğ¿ø¾à
´ã´ç Àü°øÀÇ»ç¸í
±ÇÇı¶õ
±â·ÏÀÚ¸í
±ÇÇı¶õ
ÁÖÄ¡ÀÇ»ç¸í
¾ÈÃ¶¹Î
<¾à¾î ¼³¸í>
CAOD coronary artery obstructive disease
RFCA radio-frequency catheter ablation
NSTEMI non-ST elevation myocardial infarction
C-angio : coronary angiogram
A.fib: atrial fibrillation
EPS electrophysiologic studies
DCMP: dilated cardiomyopathy
HCMP hypertrophic cardiomyopathy
PAF paroxysmal atrial fibrillation
RHD rheumatic heart disease
NSVT non-sustained ventricular tachycardia
A-flutter : atrial flutter
Åğ¿ø¿ä¾à
2019-01-29
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
3/3
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
ÀÔ¿øÀÏÀÚ
2019-01-27
ÀÔ¿ø°ú ½ÉÀå³»°ú
ÀÔ¿øÁÖÄ¡ÀÇ
¾ÈÃ¶¹Î
ÀÔ¿ø°áÁ¤ÀÇ»ç ¾ÈÃ¶¹Î
ÁÖÈ£¼Ò ¶Ç´Â ÀÔ¿ø»çÀ¯
For PTA
ÇöÀçÁúº´»óÅÂ
»ó±â 64¼¼ ³²È¯ DM, CAOD (2vd, s/p CAG), PAOD Áø´Ü ¹ŞÀº ºĞÀ¸·Î
PTA ½ÃÇà À§ÇØ ±İÀÏ ÀÔ¿øÇÔ.
V/S 120/70 78 20
Current Sx none
°ú°Å·Â
Hypertension
No
Yes
Pul. Tbc
No
Yes
DM
No
Yes
Hepatitis
No
Yes
Smoking
No
Yes
±İ¿¬±³À° ¿©ºÎ
½ÃÇà
¹Ì½ÃÇà
|ÇØ´ç¾øÀ½
Alcohol
No
Yes
Drug Allergy
No
Yes
Penicillin
Sulfonamide
? Cephalosporin
Other
¾Ë·¹¸£±â
No
Yes
Hypercholesterolemia
No
Yes
Cardiac disease
No
Yes
Old CVA
No
Yes
¸»ÃÊµ¿¸Æ ¹× °æµ¿¸Æ ÁúÈ¯
No
Yes
Coronary artery bypass graft
No
Yes
Others
°¡Á··Â
°èÅë¹®Áø
Generalized Weakness
No
Easy Fatigue
No
Fever
No
Chill
No
Headache
No
00000
Yes
Yes
Yes
Yes
Yes
Dizziness
No
Yes
Insomnia
No
Yes
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
ÀÔ¿ø±â·Ï
2019-01-27
1/5
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
ÀÔ¿ø±â·Ï
2019-01-27
Cough
Sputum
Dyspnea
DOE
z z zz z z z z z z z
No
No
Yes
Yes
Yes
No
Yes
No
No
No
Yes
Yes
Yes
No
Yes
No
Yes
No
Yes
0000000000
Chest pain
Palpitation
Hemoptysis
Hematemesis
Anorexia
Nausea
No
Vomiting
No
Yes
Constipation
No
Yes
Diarrhea
No
Yes
Abdominal pain No
Yes
Abdominal discomfort
No
Hematochezia No
Melena
No
000
Yes
Yes
Yes
Dysuria
No
Yes
Oliguria
No
Yes
Hematuria
No
Yes
Poor oral intake
No
Yes
Weight Loss
No
Yes
Weight Gain
No
Yes
Others
½ÅÃ¼Á¶»ç
General Appearance
Appearance Not so ill-looking appearance
Mental Status Alert Drowsy
Stupor
Semicoma
Coma
Nutritional and Developement status
Good
Moderate
Poor
Skin
ÇÇºÎ
Abnormal skin rash
Warm ? Cold
Wet
Dry
No
Yes
Skin tugor
Good
HEENT
Normocephaly without deformity
Yes No
Sclera
not icteric
not injected
Throat
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Conjunctiva
not pale
Lips & tongues
not dried
2/5
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Neck
Stiffness
supple
Cervical LNs not palpable
Neck veins
not engorged
Chest/lung
Symmetric expansion
Yes
No
Retraction
No
Yes ( Both
Rt Lt)
Breath sounds
clear
increased
decreased
character
High-pitched sound
Continuous sound
Wheezing
Discontinuous sound
Fine crackle
Low-pitched sound
Location
Stridor ? Velcro rale
Right upper lung field
Rhonchi
? Coarse crackle
Right middle lung field
Left upper lung field
? Left middle lung field
Right lower lung field
? Left lower lung field
Heart
PMI
(5th ICS LMCL)
ÀÌ»ó
RHB
without murmur
with murmur
Thrill
No
Yes
Heaving
No
Yes
Abdomen
Palpation
? soft
? rigid
flat
distended
Bowel sound
normoative
Tenderness
No
Yes
Palpation of organ
No
liver
kidney
spleen
Shifting dullness
No
Yes
Fluid wave
No
Yes
Back and Extremity
LOM
No
Yes
CVA tenderness
No
Rt. Lt.
Both
Pitting edema
No
Yes
Paresthesia
No
Yes
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
ÀÔ¿ø±â·Ï
2019-01-27
3/5
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
ÀÔ¿ø±â·Ï
2019-01-27
others (Physical Exam)
°¨¿°¼ºÁúÈ¯ ÃÊ±âÆò°¡
1. Áõ»ó ¹× ±â°£
¹ß¿­
±â°£
ÀÏÀü
È£Èí±âÁõ»ó
±â°£
ÀÏÀü
¼ÒÈ­±âÁõ»ó
±â°£
ÀÏÀü
ÇØ´ç¾øÀ½ (¹Ì»óÈ¯ÀÚ Æ÷ÇÔ)
2. ÃÖ±Ù 1´Ş ÀÌ³» ¹æ¹®ÇÑ³ª¶ó
ÇØ´ç¾øÀ½
¾øÀ½
ÀÖÀ½
3. ÃÖ±Ù 1´Ş ÀÌ³» ÀÔ¿øÇß´ø º´¿ø (°¨¿°ÁÖÀÇ º´¿ø)
¾øÀ½ ÀÖÀ½
4. ¹ĞÁ¢ Á¢ÃËÀÚ
ÇØ´ç¾øÀ½
¾Æ´Ï¿À ¿¹
5. ½ÅÁ¾ °¨¿°º´ ÀÇ½ÉÈ¯ÀÚ
¾Æ´Ï¿À ¿¹
ÅëÁõÆò°¡ ÅëÁõ¿©ºÎ
No
Yes
ÃßÁ¤Áø´Ü PAOD
°èÈ¹
PTA °í·Á
Åğ¿ø°èÈ¹
Åğ¿ø ÈÄ Ä¡·á½ÄÀÌ ¿©ºÎ
? N ? Y
ÃßÈÄ °ü¸® °èÈ¹
|°¡Á¤°£È£»ç¾÷¼Ò È£½ºÇÇ½º
Å¸ º´¿ø Àü¿ø
¿Ü·¡
»çÈ¸ º¹Áö¼­ºñ½º ¿¬°è ÇÊ¿ä¼º
? N
? Y
±âÅ¸ Åğ¿ø½Ã ¿ä±¸»çÇ×
Ä¡·á°èÈ¹
+
Problem
Goal
¸ñÇ¥ÀÏ
¼öÁ¤¸ñÇ¥ÀÏ
°èÈ¹ÀÏ
ºÎ
PAOD
PTA
2019-01-28
2019-01-27
±â·ÏÀÚ¸í ÇÏÀå¿ì
<¾à¾î ¼³¸í>
BMI : body mass index
BP(D): Blood Pressure(Diastolic)
BP(S) : Blood Pressure(Systolic)
BT body temperature
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
ICS: impulse conducting system(of the heart)
LMCL left midclavicular line
LNs lymph nodes
LOM limitation of motion
4/5
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/68¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
°Ë»ç°á°ú
1. ABI (Ankle / Brachial Index) - Rt: 0.90
/Lt: 0.84
1-1. TBI (Toe / Brachial Index)- Rt: 0.39/Lt: 0.36
Impression
Name
Image 1
ÀüÀÚ¼­¸íÀÚ: ¸ğÇıÀÎ
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
±â´É°Ë»ç°á°ú(I/FÇü)
2023-03-22
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/68¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Name: LEE K.W.
ID #:
8633158
Exam Date: 03/22/2023 11:08 AM
Operator: M
±â´É°Ë»ç°á°ú(I/FÇü)
SEVERANCE HOSPITAL
Sex: M
MultiLab Series !!
SEGMENTAL PRESSURE
AND PVR STUDY
Brachial
RIGHT LEFT
108 109
RIGHT
LEFT
0.85 93 PT
92 0.84
0.90
98 DP
91 0.83
¬Ş¬Ú
PVR 64mmHg 187cc
LEFT Ankle
ABI: 0.84 Gain: 2 Spd:25 Amp:16
TBI: 0.36
0.39 43
39 0.36
PVR 65mmHg 175cc RIGHT Ankle
Gain:
2 Spd:25 Amp:19
ABI: 0.90
TBI: 0.39
PPG RIGHT Great Toe
Gain:.50 Speed: 25 Amp:01
ÆÇµ¶ÀÇ(1Â÷)
¹ÚÇÑÁø
ÆÇµ¶ÀÇ(2Â÷) ¾ÈÃ¶¹Î
ABI INDEX
0.97- 1.25 NORMAL
0.75 0.96 MILD
0.50 0.74 MODERATE
<0.50 SEVEREE
TBI(FBI) INDEX
>0.80 NORMAL
0.20 0.54 CLAUDICATION
<0.20 REST PAIN
PPG LEFT Great Toe
Gain:.50 Speed: 25 Amp:01
2023-03-22
ÀüÀÚ¼­¸íÀÚ: ¸ğÇıÀÎ
2/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/67¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
°­Àº¼®
BP(S)
150mmHg
BP(D) 58 mmHg
HR 89/min
°æ°ú ¹× Plan
Áø´Ü¸í
±¸ºĞ
È®Áø
CAD(2vd+ LM)
s/p CAG (2018.04, ÀÏ»ê¹é)
s/p 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA
composite Y, Aorta to rPL with RA) (2018-04-09)
Rt. ICA stenosis s/p stent insertion (2018.10.02)
PAD
s/p PTA c DCB at Rt. SFA (2019.01.28)
DM(11yrs)
Ex-smoker (30yr, 2³âÀü Áß´Ü)
Aorta to rPL with RA)
Glucose 140
Glycoalbumin 20.6
Glucose (¿¬¼Ó) - ½ÄÈÄ 2½Ã°£ 195
HbA1c 7.3
Cholesterol 121
Triglyceride 77
HDL-Cholesterol 56
LDL-Cholesterol (Friedewald) 49.6
BUN 24.4
Creatinine 1.22
Urine Albumin-to-Creatinine Ratio 78.07
>>
»ıÈ°½À°ü °³¼± ÇÊ¿äÇÔ
repeat med
6mo f/u
ÁÖÁø´Ü È®Áø Diabetes mellitus type 2 with dyslipidemia
±âÅ¸Áø´Ü È®Áø Thyroid nodule
±âÅ¸Áø´Ü È®Áø
Internal carotid artery stenosis
±â·ÏÀÚ¸í
°­Àº¼®
Áø´Ü¸í
¿Ü·¡ÀçÁø±â·Ï
2022-07-19
ÀüÀÚ¼­¸íÀÚ: °­Àº¼®
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/67¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2022-09-21
Áø·á°ú
½ÉÀå³»°ú
ÁÖÄ¡ÀÇ
ÀÏ¹İ
BP(S)
mmHg
HR
/min
Subjective
Objective
Assessment
Plan
Áø´Ü¸í
±¸ºĞ
È®Áø
ÁÖÁø´Ü
±âÅ¸Áø´Ü
±âÅ¸Áø´Ü
È®Áø
È®Áø
È®Áø
BP(D) mmHg
chest pain / discomfort (-/-)
dyspnea / DOE (-/-)
palpitation (-)
functional capacity >4METS
ÀßÁö³Â´Ù. Áõ»ó¾øÀ½
PAD, S/P PTA 2019.1.28 - IVUS-DCB
-
s/p PTA DCB at Rt. SFA[2019-01-28]
ABI 1.04/1.09 <== 0.69/0.99
CAD(2vd+ LM)
s/pCAG(2018.04, ÀÏ»ê¹é)
s/p 2018-04-09 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA)
DM
herben ÀÏ³â Á¤µµ »ç¿ë - À¯°æÁ¾ ±³¼ö´Ô - radial graft
HTN_Q
Repeat med
Unstable angina
Coronary artery disease (left main)
Coronary artery disease (2 vessel disease)
±â·ÏÀÚ¸í
ÃÖ±âÁ¤
<¾à¾î ¼³¸í>
BP(D) : Blood Pressure(Diastolic)
Áø´Ü¸í
HR : Heart Rate
BP(S) : Blood Pressure (Systolic)
med Medication
ÀüÀÚ¼­¸íÀÚ: ÃÖ±âÁ¤
¼¼ºê¶õ½ºº´¿ø
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ
SEVERANCE HOSPITAL

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/67¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
½Å°æ°ú
ÁÖÄ¡ÀÇ
È«¼øÈ£
SBP
129 mmHg
DBP 60mmHg
¸Æ¹Ú 81È¸/ºĞ
°æ°ú
Rt. pICA severe stenosis s/p stent insertion (2018)
--4 vessel 2019.09.05
Occlusion of Lt VA.
No residual stenosis or in-stent thrombosis in Rt pICA.
--brain MRIA 2022.09.14
Small old infarction in left side medulla.
Microbleed in right parietal lobe.
Stenosis in right carotid bulb and right distal VA.
Steno-occlusion in left VA.
Stenosis in left proximal ICA, left cavernous ICA.
-->interval change ¾ø¾îº¸ÀÓ.
º°ÀÏ ¾øÀ¸¼Ì´Ù
2024 brain MRIA
¿Ü·¡ÀçÁø±â·Ï
2022-09-21
ÀüÀÚ¼­¸íÀÚ: È«¼øÈ£
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/67¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø´Ü¸í
±¸ºĞ
È®Áø
ÁÖÁø´Ü È®Áø
|±âÅ¸Áø´Ü
È®Áø
|±âÅ¸Áø´Ü
È®Áø
Internal carotid artery stenosis
Unstable angina
Coronary artery disease (2 vessel disease)
Áø´Ü¸í
±â·ÏÀÚ¸í
È«¼øÈ£
¿Ü·¡ÀçÁø±â·Ï
2022-09-21
ÀüÀÚ¼­¸íÀÚ: È«¼øÈ£
2/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/69¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿µ»ó°Ë»ç CT& MR
¿µ»ó°Ë»ç CT& MR
°Ë»ç¸í
MRI Brain & Angio 3D(NeckÆ÷ÇÔ) (contrast)
°Ë»ç¹æ¹ı
°Ë»çÀÏÀÚ
ÆÇµ¶ÀÏÀÚ
2024.09.12 10:33
2024.10.22 15:34
ÃÔ¿µ½Ç
MRI 74È£(º»°ü 4Ãş)
Description
ÆÇµ¶ÀÇ/Àü¹®ÀÇ
Clinical information: Internal carotid artery stenosis
Imaging technique: sagittal T1Wl, axial T1WI, T2WI, T2 FLAIR. T2*WI, contrast enhanced
3D T1Wl with axial/coronal/sagittal reconstruction, intracranial TOF MRA, contrast
enhanced intracranial and neck MRA.
Contrast media: Used
Small old infarction in left side medulla.
Microbleed in right parietal lobe.
Stenosis in right carotid bulb and right distal VA.
Steno-occlusion in left VA.
Stenosis in left proximal ICA, left cavernous ICA.
IMP: No interval change
¨êÁ¶¿µÁ¦
Dotarem inj[20ml/Syringe] [Meglumine gadoterate 376.9mg/ml] [20ml/Syringe]:1
¾È¼º¼ö/¾È¼º¼ö/¾È¼º¼ö
ÀüÀÚ¼­¸íÀÚ: ¾È¼º¼ö
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/68¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
°­Àº¼®
BP(S) 163mmHg
BP(D) 70mmHg
HR 91/min
°æ°ú ¹× Plan
CAD(2vd+ LM)
s/p CAG (2018.04, ÀÏ»ê¹é)
s/p 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA
composite Y, Aorta to rPL with RA) (2018-04-09)
Rt. ICA stenosis s/p stent insertion (2018.10.02)
PAD
s/p PTA c DCB at Rt. SFA (2019.01.28)
DM(11yrs)
Ex-smoker (30yr, 2³âÀü Áß´Ü)
Aorta to rPL with RA)
Glucose 124
Glycoalbumin 20.9
Glucose (¿¬¼Ó) - ½ÄÈÄ 2½Ã°£ 226
HbA1c 7.2
Cholesterol 116
Triglyceride 76
HDL-Cholesterol 50
LDL-Cholesterol (Friedewald) 50.8
Urine Albumin-to-Creatinine Ratio 69.81
>>
¿îµ¿ ¹× »ıÈ°½À°ü °³¼± ÇÊ¿äÇÔ
repeat med
6mof/u
Áø´Ü¸í
±¸ºĞ
È®Áø
ÁÖÁø´Ü È®Áø
±âÅ¸Áø´Ü È®Áø
±âÅ¸Áø´Ü È®Áø
Diabetes mellitus type 2 with dyslipidemia
Thyroid nodule
Internal carotid artery stenosis
±â·ÏÀÚ¸í
°­Àº¼®
Áø´Ü¸í
¿Ü·¡ÀçÁø±â·Ï
2023-01-17
ÀüÀÚ¼­¸íÀÚ: °­Àº¼®
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/68¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2023-03-22
Áø·á°ú
½ÉÀå³»°ú
ÁÖÄ¡ÀÇ
¾ÈÃ¶¹Î
BP(S)
122 mmHg
BP(D)
52mmHg
HR
88/min
Subjective
Objective
Assessment
Plan
Good/No interval change
Non-HDL Cholesterol 53
LDL-Cholesterol (Friedewald) 39.4
Glucose 134
BUN 19.8
Creatinine 1.06
TMT 10.1 METs, equivocal
ABI (Ankle / Brachial Index)
0.84/Lt: 0.82
PAD, s/p PTA 2019.1.28 - IVUS-DCB
-
-
Rt: 0.90 /Lt: 0.84 <==Rt: 0.96/Lt: 0.88 <== Rt:
s/p PTA DCB at Rt. SFA[2019-01-28]
ABI 1.04/1.09 <== 0.69/0.99
CAD(2vd+ LM)
s/p CAG(2018.04, ÀÏ»ê¹é)
s/p 2018-04-09 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA)
DM
herben ÀÏ³â Á¤µµ »ç¿ë - À¯°æÁ¾ ±³¼ö´Ô - radial graft
HTN
Repeat med
3°³¿ù ÈÄ local refer
2yr EKG/CXR/LAB/full(ºñ±Ş¿© ¼³¸íµå¸²)
Áø´Ü¸í
±¸ºĞ
È®Áø
ÁÖÁø´Ü È®Áø
Unstable angina
|±âÅ¸Áø´Ü È®Áø
Coronary artery disease (left main)
|±âÅ¸Áø´Ü È®Áø
Coronary artery disease (2 vessel disease)
±â·ÏÀÚ¸í
¾ÈÃ¶¹Î
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Áø´Ü¸í
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/70¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
°Ë»ç°á°ú
1. ABI (Ankle/ Brachial Index)
-
Rt: 0.80
/Lt: 0.72
1-1. TBI (Toe Brachial Index) - Rt: 0.51/Lt: 0.33
Impression
Name
Image 1
0.5-
0-
Patient name: 012
Patient ID: 8633158
Gender:
R Thigh
PVR
E
0.5-
0-
0.98 124]
127 1.00
-0.5-
±â´É°Ë»ç°á°ú(I/FÇü)
2025-03-19
Exam Date/Time: 19-03-2025 10:27
Examiner:
Ref Physician:
L Thigh
-3.5-
45
P=59 HR-73 Amp-1.060 RT-232 Sc=x4 G=6
R BI Knee
PVR
0.99 126
131 1.03
0.5-
0.5-
0.90 114
113 89
0-
0-
-05-
4s
R
P=56 HR=72 Amp=1.248 RT=264 Sc=x4 G=6
R Ankle
0.80 10192 0.72
0.75 95 OP 90 0.71
0.79 100 103 0.81
0.51 65
42 0.33
-0.5-
PVR
0.5-
L Ankle
0.5-
0-
-0.5-
0.5
0-
-0.5-
0-
-0.5-
4s
P=57 HR=75 Amp=0.678 RT=236 Sc=x4 G=6
R Metatarsal
PVR
0.5
0-
-0.5-
4s
P=62 HR 75 Amp=0.270 RT-244 Sc=x4 G=6
R Toe 1
A
¬ß¬Ú¬ê
0-
-10-
45
HR 73 Amp=17.4 RT=282 Sc=x4 G=4
ÆÇµ¶ÀÇ(1Â÷)
ÀÌÂùÁÖ
ÆÇµ¶ÀÇ(2Â÷)
¾ÈÃ¶¹Î
ÀüÀÚ¼­¸íÀÚ: ÀÌÀçÀÎ
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
VIASONIX
0-
-10-
PVR
4s
P=59 HR=73 Amp=0.938 RT=264 Sc=x4 G=6
L BI Knee
PVR
¬ß¬Ú
45
P=57 HR=72 Amp=1.185 RT=238 Sc=x4 G=6
PVR
¬Ş¬Ú
P=55 HR=N/A Amp=N/A RT=N/A Sc=x4 G=6
L Metatarsal
PVR
45
P=58 HR=N/A Amp=N/A RT=N/A Sc=x4 G=6
L Toe 1
¬Ş¬Ú
4s
HR 73 Amp=20.4 RT=282 Sc=x4 G=4
Page 1 of 1
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
C-sec: cesarean section
CVA cerebrovascular accident
CVA tenderness costovertebral angle
DM diabetes mellitus
DOE dyspnea on exertion
ECOG eastern cooperative oncology group
HEENT: head, ear, eye, nose and throat
NSVD normal spontaneous vaginal delivery
PAOD peripheral arterial occlusive disease
:
PMI point of maximum impulse
PR: pulse rate
Pul. Tbc pulmonary tuberculosis
RHB regular heart beat
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
ÀÔ¿ø±â·Ï
2019-01-27
5/5
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
½ÉÀå³»°ú
ÁÖÄ¡ÀÇ
¾ÈÃ¶¹Î
°æ°ú
°èÈ¹
>>PTA
CAD(2vd+ LM)
s/pCAG(2018.04, ÀÏ»ê¹é)
s/p_20182-04-09 4OPCAB(LIMA to dLAD, to OM(seq) to DG with
RIMA composite Y, Aorta to rPL with RA)
DM
s/p carotid stenting
@ CT angio
Multifocal stenosis with calcifications in both SFA and both ATA.
Diffuse atherosclerosis with calcification, infrarenal aorta.
Varicose vein, left calf.
No evidence of DVT.
Otherwise unremarkable.
PTA
Ä¡·á°èÈ¹: ÁÖÄ¡ÀÇ°¡ È¯ÀÚÀÇ Ä¡·á°èÈ¹À» È®ÀÎÇÔ.
ÁÖÄ¡ÀÇ Comment
ÁÖÄ¡ÀÇ°¡ È¸ÁøÀ» µ¹¾Æ È¯ÀÚÀÇ »óÅÂ¸¦ È®ÀÎÇÏ¿´°í Ã³¹æ»óÅÂ¸¦ È®ÀÎ ÈÄ
È¯ÀÚ¿¡°Ô ÇöÀç »óÅÂ¸¦ ¼³¸íÇÔ.
Ä¡·á°èÈ¹
+
Problem
ºÎ
E
Acute myocardial
infarction, ST elevation
E
PAOD
±â·ÏÀÚ¸í
±ÇÇı¶õ
Goal
PTA
PTA
¸ñÇ¥ÀÏ ¼öÁ¤¸ñÇ¥ÀÏ °èÈ¹ÀÏ
2019-01-28
2019-01-27
2019-01-28
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
1/1
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
2019-01-27
Ãâ·ÂÀÏ: 2025-04-11
°æ°ú±â·Ï
2019-01-27
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
½ÉÀå³»°ú
ÁÖÄ¡ÀÇ
¾ÈÃ¶¹Î
°æ°ú
°èÈ¹
>>PTA
CAD(2vd+ LM)
s/p CAG(2018.04, ÀÏ»ê¹é)
s/p_20182-04-09 40PCAB(LIMA to dLAD, to OM(seq) to DG with
RIMA composite Y, Aorta to rPL with RA)
DM
s/p carotid stenting
@ CT angio
Multifocal stenosis with calcifications in both SFA and both ATA.
Diffuse atherosclerosis with calcification, infrarenal aorta.
Varicose vein, left calf.
No evidence of DVT.
Otherwise unremarkable.
@PTA(19.1.28)
PTA
Ä¡·á°èÈ¹: ÁÖÄ¡ÀÇ°¡ È¯ÀÚÀÇ Ä¡·á°èÈ¹À» È®ÀÎÇÔ.
ÁÖÄ¡ÀÇ Comment
Ä¡·á°èÈ¹
+
Problem
ºÎ
E
Acute myocardial
ÁÖÄ¡ÀÇ°¡ È¸ÁøÀ» µ¹¾Æ È¯ÀÚÀÇ »óÅÂ¸¦ È®ÀÎÇÏ¿´°í Ã³¹æ»óÅÂ¸¦ È®ÀÎ ÈÄ
È¯ÀÚ¿¡°Ô ÇöÀç »óÅÂ¸¦ ¼³¸íÇÔ.
Goal
PTA
¸ñÇ¥ÀÏ ¼öÁ¤¸ñÇ¥ÀÏ °èÈ¹ÀÏ
2019-01-28
2019-01-27
infarction, ST elevation
E
PAOD
±â·ÏÀÚ¸í
±ÇÇı¶õ
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
PTA
2019-01-28
1/1
2019-01-27
Ãâ·ÂÀÏ: 2025-04-11
°æ°ú±â·Ï
2019-01-28
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
°æ°ú
°èÈ¹
[Puncture site assessment]: POD #0
1. Lt.CFA (Proglide)
1) Bleeding/Oozing (-)
2) Hematoma/Color change (-/-)
3) Distal assessment: Color/Pulse/Temperature change (-/-/-)
* Lt.DPA (2+)
4) Infection sign (-)
5) Puncture site pulse check (2+)
+) Pulse examination
*
0-absent/1+ diminished/2+ normal/3+ bounding
ÃµÀÚºÎÀ§°¡ Á¡Á¡ ºÎ¾î¿À¸£´Â ´À³¦ÀÌ³ª °ÅÁî À§·Î ÇÇ°¡ ¹è¾î³ª¿À°Å³ª
Èå¸£´Â °æ¿ì, °©ÀÚ±â ¾îÁö·´°Å³ª ÅëÁõ ¹× ºÒÆí°¨ ½ÉÇØÁö´Â °æ¿ì Áï½Ã
ÀÇ·áÁø¿¡°Ô ¾Ë¸®µµ·Ï È¯ÀÚ¿Í º¸È£ÀÚ ±³À°ÇÔ.
Puncture site close monitoring
4hrs ABR
±â·ÏÀÚ¸í ±èÁö¿µ
Àü´ã°£È£»ç °æ°ú±â·Ï
2019-01-28
ÀüÀÚ¼­¸íÀÚ: ±èÁö¿µ
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
°æ°ú
[Puncture site assessment]: POD #1
1. Lt.CFA (Proglide)
1) Bleeding/Oozing (-)
2) Hematoma/Color change (-/-)
3) Distal assessment: Color/Pulse/Temperature change (-/-/-)
Lt.DPA (2+)
4) Infection sign (-)
5) Puncture site pulse check (2+)
6) Bruit(+)/ Thrill (-)
7) ±âÁ¸ compressive Dx Á¦°Å ÈÄ betadine ball·Î ¼Òµ¶ÇÔ. Medress
#1·Î »õ·Î DX ½ÃÇàÇÔ.
+) Pulse examination
*
0-absent/1+ diminished/2+ normal/3+ bounding
Åğ¿ø ÈÄ ÃµÀÚºÎÀ§ ÅëÁõ Áõ°¡, ºÎÁ¾, °¨¿°ÀÇ Â¡ÈÄ, ¸»ÃÊºÎÀ§ ÇÇºÎ»ö º¯
È­, »óÃ³ ¾ÇÈ­ µîÀÌ ÀÖÀ» °æ¿ì º´¿ø ³»¿øÇÏ°Å³ª ¿¬¶ôÇÏ½Ãµµ·Ï È¯ÀÚ¿Í
º¸È£ÀÚ ±³À°ÇÔ.
°èÈ¹
f/u
±â·ÏÀÚ¸í ±èÁö¿µ
Àü´ã°£È£»ç °æ°ú±â·Ï
2019-01-29
ÀüÀÚ¼­¸íÀÚ: ±èÁö¿µ
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿¬·É ±¸ºĞ
ºĞ·ù
¿µÀ¯¾Æ±â ÇĞ·ÉÀü±â ÇĞ·É±â
ÀÏ¹İ »ê¸ğ ¤·Á¤½Å
Ã»¼Ò³â±â
¼ºÀÎ
Çöº´·Â
ÁÖ Áõ»ó ¹× ³»¿ø °úÁ¤
Hx. DM, HTN, dyslipidemia, Unstable angina, CAOD, (2018.04), s/p
CABG(2018.04), Rt. ICA stent insertion(2018.09)
PTA À§ÇØ ÀÔ¿øÇÔ.
º¹¿ëÁßÀÎ ¾à
Åõ¾à »óÅÂ
°³¼ö
¾à¸í
È½¼ö
¿ë¹ı
¾àÇ° ÄÚµå
°³¼ö
´ÜÀ§
Aspirin protect [100 mg/1
T
1
PO ¾ÆÄ§ ½ÄÈÄ
D2ASPI01
Glupa (48hr ÀüÈÄ Á¶¿µÁ¦ 1
T
1
PO ¾ÆÄ§ ½ÄÈÄ
D2GLUP02
º´¿ë±İ±â) [500 mg/T]
Herben [30 mg/T)
1
T
2
PO
D2HERBO1
Lipitor [80 mg/T]
1
T
1
PO ¾ÆÄ§ ½ÄÈÄ
D2LIPI12
Lozasartan(¿ø¿Ü) [100
1
T
1
PO ¾ÆÄ§ ½ÄÈÄ
DZLOZA02
mg/T]
Platless [75 mg/T]
1
T
1
PO ¾ÆÄ§ ½ÄÈÄ
D2PLAT01
Rabiet [10mg/T]
1
T
1
Sigmart [5 mg/T]
1
T
2
22
PO ¾ÆÄ§ ½ÄÀü
D2RABI01
PO
D2SIGM01
Xigduo XR 10/1000 (¿ø
1
T
1 PO ¾ÆÄ§ ½ÄÈÄ
D2XIGD02
¿Ü,48hr ÀüÈÄ Á¶¿µÁ¦ º´¿ë
±İ±â) [1/1]
°£È£Á¤º¸Á¶»ç
2019-01-27
ÅëÁõ
ÅëÁõ
¾øÀ½ ÀÖÀ½ ÀÔ¿ø Àü¿¡ ÀÖ¾úÀ½
°ú°Å·Â
°ú°Å·Â ¹« À¯
ÀÔ¿ø ¹× ¼ö¼ú ÀÌ·Â
¾øÀ½
°ú°Åº´·Â °íÇ÷¾Ğ
´ç´¢ ¡à °áÇÙ ¡à¾Ï ¡à °£¿°
ÀÖÀ½ Àß¸ğ¸§
°æ·Ã | ±âÅ¸
CAOD 2vd s/pCABG
°ú°Å·Â(ÀÔ¿ø ¹× ¼ö¼ú)
ÀÔ¿ø½Ã Áø´Ü¸í ¹× ¼ö¼ú¸í
ÀÔ¿ø ¹× ¼ö¼ú ½Ã±â
CAOD 2vd s/pCABG
2018.4¿ù
Rt. ICA stent insertion
2018.09
s/p CAG
ÀüÀÚ¼­¸íÀÚ: ±èÀº°æ
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
(2018.04, ÀÏ»ê¹é)
1/5
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/64¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
°£È£Á¤º¸Á¶»ç
2019-01-27
Allergy
Allergy
¾øÀ½ ¡à ¾à ¡à À½½Ä
±â´É Æò°¡
ÀÏ»ó»ıÈ°(ADL) ¼öÇà ´É·Â
µ¶¸³Àû ¼öÇà
ºÎºĞ º¸Á¶ ÇÊ¿ä
¿ÏÀü º¸Á¶
º¸Á¶±â(ÀÌµ¿) »ç¿ë ¾øÀ½ ¤· ¸ñ¹ß ¤· ÁöÆÎÀÌ Owalker
ÈÙÃ¼¾î ¤·±âÅ¸
*ÀÌµ¿½Ã ÁÖ·Î »ç¿ëÇÏ´Â º¸Á¶±â¸¦ ¼±ÅÃÇØ ÁÖ¼¼¿ä.
½Ä»çÇÏ±â µ¶¸³Àû ¼öÇà°¡´É
¸ñ¿åÇÏ±â µ¶¸³Àû ¼öÇà°¡´É
°³ÀÎ À§»ı µ¶¸³Àû ¼öÇà°¡´É
¿ÊÀÔ±â µ¶¸³Àû ¼öÇà°¡´É
È­Àå½Ç »ç¿ë µ¶¸³Àû ¼öÇà°¡´É
°è´Ü ¿À¸£±â
µ¶¸³Àû ¼öÇà°¡´É
ÀÌµ¿ÇÏ±â µ¶¸³Àû ¼öÇà°¡´É(ÈÙÃ¼¾î¸¦ Á¦¿ÜÇÑ walking aid »ç¿ë ÇÒ ¼ö ÀÖÀ½)
ÀÌµ¿ ÇÏ±â(ÀÇÀÚ¿Í Ä§´ë°£) µ¶¸³Àû ¼öÇà°¡´É
ÀÌµ¿ ÇÏ±â (ÈÙÃ¼¾î)
¿îµ¿
±ÔÄ¢ÀûÀ¸·Î ÇÏ´Â ¿îµ¿ ÀÖÀ½
¿îµ¿ÀÇ Á¾·ù
°È±â ¡à ´Ş¸®±â ¡à ¼ö¿µ
1µî»ê °ñÇÁ
±âÅ¸
¿îµ¿ È½¼ö (¸ÅÀÏ )È¸/ÁÖ
1È¸ ¿îµ¿ ½Ã°£
1½Ã°£~1½Ã°£30
À½ÁÖ·Â Onondrinker
ex-drinker current drinker
À½ÁÖ·Â(Á¾·ù, ¾ç, È½¼ö/wk) ¼ÒÁÖ 1º´ ÁÖ 3~4È¸
À½ÁÖ ½ÃÀÛ ½Ã±â 20»ì
²÷Àº ½Ã±â 2018.4
Èí¿¬·Â
Èí¿¬·Â Ononsmoker
ex-smoker
current smoker
ÇÏ·çÀÇ Èí¿¬·® (1)°©/ÀÏ
Èí¿¬ ½ÃÀÛ½Ã±â 20»ì
²÷Àº ½Ã±â 2016³â
*
²÷Àº ½Ã±â°¡ 1³â ÀÌÇÏÀÎ °æ¿ì ²À ±İ¿¬±³À°À» ½ÃÇàÇØ ÁÖ¼¼¿ä. (Åğ¿øÀü±îÁö)
¿¹¹æ Á¢Á¾
BÇü °£¿° Àß¸ğ¸§
Rubella Àß¸ğ¸§
Æó±¸±Õ Àß¸ğ¸§
¿µ¾ç »óÅÂ
1°³¿ù°£ Ã¼Áßº¯È­ ¾øÀ½ ¤· Áõ°¡ÇÔ ¤· °¨¼ÒÇÔ
Ã¼Áßº¯È­ kg
ÃÖ±Ù 1ÁÖÀÏ°£ ½Ä»ç·® º¯È­ ¾øÀ½ ¤· Áõ°¡ °¨¼Ò
½ÄÀÌ ÁÖÀÇ »çÇ× ) ¾øÀ½ ¤· ¿­·® Á¶Àı ¤· Ã¼Áß Á¶Àı ¤· ¿°ºĞ Á¦ÇÑ ¡Û ¼öºĞ Á¦ÇÑ ¡Û ´Ü¹éÁú Á¦ÇÑ ¤· Áö¹æ Á¦ÇÑ
±âÅ¸
½Ä½À°ü
½Ä»çÈ½¼ö 3È¸/ÀÏ
Æí½Ä ½À°ü
¹«
¼±È£ À½½Ä
±âÇÇ À½½Ä
¼ö¸é »óÅÂ
ÀüÀÚ¼­¸íÀÚ: ±èÀº°æ
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
2/5
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¼ö¸é½Ã°£ 5½Ã°£
¼ö¸éÀ» µ½´Â¹ı ¹«
¼ö¸éÀå¾Ö ¾øÀ½
½Å°æ°è
½Ã°£¿¡ ´ëÇÑ Áö³²·Â ÀÖÀ½
Àå¼Ò¿¡ ´ëÇÑ Áö³²·Â ÀÖÀ½
»ç¶÷¿¡ ´ëÇÑ Áö³²·Â ÀÖÀ½
ÀÇ»ç ¼ÒÅë ¡à ¿ø¸¸ÇÔ ¾î·Á¿ò ¡à ºÒ°¡´ÉÇÔ ¡à ±âÅ¸
Á¤¼­ »óÅÂ
Áö³­ 2ÁÖµ¿¾È ±âºĞÀÌ °¡¶ó¾É°Å³ª, ¿ì¿ïÇÏ°Å³ª, Èñ¸ÁÀÌ ¾ø´Ù°í ´À³¤ ±â°£
) ¾øÀ½ 2~3ÀÏ ÀÌ»ó ¡Û7ÀÏ ÀÌ»ó ¡Û °ÅÀÇ ¸ÅÀÏ ¡Û È®ÀÎ ºÒ°¡´É
Áö³­ 2ÁÖµ¿¾È Æò¼Ò ÇÏ´ø ÀÏ¿¡ ´ëÇÑ Èï¹Ì°¡ ¾ø¾îÁö°Å³ª Áñ°Å¿òÀ» ´À³¢Áö ¸øÇÑ ±â°£
¾øÀ½ ¡Û 2~3ÀÏ ÀÌ»ó ¡Û7ÀÏ ÀÌ»ó ¡Û °ÅÀÇ ¸ÅÀÏ È®ÀÎºÒ°¡´É
Á¤¼­ Æò°¡ 0
*The Patient Health Questionnaire -2(PHQ-2) (2003).
¸¶ºñ ¹« À¯È®ÀÎ ºÒ°¡´É
Weakness ¹«
È®ÀÎ ºÒ°¡´É
½Ã°¢
½Ã·Â Àå¾Ö
À¯
½Ã·Â Àå¾Ö
½Ã·ÂÀå¾Ö ºÎÀ§
¾ç¾È
½Ã·ÂÀúÇÏ ¡à ½Ã·Â»ó½Ç ¡à º¹½Ã ¡à ¹İÁ¡ ¡à ÅëÁõ
¾È°æ
|±âÅ¸
º¸Á¶±â »ç¿ë
Ã»°¢
Ã»·Â Àå¾Ö
¹«
ot
¼ÒÈ­±â°è
¼ÒÈ­±â °ü·Ã Áõ»ó
¹èº¯ ¾ç»ó
¹èº¯ È½¼ö 1È¸/ÀÏ
À¯
´ëº¯ »ö±ò ¡à ´©·±»ö °¥»ö ¡à ³ì»ö ¡à °ËÀº»ö
°£È£Á¤º¸Á¶»ç
2019-01-27
¹èº¯ Àå¾Ö
¹«À¯
¼±È«»ö |Èò»ö |±âÅ¸
¹èº¯ Á¶Àı Á¶Àı¿¡ ¹®Á¦ ¾øÀ½
¹è´¢ ¾ç»ó
¹è´¢ ¹æ¹ı ? spont voiding
Foley catheter ? CIC
Kissmo
¡à ±âÅ¸
catheter ±³È¯ ¿¹Á¤ÀÏ
¹è´¢ Àå¾Ö
¹« ¡Û À¯
¹è´¢ Á¶Àı Á¶Àı¿¡ ¹®Á¦ ¾øÀ½
±â´ÉÆò°¡
100
¼øÈ¯±â°è
¸Æ¹Ú ±ÔÄ¢ÀûÀÓ
Pacemaker
¾øÀ½
ºÎÁ¾
¾øÀ½
ÀÖÀ½
¼øÈ¯±â °ü·ÃÁõ»ó
¾øÀ½
ÀÖÀ½
È£Èí±â°è
È£Èí¾ç»ó
Regular
? Irregular
Suppressed
Labored
±âÅ¸
È£Èí±â °ü·ÃÁõ»ó
¾øÀ½ ÀÖÀ½
ÀüÀÚ¼­¸íÀÚ : ±èÀº°æ
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
3/5
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
ÇÇºÎ
ÇÇºÎ ¿Âµµ µû¶æÇÔ
ÇÇºÎ ½Àµµ Àû´çÇÔ
ÇÇºÎ»ö ÀÌ»ó¾øÀ½
ÇÇºÎ º¯È­
¹« À¯
¬à¬ä¬à ¬à¬ä¬à
[Comment]
»ç¸Á »ç¸Á »ç¸Á »ç¸Á
Çü: CAOD
»ç¸Á
»ç¸Á
PT
°£È£Á¤º¸Á¶»ç
Åğ¿ø
Åğ¿ø ÈÄ º¸È£ÀÚ (Main care giver)
¾øÀ½
¹è¿ìÀÚ ºÎ
¸ğ
¡à ÀÚ³à
Á¶ºÎ
?
Á¶¸ğ
ÇüÁ¦ÀÚ¸Å
°£º´ÀÎ
±âÅ¸
Åğ¿ø ¿¹Á¤Áö
?ÀÚÅÃ Ä£Ã´Áı Å¸º´¿ø
¿ä¾ç½Ã¼³
±âÅ¸
Åğ¿ø ¿¹Á¤ ±³Åë ¼ö´Ü(Discharge transportation)
ÀÚ°¡ ´ëÁß ±³Åë
Ç×°ø
¡à ±¸±ŞÂ÷
|±âÅ¸
ÀÏ¹İ Á¤º¸(6¼¼ ÀÌ»ó)
±³À° Á¤µµ °íµîÁ¹
°áÈ¥ »óÅÂ
°áÈ¥
Á÷¾÷ »ç¹«Á÷
¿ø¸ñ ¿¬¶ô
ÀüÈ­¹øÈ£ 01037588088
¿øÇÔ
¿øÇÏÁö ¾ÊÀ½
Á¾±³ ¾øÀ½ ±âµ¶±³ ÃµÁÖ±³ ºÒ±³ ±âÅ¸
º¸È£ÀÚ (Main care giver)
¡à ¾øÀ½ V¹è¿ìÀÚ
ºÎ
ÀÚ³à
Á¶ºÎ
Á¶¸ğ
ÇüÁ¦
ÀÚ¸Å
°£º´ÀÎ ¡à ±âÅ¸
±³À° ¿ä±¸µµ
È¯ÀÚ
º¸È£ÀÚ
±âÅ¸
±³À° ¿ä±¸
ÁÖ »ç¿ë ¾ğ¾î
ÇÑ±¹¾î ¡à ¿µ¾î
ÀÏº»¾î ¡à Áß±¹¾î ¡à ·¯½Ã¾Æ¾î ¡à ±âÅ¸
±³À° ¹æ¹ı(È¯ÀÚ ¼±È£) ±¸µÎ¡à À¯ÀÎ¹° ¡à ½Ã¹ü º¸ÀÌ±â
|½ÃÃ»°¢ ¸ÅÃ¼(°¡´ÉÇÏ´Ù¸é)
ÀĞ°í ¾²´Âµ¥ ¾î·Á¿ò ¾øÀ½ ¡à ÀÖÀ½ ¡à ±âÅ¸
¿øÇÏ´Â ±³À° ³»¿ë ¡à Áúº´ ¡à ¾à¹° ¡à °Ë»ç ¡à ¼ö¼ú ¡àÀÚ°¡ °£È£
¡à ±âÅ¸
¿µ¾ç
±³À°°ú Áø·á¿¡ ¿µÇâÀ» ÁÖ´Â °¡Ä¡¿Í ½Å³ä(Value & belief) ¾øÀ½ ÀÖÀ½
°æÁ¦Àû »óÅÂ
ÀüÀÚ¼­¸íÀÚ: ±èÀº°æ
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
2019-01-27
4/5
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

|µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
ÀÔ¿øºñ ÁöºÒÀÇ ¾î·Á¿ò
ÀÖÀ½ ¾øÀ½ ±âÅ¸
ÀÔ¿øºñ ÁöºÒ°ú °ü·ÃÇÑ »çÈ¸ »ç¾÷ÆÀ »ó´ã ÇÊ¿ä ÀÖÀ½
¾øÀ½
±âÅ¸
°£È£Á¤º¸Á¶»ç
2019-01-27
ÀüÀÚ¼­¸íÀÚ: ±èÀº°æ
5/5
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/70¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
°Ë»ç°á°ú
Impression
Image Name
ÀüÀÚ¼­¸íÀÚ: ¼­µ¿¿ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
±â´É°Ë»ç°á°ú(I/FÇü)
*CAD-2VD, S/POPCAB(2018), DM, HTN
*Compare with previous echo (2018.04.16)
1. No RWMA
2. Still enlarged LA(LAVI : 39ml/m2) with normal global LV systolic
function (EF: 77%)
3. Relaxation abnormality of LV filling pattern with elevated LV filling
pressure (E/e': 10->15)
4. Mild pulmonary hypertension (RVSP: 41mmHg)
5. Slightly dilated sinus of Valsalva (38mm) and ascending aorta
(39mm)
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/70¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
±â´É°Ë»ç°á°ú(I/FÇü)
ECHOCARDIOGRAPHY LABORATORY, SEVERANCE CARDIOVASCULAR HOSPITAL
YONSEI UNIVERSITY COLLEGE OF MEDICINE, SEOUL KOREA
Exam Date: 2025-03-19
Patient ID: 8633158
Echo No.: 25
Name: ÀÌ±¤¿í
Referring Dr.: ¾ÈÃ¶¹Î
Sex/Age: M 1 70Y
Location: OPD
Study Remark:
Height
170.0cm
Weight
78kg
BSA
1.89m2
BP
149/62mmHg
1. Comments
Àü¹®½ÉÃÊÀ½ÆÄ
*CAD-2VD, S/P OPCAB(2018), DM, HTN
"Compare with previous echo (2018.04.16)
1. No RWMA
2. Still enlarged LA(LAVI 39ml/m2) with normal global LV systolic function (EF: 77%)
3. Relaxation abnormality of LV filling pattern with elevated LV filling pressure (E/e: 10->15)
4. Mild pulmonary hypertension (RVSP: 41mmHg)
5. Slightly dilated sinus of Valsalva (38mm) and ascending aorta (39mm)
2. Regional Wall Motion Abnormality: No
3. [LV GLS]: 15-20%
4. Valves:
MV
Native
Slightly thickened
AV
Native
Senile sclerocalcified
TV
Native
Slightly thickened
5. Regurgitation: MR
Trivial
AR
No
TR.
GI
PR
No
6. Stenosis:
MS
No
AS
No
7. Pericardial Effusion:
No
TS:
Intracardiac Thrombi: No
No
PS
No
Mass: No
8. Diastolic function:
Relaxation abnormality of LV filling pattern
M-mode/2D Measurement
RVD (9-26)
mm
LVEDD (42-54):
51
mm
IVSD (8-11):
IVSS:
11
mm
Ao root (22-33)
mm
13
mm
LA (AP/ML/SI):
40//
mm
LVESD (24-36):
29
mm
PWD (8-11):
9
mm
LA Vol
LVEF (55-76):
PWS:
13
mm
by M-mode:
77
%
LVOT (18-22):
mm
by Biplane.
%
LV Mass:
188.0
g
by prolate ellipse
by mod simpson
LA Vol index (18-28)
ml
76.0
ml
TV Annulus:
mm
LV Mass index:
97.9
g/m2
IVC:
mm
RWT:
0.35
Echo Score:
Doppler Measurement
Total
M
T S
C
by prolate ellipse:
by mod simpson
MV Annulus (4C/2C):
39.6
ml/m2
ml/m2
mm
Aortic
Mitral
Tricuspid
LVOT (TVI):
AV (TVI):
cm
cm
TVI of MR jet:
cm
TR jet.
2.98
m/sec
E (0.6-1):
0.77
m/sec
RVSP:
41
mmHg
LVOT peak V
m/sec
A (0.3-0.8):
1.10
m/sec
RAP
5
mmHg
PSPG/MSPG:
1
mmHg
DT (170-210)
224
msec
MPAP
mmHg
AV Peak V:
m/sec
PHT:
msec
PVR
PSPG/MSPG:
9/5
mmHg
MDPG:
mmHg
MDPG
mmHg
AVA by 2D
HR:
/min
RVOT VTI
cm
by continuity:
cm2
MVA by 2D:
cm2
Pulmonic
PHT of AR jet:
msec
by PHT:
cm2
PSPG/MSPG:
mmHg
by continuity:
cm2
TDI
S
11.0
cm/sec
E': 5.0
cm/sec
A
11.0
RVOT AT:
cm/sec
m/sec
E/E
15.40
Reported by:
¼­µ¿¿ì
ÆÇµ¶ÀÇ(1Â÷)
¼­µ¿¿ì
ÆÇµ¶ÀÇ(2Â÷)
½ÉÁö¿µ
ÀüÀÚ¼­¸íÀÚ: ¼­µ¿¿ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Responsible Dr. : ½ÉÁö¿µ
2/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/68¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
°­Àº¼®
BP(S)
132 mmHg
BP(D) 62 mmHg
HR 82/min
°æ°ú ¹× Plan
CAD(2vd+ LM)
s/p CAG (2018.04, ÀÏ»ê¹é)
s/p 40PCAB(LIMA to dLAD, to OM(seq) to DG with RIMA
composite Y, Aorta to rPL with RA) (2018-04-09)
Rt. ICA stenosis s/p stent insertion (2018.10.02)
PAD
s/p PTA c DCB at Rt. SFA (2019.01.28)
DM(11yrs)
Ex-smoker (30yr, 2³âÀü Áß´Ü)
Aorta to rPL with RA)
Glucose
114
Glycoalbumin 20.5
Glucose (¿¬¼Ó) - ½ÄÈÄ 2½Ã°£ 181
HbA1c 7.2
Cholesterol 112
Triglyceride 57
HDL-Cholesterol 48
LDL-Cholesterol (Friedewald) 52.6
Urine Albumin-to-Creatinine Ratio 42.04
>>
repeat med
6mo f/u
Áø´Ü¸í
±¸ºĞ
È®Áø
ÁÖÁø´Ü
±âÅ¸Áø´Ü
±âÅ¸Áø´Ü
Thyroid nodule
È®Áø Diabetes mellitus type 2 with dyslipidemia
È®Áø
È®Áø
Internal carotid artery stenosis
±â·ÏÀÚ¸í
°­Àº¼®
ÀüÀÚ¼­¸íÀÚ: °­Àº¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Áø´Ü¸í
¿Ü·¡ÀçÁø±â·Ï
2023-07-18
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/69¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
±è´ÙÇÔ
Progress
U/S °æºÎ(neck)(Doppler) 2024.01.16
Clinical information: Diabetes mellitus type 2 with dyslipidemia
US examination was done with linear transducer> =10 MHz (central frequency).
ÀÌÀü US¿Í ºñ±³ÇÔ
Both thyroid gland ¿¡ multiple probably benign nodules µéÀÌ °üÂûµÇ¸ç °¡Àå Å« °ÍÀº
Rt thyroid lower poleÀÇ 21mm Å©±âÀÇ nodule ÀÓ.
Background echotexture subtle heterogeneous mild diffuse enlarge 001
À½..
Both neck¿¡ pathologically enlarged LNs ¾øÀ½.
Doppler ultrasound images »ó Æ¯ÀÌ¼Ò°ß ¾øÀ½.
Imp: Multiple probably benign nodules in both thyroids (K-TIRADS: 3)
R/O Diffuse thyroid disease
recommend follow up.
T3 0.47
Free T4
1.08
TSH
2.12
Ãß°¡»çÇ× Thyroid nodule
Plan
2y f/u
Áø´Ü¸í
±¸ºĞ
È®Áø
ÁÖÁø´Ü È®Áø
Diabetes mellitus type 2 with dyslipidemia
|±âÅ¸Áø´Ü È®Áø
Diabetic polyneuropathy
|±âÅ¸Áø´Ü È®Áø
Internal carotid artery stenosis
Áø´Ü¸í
±â·ÏÀÚ¸í ±è´ÙÇÔ
¿Ü·¡ÀçÁø±â·Ï
2024-01-16
ÀüÀÚ¼­¸íÀÚ: ±è´ÙÇÔ
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/69¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
°­Àº¼®
BP(S)
142 mmHg
BP(D) 62 mmHg
HR 77/min
°æ°ú ¹× Plan
CAD(2vd+ LM)
s/p CAG (2018.04, ÀÏ»ê¹é)
s/p 40PCAB(LIMA to dLAD, to OM(seq) to DG with RIMA
composite Y, Aorta to rPL with RA) (2018-04-09)
Rt. ICA stenosis s/p stent insertion (2018.10.02)
PAD
s/p PTA DCB at Rt. SFA (2019.01.28)
DM(11yrs)
Ex-smoker (30yr, 2³âÀü Áß´Ü)
Aorta to rPL with RA)
Glucose
106
Glycoalbumin20.0
Glucose (¿¬¼Ó) - ½ÄÈÄ 2½Ã°£ 177
HbA1c 7.0
Cholesterol 104
Triglyceride 77
HDL-Cholesterol 42
LDL-Cholesterol (Friedewald) 46.6
Urine Albumin-to-Creatinine Ratio 69.15
°¡²û¾¿ Á¹¸° Áõ»ó?
>>
½Ä½À°ü ²ÙÁØÈ÷ °ü¸®ÇØº¸½Ã°í, ½ÄÈÄ 1½Ã°£ ÀÚ°¡Ç÷´ç ÃøÁ¤ÇØº¸¼¼¿ä.
repeat med
6mo f/u
Áø´Ü¸í
±¸ºĞ
È®Áø
ÁÖÁø´Ü È®Áø
Diabetes mellitus type 2 with dyslipidemia
|±âÅ¸Áø´Ü È®Áø
Diabetic polyneuropathy
|±âÅ¸Áø´Ü È®Áø
Internal carotid artery stenosis
±â·ÏÀÚ¸í
°­Àº¼®
ÀüÀÚ¼­¸íÀÚ: °­Àº¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Áø´Ü¸í
¿Ü·¡ÀçÁø±â·Ï
2024-01-16
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ |

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/69¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
°­Àº¼®
BP(S)
mmHg
BP(D) mmHg
HR
/min
°æ°ú ¹× Plan
Áø´Ü¸í
±¸ºĞ
È®Áø
CAD(2vd+ LM)
s/p CAG (2018.04, ÀÏ»ê¹é)
s/p 40PCAB(LIMA to dLAD, to OM(seq) to DG with RIMA
composite Y, Aorta to rPL with RA) (2018-04-09)
Rt. ICA stenosis s/p stent insertion (2018.10.02)
PAD
s/p PTA c DCB at Rt. SFA (2019.01.28)
DM(11yrs)
Ex-smoker (30yr, 2³âÀü Áß´Ü)
Aorta to rPL with RA)
Glucose 121
Glycoalbumin23.6
Glucose (¿¬¼Ó) - ½ÄÈÄ 2½Ã°£ 116
HbA1c 6.9
Cholesterol 115
Triglyceride 57
HDL-Cholesterol 51
LDL-Cholesterol (Friedewald) 52.6
Urine Albumin-to-Creatinine Ratio 36.11
>>
repeat med
6mo f/u
ÁÖÁø´Ü È®Áø Diabetes mellitus type 2 with dyslipidemia
È®Áø Thyroid nodule
±âÅ¸Áø´Ü
±âÅ¸Áø´Ü
È®Áø
Internal carotid artery stenosis
±â·ÏÀÚ¸í
°­Àº¼®(ÀÇ»ç)
ÀüÀÚ¼­¸íÀÚ: °­Àº¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Áø´Ü¸í
¿Ü·¡ÀçÁø±â·Ï
2024-07-16
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/69¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2024-10-01
Áø·á°ú
½Å°æ°ú
ÁÖÄ¡ÀÇ
³²È¿¼®
Subjective
Brain MRI and MRA
2024-09-12
Small old infarction in left side medulla.
Stenosis in right carotid bulb and right distal VA.
Steno-occlusion in left VA.
Stenosis in left proximal ICA, left cavernous ICA.
--> ºñ½ÁÇÏ½Ê´Ï´Ù.
Æò¼Ò¿¡ ±¦ÂúÀ½.
¿îÀüÇÏ°í ³»¸± ¶§ ¾îÂñÇÔ. <5ÃÊ
-
2022-09-14 ¿¡ ºñÇØ¼­ Rt distal VA stenosis °¡ ½ÉÇØÁü.
one-way ¶ó¼­ ¿ì·ÁµÊ.
LDL-Cholesterol (Friedewald)
52.6
Objective
Assessment
Plan
plavix, ¾Æ¸ğÀßÅº Q (·Î¼ö¹Ù 20 º¹ÇÕÁ¦)
¢º¾Æ½ºÇÇ¸° Ãß°¡
Stroke ¹ß»ı
Cerebral infarction
Hemorrhage stroke
Unknown stroke
TIA
Stroke ¹ß»ı ³¯Â¥
Stroke Comment
CAOD ¹ß»ı
? Acute MI ? Unstable angina
PTCA/stent
CABG
Others
CAOD ¹ß»ı ³¯Â¥
CAOD ¹ß»ı Comment
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
1/3
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/69¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2024-10-01
121067Y|M
8633158
Study Date 2022-09-14
A1069Y|M
8633158
Study Date 2024-09-12
AR
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
B1050mm
RF
2/3
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/69¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø´Ü¸í
±¸ºĞ
È®Áø
HP
Bricktha
Study Date 202409 12
LH
11069YM
8633158
Study Dale 2024-09-12
503 18m
RA
ÁÖÁø´Ü È®Áø Internal carotid artery stenosis
HP
±âÅ¸Áø´Ü È®Áø
±âÅ¸Áø´Ü È®Áø
Coronary artery disease (2 vessel disease)
Unstable angina
±â·ÏÀÚ¸í ³²È¿¼®(ÀÇ»ç)
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Áø´Ü¸í
¿Ü·¡ÀçÁø±â·Ï
2024-10-01
3/3
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/70¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
°­Àº¼®
BP(S)
170mmHg
BP(D) 50mmHg
HR 103/min
°æ°ú ¹× Plan
CAD(2vd+ LM)
s/p CAG (2018.04, ÀÏ»ê¹é)
s/p 40PCAB(LIMA to dLAD, to OM(seq) to DG with RIMA
composite Y, Aorta to rPL with RA) (2018-04-09)
Rt. ICA stenosis s/p stent insertion (2018.10.02)
PAD
s/p PTA c DCB at Rt. SFA (2019.01.28)
DM(11yrs)
Ex-smoker (30yr, 2³âÀü Áß´Ü)
Aorta to rPL with RA)
Glucose
132
20.1
Glycoalbumin
Glucose (¿¬¼Ó) - ½ÄÈÄ 2½Ã°£ 235
HbA1c 6.8
Total cholesterol
112
Triglyceride 70
HDL-Cholesterol 56
LDL-Cholesterol (Friedewald) 42
Urine Albumin-to-Creatinine Ratio 63.99
Ã¼Áß ÀÌÀü°ú ºñ½ÁÇÔ
>>
repeat med
6mo f/u
Áø´Ü¸í
±¸ºĞ
È®Áø
ÁÖÁø´Ü È®Áø
±âÅ¸Áø´Ü È®Áø
±âÅ¸Áø´Ü È®Áø
Diabetes mellitus type 2 with dyslipidemia
Diabetic polyneuropathy
Áø´Ü¸í
Internal carotid artery stenosis
±â·ÏÀÚ¸í
°­Àº¼®(ÀÇ»ç)
ÀüÀÚ¼­¸íÀÚ: °­Àº¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿Ü·¡ÀçÁø±â·Ï
2025-01-14
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/70¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
½ÉÀå³»°ú
ÁÖÄ¡ÀÇ
¾ÈÃ¶¹Î
BP(S)
131 mmHg
BP(D)
56mmHg
HR
86/min
Subjective
Good/No interval change
Objective
Non-HDL Cholesterol 50
Assessment
LDL-Cholesterol (Friedewald) 34.8
¿Ü·¡ÀçÁø±â·Ï
ÀÏ»ê21¼¼±âº´¿ø ¾à) Platless 75mg qd, Amosartan Q5/100/20mg qd, Sigmart 5mg
bid, Herben 30mg bid
ABI (Ankle / Brachial Index)
-
Rt: 0.80 /Lt: 0.72 <=-Rt: 0.90 /Lt: 0.84 <== Rt:
0.96 /Lt: 0.88 <==Rt: 0.84/Lt: 0.82
echo
*CAD-2VD, S/P OPCAB(2018), DM, HTN
*Compare with previous echo (2018.04.16)
1. No RWMA
2. Still enlarged LA(LAVI: 39ml/m2) with normal global LV systolic function (EF:
77%)
3. Relaxation abnormality of LV filling pattern with elevated LV filling pressure (E/e':
10->15)
4. Mild pulmonary hypertension (RVSP: 41mmHg)
5. Slightly dilated sinus of Valsalva (38mm) and ascending aorta (39mm)
TMT 10.1 METS equivocal
PAD, s/p PTA 2019.1.28 - IVUS-DCB
-
s/p PTA CDCB at Rt. SFA[2019-01-28]
ABI 1.04/1.09 <== 0.69/0.99
CAD(2vd+ LM)
s/pCAG(2018.04, ÀÏ»ê¹é)
s/p 2018-04-09 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA)
DM
herben ÀÏ³â Á¤µµ »ç¿ë - À¯°æÁ¾ ±³¼ö´Ô - radial graft
HTN
Plan
2yr EKG/CXR/LAB/full(ºñ±Ş¿© ¼³¸íµå¸²)
Áø´Ü¸í
±¸ºĞ
È®Áø
Áø´Ü¸í
ÁÖÁø´Ü È®Áø
Unstable angina
|±âÅ¸Áø´Ü È®Áø
Peripheral arterial occlusive disease (lower extremities)
|±âÅ¸Áø´Ü È®Áø
Coronary artery disease (2 vessel disease)
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
2025-03-26
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/70¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2025-03-26
±â·ÏÀÚ¸í
¾ÈÃ¶¹Î(ÀÇ»ç)
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
2/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/70¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
½Å°æ°ú
ÁÖÄ¡ÀÇ
³²È¿¼®
Subjective
Objective
Assessment
Plan
Rt distal VA stenosis °¡ ÁøÇàÇÑ °Í °°½À´Ï´Ù.
À§Çè¼®ÀÌ Ä¿¼­ Áõ»óÀÌ ÀÖÀ¸¸é ½ºÅÙÆ® °í·ÁÇÏ°Ú½À´Ï´Ù.
Stroke ¹ß»ı
Cerebral infarction
Hemorrhage stroke
Unknown stroke
TIA
Stroke ¹ß»ı ³¯Â¥
Stroke Comment
CAOD ¹ß»ı
Acute MI ? Unstable angina
PTCA/stent
CABG
Others
CAOD ¹ß»ı ³¯Â¥
CAOD ¹ß»ı Comment
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
8633158M070YCT Brain + Angio (Brain+Neck) (contrast 2025-03-19 13 08:17
AL
¿Ü·¡ÀçÁø±â·Ï
2025-03-26
1/3
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ |

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/70¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
JOYCT Brain + Angio (Brain+Neck) (contrast)2025-03-19 13:08:17
HR
M070YCT Brain + Angio (Brain+Neck) (contrast)2025-03-19 13:08 17
A
¿Ü·¡ÀçÁø±â·Ï
2025-03-26
2/3
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/70¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
BOYCT Brain + Angio (Brain+Neck) (contrast)2025-03-19 13:08:17
A
Áø´Ü¸í
±¸ºĞ
È®Áø
Áø´Ü¸í
ÁÖÁø´Ü È®Áø
±âÅ¸Áø´Ü È®Áø Unstable angina
Internal carotid artery stenosis
±âÅ¸Áø´Ü
È®Áø Coronary artery disease (2 vessel disease)
±â·ÏÀÚ¸í
³²È¿¼®(ÀÇ»ç)
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿Ü·¡ÀçÁø±â·Ï
2025-03-26
3/3
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

Áø·áºñ ¼¼ºÎ»êÁ¤³»¿ª(¿Ü·¡)
È¯ÀÚµî·Ï¹øÈ£
8633158
È¯ÀÚ¼º¸í
ÀÌ±¤¿í
È¯ÀÚ±¸ºĞ
°Ç°­º¸Çè
ºñ°í
Áø·á°ú
½ÉÀå³»°ú
Áø·á±â°£
2023-03-22
º´½Ç
¹ßÇàÀÏÀÚ 2025-04-11
¹ßÇàÀÚ
Á¤¼¼Èñ
¿ä¾ç±â°ü±âÈ£
11100206
ÀÇ»ç¸í
¾ÈÃ¶¹Î
ÀÇ»ç¸éÇã¹øÈ£
63949
±Ş¿©
ÄÚµå
Ç×¸ñ
½ÃÇàÀÏÀÚ ¼ö³³ÀÏÀÚ
(EDI)
¸íÄª
±İ¾× È½¼ö ÀÏ¼ö
ÃÑ¾×
ÀÏºÎº»ÀÎºÎ´ã
Àü¾×
ºñ±Ş¿©
º»ÀÎºÎ´ã±İ
°ø´ÜºÎ´ã±İ º»ÀÎºÎ´ã
°Ë»ç·á
20250319 20250319 D0002013 ¹éÇ÷±¸¼ö(´©000³ª(01))
1,090 1
1
1,090
654
436
0
0
°Ë»ç·á
°Ë»ç·á 20250319 20250319 D0002033 ÀûÇ÷±¸¼ö(´©000³ª(03))
20250319 20250319 D0002043 Çì¸¶ÅäÅ©¸®Æ®(´©000³ª(04))
1,090 1
1
1,090
654
436
ÀÌ
0
1,090 1
1
1,090
654
436
0
0
°Ë»ç·á
°Ë»ç·á
20250319
20250319 20250319 D0002053 Ç÷»ö¼Ò [±¤Àüºñ»ö¹ı] (´©000³ª(05))
20250319 D0002073 Ç÷¼ÒÆÇ¼ö(´©000³ª(07))
1,090 1
1
1,090
654
436
0
0
1,090 1
1
1,090
654
436
0
°Ë»ç·á 20250319
20250319 D1830003 ÃÑºô¸®·çºóÁ¤·® [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©183°¡)
1,340
1
1
1,340
804
536
0
0
°Ë»ç·á
20250319
20250319 D1840003 ÃÑ´Ü¹éÁ¤·® [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©184°¡)
1,420
1
1
1,420
852
568
0
0
°Ë»ç·á
20250319
20250319 D1850003 ALT (SGPT) [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©185°¡)
1,950 1
1
1,950
1,170
780
0
0
°Ë»ç·á
20250319 20250319 D1860003 AST (SGOT) [È­ÇĞ¹İÀÀ-Àåºñ ÃøÁ¤](´©186°¡)
1,990 1
1
1,990
1,194
796
0
0
°Ë»ç·á
20250319 20250319 D1870003 ¾ËÄ®¸®Æ÷½ºÆÄÅ¸Á¦ [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©187°¡)
1,570 1
1
1,570
942
628
0
0
°Ë»ç·á
20250319
20250319 D1880003 ¾ËºÎ¹Î [È­ÇĞ¹İÀÀ-Àåºñ ÃøÁ¤ ] (188)
1,660 1
1
1,660
996
664
0
0
°Ë»ç·á
20250319 20250319 D2201023 ¿äÄ§»ç °Ë»ç- [°üÂûÆÇÁ¤-À°¾È¡¤ÀåºñÃøÁ¤]_ÀÌ¹ÌÁöºĞ¼®¹ı(´©220
1,350 1
1
1,350
810
540
0
0
°Ë»ç·á
20250319
20250319 D2253003 ¿ä ÀÏ¹İ°Ë»ç-10Á¾±îÁö [È­ÇĞ¹İÀÀ-À°¾È°Ë»ç/È­ÇĞ¹İÀÀ-ÀåºñÅª
2,060 1
1
2,060
1,236
824
0
0
°Ë»ç·á
20250319
20250319 D2263003 Æ®¸®±Û¸®¼¼¶óÀÌµå [È­ÇĞ¹İÀÀ-Àåºñ ÃøÁ¤](260)
3,940 1
1
3,940
2,364
1,576
0
0
°Ë»ç·á 20250319
20250319 D2280003 Å©·¹¾ÆÆ¼´Ñ [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©228°¡)
1,760 1
1
1,760
1,056
704
0
0
°Ë»ç·á
20250319 20250319 D2300003 Ç÷Áß ¿ä¼ÒÁú¼Ò [NPNÆ÷ÇÔ] [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©230)
1,600
1
1
1,600
960
640
0
0
1/10 ÆäÀÌÁö

±Ş¿©
ÄÚµå
Ç×¸ñ
½ÃÇàÀÏÀÚ ¼ö³³ÀÏÀÚ
¸íÄª
±İ¾×
È½¼ö ÀÏ¼ö
ÃÑ¾×
ÀÏºÎº»ÀÎºÎ´ã
(EDI)
Àü¾×
ºñ±Ş¿©
º»ÀÎºÎ´ã±İ °ø´ÜºÎ´ã±İ º»ÀÎºÎ´ã
°Ë»ç·á 20250319
20250319 D2310003 ¿ä»ê [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©231°¡)
2,270
1
1
2,270
1,362
908
0
0
°Ë»ç·á 20250319
20250319 D2510013 CPK[È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©251°¡(01))
2,970
1
1
2,970
1,782
1,188
0
0
°Ë»ç·á
20250319
20250319 D2611003 ÃÑÄİ·¹½ºÅ×·ÑÁ¤·® [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©261°¡(1))
1,650
1
1
1,650
990
660
0
0
°Ë»ç·á
20250319
20250319D2613003 HDLÄİ·¹½ºÅ×·Ñ [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©261´Ù(1))
6,690
1
1
6,690
4,014
2,676
0
0
°Ë»ç·á
20250319
20250319 D2800023 ¼Òµğ¿ò [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©280(02))
1,730 1
1
1,730
1,038
692
0
0
°Ë»ç·á
°Ë»ç·á
20250319
20250319 D2800043 ÀÎ [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©280(04))
1,730 1
1
1,730
1,038
692
0
0
20250319
20250319 D2800053 ÃÑÄ®½· [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©280(05))
1,730 1
1.
1,730
1,038
692
0
0
°Ë»ç·á
20250319
20250319 D2800063 Æ÷Å¸½· [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©280(06))
1,730 1
1
1,730
1,038
692
ÀÌ
0
°Ë»ç·á
20250319
20250319 D3022003 ´ç°Ë»ç [È­ÇĞ¹İÀÀ-Àåºñ ÃøÁ¤] [Á¤·®](´©302³ª)
1,390 1
1
1,390
834
556
0
0
°Ë»ç·á
20250319 20250319 D3061003 Çì¸ğ±Û·ÎºóA1C-[È­ÇĞ¹İÀÀ-Àåºñ ÃøÁ¤](´©306°¡)
7,640 1
1
7,640
4,584
3,056
0
0
°Ë»ç·á 20250319 20250319 E6541 ½ÉÀüµµ°Ë»ç(³ª725°¡)
9,844 1
1
9,844
5,906
3,938
0
0
°Ë»ç·á 20250319 20250319 E6543
TREADMILL TEST(³ª725³ª(2))
50,117 1
1
50,117
30,070
20,047
0
ÀÌ
°Ë»ç·á 20250319 20250319 K0001022 EKG Electrode(MT450)
¿µ»óÁø´Ü·á 20250319 20250319 G2102006 ÈäºÎ 2¸ÅÃÔ¿µ(´Ù1214)
2,390 10 1
2,390
1,434
956
0
10,930 1
1
10,930
6,558
4,372
0
0
¿µ»óÁø´Ü·á 20250319
ÃÊÀ½ÆÄÁø´Ü·á 20250319 20250319
ÃÊÀ½ÆÄÁø´Ü·á 20250319 20250319
°è
20250319
GB012 ´Ü¼ø ¿µ»óÀúÀå ¹× Àü¼Û½Ã½ºÅÛ(2¸Å)
2,350 1
1
2,350
1,410
940
0
0
EB433
°æÈäºÎ ½ÉÃÊÀ½ÆÄ(Àü¹®) ÃÊÀ½ÆÄ(³ª943°¡(3))
203,890
1
1
203,890
122,334
81,556
0
0
EB487 »çÁöÇ÷°ü(ÇÏÁöµ¿¸Æ) µµÇÃ·¯ ÃÊÀ½ÆÄ
275,000
1
1
275,000
0
0
0
275,000
610,141
201,084
134,057
0
275,000
³¡¼öÃ³¸® Á¶Á¤±İ¾×
ÇÕ°è
16
16
0
0
0
610,157
201,100
134,057
275,000
2/10 ÆäÀÌÁö

½ÅÃ»ÀÎ ±è°æÈ¯ (È¯ÀÚ¿ÍÀÇ °ü°è : ±âÅ¸)ÀÇ ¿äÃ»¿¡ µû¶ó
Áø·áºñ °è»ê¼­¡¤¿µ¼öÁõ ¼¼ºÎ»êÁ¤³»¿ªÀ» ¹ß±ŞÇÕ´Ï´Ù.
2025³â 4¿ù 11ÀÏ
¿ä¾ç±â°ü ¸íÄª
¿¬¼¼´ëÇĞ±³ ÀÇ·á¿ø
3/10 ÆäÀÌÁö
´ëÇ¥ÀÚ
±İ±âÃ¢

Áø·áºñ ¼¼ºÎ»êÁ¤³»¿ª(¿Ü·¡)
È¯ÀÚµî·Ï¹øÈ£
Áø·á°ú
8633158
³»ºĞºñ³»°ú
È¯ÀÚ¼º¸í
Áø·á±â°£
ÀÌ±¤¿í
2024-07-16
È¯ÀÚ±¸ºĞ
º´½Ç
°Ç°­º¸Çè
ºñ°í
¹ßÇàÀÏÀÚ 2025-04-11
¹ßÇàÀÚ
Á¤¼¼Èñ
¿ä¾ç±â°ü±âÈ£
11100206
ÀÇ»ç¸í
°­Àº¼®
ÀÇ»ç¸éÇã¹øÈ£
52819
±Ş¿©
ÄÚµå
Ç×¸ñ
½ÃÇàÀÏÀÚ ¼ö³³ÀÏÀÚ
¸íÄª
±İ¾×
(EDI)
È½¼ö ÀÏ¼ö
ÃÑ¾×
ÀÏºÎº»ÀÎºÎ´ã
Àü¾×
ºñ±Ş¿©
º»ÀÎºÎ´ã±İ°ø´ÜºÎ´ã±İ º»ÀÎºÎ´ã
°Ë»ç·á
20250108
20250108 D1830003 ÃÑºô¸®·çºóÁ¤·® [È­ÇĞ¹İÀÀ-Àåºñ ÃøÁ¤](´©183°¡)
1,340
1
1
1,340
804
536
0
0
°Ë»ç·á 20250108
°Ë»ç·á 20250108
°Ë»ç·á 20250108
°Ë»ç·á 20250108
°Ë»ç·á 20250108
20250108 D1840003 ÃÑ´Ü¹éÁ¤·® [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©184°¡)
1,420
1
1
1,420
852
568
0
0
20250108 D1840003 ´¢ÁßÃÑ´Ü¹éÁ¤·®[È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©184°¡)
1,420
1
1
1,420
852
568
0
0
20250108 D1850003 ALT (SGPT) [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©185°¡)
1,950 1
1
1,950
1,170
780
0
20250108 D1860003 AST (SGOT) [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©186°¡)
1,990 1
1
1,990
1,194
796
0
0
20250108 D1870003 ¾ËÄ®¸®Æ÷½ºÆÄÅ¸Á¦[È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©187°¡)
1,570 1
1.
1,570
942
628
0
0
°Ë»ç·á
20250108
20250108 D1880003 ¾ËºÎ¹Î [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©188°¡)
1,660 1
1
1,660
996
664
0
0
°Ë»ç·á
20250108
20250108 D2201023 ¿äÄ§»ç°Ë»ç-[°üÂûÆÇÁ¤-À°¾È¡¤ÀåºñÃøÁ¤]_ÀÌ¹ÌÁöºĞ¼®¹ı(´©220
1,350 1
1
1,350
810
540
0
0
°Ë»ç·á
20250108
20250108 D2253003 ¿ä ÀÏ¹İ°Ë»ç-10Á¾±îÁö [È­ÇĞ¹İÀÀ-À°¾È°Ë»ç/È­ÇĞ¹İÀÀ-ÀåºñÅª
2,060 1
T
2,060
1,236
824
0
0
°Ë»ç·á
20250108
20250108 D2263003 Æ®¸®±Û¸®¼¼¶óÀÌµå [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](260)
3,940 1
1
3,940
2,364
1,576
0
0
°Ë»ç·á 20250108
20250108 D2280003 Å©·¹¾ÆÆ¼´Ñ [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©228°¡)
1,760 1
1
1,760
1,056
704
0
0
°Ë»ç·á
20250108
20250108 D2280003 Å©·¹¾ÆÆ¼´Ñ [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©228°¡)
1,760 1
1
1,760
1,056
704
0
0
20250108
°Ë»ç·á 20250108
°Ë»ç·á 20250108
°Ë»ç·á 20250108 20250108 D2310003 ¿ä»ê [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©231°¡)
°Ë»ç·á
20250108 D2300003 Ç÷Áß ¿ä¼ÒÁú¼Ò[NPNÆ÷ÇÔ] [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤] (230)
20250108 D2611003 ÃÑÄİ·¹½ºÅ×·ÑÁ¤·® [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©261°¡(1))
20250108 D2613003 HDLÄİ·¹½ºÅ×·Ñ [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©261´Ù(1))
1,600 1
1
1,600
960
640
0
0
2,270
1
1
2,270
1,362
908
0
0
1,650 1
1
1,650
990
660
0
0
6,690
1
1
6,690
4,014
2,676
0
0
4/10 ÆäÀÌÁö

±Ş¿©
Ç×¸ñ
½ÃÇàÀÏÀÚ ¼ö³³ÀÏÀÚ
ÄÚµå
¸íÄª
(EDI)
±İ¾×
È½¼ö ÀÏ¼ö
ÃÑ¾×
ÀÏºÎº»ÀÎºÎ´ã
Àü¾×
ºñ±Ş¿©
º»ÀÎºÎ´ã±İ°ø´ÜºÎ´ã±İ º»ÀÎºÎ´ã
°Ë»ç·á 20250108
20250108 D2800023 ¼Òµğ¿ò [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©280(02))
1,730
1
1
1,730
1,038
692
0
0
°Ë»ç·á
20250108
°Ë»ç·á
20250108
20250108 D2800043 ÀÎ [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©280(04))
20250108 D2800053 ÃÑÄ®½· [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©280(05))
1,730
1
1
1,730
1,038
692
0
0
1,730
1
1
1,730
1,038
692
0
ÀÌ
°Ë»ç·á
20250108
20250108 D2800063 Æ÷Å¸½· [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©280(06))
1,730 1
1
1,730
1,038
692
0
0
°Ë»ç·á
20250108
20250108 D3002003 ¹Ì·®¾ËºÎ¹Î-[Á¤¹Ğ¸é¿ª°Ë»ç(Á¤·®)](´©300)
18,650
1
1
18,650
11,190
7,460
0
0
°Ë»ç·á
20250108
20250108 D3022003 ´ç°Ë»ç [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤] [Á¤·®](´©3024)
1,390 1
1
1,390
834
556
0
0
°Ë»ç·á
20250108
20250108 D3022003 ´ç°Ë»ç [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤] [Á¤·®](´©3024)
1,390
1
1
1,390
834
556
0
0
°Ë»ç·á
20250108
°Ë»ç·á
20250108
20250108 D3022003 ´¢Áß ´ç°Ë»ç[È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤] [Á¤·®](´©3024)
20250108 D3061003 Çì¸ğ±Û·ÎºóA1C-[È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©306°¡)
1,390 1
1
1,390
834
556
0
0
7,640
1
1
7,640
4,584
3,056
0
0
°Ë»ç·á
20250108 20250108 D3090003 ´çÈ­¾ËºÎ¹Î [È­ÇĞ¹İÀÀ-ÀåºñÃøÁ¤](´©309)
°è
10,810 1
1
10,810
6,486
4,324
ÀÌ
0
82,620
49,572
33,048
0
0
³¡¼öÃ³¸® Á¶Á¤±İ¾×
-72
-72
0
0
0
ÇÕ°è
82,548
49,500
33,048
0
0
½ÅÃ»ÀÎ ±è°æÈ¯ (È¯ÀÚ¿ÍÀÇ °ü°è: ±âÅ¸)ÀÇ ¿äÃ»¿¡ µû¶ó
Áø·áºñ °è»ê¼­¡¤¿µ¼öÁõ ¼¼ºÎ»êÁ¤³»¿ªÀ» ¹ß±ŞÇÕ´Ï´Ù.
2025³â 4¿ù 11ÀÏ
¿ä¾ç±â°ü ¸íÄª
¿¬¼¼´ëÇĞ±³ ÀÇ·á¿ø
5/10 ÆäÀÌÁö
´ëÇ¥ÀÚ
±İ±âÃ¢

Áø·áºñ ¼¼ºÎ»êÁ¤³»¿ª(¿Ü·¡)
È¯ÀÚµî·Ï¹øÈ£
8633158
È¯ÀÚ¼º¸í
ÀÌ±¤¿í
Áø·á°ú
½Å°æ°ú
Áø·á±â°£
2024-10-01
È¯ÀÚ±¸ºĞ
º´½Ç
°Ç°­º¸Çè
ºñ°í
¹ßÇàÀÏÀÚ 2025-04-11 ¹ßÇàÀÚ
Á¤¼¼Èñ
¿ä¾ç±â°ü±âÈ£
11100206
ÀÇ»ç¸í
³²È¿¼®
ÀÇ»ç¸éÇã¹øÈ£
58050
±Ş¿©
ÄÚµå
Ç×¸ñ ½ÃÇàÀÏÀÚ ¼ö³³ÀÏÀÚ
(EDI)
¸íÄª
±İ¾× È½¼ö ÀÏ¼ö
ÃÑ¾×
ÀÏºÎº»ÀÎºÎ´ã
Àü¾×
º»ÀÎºÎ´ã±İ°ø´ÜºÎ´ã±İ º»ÀÎºÎ´ã
ºñ±Ş¿©
Åõ¾à¡¤Á¶Á¦
ÇàÀ§·á
20250319 20250319
AL100 ¿Ü·¡È¯ÀÚ ÀÇ¾àÇ°°ü¸®·á(¹æ¹®´ç)(°¡11°¡(1))
40 1
1
40
24
16
0
0
CTÁø´Ü·á
CTÁø´Ü·á
20250319
20250319 621400134 ÀÌ¿ÀÆÄ¹Ì·Î370ÁÖ»ç¾× 150ML/V-CT¿ë
66,785 1
1
66,785
40,071
26,714
0
0
20250319
20250319 HA531006 µÎºÎ(Brain) CT (Ç÷°üÁ¶¿µ)(´Ù245°¡(3)(´Ù)
134,630 1
1
134,630
80,778
53,852
0
0
CTÁø´Ü·á 20250319 20250319 HB011 CT ¿µ»óÀúÀå ¹× Àü¼Û½Ã½ºÅÛ
4,710 1
1.
4,710
2,826
1,884
0
0
¼±º°±Ş¿© 20250319 20250319 K9206017 °Ë»ç¿ë_¿¡½ººñ¹êµå(SB Band) 5*7.6cm
°è
600 1
1
600
0
0
0
600
206,765
123,699
82,466
600
³¡¼öÃ³¸® Á¶Á¤±İ¾×
ÇÕ°è
1
1
0
0
0
206,766
123,700
82,466
0
600
½ÅÃ»ÀÎ ±è°æÈ¯ (È¯ÀÚ¿ÍÀÇ °ü°è: ±âÅ¸)ÀÇ ¿äÃ»¿¡ µû¶ó
Áø·áºñ °è»ê¼­¡¤¿µ¼öÁõ ¼¼ºÎ»êÁ¤³»¿ªÀ» ¹ß±ŞÇÕ´Ï´Ù.
2025³â 4¿ù 11ÀÏ
¿ä¾ç±â°ü ¸íÄª
¿¬¼¼´ëÇĞ±³ ÀÇ·á¿ø
6/10 ÆäÀÌÁö
´ëÇ¥ÀÚ
±İ±âÃ¢

Áø·áºñ ¼¼ºÎ»êÁ¤³»¿ª(¿Ü·¡)
È¯ÀÚµî·Ï¹øÈ£
Áø·á°ú
8633158
È¯ÀÚ¼º¸í
ÀÌ±¤¿í
È¯ÀÚ±¸ºĞ
°Ç°­º¸Çè
ºñ°í
³»ºĞºñ³»°ú
Áø·á±â°£
2025-01-14
º´½Ç
¹ßÇàÀÏÀÚ 2025-04-11 ¹ßÇàÀÚ
Á¤¼¼Èñ
¿ä¾ç±â°ü±âÈ£
11100206
ÀÇ»ç¸í
°­Àº¼®
ÀÇ»ç¸éÇã¹øÈ£
52819
±Ş¿©
ÄÚµå
Ç×¸ñ
½ÃÇàÀÏÀÚ ¼ö³³ÀÏÀÚ
(EDI)
¸íÄª
±İ¾×
È½¼ö ÀÏ¼ö
ÃÑ¾×
ÀÏºÎº»ÀÎºÎ´ã
Àü¾×
ºñ±Ş¿©
º»ÀÎºÎ´ã±İ °ø´ÜºÎ´ã±İ º»ÀÎºÎ´ã
ÁøÂû·á 20250114 20250114
ÁøÂû·á 20250114 20250114
ÁøÂû·á 20250114 20250114
ÁøÂû·á
AA257
ÀçÁø·á(°¡³ª(4))
16,300
1
1
16,300
16,300
0
0
0
AU210
ÀÇ·áÁúÆò°¡Áö¿ø±İ [¿Ü·¡: ÀÇ·áÁú, ¾ÈÀü] [°¡22°¡(1) (°¡)2°¡)]
8,390
1
1
8,390
5,034
3,356
0
0
AU311
ÀÇ·áÁúÆò°¡Áö¿ø±İ [¿Ü·¡:±³À°¼ö·Ã](°¡22³ª(1)³ª)
680 1
1
680
408
272
0
0
20250114 20250114
AU411
ÀÇ·áÁúÆò°¡Áö¿ø±İ [¿Ü·¡:¿¬±¸](°¡22´Ù(1)³ª)
580 1
1
580
348
232
0
0
°è
25,950
22,090
3,860
0
0
³¡¼öÃ³¸® Á¶Á¤±İ¾×
-90
-90
ÀÌ
0
0
ÇÕ°è
25,860
22,000
3,860
ÀÌ
0
½ÅÃ»ÀÎ ±è°æÈ¯ (È¯ÀÚ¿ÍÀÇ °ü°è: ±âÅ¸)ÀÇ ¿äÃ»¿¡ µû¶ó
Áø·áºñ °è»ê¼­¡¤¿µ¼öÁõ ¼¼ºÎ»êÁ¤³»¿ªÀ» ¹ß±ŞÇÕ´Ï´Ù.
2025³â 4¿ù 11ÀÏ
¿ä¾ç±â°ü ¸íÄª
¿¬¼¼´ëÇĞ±³ ÀÇ·á¿ø
7/10 ÆäÀÌÁö
´ëÇ¥ÀÚ
±İ±âÃ¢

Áø·áºñ ¼¼ºÎ»êÁ¤³»¿ª(¿Ü·¡)
È¯ÀÚµî·Ï¹øÈ£
8633158
È¯ÀÚ¼º¸í
ÀÌ±¤¿í
È¯ÀÚ±¸ºĞ
°Ç°­º¸Çè
ºñ°í
Áø·á°ú
½Å°æ°ú
Áø·á±â°£
2025-03-26
º´½Ç
¹ßÇàÀÏÀÚ 2025-04-11
¹ßÇàÀÚ
Á¤¼¼Èñ
¿ä¾ç±â°ü±âÈ£
11100206
ÀÇ»ç¸í
³²È¿¼®
ÀÇ»ç¸éÇã¹øÈ£
58050
±Ş¿©
ÄÚµå
Ç×¸ñ
½ÃÇàÀÏÀÚ ¼ö³³ÀÏÀÚ
(EDI)
¸íÄª
±İ¾× È½¼ö ÀÏ¼ö
ÃÑ¾×
ÀÏºÎº»ÀÎºÎ´ã
Àü¾×
ºñ±Ş¿©
º»ÀÎºÎ´ã±İ °ø´ÜºÎ´ã±İ º»ÀÎºÎ´ã
ÁøÂû·á
20250326 20250326
AA257
ÀçÁø·á(°¡1³ª(4))
16,300 1
1
16,300
16,300
0
0
0
ÁøÂû·á 20250326 20250326
ÁøÂû·á 20250326 20250326
ÁøÂû·á 20250326 20250326
°è
AU210
ÀÇ·áÁúÆò°¡Áö¿ø±İ [¿Ü·¡: ÀÇ·áÁú, ¾ÈÀü] [°¡22°¡(1)(°¡)2)°¡)]
8,390 1
1
8,390
5,034
3,356
0
0
AU311
ÀÇ·áÁúÆò°¡Áö¿ø±İ [¿Ü·¡ :±³À°¼ö·Ã] (°¡22³ª(1)³ª)
680 1
1
680
408
272
0
0
AU411
ÀÇ·áÁúÆò°¡Áö¿ø±İ [¿Ü·¡:¿¬±¸](°¡22´Ù(1)³ª)
580 1
1
580
348
232
0
0
25,950
22,090
3,860
0
ÀÌ
³¡¼öÃ³¸® Á¶Á¤±İ¾×
-90
-90
0
0
0
ÇÕ°è
25,860
22,000
3,860
0
0
½ÅÃ»ÀÎ ±è°æÈ¯ (È¯ÀÚ¿ÍÀÇ °ü°è: ±âÅ¸)ÀÇ ¿äÃ»¿¡ µû¶ó
Áø·áºñ °è»ê¼­¡¤¿µ¼öÁõ ¼¼ºÎ»êÁ¤³»¿ªÀ» ¹ß±ŞÇÕ´Ï´Ù.
2025³â 4¿ù 11ÀÏ
¿ä¾ç±â°ü ¸íÄª
¿¬¼¼´ëÇĞ±³ ÀÇ·á¿ø
8/10 ÆäÀÌÁö
´ëÇ¥ÀÚ
±İ±âÃ¢
¸Ş¸®

Áø·áºñ ¼¼ºÎ»êÁ¤³»¿ª(¿Ü·¡)
È¯ÀÚµî·Ï¹øÈ£
8633158
È¯ÀÚ¼º¸í
ÀÌ±¤¿í
È¯ÀÚ±¸ºĞ
°Ç°­º¸Çè
ºñ°í
Áø·á°ú
½ÉÀå³»°ú
Áø·á±â°£
2025-03-26
º´½Ç
¹ßÇàÀÏÀÚ 2025-04-11
¹ßÇàÀÚ
Á¤¼¼Èñ
¿ä¾ç±â°ü±âÈ£
11100206
ÀÇ»ç¸í
¾ÈÃ¶¹Î
ÀÇ»ç¸éÇã¹øÈ£
63949
±Ş¿©
Ç×¸ñ ½ÃÇàÀÏÀÚ ¼ö³³ÀÏÀÚ
ÄÚµå
¸íÄª
(EDI)
±İ¾× È½¼ö ÀÏ¼ö
ÃÑ¾×
ÀÏºÎº»ÀÎºÎ´ã
Àü¾×
ºñ±Ş¿©
º»ÀÎºÎ´ã±İ °ø´ÜºÎ´ã±İ º»ÀÎºÎ´ã
ÁøÂû·á 20250326 20250326
ÁøÂû·á 20250326 20250326
ÁøÂû·á 20250326 20250326
ÁøÂû·á 20250326 20250326
ÁøÂû·á 20250326 20250326
°è
AA157 ÃÊÁø·á(°¡1°¡(4))
21,030 1
1
21,030
21,030
0
0
0
AU210
ÀÇ·áÁúÆò°¡Áö¿ø±İ [¿Ü·¡: ÀÇ·áÁú, ¾ÈÀü] [°¡22°¡(1)(°¡)2)°¡)]
AU311 ÀÇ·áÁúÆò°¡Áö¿ø±İ [¿Ü·¡ :±³À°¼ö·Ã] (°¡22³ª(1)³ª)
8,390 1
1
8,390
5,034
3,356
0
0
680 1
1
680
408
272
0
0
AU411
ÀÇ·áÁúÆò°¡Áö¿ø±İ [¿Ü·¡:¿¬±¸](°¡22´Ù(1)³ª)
580 1
1
580
348
232
0
0
IE022
È¸¼Û·á II (¿Ü·¡) (ºñ»óÁø·á±â°£)
83,460 1
1
83,460
0
83,460
0
0
114,140
26,820
87,320
0
0
³¡¼öÃ³¸® Á¶Á¤±İ¾×
-20
-20
0
0
0
ÇÕ°è
114,120
26,800
87,320
0
0
½ÅÃ»ÀÎ ±è°æÈ¯ (È¯ÀÚ¿ÍÀÇ °ü°è: ±âÅ¸)ÀÇ ¿äÃ»¿¡ µû¶ó
Áø·áºñ °è»ê¼­¡¤¿µ¼öÁõ ¼¼ºÎ»êÁ¤³»¿ªÀ» ¹ß±ŞÇÕ´Ï´Ù.
2025³â 4¿ù 11ÀÏ
¿ä¾ç±â°ü ¸íÄª
¿¬¼¼´ëÇĞ±³ ÀÇ·á¿ø
9/10 ÆäÀÌÁö
´ëÇ¥ÀÚ
±İ±âÃ¢

Áø·áºñ ¼¼ºÎ»êÁ¤³»¿ª(¿Ü·¡)
È¯ÀÚµî·Ï¹øÈ£
Áø·á°ú
8633158
È¯ÀÚ¼º¸í
ÀÌ±¤¿í
È¯ÀÚ±¸ºĞ
ÀÏ¹İ
ºñ°í
¼¼ºê)¼­·ù¿µ»ó¹ß±Ş¼¾ÅÍ
Áø·á±â°£
2025-04-11
º´½Ç
¹ßÇàÀÏÀÚ 2025-04-11
¹ßÇàÀÚ
Á¤¼¼Èñ
¿ä¾ç±â°ü±âÈ£
11100206
ÀÇ»ç¸í
ÀÏ¹İ
ÀÇ»ç¸éÇã¹øÈ£
ÄÚµå
Ç×¸ñ
½ÃÇàÀÏÀÚ ¼ö³³ÀÏÀÚ
¸íÄª
(EDI)
Á¦Áõ¸í¼ö¼ö·á 20250411 20250411
Á¦Áõ¸í¼ö¼ö·á 20250411 20250411
°è
Áø·á±â·Ï»çº»(1~5¸Å±îÁö, 1¸Å´ç)
Áø·á±â·Ï»çº»(6¸Å ÀÌ»ó, 1¸Å´ç)
³¡¼öÃ³¸® Á¶Á¤±İ¾×
ÇÕ°è
±Ş¿©
±İ¾× È½¼ö ÀÏ¼ö
ÃÑ¾×
ÀÏºÎº»ÀÎºÎ´ã
Àü¾×
ºñ±Ş¿©
º»ÀÎºÎ´ã±İ °ø´ÜºÎ´ã±İ º»ÀÎºÎ´ã
1,000 5
1
5,000
0
0
0
5,000
100 118 1
11,800
0
0
0
11,800
16,800
0
0
0
16,800
0
0
0
0
0
16,800
0
0
0
16,800
½ÅÃ»ÀÎ ±è°æÈ¯ (È¯ÀÚ¿ÍÀÇ °ü°è: ±âÅ¸)ÀÇ ¿äÃ»¿¡ µû¶ó
Áø·áºñ °è»ê¼­¡¤¿µ¼öÁõ ¼¼ºÎ»êÁ¤³»¿ªÀ» ¹ß±ŞÇÕ´Ï´Ù.
2025³â 4¿ù 11ÀÏ
¿ä¾ç±â°ü ¸íÄª
¿¬¼¼´ëÇĞ±³ ÀÇ·á¿ø
10/10 ÆäÀÌÁö
´ëÇ¥ÀÚ
±İ±âÃ¢

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
Peripheral angiography (Lower extremity)
[IVUS-DCV: Angio]
POBA 6*60
-> DCB 6*150*2ea
±â·ÏÀÚ¸í
ÀÓ¼ºÀÏ
ÀÛ¼ºÀÚ: ÀÓ¼ºÀÏ
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Hybrid peripheral angiography (Lower
extremity)
2019-01-28
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
°Ë»ç°á°ú
Impression
Image Name
ABI (Ankle/Brachial Index) - Rt: 1.04 /Lt: 1.09
TBI (Toe/Brachial Index) - Rt:0.75 /Lt:0.68
pvr Image1
Name:
ID #:
LEE GWANG WOOK
8633158
01/29/2019 09:16 AM
Exam Date:
Operator: H
SEVERANCE HOSPITAL
Sex: M
SEGMENTAL PRESSURE
AND PVR STUDY
Brachial
RIGHT LEFT
167 162
¬Ş¬Ú
PVR 68mmHg 919cc RIGHT High Thigh
Gain: 2 Spd:25 Amp:20
¬Ş¬Ú
PVR 65mmHg 165cc
Gain: 2 Spd:25 Amp: 20
±â´É°Ë»ç°á°ú(I/FÇü)
PVR 69mmHg 919cc
Gain: 2 Spd:25
1.15 192 181 1.08
MultiLab Sales Il
LEFT High Thigh
Amp:15
RIGHT Calf
1.10 183
188
1.13 PVR 67mmHg 190cc
Gain: 2 Spd:25
LEFT Calf
Amp:14
RIGHT
LEFT
1.01 169 PT 176 1.05
1.04 174 DP 182 1.09
211
NC
167 1.00
0.75 126
PVR 65mmHg 168cc RIGHT Ankle
Gain: 2 Spd:25 Amp:09
ABI: 1.04
TBI: 0.75
113 0.68
PVR 67mmHg 169cc
ABI: 1.09 Gain: 2 Spd:25 Amp:08
TBI: 0.68
LEFT Ankle
ABI INDEX
PVR 63mmHg 72cc RIGHT Metatarsal
Gain: 2 Spd: 25 Amp:03
0.97 1.25 NORMAL
0.75 0.96 MILD
0.50 0.74 MODERATE
<0.50 SEVEREE
PVR 60mmHg 71cc LEFT Metatarsal
Gain: 2 Spd:25 Amp:03
PPG RIGHT Great Toe
Gain:.50 Speed:25 Amp:10
TBI(FBI) INDEX
>0.80 NORMAL
0.20 0.54 CLAUDICATION
<0.20 REST PAIN
PPG LEFT Great Toe
Gain:.50 Speed:25 Amp:03
ÀüÀÚ¼­¸íÀÚ: ÇÑÇı¼ö
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
ÆÇµ¶ÀÇ(1Â÷)
ÃÖÁ¤È£
ÆÇµ¶ÀÇ(2Â÷)
¾ÈÃ¶¹Î
ÀüÀÚ¼­¸íÀÚ: ÇÑÇı¼ö
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
±â´É°Ë»ç°á°ú(I/FÇü)
2/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
°Ë»ç°á°ú
Impression
Skin Perfusion Pressure Test
1. Rt: 65mmHg/ Lt: 76mmHg <¹ßµî>
2. Rt: 77mmHg/Lt: 77mmHg <¹ß¹Ù´Ú>
(Normal value: 50 ÀÌ»ó)
n
Name
107161 Image1
ÀüÀÚ¼­¸íÀÚ: ÇÑÇı¼ö
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
±â´É°Ë»ç°á°ú(I/FÇü)
2019-01-29
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

% Perfusion
µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Name:
lee, kwang uk
ID:
8633158
Right Foot Dorsal
Perfusion
SPP
< 30 mmHg
Severe Disease
ÆÇµ¶ÀÇ(1Â÷)
ÃÖÁ¤È£
ÆÇµ¶ÀÇ(2Â÷)
¾ÈÃ¶¹Î
SPP 65 mmHg
65
¬à¬ã ¬Ó¬ã
TO
C
90 40 30
Cuff Pressure (mmHg)
Right Foot Medial Plantar
77 mmHg
100
TO 40
Cuff Pressure (mmHg)
20
±â´É°Ë»ç°á°ú(I/FÇü)
2019-01-29
SensiLase¢ç Skin Perfusion Pressure Results
SensiLas
PAD-IQ
Date:
2019-01-29
CPT Code:
Left Foot Dorsal
SPP 76 mmHg
Perfusion
% Perfusion
0800 1400 120 0100 0 0 TO 0 0 40 20
Cuff Pressure (mmHg)
SPP
Left Foot Medial Plantar
77 mmHg
Skin Perfusion Pressure (SPP) Interpretive Values
30-40 mmHg
Moderate Disease
40-50 mmHg
Mild Disease
2/2
Cuff Pressure (mmHg)
> 50 mmHg
Adequate Perfusion
::
ÀüÀÚ¼­¸íÀÚ: ÇÑÇı¼ö
2/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/64¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
Cath No.
Date
2019-01-28
Pre-procedural diagnosis
PTA
½Ã¼ú°úÁ¤ Áß Æ¯ÀÌ»çÇ×
Coronary artery disease (left main); Coronary artery disease (2 vessel
disease); Unstable angina;
Access site: Lt CFA
Approach method: contralateral antegrade
Peripheral angiography with JR 5F catheter revealed
total occlusion of Rt. SFA OS (TIMI 1) with diffuse irregular up to 70% LN of p-mSFA
total occlusion of Rt. ATA (TIMI 0)
Taget lesion: Rt. SFA
7F Balkin sheath c 018 command wire
The guiding wire was passed through the lesion.
Balloon angioplasty was done with 6x60 mm Mustang PTA balloon at Rt. SFA OS~mSFA
F/U angio revealed 60 % residual stenosis without dissection
Two DCB with 6x150 mm Inpact Admiral were inflated at Rt. SFA OS-MSFA
F/U angio revealed 10 % residual stenosis without dissection or flow limitation
Blood loss
No
Yes
ÇÇºÎ »óÅÂ ÀÌ»ó
No
Yes
Á¶¿µÁ¦ ¾Ë·¯Áö
No
Yes
Conclusions
½Ã¼ú ÈÄ °èÈ¹
Recommendation
Successful PTA c DCB at Rt. SFA
1. Close monitor for puncture site
2. Close monitor for development of chest pain
Operator 1 (ÀÔ¿øÁÖÄ¡ÀÇ)
¾ÈÃ¶¹Î
Operator 2 (½Ã¼ú¼±ÅÃÀÇ, ÇùÁøÁÖÄ¡ÀÇ)
¾ÈÃ¶¹Î
Assisstant
¹Ú¿¬Á¤
<¾à¾î ¼³¸í>
BAL balloon
C-angio: coronary angiography
JRG Judkins right guiding
MLD minimal lumen diameter
DS: diameter stenosis
JLG: Judkins left guiding
NC non-compliance
PLAD proximal left ascending artery
JR Judkins right
R/S residual stenosis
RI: ramus intermedius
SH side hole
XBG extra backup guiding
PTA note
ÀüÀÚ¼­¸íÀÚ: ¼­Áö¿ø
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2019-02-13
Áø·á°ú
½ÉÀå³»°ú
ÁÖÄ¡ÀÇ
¾ÈÃ¶¹Î
BP(S)
BP(D)
HR
Subjective
Objective
154 mmHg
85 mmHg
95/min
Good/No interval change
Áı¿¡¼­´Â Ç÷¾Ğ stable
Glucose 138
BUN 25.6
Creatinine 0.92
Assessment
Plan
PAD, S/p PTA 2019.1.28-IVUS-DCB
s/p PTA DCB at Rt. SFA[2019-01-28]
ABI 1.04/1.09 <== 0.69/0.99
CAD(2vd+ LM)
s/pCAG(2018.04, ÀÏ»ê¹é)
s/p 2018-04-09 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA)
DM
herben ÀÏ³â Á¤µµ »ç¿ë - À¯°æÁ¾ ±³¼ö´Ô - radial graft
Repeat med
4°³¿ù ÈÄ OPD
EKG/CXR/LAB/ABI
±â·ÏÀÚ¸í
¾ÈÃ¶¹Î
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
µ¿¸Æ°æÈ­ ÇùÂø °Ë»ç
Pulse Wave Diagnosis Results Ask a doctor's advice for the examination result and do not interpret by yourself.
Check-up Date: Jun./18/2019
8:17
How is your artery?
Let's check your arteriosclerosis level
from vascular "stiffness" and "occlusion".
Name:
ID: 8633158
Age: 64
BMI: 23.9
Height:
171 cm
Weight 70.0 kg [
Disease:
58-
70 kgl
Blood Pressure Value
R-arm
L-arm
HR: 83 bpm
(Pre.value:
90 bpm)
(ME)
129/72
(Pre.value: 159/ 85 )
R-ankle
129/69
(Pre value 110/ 73 )
132/75
(Pre value 154/ 85 )
L-ankle
131/ 68
(Pre value: 157/82)
How is your arterial stiffness (baPWV)?
R:1366 DL: 1515
Pre value R: 1292 L: 1750)
Compared to the healthy men of
the age 64,
(cm/s)
baPWV.c
Hard 2600
2400
2200
(2) Arterial stiffness
2000
1800
1600
it is within normal range.
However, be aware the artery
is getting older with age.
measures the large
it does
corebrovascular
lar stiffness.
1400
Standard line of healty subjects (male)
Touch the artificial
blood vessel
D
1200
1000
Soft
800
20
30 40 50 60
70
80
90 (Age)
How is your arterial occlusion (ABI)?
2500
1600
Hard
Hardish
Soft
R-leg: 0.98 L-leg: 0.99
04 0.5
(Pre.value R-leg: 0.69 L-leg: 0.99 )
There may be a possibility of
the vascular occlusion in legs.
Ask a doctor's advice in case
you have palsy in legs.
0.9
1.3
90
06
0.7
0.8
1.0
1.1
1.2
1.4
Caption Seeded
O
Progress of arteriosclerosis and its target value
Normal Bange
Castion
Needed
baPWV (cm/s)
Brachial BP (mmHg)
2600
260
2400
240
Check up the
2200
200
220 arteriosclerosis
2000
1800
180
periodically.
160
1600
140
1400
1200
120
100
1000
Next check-up date
800
80
600
60
1
Nov.
Jan.
Mar.
May.
Jul.
Sep.
2016
2019
ÀÛ¼ºÀÚ: ÇÑÇı¼ö
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
133572P1104102 AATI 966-691-MCU308
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Pulse Wave Diagnosis Results >
8633158
Age : 64
Disease:
Height: 171
Weight: 70.0 kg
Sex : Male
BMI
: 23.9
Mechanocardiogram/Pulse Volume Recorder
EOG:
83 pm
R-Bra.
MAP: 50%
MAP: 50 %
R-Ank.
SMAP: 47%
UT :168 ms
SMAR: 43%
UT
:163 ms
UT: Urstrok
Measurement
µ¿¸Æ°æÈ­ ÇùÂø °Ë»ç
Jan./18/2019
1326:
Auto
Systolic Time Intervals
PEP:
94 ms
R-Bra.
L-Bra.
57:
275 ms
SYS 129
MAP
93
SYS
MAP
132
97
DIA
72
DIA 75
PP
57
PP
57
R-Ank.
SYS 129
L-Ank.
SYS
131
MAP 94
MAP 95
DIA 69
baPWV
PP
60 1366
baPWV
1515
ABI 0.98
DIA 68
PP
ABI 0.99
63
ET/PEP: 2.93
Observation (ased on AHA
[Upper extremity]
[Right foot]
A possibility of arterial stenosis
cannot be denied.
ABT te below ..HAP
(Left foot]
456.
A possibility of arterial stenosis
cannot be denied.
ABD s celow...
[Comment]
Stress test is effective as the
second examination. Medical
supervision is necessary during
exercise.
baPWV (cm/s)
RA
DLA
baPWV (cm/s)
RA DLA
2400
2400
2200
2000
1800
1600
1400
1300
1000
800
2000
15D
1800
1600
avg.
-1SD
1400
1200
1000
Standard value of PWV (Male)
3.4 0.5 0.6 0.7 0.50.91.0 1.1 1.2 1.3 1.4ABI
Colin Medical
30
40
50 60
70 60 Age
nology Corporation
ÀÛ¼ºÀÚ: ÇÑÇı¼ö
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Comments/Revising point for measurement
2/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
°æ°ú
°­Àº¼®
CAD(2vd+LM)
s/p CAG (2018.04, ÀÏ»ê¹é)
s/p 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA) (2018-04-09)
Rt. ICA stenosis s/p stent insertion (2018.10.02)
DM(10yrs)
Ex-smoker (30yr, 2³âÀü Áß´Ü)
Aorta to rPL with RA)
140/72-91
Glucose 136
Glycoalbumin 19.8
Glucose (¿¬¼Ó) - ½ÄÈÄ 2½Ã°£ 206
HbA1c 7.0
BUN 24.9
Creatinine 1.00
Urine Albumin-to-Creatinine Ratio 81.81
>> È¿°ú ÀÖ¾î ¾à ±×´ë·Î À¯ÁöÇÏ°Ú½À´Ï´Ù. °è¼Ó °ü¸® Àß ÇÏ¼Å¾ß ÇÕ´Ï´Ù.
3°³¿ù µÚ
±â·ÏÀÚ¸í
°­Àº¼®
ÀüÀÚ¼­¸íÀÚ: °­Àº¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿Ü·¡ÀçÁø±â·Ï
2019-03-27
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ |

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2019-03-27
Áø·á°ú
½Å°æ°ú
ÁÖÄ¡ÀÇ
³²È¿¼®
Subjective
Objective
Assessment
Plan
159/82
Áı¿¡¼­´Â Ç÷¾Ğ stable
120-140
Ç÷¾Ğ ÀÏ±â ´ÙÀ½¿¡ °¡Á®¿À½Ã±â·Î ÇÔ.
¾ÈÃ¶¹Î ±³¼ö´ÔÀÌ ¸®ÇÇÅä 80 ±îÁö Ã³¹æÇÔ.
9¿ù¿¡ follow up DSA
3ÀÏ ÀÔ¿ø
±â·ÏÀÚ¸í
³²È¿¼®
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2019-06-18
Áø·á°ú
½ÉÀå³»°ú
ÁÖÄ¡ÀÇ
¾ÈÃ¶¹Î
BP(S)
BP(D)
HR
Subjective
Objective
Assessment
Plan
120 mmHg
70mmHg
86/min
Good/No interval change
0.98/0.99
PAD, S/p PTA 2019.1.28-IVUS-DCB
-
s/p PTA c DCB at Rt. SFA[2019-01-28]
ABI 1.04/1.09 <== 0.69/0.99
CAD(2vd+LM)
s/pCAG(2018.04, ÀÏ»ê¹é)
s/p 2018-04-09 40PCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA)
DM
herben ÀÏ³â Á¤µµ »ç¿ë - À¯°æÁ¾ ±³¼ö´Ô - radial graft
Repeat med
4°³¿ù ÈÄ OPD
PVR check
±â·ÏÀÚ¸í
¾ÈÃ¶¹Î
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
°Ë»ç°á°ú
ABI (Ankle/Brachial Index) - Rt: 0.81 /Lt: 0.80
Impression
Image Name
pvr Image1
Name:
ID #:
Exam Date:
LEE KWANG WOOK
8633158
10/16/2019 10:33 AM
Operator: J
¬Ş¬Ú
PVR 67mmHg 595cc
Gain: 2 Spd:25
RIGHT High Thigh
Amp: 15
¬İ¬Ú
PVR 66mmHg 208cc
Gain: 2 Spd:25
±â´É°Ë»ç°á°ú(I/FÇü)
SEVERANCE HOSPITAL
Sex: M
MultiLab Series!!
SEGMENTAL PRESSURE
AND PVR STUDY
Brachial
RIGHT LEFT
137
142
0.89 127
156
1.10
PVR 69mmHg 724cc LEFT High Thigh
Gain: 2 Spd:25 Amp:12
¬ê
LEFT Calf
Amp:23
RIGHT Calf
Amp:24
0.91 129 149 1.05 PVR 65mmHg 238cc
Gain: 2 Spd:25
RIGHT
LEFT
0.76 108 PT 108 0.76
0.81 115 DP 114 0.80
0.98 139
111 0.78
0.35 49
51 0.36
PVR 67mmHg 176cc
RIGHT Ankle
Gain: 2 Spd:25 Amp:14
ABI: 0.81
TBI: 0.35
LEFT Ankle
PVR 66mmHg 151cc
ABI: 0.80 Gain: 2 Spd:25 Amp:07
TBI: 0.36
PVR 63mmHg 70cc RIGHT Metatarsal
Gain: 2 Spd:25 Amp:04
ABI INDEX
0.97 1.25 NORMAL
0.75 0.96 MILD
0.50 0.74 MODERATE
<0.50 SEVEREE
TBI (FBI) INDEX
>0.80 NORMAL
0.20 0.54 CLAUDICATION
PPG RIGHT Great Toe
Gain:.50 Speed: 25 Amp:09
<0.20 REST PAIN
PVR 62mmHg
71cc
Gain: 2 Spd:25
LEFT Metatarsal
Amp:06
PPG LEFT Great Toe
Gain:.50 Speed: 25 Amp: 11
ÀüÀÚ¼­¸íÀÚ : ÇÑÇı¼ö
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
ÆÇµ¶ÀÇ(1Â÷)
ÀÌ¿ëÁØ
ÆÇµ¶ÀÇ(2Â÷)
¾ÈÃ¶¹Î
ÀüÀÚ¼­¸íÀÚ: ÇÑÇı¼ö
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
±â´É°Ë»ç°á°ú(I/FÇü)
2/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2019-06-18
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
°­Àº¼®
°æ°ú
VS 128/71 HR 83
Glucose 117
Glucose (¿¬¼Ó) - ½ÄÈÄ 2½Ã°£ 213
Glycoalbumin 20.5
HbA1c 7.1
@ROS
½ÄÈÄ¿¡ ¿îµ¿À» 1½Ã°£ ÀÌ»ó¾¿ ÀÚÁÖ ÇÕ´Ï´Ù.
>>
½ÄÈÄ Ç÷´ç Á¶ÀıÇÏ´Â ¾àÀ¸·Î º¯°æÇØ º¾½Ã´Ù.
glupa¡æ trajenta ·Î º¯°æ ÇÕ´Ï´Ù.
±â·ÏÀÚ¸í
°­Àº¼®
ÀüÀÚ¼­¸íÀÚ: °­Àº¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
ÀÔ¿øÁ¤º¸
ÀÔ¿øÀÏÀÚ 2019-09-04
ÀÔ¿ø°ú ½Å°æ°ú
ÀÔ¿øÁÖÄ¡ÀÇ ³²È¿¼®
Åğ¿øÁ¤º¸
Åğ¿øÀÏÀÚ 2019-09-06
Åğ¿ø°ú ½Å°æ°ú
Åğ¿øÁÖÄ¡ÀÇ ³²È¿¼®
ÃÖÁ¾Áø´Ü¸í(*)
¼ø¼­
¼ø
ÇÑ±¹Áúº´
±¸ºĞ
È®Áø
Áø´Ü¸í
ºĞ·ù¹øÈ£
1 ÁÖÁø´Ü
È®Áø Internal carotid artery stenosis
165.2
°ú°ÅÁø´Ü¸í
°ú°ÅÁø´ÜÄÚµå
ÁÖÈ£¼Ò (*)
Diabetes mellitus other, without complication; Diabetes mellitus type 2, without
complication;Diabetic polyneuropathy;Internal carotid artery stenosis;Internal
carotid artery stenosis, right;Type 2 diabetes mellitus, coronary artery disease;
E11.58;E11.9;E13.9;E14.41;165.2;
C.C F/UDSA
°ú°Å·Â ¹× ÇöÀçº´·Â »ó±â 64¼¼ ³²È¯ HTN, DM, CAOD (2vd, s/p CAG), PAOD s/p PTA °ú°Å·Â ÀÖ´ÂºĞÀ¸·Î
2018.04 CABG À§ÇØ Rt ICA stenosis ·Î ½Å°æ°ú ÇùÁø ÈÄ CD »ó Rt. ICA 75~99%
stenosis ÀÖ¾î
2018.09.05 Rt ICA stenosis¿¡ stent insertion ÈÄ F/U DSA À§ÇØ ÀÔ¿øÇÔ.
(*)
ÀÌ»ó ÁøÂû ¼Ò°ß
## neurologic exam
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
(1) Mental status & Mental function
-Mental status: alert
-Mental function: all preserved
- Orientation Time/Place/Person: +/+/+
- Language
Fluency: intact
-Comprehension: intact
- Reading: intact
Writing: intact
- Naming intact
Repetition: intact
(2) Cranial nerve Function:
-Isocoria 3mm/3mmcPLR (+/+)
-No EOM limitation s nystagmus
-No Visual field defect by confrontation test
-No facial palsy s sensory change
-Gag reflex: ok
-No tongue deviation / No uvula deviation
Åğ¿ø¿ä¾à
2019-09-06
(3) Motor:
- Upper ext: prox GV / GV dist GV / GV
1/3
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
hand grip GV / GV, pronator drift (-/-)
Spasticity: Go/o
- Lower ext: prox GV / GV dist GV / GV
hopping: intact/intact
Spasticity: Go/0
(4) Sensory :
- Light touch: intact
- Pinprick or pain: intact
- Position: intact
- Vibration: intact
(5) Deep Tendon Reflex:
-biceps(++/++), triceps(++/++)
- knee jerk(++/++), ankle jerk(++/++)
- Babinski sign (-/-)
- Ankle clonus (-/-)
(6) Cerebellar function:
- Finger To Nose: intact
-Heel To Shin: intact
Romberg test (eye opening/eye closing: intact/intact)
(7) Gait
-Gait: independent gait °¡´É
- Tandem gait : no sway
Àç¿øÁß Åõ¾à³»¿ª (*) NS CJ inj [1000 ml/Bag]
Aspirin protect [100 mg/T]
Herben [30 mg/T]
Lipitor [80 mg/T]
Platless [75 mg/T]
Rabiet [10mg/T]
Sigmart [5mg/T]
Cozaar [100 mg/T]
Trajenta [5mg/T]
Forxiga [10 mg/T]
Åõ¿©µÈ ¾à¹° Áß ÀÜ·ùÈ¿°ú·Î Åğ¿ø ÈÄ ÁÖÀÇ°¡ ÇÊ¿äÇÑ ¾à¹° (¡Ú)
¾øÀ½
ÀÖÀ½
°Ë»ç¼Ò°ß (*)
Cerebral Angiography**
Ä¡·á ¹× È¿°ú (*)
Cerebral Angiography**;
ÁÖ½Ã¼ú¸í
Cerebral Angiography**
ÁÖ½Ã¼úÄÚµå
±âÅ¸½Ã¼ú¸í
±âÅ¸½Ã¼úÄÚµå
Implantable Medical Device »ç¿ë ¿©ºÎ
No
Yes
Ä¡·á°á°ú (*)
¿ÏÄè ¤·°æÄè
48½Ã°£ÀÌ³» »ç¸Á
¼±Çà»çÀÎ
È£Àü¾ÈµÊ
Áø´Ü»Ó
°¡¸Á¾ø´Â Åğ¿ø
48½Ã°£ÀÌÈÄ »ç¸Á
¼±Çà»çÀÎ
¼±Çà»çÀÎ
ºĞ·ùÄÚµå
È°·ÂÁõ»ó
Ç÷¾Ğ 163/74 mmHg
Åğ¿øÇüÅÂ (*)
Åğ¿øÁö½ÃÈÄ
¸Æ¹Ú¼ö 72
Å¸º´¿øÀü¿ø
È¸/ºĞ Ã¼¿Â 36.5
)ÀÚÀÇÅğ¿ø
Å»¿ø
È£Èí¼ö 16
È¸/ºĞ
ÇâÈÄ Ä¡·á°èÈ¹
¿Ü·¡ ÃßÈÄ°ü¸®
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Åğ¿ø¿ä¾à
2019-09-06
2/3
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
ÀçÀÔ¿ø
¾øÀ½
±âÅ¸
Åğ¿ø¾à
¾àÇ°¸í (Name)
¿ë·®(Dose)
ÀÏ¼ö(Days)
¾Æ½ºÇÇ¸°ÇÁ·ÎÅØÆ® 100
Á¤100mg
¿ë¹ı(Direction)
ÁöÂü¾à °è¼Ó º¹
¿ë)
Ã³¹æ ºĞ·ù (Type)
Åğ¿øÁöÂü¾à
È¿´É
Çì¸£º¥Á¤ 30mg
30
ÁöÂü¾à °è¼Ó º¹
¿ë)
Åğ¿øÁöÂü¾à
¸®ÇÇÅäÁ¤80mg
80
ÁöÂü¾à °è¼Ó º¹
¿ë)
Åğ¿øÁöÂü¾à
ÇÃ·¡¸®½ºÁ¤
75
ÁöÂü¾à °è¼Ó º¹
¿ë)
Åğ¿øÁöÂü¾à
¶óºñ¿¡Æ®Á¤10mg 10
ÁöÂü¾à °è¼Ó º¹
¿ë)
Åğ¿øÁöÂü¾à
Áß¿Ü½Ã±×¸¶Æ®Á¤
5mg
5
ÁöÂü¾à (°è¼Ó º¹
¿ë)
Åğ¿øÁöÂü¾à
ÄÚÀÚÁ¤100mg
100
ÁöÂü¾à °è¼Ó º¹
¿ë)
Åğ¿øÁöÂü¾à
Æ®¶óÁ¨Å¸Á¤
5
ÁöÂü¾à (°è¼Ó º¹
¿ë)
Åğ¿øÁöÂü¾à
Á÷µà¿À¼­¹æÁ¤
10/1000
1
ÁöÂü¾à °è¼Ó º¹
¿ë)
Åğ¿øÁöÂü¾à
´ã´ç Àü°øÀÇ»ç¸í
¿ÁÅÂµ¿
±â·ÏÀÚ¸í
¿ÁÅÂµ¿
ÁÖÄ¡ÀÇ»ç¸í
³²È¿¼®
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Åğ¿ø¿ä¾à
2019-09-06
3/3
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
ÀÔ¿øÀÏÀÚ
2019-09-04
ÀÔ¿ø°ú ½Å°æ°ú
ÀÔ¿øÁÖÄ¡ÀÇ
³²È¿¼®
ÀÔ¿ø°áÁ¤ÀÇ»ç ³²È¿¼®
ÁÖÈ£¼Ò ¶Ç´Â ÀÔ¿ø»çÀ¯
C.C F/U DSA
ÇöÀçÁúº´»óÅÂ
»ó±â 64¼¼ ³²È¯ HTN, DM, CAOD (2vd, s/p CAG), PAOD S/p PTA °ú°Å
·Â ÀÖ´ÂºĞÀ¸·Î
2018.04 CABG À§ÇØ Rt ICA stenosis ·Î ½Å°æ°ú ÇùÁø ÈÄ CD »ó Rt. ICA
75~99% stenosis ÀÖ¾î
2018.09.05 Rt ICA stenosis¿¡ stent insertion ÈÄ F/U DSA À§ÇØ ÀÔ¿øÇÔ.
°ú°Å·Â
Hypertension
No
Yes
Pul. Tbc
No
Yes
DM
No
Yes
Hepatitis
No
Yes
Smoking
No
Yes
±İ¿¬±³À° ¿©ºÎ
½ÃÇà
¹Ì½ÃÇà
ÇØ´ç¾øÀ½
Alcohol
No
Yes
Adverse Reaction
No
Yes
Ç×»ıÁ¦
¾Ë·¹¸£±â
No Yes
ÁøÅëÁ¦ ¡ÚFentanyl injÆæÅ¸´Ò) 100mcg/A(¾îÁö·¯¿ò Á¹¸²)
Á¶¿µÁ¦
±âÅ¸
Cardiac disease
No
? Yes
? MI
stent
CABG
unstable angina
? Angiographically confirmed CAOD
? A.fib
others
? valvular heart disease
Congestive heart failure
CNS disorder
No
Yes
Others
°¡Á··ÂÇü: CAOD
ÀÔ¿ø±â·Ï
2019-09-04
°èÅë¹®Áø
Generalized Weakness
No
Yes
Easy Fatigue
No
Yes
Fever
No
Yes
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
1/6
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ
SEVERANCE HOSPITAL

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
ÀÔ¿ø±â·Ï
2019-09-04
Chill
Headache
Dizziness
Insomnia
Cough
Sputum
Dyspnea
z z z z z z
No
Yes
Yes
No
No
0000000
Yes
Yes
Yes
Yes
Yes
DOE
No
Chest pain
No
00
Yes
Yes
Palpitation
No
Yes
Hemoptysis
No
Yes
Hematemesis
No
Yes
Anorexia
No
Yes
Nausea
No
Yes
Vomiting
No
Yes
Constipation
No
Yes
Diarrhea
No
Yes
Abdominal pain
No Yes
Abdominal discomfort
No
Yes
Hematochezia
No
Yes
Melena
No
Yes
Dysuria
No
Yes
Oliguria
No
Yes
Hematuria
No
Yes
Poor oral intake
No
Yes
Weight Loss
No
Yes
Weight Gain
No
Yes
Others
½ÅÃ¼Á¶»ç
General Appearance
Appearance Not so ill-looking appearance
Mental Status Alert Drowsy
Stupor
Semicoma
Coma
Moderate
Poor
Nutritional and Developement status Good
Skin
ÇÇºÎÁ·
Abnormal skin rash
Warm ? Cold
? Wet
Dry
No
Yes
Skin tugor Good
HEENT
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
2/6
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Normocephaly without deformity
Yes No
Sclera
not icteric
Throat
not injected
Conjunctiva
Lips & tongues
not dried
not pale
Neck
Stiffness
supple
Cervical LNs
not palpable
Neck veins
not engorged
Chest/lung
Symmetric expansion
Yes
No
Retraction
No
Yes
Both Rt Lt)
Breath sounds
clear
increased
decreased
character
Continuous sound
Discontinuous sound
High-pitched sound
Low-pitched sound
Wheezing
Rhonchi
Fine crackle
Coarse crackle
Stridor
Velcro rale
Location
Right upper lung field
Left upper lung field
Right middle lung field
Left middle lung field
Right lower lung field
Left lower lung field
ÀÔ¿ø±â·Ï
2019-09-04
Heart
PMI
(5th ICS LMCL)
?ÀÌ»ó
RHB
without murmur
with murmur
Thrill
No
Yes
Heaving
No
Yes
Abdomen
Palpation
? soft
? rigid
flat
distended
Bowel sound
normoative
Tenderness
No
Yes
Palpation of organ ? No.
? liver
kidney
spleen
Shifting dullness
No
Yes
Fluid wave
No
Yes
Back and Extremity
LOM
No Yes
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
3/6
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
CVA tenderness
No
Rt.
Lt. Both
Pitting edema
No
Yes
Paresthesia
No
Yes
½Å°æÇĞÀû °Ë»ç
## neurologic exam
(1) Mental status & Mental function
-Mental status: alert
-Mental function: all preserved
- Orientation Time/Place/Person: +/+/+
- Language
- Fluency: intact
- Comprehension: intact
- Reading intact
- Writing intact
- Naming intact
- Repetition: intact
(2) Cranial nerve Function:
-Isocoria 3mm/3mm c PLR (+/+)
-No EOM limitation s nystagmus
-No Visual field defect by confrontation test
-No facial palsy s sensory change
-Gag reflex: ok
-No tongue deviation / No uvula deviation
(3) Motor:
- Upper ext: prox GV / GV dist GV/GV
hand grip GV/GV, pronator drift (-/-)
Spasticity: Go/o
- Lower ext: prox GV / GV dist GV / GV
hopping intact/intact
Spasticity: Go/o
(4) Sensory:
- Light touch: intact
Pinprick or pain: intact
- Position: intact
- Vibration: intact
(5) Deep Tendon Reflex:
- biceps(++/++), triceps(++/++)
- knee jerk(++/++), ankle jerk(++/++)
- Babinski sign (-/-)
- Ankle clonus (-/-)
(6) Cerebellar function:
- Finger To Nose: intact
- Heel To Shin: intact
- Romberg test (eye opening/eye closing: intact/intact)
(7) Gait
- Gait: independent gait
- Tandem gait : no sway
Motor
Rt
Lt
U/Ex
dis
À½À½
pro
pro
L/Ex
dis
others (Physical Exam)
°¨¿°¼ºÁúÈ¯ ÃÊ±âÆò°¡
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
ÀÔ¿ø±â·Ï
2019-09-04
4/6
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/64¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
1. Áõ»ó ¹× ±â°£
ÀÔ¿ø±â·Ï
2019-09-04
¡à ¹ß¿­
±â°£
ÀÏÀü
|È£Èí±âÁõ»ó
±â°£
ÀÏÀü
¼ÒÈ­±âÁõ»ó
±â°£
ÇØ´ç¾øÀ½ (¹Ì»óÈ¯ÀÚ Æ÷ÇÔ)
ÀÏÀü
2. ÃÖ±Ù 1´Ş ÀÌ³» ¹æ¹®ÇÑ³ª¶ó ÇØ´ç¾øÀ½
¾øÀ½
ÀÖÀ½
3. ÃÖ±Ù 1´Ş ÀÌ³» ÀÔ¿øÇß´øº´¿ø (°¨¿°ÁÖÀÇ º´¿ø)
¾øÀ½
ÀÖÀ½
4. ¹ĞÁ¢ Á¢ÃËÀÚ
ÇØ´ç¾øÀ½
¾Æ´Ï¿À
¿¹
5. ½ÅÁ¾ °¨¿°º´ ÀÇ½ÉÈ¯ÀÚ
¾Æ´Ï¿À
ÅëÁõÆò°¡ ÅëÁõ¿©ºÎ
No
Yes
°èÈ¹
ÃßÁ¤Áø´Ü Rt ICA stenosis s/p stent insertion
F/U DSA
Åğ¿ø°èÈ¹
Åğ¿ø ÈÄ Ä¡·á½ÄÀÌ ¿©ºÎ
? N
ÃßÈÄ °ü¸® °èÈ¹
|°¡Á¤°£È£»ç¾÷¼Ò
È£½ºÇÇ½º
Å¸ º´¿ø Àü¿ø
¡î ¿Ü·¡
»çÈ¸ º¹Áö¼­ºñ½º ¿¬°è ÇÊ¿ä¼º
? N
±âÅ¸ Åğ¿ø½Ã ¿ä±¸»çÇ×
Ä¡·á°èÈ¹
+
Problem
Goal
ºÎ
stenosis
¸ñÇ¥ÀÏ
¼öÁ¤¸ñÇ¥ÀÏ
°èÈ¹ÀÏ
E cerebral or carotid artery ³úÇ÷°ü ÃÔ¿µÀ» ÅëÇÏ¿©
2019-09-11
2019-09-04
stenosis degree¸¦ È®ÀÎÇÑ´Ù.
±â·ÏÀÚ¸í
<¾à¾î ¼³¸í>
¿ÁÅÂµ¿
BMI : body mass index
BP(D): Blood Pressure(Diastolic)
BP(S) : Blood Pressure(Systolic)
BT body temperature
C-sec: cesarean section
CVA cerebrovascular accident
CVA tenderness costovertebral angle
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
ICS: impulse conducting system(of the heart)
LMCL left midclavicular line
LNs lymph nodes
LOM limitation of motion
NSVD normal spontaneous vaginal delivery
PAOD peripheral arterial occlusive disease
PMI point of maximum impulse
5/6
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
DM diabetes mellitus
DOE dyspnea on exertion
ECOG eastern cooperative oncology group
HEENT : head, ear, eye, nose and throat
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
PR: pulse rate
Pul. Tbc pulmonary tuberculosis
RHB regular heart beat
ÀÔ¿ø±â·Ï
2019-09-04
6/6
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
°æ°ú±â·Ï
2019-09-05
Áø·á°ú
½Å°æ°ú
ÁÖÄ¡ÀÇ
³²È¿¼®
°æ°ú
Progress
Ifor f/u DSA
HTN, DM, CAOD (2vd, s/p CAG), PAOD s/p PTA
Rt ICA stenosis¿¡ stent insertion (2018.09)
Problem List
#1. for DSA f/u
½ÉÀå³»°ú¿¡¼­ aspirin, platless º¹¿ëÁßÀÓ. ²ÙÁØÈ÷ º¹¿ëÇÔ.
½Å°æÇĞÀû ÀÌ»ó ¾øÀÌ Áö³¿.
Evaluation
ODSA
°èÈ¹
DSA
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
°æ°ú±â·Ï
2019-09-05
Ä¡·á°èÈ¹: ÁÖÄ¡ÀÇ°¡ È¯ÀÚÀÇ Ä¡·á°èÈ¹À» È®ÀÎÇÔ.
ÁÖÄ¡ÀÇ Comment fu
Ä¡·á°èÈ¹
8:17
+
Problem
Goal
ºÎ
E
cerebral or carotid artery ³úÇ÷°ü ÃÔ¿µÀ» ÅëÇÏ¿©
¸ñÇ¥ÀÏ ¼öÁ¤¸ñÇ¥ÀÏ
2019-09-11
°èÈ¹ÀÏ
2019-09-04
stenosis
stenosis degree¸¦ È®ÀÎÇÑ´Ù.
±â·ÏÀÚ¸í ¿ÁÅÂµ¿
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
2/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ
SEVERANCE HOSPITAL

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿¬·É ±¸ºĞ
ºĞ·ù
¿µÀ¯¾Æ±â ÇĞ·ÉÀü±â ÇĞ·É±â Ã»¼Ò³â±â
ÀÏ¹İ »ê¸ğ Á¤½Å
¼ºÀÎ
Çöº´·Â
ÁÖ Áõ»ó ¹× ³»¿ø °úÁ¤ follow up DSA(9/5 DSA(stent fu&4-vessel)) [¿Ü·¡->ÀÔ¿ø]
º¹¿ëÁßÀÎ ¾à
¤· ¹« À¯
Åõ¾à »óÅÂ
°³¼ö
¾à¸í
È½¼ö
¿ë¹ı
¾àÇ° ÄÚµå
°³¼ö
´ÜÀ§
Aspirin protect [100 mg/1
T
1
PO
Cozaar [100 mg/T]
1
T
1
PO
Herben [30mg/T]
1
T
2
PO
D2ASPI01
D2COZA03
D2HERBO1
Lipitor [80 mg/T]
1
T
1
PO
D2LIPI12
Platless [75 mg/T]
1
T
1
PO
D2PLAT01
Rabiet [10mg/T]
1
T
1
PO
D2RABI01
Sigmart [5 mg/T]
1
T
2
PO
D2SIGM01
Trajenta [5mg/T]
1
T
1
PO
D2TRAJ01
Xigduo XR 10/1000 (¿ø
1
T
1
PO
D2XIGD02
|¿Ü 48hr ÀüÈÄ Á¶¿µÁ¦ º´¿ë
±İ±â) [1T/T]
°£È£Á¤º¸Á¶»ç
2019-09-04
ÅëÁõ
ÅëÁõ
¾øÀ½ ÀÖÀ½ ¤· ÀÔ¿ø Àü¿¡ ÀÖ¾úÀ½
°ú°Å·Â
°ú°Å·Â ¹« À¯
ÀÔ¿ø ¹× ¼ö¼ú ÀÌ·Â ¤· ¾øÀ½
ÀÖÀ½ ¤·Àß¸ğ¸§
°ú°Åº´·Â °íÇ÷¾Ğ
´ç´¢ ¡à °áÇÙ ¡à ¾Ï ¡à °£¿° ¡à °æ·Ã | ±âÅ¸ CAOD 2vd s/pCABG
°ú°Å·Â(ÀÔ¿ø ¹× ¼ö¼ú)
ÀÔ¿ø½Ã Áø´Ü¸í ¹× ¼ö¼ú¸í
CAOD 2vd s/pCABG
ÀÔ¿ø ¹× ¼ö¼ú ½Ã±â
2018.4¿ù
Rt. ICA stent insertion
2018.09
(2018.04, ÀÏ»ê¹é)
s/p CAG
PTA
2019.1.27
Allergy
ÀüÀÚ¼­¸íÀÚ: ÇÔ°æÈñ
1/4
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
¿øº»´ëÁ¶ÇÊ
SEVERANCE HOSPITAL

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Allergy
¾øÀ½
¾à ¡à À½½Ä
±â´É Æò°¡
ÀÏ»ó»ıÈ°(ADL) ¼öÇà ´É·Â
µ¶¸³Àû ¼öÇà ¡Û ºÎºĞ º¸Á¶ ÇÊ¿ä
¿ÏÀü º¸Á¶
º¸Á¶±â(ÀÌµ¿) »ç¿ë ¾øÀ½ ¡Û ¸ñ¹ß ¤· ÁöÆÎÀÌ Owalker ¡Û ÈÙÃ¼¾î ±âÅ¸
?ÀÌµ¿½Ã ÁÖ·Î »ç¿ëÇÏ´Â º¸Á¶±â¸¦ ¼±ÅÃÇØ ÁÖ¼¼¿ä.
½Ä»çÇÏ±â µ¶¸³Àû ¼öÇà°¡´É
°³ÀÎ À§»ı µ¶¸³Àû ¼öÇà°¡´É
¸ñ¿åÇÏ±â µ¶¸³Àû ¼öÇà°¡´É
¿ÊÀÔ±â µ¶¸³Àû ¼öÇà°¡´É
È­Àå½Ç »ç¿ë
µ¶¸³Àû ¼öÇà°¡´É
°è´Ü ¿À¸£±â
µ¶¸³Àû ¼öÇà°¡´É
ÀÌµ¿ÇÏ±â µ¶¸³Àû ¼öÇà°¡´É(ÈÙÃ¼¾î¸¦ Á¦¿ÜÇÑ walking aid »ç¿ë ÇÒ ¼ö ÀÖÀ½)
ÀÌµ¿ÇÏ±â(ÀÇÀÚ¿Í Ä§´ë°£) µ¶¸³Àû ¼öÇà°¡´É
ÀÌµ¿ÇÏ±â (ÈÙÃ¼¾î)
¿îµ¿
±ÔÄ¢ÀûÀ¸·Î ÇÏ´Â ¿îµ¿ ¾øÀ½
¿îµ¿ÀÇ Á¾·ù ¡à °È±â
´Ş¸®±â ¡à ¼ö¿µ
µî»ê °ñÇÁ
±âÅ¸
¿îµ¿ È½¼ö
1È¸/ÁÖ
1È¸ ¿îµ¿ ½Ã°£
À½ÁÖ·Â ¤·nondrinker
ex-drinker
current drinker
À½ÁÖ·Â(Á¾·ù, ¾ç, È½¼ö/wk) ¼ÒÁÖ 1º´ / ÁÖ 3~4È¸
À½ÁÖ ½ÃÀÛ ½Ã±â 20»ì
²÷Àº ½Ã±â 2018.4
Èí¿¬·Â
Èí¿¬·Â Ononsmoker ex-smoker
current smoker
ÇÏ·çÀÇ Èí¿¬·®
(1)°©/ÀÏ
Èí¿¬ ½ÃÀÛ½Ã±â 20»ì
*
²÷Àº ½Ã±â 2016³â
²÷Àº ½Ã±â°¡ 1³â ÀÌÇÏÀÎ °æ¿ì ²À ±İ¿¬±³À°À» ½ÃÇàÇØ ÁÖ¼¼¿ä. (Åğ¿øÀü±îÁö)
°£È£Á¤º¸Á¶»ç
2019-09-04
¿¹¹æ Á¢Á¾
BÇü °£¿° Àß¸ğ¸§
Rubella Àß¸ğ¸§
Æó±¸±Õ Àß¸ğ¸§
¿µ¾ç »óÅÂ
1°³¿ù°£ Ã¼Áßº¯È­ ¾øÀ½ ¤·Áõ°¡ÇÔ ¤· °¨¼ÒÇÔ
ÃÖ±Ù 1ÁÖÀÏ°£ ½Ä»ç·® º¯È­ ¾øÀ½ ¤· Áõ°¡ °¨¼Ò
½ÄÀÌ ÁÖÀÇ »çÇ× ¾øÀ½ ¤· ¿­·® Á¶Àı ¤· Ã¼Áß Á¶Àı
±âÅ¸
Ã¼Áßº¯È­
kg
¤ı¿°ºĞ Á¦ÇÑ ¼öºĞ Á¦ÇÑ ´Ü¹éÁú Á¦ÇÑ ¡Û Áö¹æ Á¦ÇÑ
½Ä½À°ü
½Ä»çÈ½¼ö 3È¸/ÀÏ
Æí½Ä ½À°ü
¹«
¼±È£ À½½Ä
±âÇÇ À½½Ä
¼ö¸é »óÅÂ
¼ö¸é½Ã°£ 6
¼ö¸éÀ» µ½´Â¹ı
¼ö¸éÀå¾Ö ¾øÀ½
ÀüÀÚ¼­¸íÀÚ : ÇÔ°æÈñ
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
2/4
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
½Å°æ°è
½Ã°£¿¡ ´ëÇÑ Áö³²·Â ÀÖÀ½
Àå¼Ò¿¡ ´ëÇÑ Áö³²·Â ÀÖÀ½
»ç¶÷¿¡ ´ëÇÑ Áö³²·Â ÀÖÀ½
ÀÇ»ç ¼ÒÅë ¡î ¿ø¸¸ÇÔ ¾î·Á¿ò ¡à ºÒ°¡´ÉÇÔ ¡à ±âÅ¸
Á¤¼­ »óÅÂ
Áö³­ 2ÁÖµ¿¾È ±âºĞÀÌ °¡¶ó¾É°Å³ª, ¿ì¿ïÇÏ°Å³ª, Èñ¸ÁÀÌ ¾ø´Ù°í ´À³¤ ±â°£
¾øÀ½ 2~3ÀÏ ÀÌ»ó ¡Û7ÀÏ ÀÌ»ó ¡Û °ÅÀÇ ¸ÅÀÏ
È®ÀÎ ºÒ°¡´É
Áö³­ 2ÁÖµ¿¾È Æò¼Ò ÇÏ´ø ÀÏ¿¡ ´ëÇÑ Èï¹Ì°¡ ¾ø¾îÁö°Å³ª Áñ°Å¿òÀ» ´À³¢Áö ¸øÇÑ ±â°£
¾øÀ½ 2~3ÀÏ ÀÌ»ó ¡Û7ÀÏ ÀÌ»ó °ÅÀÇ ¸ÅÀÏ È®ÀÎºÒ°¡´É
Á¤¼­ Æò°¡ 0
The Patient Health Questionnaire-2(PHQ-2) (2003).
¡Ú
¸¶ºñ
½Ã°¢
½Ã·Â Àå¾Ö
À¯ È®ÀÎ ºÒ°¡´É
¹«
Ã»°¢
Ã»·Â Àå¾Ö
¹«À¯
¼ÒÈ­±â°è
¼ÒÈ­±â °ü·Ã Áõ»ó
Weakness ¹«
È®ÀÎ ºÒ°¡´É
¹èº¯ ¾ç»ó
¹èº¯ È½¼ö 1È¸/ÀÏ
´ëº¯ »ö±ò ¡î ´©·±»ö ¡à °¥»ö
¹èº¯ Àå¾Ö
¹«
¡à ³ì»ö ¡à °ËÀº»ö ¡à ¼±È«»ö
¹èº¯ Á¶Àı Á¶Àı¿¡ ¹®Á¦ ¾øÀ½
|Èò»ö ¡à ±âÅ¸
¹è´¢ ¾ç»ó
¹è´¢ ¹æ¹ı
spont voiding
Foley catheter ? CIC
Kissmo
±âÅ¸
catheter ±³È¯ ¿¹Á¤ÀÏ
¹è´¢ Àå¾Ö
¹«À¯
¹è´¢ Á¶Àı Á¶Àı¿¡ ¹®Á¦ ¾øÀ½
±â´ÉÆò°¡ 100
¼øÈ¯±â°è
¸Æ¹Ú ±ÔÄ¢ÀûÀÓ
Pacemaker
¾øÀ½
ºÎÁ¾
¾øÀ½
ÀÖÀ½
¼øÈ¯±â °ü·ÃÁõ»ó
¾øÀ½
ÀÖÀ½
È£Èí±â°è
È£Èí¾ç»ó
Regular
È£Èí±â °ü·ÃÁõ»ó
¾øÀ½
Irregular
ÀÖÀ½
Suppressed
Labored
| ±âÅ¸
°£È£Á¤º¸Á¶»ç
2019-09-04
ÇÇºÎ
ÇÇºÎ ¿Âµµ µû¶æÇÔ
ÇÇºÎ ½Àµµ Àû´çÇÔ
ÇÇºÎ»ö ÀÌ»ó¾øÀ½
ÀüÀÚ¼­¸íÀÚ : ÇÔ°æÈñ
3/4
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/64¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
°£È£Á¤º¸Á¶»ç
2019-09-04
ÇÇºÎ º¯È­
¹«
[Comment]
»ç¸Á
»ç¸Á
»ç¸Á »ç¸Á
Çü: CAOD
»ç¸Á
»ç¸Á
PT
Åğ¿ø
Åğ¿ø ÈÄ º¸È£ÀÚ (Main care giver) ¾øÀ½ ¡î ¹è¿ìÀÚ ¡à ºÎ
¸ğ
ÀÚ³à
Á¶ºÎ
Á¶¸ğ
ÇüÁ¦ÀÚ¸Å
°£º´ÀÎ
±âÅ¸
Åğ¿ø ¿¹Á¤Áö
ÀÚÅÃ ¤· Ä£Ã´Áı
Å¸º´¿ø ¿ä¾ç½Ã¼³
±âÅ¸
Åğ¿ø ¿¹Á¤ ±³Åë ¼ö´Ü(Discharge transportation) ¡î ÀÚ°¡
ÀÏ¹İ Á¤º¸(6¼¼ ÀÌ»ó)
´ëÁß±³Åë
Ç×°ø
¡à ±¸±ŞÂ÷
| ±âÅ¸
±³À° Á¤µµ °íµîÁ¹
°áÈ¥ »óÅÂ °áÈ¥
ÀüÈ­¹øÈ£ 01037588088
Á÷¾÷ »ç¹«Á÷
¿ø¸ñ ¿¬¶ô
¿øÇÔ
¿øÇÏÁö ¾ÊÀ½
Á¾±³ ¤·¾øÀ½
±âµ¶±³
º¸È£ÀÚ (Main care giver)
ÃµÁÖ±³
¾øÀ½
ºÒ±³
¹è¿ìÀÚ
±âÅ¸
ºÎ
¸ğ
ÀÚ³à
Á¶ºÎ
Á¶¸ğ
ÇüÁ¦
ÀÚ¸Å
°£º´ÀÎ
|±âÅ¸
±³À° ¿ä±¸µµ
¡î È¯ÀÚ
º¸È£ÀÚ
| ±âÅ¸
±³À° ¿ä±¸
ÁÖ »ç¿ë ¾ğ¾î ÇÑ±¹¾î ¡à ¿µ¾î ¡à ÀÏº»¾î ¡à Áß±¹¾î ¡à ·¯½Ã¾Æ¾î ¡à ±âÅ¸
±³À° ¹æ¹ı(È¯ÀÚ ¼±È£) ±¸µÎ ¡à À¯ÀÎ¹° ½Ã¹ü º¸ÀÌ±â ¡à ½ÃÃ»°¢ ¸ÅÃ¼(°¡´ÉÇÏ´Ù¸é)
ÀĞ°í ¾²´Âµ¥ ¾î·Á¿ò ¾øÀ½ ¡à ÀÖÀ½ ¡à ±âÅ¸
¿øÇÏ´Â ±³À° ³»¿ë ¡à Áúº´ ¡à ¾à¹° V °Ë»ç ¡à ¼ö¼ú ¡àÀÚ°¡ °£È£
¿µ¾ç
±âÅ¸
±³À°°ú Áø·á¿¡ ¿µÇâÀ» ÁÖ´Â °¡Ä¡¿Í ½Å³ä(Value & belief) ¾øÀ½ ÀÖÀ½
°æÁ¦Àû »óÅÂ
ÀÔ¿øºñ ÁöºÒÀÇ ¾î·Á¿ò ÀÖÀ½ ¾øÀ½ ¤·±âÅ¸
ÀÔ¿øºñ ÁöºÒ°ú °ü·ÃÇÑ »çÈ¸ »ç¾÷ÆÀ »ó´ã ÇÊ¿ä ÀÖÀ½
¾øÀ½
±âÅ¸
ÀüÀÚ¼­¸íÀÚ: ÇÔ°æÈñ
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
4/4
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
¿µ»ó°Ë»ç Æ¯¼öÃÔ¿µ-Intervention
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
°Ë»ç¸í
°Ë»ç¹æ¹ı
°Ë»çÀÏÀÚ
ÆÇµ¶ÀÏÀÚ
Description
¿µ»ó°Ë»ç Æ¯¼öÃÔ¿µ-Intervention
4 Vessel Angiography
2019.09.05 10:40
2019.09.06 09:06
ÃÔ¿µ½Ç
Ç÷°üÃÔ¿µ 52È£
Both CCA, VA angiograms were performed for evaluation of s/p stent insertion Rt pICA.
Under supine position, sterilization with alcohol at both inguinal areas and aseptic
draping were done. After local anesthesia with 1% lidocaine, right femoral arterial
puncture was performed using Seldinger's method. 5F Sheath, 5F headhunter
angiocatheter, 035 Terumo guidewire were used for selective angiography.
The puncture site was sealed with Perclose.
The patient tolerated well without specific procedure-related complications.
Impression:
Occlusion of Lt VA.
No residual stenosis or in-stent thrombosis in Rt pICA.
Operators: ±èµ¿ÁØ, ¹ÚÇØ±â
Assistants: ¹ÚÇØ±â, ¹ÚÃ¤Á¤
Written by: ¹ÚÇØ±â
ÆÇµ¶ÀÇ/Àü¹®ÀÇ
±èµ¿ÁØ/±èµ¿ÁØ/±èµ¿ÁØ
ÀüÀÚ¼­¸íÀÚ: ±èµ¿ÁØ
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
K-MMSE
2019-09-04
Áø·á°ú ½Å°æ°ú
°Ë»çÀÏ
2019-09-04
°Ë»çÀÚ ¿ÁÅÂµ¿
ÃÖÁ¾ÇĞ·Â ´ëÁ¹
Ç× ¸ñ
Dominant hand Right
¹İÀÀ
Á¡¼ö
Áö³²·Â(½Ã°£)
1
1Á¡
¿ù
1
1Á¡
ÀÏ
1
1Á¡
¿äÀÏ
1
1Á¡
°èÀı
1
1Á¡
Áö³²·Â(Àå¼Ò)
³ª¶ó
1
1Á¡
½Ãµµ
1
1Á¡
¹«¾ùÇÏ´Â °÷
1
1Á¡
ÇöÀç Àå¼Ò¸í
1
1Á¡
¸î Ãş
1
1Á¡
±â¾ïµî·Ï
ºñÇà±â
1
¿¬ÇÊ
1
¼Ò³ª¹«
1
Á¡Á¡Á¡
ÁÖÀÇÁıÁß ¹× °è»ê
100-7
1
1Á¡
-7
1
1Á¡
-7
1
1Á¡
-7
1
1Á¡
-7
1
1Á¡
±â¾ïÈ¸»ó
ºñÇà±â
1
¿¬ÇÊ
¼Ò³ª¹«
1
0
Á¡Á¡Á¡
¾ğ¾î ¹× ½Ã°ø°£±¸¼º
ÀÌ¸§´ë±â
½Ã°è
1
1Á¡
º¼Ææ
1
1Á¡
¸í·É½ÃÇà
Á¾ÀÌ¸¦ µÚÁı°í
1
1Á¡
¹İÀ¸·Î Á¢Àº ´ÙÀ½
1
1Á¡
Àú¿¡°Ô ÁÖ¼¼¿ä
0
1Á¡
µû¶ó ¸»ÇÏ±â
¹é¹®ÀÌ ºÒ¿©ÀÏ°ß
1
1Á¡
¿À°¢Çü
1
1Á¡
ÀĞ±â
1
1Á¡
¾²±â
1
1Á¡
ÃÑÁ¡
ÀüÀÚ¼­¸íÀÚ: ¹Ú¿ìÇö
¼¼ºê¶õ½ºº´¿ø
28
/30 Á¡
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/64¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
K-MMSE
2019-09-04
±â·ÏÀÚ¸í ¹Ú¿ìÇö
ÁÖÄ¡ÀÇ
³²È¿¼®
ÀüÀÚ¼­¸íÀÚ: ¹Ú¿ìÇö
2/2
Ãâ·ÂÀÏ: 2025-04-11
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
/ ¿À¸¥¼ÕÀâÀÌ
2. ´ëÁ¹
3. µ· °è»ê.
4.ÀĞ±â? ¾²±â ¤·
5. °ø¹«¿ø
°£ÀÌ Á¤½Å»óÅÂ °Ë»ç
(Korean version of Mini-Mental State Exam, K-MMSE)
µî·Ï¹øÈ£: 8633158
È¯ÀÚ¼º¸í:
ÀÌ±¤¿í
¼ºº°/³ªÀÌ: M,64¼¼
Ç×
¸ñ
Á¡¼ö
Ç×
¸ñ
Á¡¼ö
2019
0
0
ºñÇà±â
ÁÖÀüÀÚ
±â¾ïÈ¸»ó
0
¿¬ÇÊ
0
3Á¡
ÀÏ
4
0
8.9]
¼ö
0 ¨ç
¼Ò³ª¹«
ÀÌ¸§´ë±â
X
0
1
½Ã°Ô
0
Áö³²·Â
°¡¿î
04
º¼Ææ
0
¬ã¬ä
´ëÇÑ¹Î±¹
0
¨ç
¾ğ¾î
¸í·É½ÃÇà
Á¾ÀÌ¸¦ µÚÁı°í
0
¨ç
µµ
¼­¿ï
0
¹×
¹İÀ¸·Î Á¢Àº ´ÙÀ½
0
¹«¾ù ÇÏ´Â °÷
º´¿ø
0
½Ã°ø°£
Àú¿¡°Ô ÁÖ¼¼¿ä.
I
ÇöÀçÀå¼Ò¸í
¼¼ºê¶õ½º
0
±¸¼º
µû¶ó ¸»ÇÏ±â
¡°¹é¹®ÀÌ ºÒ¿©ÀÏ°ß"
0
¸îÁß
14Ãş
0
4
9Á¡
¿À°¢Çü
0
ºñÇà±â ÁÖÀüÀÚ
0
ÀĞ
±â¾ï
¾ç¸»
0
±â
Mi ±â
"´«À» °¨À¸¼¼¿ä"
0
L
0
¼Ò³ª¹« ¸í½Ã
0
100 -7
93
0
ÃÑÁ¡:
28 130
ÁÖÀÇÁıÁß
-7
86
0
0
¹× °è»ê
-7
79
0
5Á¡
-7
72
0
-7
65
0
8
ÇĞ·Â: ¹«ÇĞ/ÃÊÁ¹/ÁßÁ¹/°íÁ¹/¸Ç¼Ö
5 ¿À°¢Çü ±×¸®±â
¢¹ ÀĞ±â
D
´«À» °¨À¸¼¼¿ä
¢º ¾²±â (¿À´Ã ±âºĞÀÌ³ª ³¯¾¾¿¡ ´ëÇØ ÇÑ ¹®ÀåÀ¸·Î ½áº¸¼¼¿ä)
¼¼ºê¶õ½ºº´¿ø
ºñ¿ÂÈÄ°Ë
Scan
ÀÛ¼ºÀÚ : ¹Ú¿ìÇö
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
¿øº»´ëÁ¶ÇÊ
SEVERANCE HOSPITAL

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2019-09-17
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
°­Àº¼®
°æ°ú
Glucose 134
BUN 16.4
Glucose (¿¬¼Ó) - ½ÄÈÄ 2½Ã°£ 187
HbA1c 6.9
Occlusion of Lt VA.
DC Trajenta
Add Actos due to prevent stroke
3M
±â·ÏÀÚ¸í
°­Àº¼®
ÀüÀÚ¼­¸íÀÚ: °­Àº¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
½Å°æ°ú
ÁÖÄ¡ÀÇ
³²È¿¼®
Subjective
Objective
Assessment
Plan
130/74
2018.09.05 Rt ICA stenosis¿¡ stent insertion ÈÄ F/U DSA À§ÇØ ÀÔ¿øÇÔ.
?¾à°£ restenosis °¡ ÀÖÀ¸³ª ½ÉÇÏÁö ¾ÊÀ½.
((¾ÈÃ¶¹Î ±³¼ö´Ô))
Follow up DSA »ó Rt ICA stent ÇÑ ºÎÀ§¿¡ ¾à°£ restenosis °¡ ÀÖÀ¸³ª ½É
ÇÏÁö ¾Ê½À´Ï´Ù.
½Å°æ°úÀûÀ¸·Î´Â antiplatelet mono Tx + moderate intensity statin µå¼Å
µµ µÉ µí ÇÕ´Ï´Ù.
½Å°æ°ú´Â 1³âÈÄ ºË°Ú½À´Ï´Ù.
½Å°æ°ú ³²È¿¼® ¹è»ó
CD, TCD
±â·ÏÀÚ¸í
³²È¿¼®
¿Ü·¡ÀçÁø±â·Ï
2019-09-18
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
½ÃÇàÀÏÀÚ 2020-09-16
º´·Â ¹× ÀÇ·Ú»çÀ¯
ÁÖ¿ä ÁøÂû ¼Ò°ß
ÀÇ·Ú°ú ½Å°æ°ú
ÀÇ·ÚÀÇ ³²È¿¼®
Carotid duplex study
Normal
Abnormal
Atheromatous plaque
No
Yes
Anterograde VA flow
No
Yes
Stent FU
No
Yes
Total plaques
11
Intima media thickness
Rt 0.80 mm
Atheromatous plaques were found (Etil: mm)
Lt 0.96 mm
Rt. CCA:
2.64
1.99
Rt. Bifurcation:
Rt. ICA:
Rt. ECA:
Lt. CCA:
1.66
2.47
1.40
.
Lt. Bifurcation:
2.57
3.50
.
Lt. ICA:
2.87
1.52
2.25
.
Lt. ECA:
2.07
.
Significant stenotic flow
No
Yes
Thyroid nodule
No
Yes
1u22
Affiniti 70G
Carotid Duplex report
°Ë»ç±â°è¸í
Inserted stent was identified from Rt CCA to Rt ICA. The flow velocity of
Rt proximal ICA with inserted stent was measured (PSV=133cm/s,
EDV 39.3cm/s, PSV ICA/CCA ratio= 1.56), on which there was no
significant stenotic flow pattern.
Lt VA occlusion was noted
Conclusion))
1. There was no evidence of restenosis on carotid stent.
2. This hemodynamic study suggested atherosclerotic change on
bilateral CCAs and Lt BIF, ICA.
3. Lt VA occlusion was noted.
4. Compared to previous study(2018-07-05), Rt ICA stent was newly
noted. Otherwise, there was no significant change.
5. 6.93 and 7.05mm sized nodular lesion was detected in right thyroid.
Further evaluation of thyroid gland is required if clinically indicated.
6. We recommend the follow up CD study to investigate the interval
change.
ÆÇµ¶ÀÇ
ÀüÀÚ¼­¸íÀÚ: ¹é¹Î·Ä
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¹é¹Î·Ä
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Carotid Duplex report
Àü¹®ÀÇ
±è¿µ´ë
´ã´ç±â»ç
ÇÑ¹ÎÈ£
º¸°íÀÏ
<¾à¾î ¼³¸í>
VA vertebral artery
2020-09-16
ICA internal carotid artery
FU: follow-up
PSV: peak systolic velocity
CCA common carotid artery
EDV: end diastolic velocity
ÀüÀÚ¼­¸íÀÚ: ¹é¹Î·Ä
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
2/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
½ÃÇàÀÏÀÚ
2020-09-16
ÀÇ·Ú°ú ½Å°æ°ú
ÀÇ·ÚÀÇ ³²È¿¼®
º´·Â ¹× ÀÇ·Ú»çÀ¯
ÁÖ¿ä ÁøÂû ¼Ò°ß
Normal Abnormal
Undetermined
TCD study
The temporal window
temporal window was
good
poor
site
bilateral side
right side
The Ophthalmic flow
ophthalmic flow was
The ACA flow
normal direction
reversed direction
site
left side
bilateral side
left side
Oright side
ACA flow was
normal direction
site
bilateral side
I reversed direction
left side
right side
Findings
Increased MV on Lt Siph (84cm/s) and BA (77cm/s).
Conclusion))
1. The previous DSA study showed occlusion of Lt VA.
2. This hemodynamic study showed increased MV on Lt Siph and
BA, which may suggest stenosis or increased blood flow.
3. We recommend the follow up TCD study to check up the interval
change of vessel status.

Findings Right
Findings Left
MV
Pl
MV
PI
Rt. MCA pro
61
1.21
Lt MCA pro
71
1.17
Rt. MCA dis
60
1.13
Lt. MCA dis
70
1.15
-52
1.19
Rt. ACA
Lt. ACA
-44
1.41
Rt. PCA
-21
1.17
Lt. PCA
-27
1.15
Rt. Opth
20
1.06
Lt. Opth
25
1.48
Rt. Siph1
48
1.26
Lt. Siph1
-84
1.06
Rt.VA
-33
1.31
Lt VA
BA pro
??
-67
1.12
BA dis
-77
1.17
ÀüÀÚ¼­¸íÀÚ: ¹é¹Î·Ä
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
TCD report
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/65¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
´ã´ç±â»ç ÃÖÁ¤Çı
ÆÇµ¶ÀÇ
¹é¹Î·Ä
È®ÀÎÀÚ
±è¿µ´ë
º¸°íÀÏ
2020-09-16
TCD report
ÀüÀÚ¼­¸íÀÚ: ¹é¹Î·Ä
2/2
Ãâ·ÂÀÏ: 2025-04-11
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/65¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
Hame LEE KWANG OOK
TCD ID 8633158
¨çLACA
¨Ş LMCA
LPCA
BA
LPCoA
¨Ş LICA
LOA
Depth
50
Proce
1.6
ROA
50
Maan
¡æ RACA
¨çRMCA
RPCA
¨Ş ACOA
RPCoA
RICA
Depth
Prope
50
1.6
25
Pl
1.48
Pask
34
Mean r
20
FI
1.06
LSIPHON T
Depth
74
Proce
1.6
RSIPHON
Depth
78
Prope
1.6
Pask
135
Mean
76
PI
1.18
Peak
89
Mean
48
Pl
1.26
LSIPHON
130
on
Depth
74
Proce
1.6
Posk
-143 Meani
-84
FI
LMCA
Depth
48
1.06
Probe
1.6
RSIPHON
130
0
RMCA
170
Paak 83
Mean
45
Fl
1.28
Peak
ÀüÀÚ¼­¸íÀÚ: ¹é¹Î·Ä
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Depth
78
Prope
1.6
-80
Mean
-35
FI
1.96
Depth
44
Probe
1.6
70
70
Mea
38
1.31
TCD report
2/6
1/6
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/65¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
Hame LEE KWANG OOK**
TCD ID
8633158
LMCA
Cept
52
Prote
Depth
1.6
RMCA
48
17
Pork
117
Mean
68
LMCA
Posk
124
LMCA -
LMCA
127
Cepth
56
Fl
Probe
1.6
1.09
Peak
105
Mean
60
Pl
1.13
Prope
1.6
RMCA
Dept
52
Prope
1.6
Hear
70
Pl
1.15
Peak
102
Mean
56
FI
1.24
Depth
60
Probe
1.6
RMCA
Depth
Probe
56
1.6
Mean
71
PI
1.17
Peak 88
Mean
50
Pl
1.16
Copth
64
Peak
127
Mean
71
LACA
130
Depth
70
PI
Proce
1.6
RMCA
Depth
Proce
58
1.6
1.17
Pesk
122 Mean
66
PL
1.29
Probe
1.6
RMCA
176
Depen
64
Probe
1.6
Pask -79
Meani
-40
FI
1.43
Fesk
110
Mean
61
PI
1.21
ÀüÀÚ¼­¸íÀÚ: ¹é¹Î·Ä
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
TCD report
3/6
2/6
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Hame LEE KWANG OOK
TCD ID 8633158
Depth
Proce
Depth,
LACA
74
1.6
RACA
70
130
Foak
LPCA
Proce
1.6
-86
Maan
-44
Fl
1.41
Posk
-45
Maan
-26
PI
1.09
Dept
66
Probe
1.6
RACA
Depth
74
Probe
1.6
Pesk
-47
Mean
-27
PI
1.15
Peak
-94
Mean
-52
PI
1.19
LVA
Faak
Maa-
LVA
Peak
Mean
LVA
Paak
ÀüÀÚ¼­¸íÀÚ: ¹é¹Î·Ä
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Depth
54
Prope
1.6
RPCA
Depre
60
Prode
1.6
Depth
64
F1
Probe
1.6
Peak
RVA
Pask
RVA
Depth
66
Proce
1.6
-38
Mean
-21
PI
1.17
Depth
54
Prote
1.6
-60
Mean
-32
Pl
1.33
Depth
60
Proce
1.6
Peak -62 Mean
-33
1.31
TCD report
4/6
3/6
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/65¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
Hame LEE KWANG OOK A
TCD ID 8633158
ÀüÀÚ¼­¸íÀÚ: ¹é¹Î·Ä
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Depth
Proce
RVA
64
1.6
Depth
BA prox.
120
78
-60
Mean
-32
F1
1.27
Probe
1.6
Peak -120
Mean
-69
P
1.11
BA prox.
Depth
84
Proce
1.6
Peak
-117 Mean
-67
BA dis.
136
-129
BA dis.
1.12
Depth
Probe
88
1.6
Mean
-73
F
1.16
Depth
90
Proce
1.6
Pazk
-123
Mean -70
Pl
1.14
TCD report
5/6
4/6
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Hane LEE KWANG OOK"
ICD ID 8633158
Depth
BA dis.
90
Peak
-138
Vean
-76
BA dis.
Depth
94
Probe
1.6
Pl
1.24
Probe
1.6
Peak
-137
Mean
-77
Pl
1.17
Dept
BA dis.
96
Probe
1.6
130
Peak
-122 Mean
-70
Pt
1.13
TCD report
6/6
ÀüÀÚ¼­¸íÀÚ: ¹é¹Î·Ä
5/6
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
SEVERANCE HOSPITAL
Name
Gender
LEE KWANG OOK^^^^
Male
TCD ID
8633158
Exam Date
Age
D.O.B
Exam Type
2020/09/16
Routine Exam
1955/01/12
Disease Type
TCD Exam Data:
In the report, the unit of Peak/Mean/Dias is cm/s (kHz),
Depth's unit is mm, others have no unit)
Vessel
Depth
Mean
Pl
Peak Dias
RI
Vessel Depth Mean
Pl
Peak Dias
RI
LOA
50
25
1.48
50
13
0.74
ROA
50
20
1.06
34
13
0.62
LSIPHON
74
76
1.18
135
46
0.66
RSIPHON
78
48
1.26
89
28
0.68
LSIPHON
74
-84
1.06
-143
-54
0.62
RSIPHON
78
-35
1.96
-80
-12
0.85
LMCA
48
45
1.28
83
26
0.69
RMCA
44
38
1.31
70
21
0.7
LMCA
52
68
1.09
117
43
0.63
RMCA
48
60
1.13
105
38
0.64
LMCA
56
70
1.15
124
43
0.65
RMCA
52
56
1.24
102
33
0.68
LMCA
60
71
1.17
127
43
0.66
RMCA
56
50
1.16
88
30
0.65
LMCA
64
71
1.17
127
43
0.66
RMCA
58
66
1.29
122
38
0.69
LACA
70
-40
1.43
-79
-21
0.73
RMCA
64
61
1.21
110
36
0.67
LACA
74
-44
1.41
-86
-23
0.73
RACA
LPCA
66
-27
1.15
-47
-16
0.65
RACA
77
70
-26
1.09
-45
-16 0.63
74
-52
1.19
-94
-32 0.66
LVA
54
RPCA
66
-21
1.17
-38
-13
0.66
LVA
60
RVA
54
-32
1.33
-60
-18
0.71
LVA
64
RVA
60
-33
1.31
-62
-19
0.7
BA prox.
78
-69
1.11
-120
-43
0.64
RVA
64
-32
1.27
-60
-19 0.69
BA prox.
84
-67
1.12
-117
-42
0.64
BA dis
88
-73
1.16
-129
-45
0.65
BA dis.
90
-70
1.14
-123
-43
0.65
BA dis
90
-76
1.24
-138
-45
0.68
BA dis.
94
-77
1.17
-137
-47
0.66
BA dis.
96
-70
1.13
-122
-43
0.64
TCD Conclusion:
Signature:
Report Date: 2020/09/16
TCD report
1/6
ÀüÀÚ¼­¸íÀÚ: ¹é¹Î·Ä
6/6
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
¿øº»´ëÁ¶ÇÊ
SEVERANCE HOSPITAL

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2019-10-16
Áø·á°ú
½ÉÀå³»°ú
ÁÖÄ¡ÀÇ
¾ÈÃ¶¹Î
BP(S)
140mmHg
BP(D)
70mmHg
HR
78/min
Subjective
¾çÃø ´Ù¸®°¡ »¶»¶ÇÑ ´À³¦ÀÌ´Ù.
Objective
ABI (Ankle / Brachial Index) - Rt: 0.81/Lt: 0.80<=ABI1.04/1.09 <== 0.69/0.99
Glucose 134
BUN 16.4
Creatinine 1.03
Assessment
Plan
PAD, s/p PTA 2019.1.28 - IVUS-DCB
s/p PTA c DCB at Rt. SFA[2019-01-28]
ABI 1.04/1.09 <== 0.69/0.99
CAD(2vd+LM)
s/pCAG(2018.04, ÀÏ»ê¹é)
s/p 2018-04-09 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA)
DM
herben ÀÏ³â Á¤µµ »ç¿ë - À¯°æÁ¾ ±³¼ö´Ô - radial graft
Repeat med
6°³¿ù ÈÄ OPD,
EKG/CXR/LAB, PVR/CT
±â·ÏÀÚ¸í
¾ÈÃ¶¹Î
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿µ»ó°Ë»ç CT& MR
¿µ»ó°Ë»ç CT& MR
°Ë»ç¸í
CT Lower Extremity angio(contrast)
°Ë»ç¹æ¹ı
°Ë»çÀÏÀÚ
ÆÇµ¶ÀÏÀÚ
Description
2020.04.01 10:37
2020.04.06 10:45
ÃÔ¿µ½Ç
CT 17È£(Á¦Áß°ü1Ãş)
ÆÇµ¶ÀÇ/Àü¹®ÀÇ
###Àü°øÀÇ ÆÇµ¶ÀÔ´Ï´Ù. ²À °ø½ÄÆÇµ¶À» È®ÀÎÇÏ½Ã±â ¹Ù¶ø´Ï´Ù. ###
Compared with previous CT taken on 2018.12.14.
Multifocal stenosis with calcifications in both SFA and both ATA.
Diffuse atherosclerosis with calcification, infrarenal aorta.
Varicose vein, left calf.
No evidence of DVT.
Otherwise unremarkable.
Conclusion: overall, no change.
¡ßÁ¶¿µÁ¦ ¡ß
Pamiray 370 inj[150ml/V] [lopamidol 755.2mg/ml(¿ä¿Àµå·Î¼­ 370mg/ml)] [150 ml/V]:1
Ãµ¼¼Çö/Ãµ¼¼Çö/ÇÑ±âÃ¢
ÀüÀÚ¼­¸íÀÚ: ÇÑ±âÃ¢
1/1
Ãâ·ÂÀÏ: 2025-04-11
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
°Ë»ç°á°ú
ABI (Ankle/Brachial Index) - Rt: 0.77 /Lt: 0.90
Impression
Image Name
pvr Image1
Name:
LEE GWANG WOOK
8633158
Exam Date: 04/01/2020 10:29 AM
ID #:
Operator: G
SEVERANCE HOSPITAL
Sex: M
SEGMENTAL PRESSURE
AND PVR STUDY
Brachial
RIGHT LEFT
124 126
PVR 63mmHg 251cc RIGHT Ankle
Gain: 2 Spd:25 Amp:12
PPG RIGHT Great Toe
Gain:.50 Speed: 25 Amp:07
RIGHT
LEFT
0.77 97 PT 111 0.88
0.75 94 DP 114 0.90
±â´É°Ë»ç°á°ú(I/FÇü)
MultiLab Series II
0.32
ABI: 0.77
TBI: 0.32
40
48 0.38
PVR 66mmHg 218cc LEFT Ankle
ABI: 0.90 Gain: 2 Spd:25 Amp:15
TBI: 0.38
ABI INDEX
0.97 1.25 NORMAL
0.75 0.96 MILD
0.50 0.74 MODERATE
<0.50 SEVEREE
TBI (FBI) INDEX
>0.80 NORMAL
0.20 0.54 CLAUDICATION
<0.20 REST PAIN
PPG LEFT Great Toe
Gain:.50 Speed: 25 Amp:09
ÀüÀÚ¼­¸íÀÚ: ¹Ú±Ô¸®
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/65¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
ÆÇµ¶ÀÇ(1Â÷)
ÀÌ¼±È­
ÆÇµ¶ÀÇ(2Â÷)
¾ÈÃ¶¹Î
ÀüÀÚ¼­¸íÀÚ: ¹Ú±Ô¸®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
±â´É°Ë»ç°á°ú(I/FÇü)
2/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/64¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
°­Àº¼®
°æ°ú
CAD(2vd+ LM)
s/p CAG (2018.04, ÀÏ»ê¹é)
s/p 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA) (2018-04-09)
Rt. ICA stenosis s/p stent insertion (2018.10.02)
PAD
s/p PTA c DCB at Rt. SFA (2019.01.28)
DM(11yrs)
Ex-smoker (30yr, 2³âÀü Áß´Ü)
Aorta to rPL with RA)
159/79-86
Glucose 131
Glycoalbumin 22.7
Glucose (¿¬¼Ó) - ½ÄÈÄ 2½Ã°£ 192
HbA1c 7.2
Cholesterol 95
Triglyceride 54
HDL-Cholesterol 44
LDL-Cholesterol (Friedewald) 40.2
>>
Ç÷´çÀÌ Á¶±İ ³ªºüÁ³½À´Ï´Ù.
Àß °ü¸®ÇÏ¼¼¿ä.
±â·ÏÀÚ¸í
°­Àº¼®
ÀüÀÚ¼­¸íÀÚ: °­Àº¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿Ü·¡ÀçÁø±â·Ï
2019-12-17
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/65¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
°­Àº¼®
°æ°ú
CAD(2vd+ LM)
s/p CAG (2018.04, ÀÏ»ê¹é)
s/p 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA) (2018-04-09)
Rt. ICA stenosis s/p stent insertion (2018.10.02)
PAD
s/p PTA CDCB at Rt. SFA (2019.01.28)
DM(11yrs)
Ex-smoker (30yr2³âÀü Áß´Ü)
Aorta to rPL with RA)
152/80-81
Glucose 125
Glycoalbumin 20.3
Glucose (¿¬¼Ó) - ½ÄÈÄ 2½Ã°£ 191
HbA1c 6.8
Cholesterol 110
Triglyceride 81
HDL-Cholesterol 46
LDL-Cholesterol (Friedewald) 47.8
>>
repeat med
3mof/u
±â·ÏÀÚ¸í
°­Àº¼®
ÀüÀÚ¼­¸íÀÚ: °­Àº¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿Ü·¡ÀçÁø±â·Ï
2020-03-17
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
½ÉÀå³»°ú
ÁÖÄ¡ÀÇ
¾ÈÃ¶¹Î
BP(S)
145 mmHg
BP(D)
HR
72mmHg
92/min
¿Ü·¡ÀçÁø±â·Ï
2020-04-08
Subjective
Objective
Assessment
Plan
Good/No interval change
ABI (Ankle / Brachial Index) - Rt: 0.77/Lt: 0.90 <= Rt: 0.81/Lt: 0.80<=ABI 1.04/1.09
<== 0.69/0.99
CT angio
Compared with previous CT taken on 2018.12.14.
Multifocal stenosis with calcifications in both SFA and both ATA.
Diffuse atherosclerosis with calcification, infrarenal aorta.
Varicose vein, left calf.
No evidence of DVT.
Otherwise unremarkable.
Conclusion: overall, no change.
PAD, s/p PTA 2019.1.28 - IVUS-DCB
s/p PTA c DCB at Rt. SFA[2019-01-28]
ABI 1.04/1.09 <== 0.69/0.99
CAD(2vd+ LM)
s/pCAG(2018.04, ÀÏ»ê¹é)
s/p 2018-04-09 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA)
DM
herben ÀÏ³â Á¤µµ »ç¿ë - À¯°æÁ¾ ±³¼ö´Ô - radial graft
Repeat med
6°³¿ù ÈÄ OPD
EKG/CXR/LAB
amosartan Q
±â·ÏÀÚ¸í
¾ÈÃ¶¹Î
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
°Ë»ç°á°ú
ABI (Ankle/Brachial Index) - Rt: 0.80 /Lt: 0.89
Impression
Image Name
pvr Image1
Name:
ID #:
Exam Date: 10/07/2020 12:42 PM
LEE GWANG WOOK
8633158
Operator: G
SEVERANCE HOSPITAL
Sex: M
SEGMENTAL PRESSURE
AND PVR STUDY
Brachial
RIGHT LEFT
128
127
RIGHT
LEFT
0.80 102 PT 114 0.89
0.80 103 DP 110 0.86
±â´É°Ë»ç°á°ú(I/FÇü)
MultiLab Series
0.38 48
49 0.38
PVR 65mmHg 151cc RIGHT Ankle
Gain: 2 Spd:25 Amp:15
ABI: 0.80
TBI: 0.38
PVR 62mmHg 155cc LEFT Ankle
ABI: 0.89 Gain: 2 Spd:25 Amp: 15
TBI: 0.38
PPG RIGHT Great Toe
Gain:.50 Speed: 25 Amp:06
ABI INDEX
0.97 1.25 NORMAL
0.75 0.96 MILD
0.50 0.74 MODERATE
<0.50 SEVEREE
TBI(FBI) INDEX
>0.80 NORMAL
0.20 0.54 CLAUDICATION
<0.20 REST PAIN
PPG LEFT Great Toe
Gain:.50 Speed: 25 Amp:08
ÀüÀÚ¼­¸íÀÚ: ¹Ú±Ô¸®
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
ÆÇµ¶ÀÇ(1Â÷)
ÀÌÂùÁÖ
ÆÇµ¶ÀÇ(2Â÷)
¾ÈÃ¶¹Î
ÀüÀÚ¼­¸íÀÚ: ¹Ú±Ô¸®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
±â´É°Ë»ç°á°ú(I/FÇü)
2/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
°­Àº¼®
°æ°ú
CAD(2vd+ LM)
s/p CAG (2018.04, ÀÏ»ê¹é)
s/p 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA) (2018-04-09)
Rt. ICA stenosis s/p stent insertion (2018.10.02)
PAD
s/p PTA c DCB at Rt. SFA (2019.01.28)
DM(11yrs)
Ex-smoker (30yr, 2³âÀü Áß´Ü)
Aorta to rPL with RA)
124/66-83
Glucose 107
Glycoalbumin 19.5
Glucose (¿¬¼Ó) - ½ÄÈÄ 2½Ã°£ 262
HbA1c 6.7
Cholesterol 107
Triglyceride 65
HDL-Cholesterol 44
LDL-Cholesterol (Friedewald) 50
Ã¤Ç÷½Ã Á× µå½É, ´ç´¢¾à º¹¿ë¾øÀÌ ½ÄÈÄÃ¤Ç÷ÇÔ
>>
repeat med
6mof/u
±â·ÏÀÚ¸í
°­Àº¼®
ÀüÀÚ¼­¸íÀÚ: °­Àº¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿Ü·¡ÀçÁø±â·Ï
2020-06-16
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125 j**** ³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2020-09-23
Áø·á°ú
½Å°æ°ú
ÁÖÄ¡ÀÇ
³²È¿¼®
Subjective
Objective
Assessment
Plan
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
159 / 77
CD, TCD
2020-09-16
11 Atheromatous plaques were found (´ÜÀ§: mm)
Increased MV on Lt Siph (84cm/s) and BA (77cm/s).
occlusion of Lt VA.
¾ÈÃ¶¹Î ±³¼ö´Ô¿¡°Ô
Ç×Ç÷¼ÒÆÇÁ¦Á¦
amosartan Q¿¡ ·Î¼ö¹Ù 20 µé¾î ÀÕÀÖÀ½.
Brain MRI and MRA 2³âÈÄ
Consult to ENDO
Rt thyroid mass
33158)
CAROTID
L12-3
36Hz
RS
2D
54%
Dyn R 55
P Low
HGen
Dist 0.199 cm
(39Images)
RT. CCA
1/3
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2020-09-23
3158) 2020-09-163
CAROTID
L12-3
36Hz
RS
2D
54%
Dyn R 55
P Low
HGen
* Dist 0.247 cm
:: Dist 0.140 cm
1158) 2020-091
CAROTID
L12-3
36Hz
RS
2D
54%
Dyn R 55
P Low
HGen
LT. CCA
Images)
RT. THYROID
Dist 0.693 cm
:: Dist 0.705 cm
X
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
2/3
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2020-09-23
±â·ÏÀÚ¸í
³²È¿¼®
CAROTID
L12-3
15Hz
2D
63%
Dyn R 50
P Low
HGen
RT. DISTAL CCA
CPA
46%
1250Hz
WF 68Hz
5.0MHz
ÀüÀÚ¼­¸íÀÚ: ³²È¿¼®
3/3
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/67¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿µ»ó°Ë»ç CT& MR
¿µ»ó°Ë»ç CT& MR
°Ë»ç¸í
MRI Brain & Angio 3D(NeckÆ÷ÇÔ) (contrast)
°Ë»ç¹æ¹ı
°Ë»çÀÏÀÚ
ÆÇµ¶ÀÏÀÚ
2022.09.14 11:28
2022.09.21 10:35
ÃÔ¿µ½Ç
MRI 75È£(º»°ü2Ãş)
Description
ÆÇµ¶ÀÇ/Àü¹®ÀÇ
Clinical information: Internal carotid artery stenosis
Imaging technique: sagittal T1Wl, axial T1WI. T2WI, T2 FLAIR, T2*WI, contrast enhanced
3D T1Wl with axial/coronal/sagittal reconstruction, intracranial TOF MRA, contrast
enhanced intracranial and neck MRA.
Contrast media: Used
Small old infarction in left side medulla.
Microbleed in right parietal lobe.
Stenosis in right carotid bulb and right distal VA.
Steno-occlusion in left VA.
Stenosis in left proximal ICA, left cavernous ICA.
¡ßÁ¶¿µÁ¦¡ß
Dotarem inj[20ml/Syringe] [Meglumine gadoterate 376.9mg/ml] [20ml/Syringe]:1
½É¿ë½Ä/½É¿ë½Ä/½É¿ë½Ä
ÀüÀÚ¼­¸íÀÚ: ½É¿ë½Ä
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/65¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2020-10-07
Áø·á°ú
½ÉÀå³»°ú
ÁÖÄ¡ÀÇ
¾ÈÃ¶¹Î
BP(S)
BP(D)
HR
Subjective
Objective
Assessment
Plan
118 mmHg
64mmHg
80/min
Good/No interval change
ABI (Ankle / Brachial Index) - Rt: 0.80 /Lt: 0.89
<==ABI (Ankle / Brachial Index) - Rt: 0.77/Lt: 0.90
Non-HDL Cholesterol 58
LDL-Cholesterol (Friedewald) 46
PAD, s/p PTA 2019.1.28 - IVUS-DCB
-
s/p PTA c DCB at Rt. SFA[2019-01-28]
ABI 1.04/1.09 <== 0.69/0.99
CAD(2vd+LM)
s/pCAG(2018.04, ÀÏ»ê¹é)
s/p 2018-04-09 40PCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA)
DM
herben ÀÏ³â Á¤µµ »ç¿ë - À¯°æÁ¾ ±³¼ö´Ô - radial graft
HTN_Q
Repeat med
6°³¿ù ÈÄ OPD
EKG/CXR/LAB
±â·ÏÀÚ¸í
¾ÈÃ¶¹Î
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/66¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
°Ë»ç°á°ú
1. ABI (Ankle/ Brachial Index) Rt: 0.79 /Lt: 0.89
-
Impression
Name
Name:
ID #:
Exam Date:
LEE K.W.
8633158
03/31/2021 08:52 AM
Operator: M
PVR 61mmHg 196cc
Gain: 2 Spd:25
±â´É°Ë»ç°á°ú(I/FÇü)
SEVERANCE HOSPITAL
Sex: M
MultiLab Series II
SEGMENTAL PRESSURE
AND PVR STUDY
Brachial
RIGHT LEFT
141 140
RIGHT
LEFT
0.79 111 PT 126 0.89
0.77 109 DP 124 0.88
0.57 81
81 0.57
RIGHT Ankle
Amp : 08
ABI: 0.79
TBI: 0.57
PVR 66mmHg 243cc LEFT Ankle
ABI: 0.89 Gain: 2 Spd:25 Amp:11
TBI: 0.57
PPG RIGHT Great Toe
Gain: .50 Speed: 25 Amp:05
ABI INDEX
0.97 1.25 NORMAL
0.75 0.96 MILD
0.50 0.74 MODERATE
<0.50 SEVEREE
TBI(FBI) INDEX
>0.80 NORMAL
0.20 0.54 CLAUDICATION
¬Ş¬Ú
<0.20 REST PAIN
PPG LEFT Great Toe
Gain:.50
Speed: 25 Amp: 16
2021-03-31
ÀüÀÚ¼­¸íÀÚ: ¹Ú±Ô¸®
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
±â´É°Ë»ç°á°ú(I/FÇü)
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/66¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
2021-03-31
ÆÇµ¶ÀÇ(1Â÷)
ÀÌÂùÁÖ
ÆÇµ¶ÀÇ(2Â÷)
¾ÈÃ¶¹Î
ÀüÀÚ¼­¸íÀÚ: ¹Ú±Ô¸®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
2/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
¿Ü·¡ÀçÁø±â·Ï
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/65¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
2020-10-13
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
±è´ÙÇÔ
Progress
134/65 87
Ãß°¡»çÇ×
Plan
Rt thyroid mass
5.6.93 and 7.05mm sized nodular lesion was detected in right thyroid. Further
evaluation of thyroid gland is required if clinically indicated.
TFT+US
±â·ÏÀÚ¸í ±è´ÙÇÔ
ÀüÀÚ¼­¸íÀÚ: ±è´ÙÇÔ
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿µ»ó°Ë»ç Æ¯¼öÃÔ¿µ-ÃÊÀ½ÆÄ
¿µ»ó°Ë»ç Æ¯¼öÃÔ¿µ-ÃÊÀ½ÆÄ
°Ë»ç¸í
U/S °æºÎ(neck)(Doppler)
°Ë»ç¹æ¹ı
°Ë»çÀÏÀÚ
ÆÇµ¶ÀÏÀÚ
2020.10.13 15:21
2020.10.13 15:32
ÃÔ¿µ½Ç
¾Ï)°©»ó¼±ÃÊÀ½ÆÄ 1°Ë»ç½Ç
Description
ÆÇµ¶ÀÇ/Àü¹®ÀÇ
ÀüÀÚ¼­¸íÀÚ: À±Á¤Çö
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Both thyroid gland ¿¡ multiple probably benign nodules µéÀÌ °üÂûµÇ¸ç, °¡Àå Å« °ÍÀº Rt
thyroid lower poleÀÇ 15mm Å©±âÀÇ nodule ÀÓ.
Both neck¿¡ pathologically enlarged LNs ¾øÀ½.
Doppler ultrasound images »ó Æ¯ÀÌ¼Ò°ß ¾øÀ½.
IMP: Multiple probably benign nodules in both thyroids, recommend follow up.
¼ÕÁø¿ì/¼ÕÁø¿ì/À±Á¤Çö
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/65¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
±è´ÙÇÔ
Progress
U/S °æºÎ(neck)(Doppler) 2020.10.13
Both thyroid gland ¿¡ multiple probably benign nodules µéÀÌ °üÂûµÇ¸ç, °¡Àå Å« °ÍÀº
Rt thyroid lower poleÀÇ 15mm Å©±âÀÇ nodule ÀÓ.
Both neck¿¡ pathologically enlarged LNs ¾øÀ½.
Doppler ultrasound images »ó Æ¯ÀÌ¼Ò°ß ¾øÀ½.
IMP: Multiple probably benign nodules in both thyroids, recommend follow up.
T3 0.81
Free T4 1.01
TSH 2.04
Ãß°¡»çÇ× Thyroid nodule
Plan
1y f/u
±â·ÏÀÚ¸í
±è´ÙÇÔ
¿Ü·¡ÀçÁø±â·Ï
2020-10-20
ÀüÀÚ¼­¸íÀÚ: ±è´ÙÇÔ
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/67¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
°Ë»ç¸í
°Ë»ç¹æ¹ı
°Ë»çÀÏÀÚ
ÆÇµ¶ÀÏÀÚ
Description
ÆÇµ¶ÀÇ/Àü¹®ÀÇ
¿µ»ó°Ë»ç Æ¯¼öÃÔ¿µ-ÃÊÀ½ÆÄ
¿µ»ó°Ë»ç Æ¯¼öÃÔ¿µ-ÃÊÀ½ÆÄ
U/S °æºÎ(neck)(Doppler)
2022.01.18 14:51
2022.01.18 15:24
ÃÔ¿µ½Ç
¾Ï)°©»ó¼±ÃÊÀ½ÆÄ 1°Ë»ç½Ç
Clinical information: Thyroid nodule
US examination was done with linear transducer> =10MHz (central frequency).
Background echotexture: homogeneous
Both thyroid gland ¿¡ multiple probably benign nodules µéÀÌ °üÂûµÇ¸ç Å©±â°¡ ÀÛ¾ÆÁø º´
º¯µéµµ ÀÖÀ½.
°¡Àå Å« °ÍÀº Rt thyroid lower poleÀÇ 15mm Å©±âÀÇ nodule ÀÌ°í º¯È­ ¾øÀ½.
Both neck¿¡ pathologically enlarged LNs ¾øÀ½.
Doppler ultrasound images »ó Æ¯ÀÌ¼Ò°ß ¾øÀ½.
Imp: Multiple probably benign nodules in both thyroids(K-TIRADS: 3)
, recommend follow up.
±Ç¿¹Áö/±Ç¿¹Áö/À±Á¤Çö
ÀüÀÚ¼­¸íÀÚ: À±Á¤Çö
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/65¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
°­Àº¼®
BP(S)
146 mmHg
BP(D)
°æ°ú ¹× Plan
±â·ÏÀÚ¸í
°­Àº¼®
75mmHg
HR 85/min
CAD(2vd+ LM)
s/p CAG (2018.04, ÀÏ»ê¹é)
s/p 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA) (2018-04-09)
Rt. ICA stenosis s/p stent insertion (2018.10.02)
PAD
s/p PTA c DCB at Rt. SFA (2019.01.28)
DM(11yrs)
Ex-smoker (30yr, 2³âÀü Áß´Ü)
Aorta to rPL with RA)
Glucose 111
Glycoalbumin 18.5
Glucose (¿¬¼Ó) - ½ÄÈÄ 2½Ã°£ 194
HbA1c 6.3
Cholesterol 111
Triglyceride 47
HDL-Cholesterol 45
LDL-Cholesterol (Friedewald) 56.6
>>
repeat med
6mof/u
¿Ü·¡ÀçÁø±â·Ï
2020-12-22
ÀüÀÚ¼­¸íÀÚ: °­Àº¼®
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/66¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2021-03-31
Áø·á°ú
½ÉÀå³»°ú
ÁÖÄ¡ÀÇ
¾ÈÃ¶¹Î
BP(S)
141 mmHg
BP(D)
65mmHg
HR
Subjective
Objective
Assessment
Plan
85/min
Good/No interval change
ABI (Ankle / Brachial Index) - Rt: 0.79/Lt: 0.89 <=Rt: 0.80 /Lt: 0.89
<==ABI (Ankle / Brachial Index) - Rt: 0.77/Lt: 0.90
Non-HDL Cholesterol 66
LDL-Cholesterol (Friedewald) 50
PAD, s/p PTA 2019.1.28-IVUS-DCB
-
s/p PTA CDCB at Rt. SFA[2019-01-28]
ABI 1.04/1.09 <== 0.69/0.99
CAD(2vd+ LM)
s/pCAG(2018.04, ÀÏ»ê¹é)
s/p 2018-04-09 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA)
DM
herben ÀÏ³â Á¤µµ »ç¿ë - À¯°æÁ¾ ±³¼ö´Ô - radial graft
HTN_Q
Repeat med
6°³¿ù ÈÄ OPD
EKG/CXR/LAB/PVR
Áõ¼¼ ¾ÇÈ­½Ã ¿ìÃø ½Ã¼ú °í·Á
±â·ÏÀÚ¸í
¾ÈÃ¶¹Î
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/66¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
°Ë»ç°á°ú
1. ABI (Ankle/ Brachial Index) - Rt: 0.84
/Lt: 0.82
Impression
Name
Name:
LEE K.W
ID #: 8633158
Exam Date: 10/06/2021 10:30 AM
Operator: J
SEVERANCE HOSPITAL
Sex: M
SEGMENTAL PRESSURE
AND PVR STUDY
Brachial
RIGHT LEFT
141 128
RIGHT
LEFT
0.83 117 PT 116 0.82
0.84 119 DP 116 0.82
±â´É°Ë»ç°á°ú(I/FÇü)
2021-10-06
MultiLab Series!!
0.35
50
58 0.41
PVR 65mmHg 223cc RIGHT Ankle
Gain:
2 Spd: 25 Amp:09
ABI: 0.84
TBI: 0.35
PVR 63mmHg 189cc
ABI: 0.82 Gain: 2 Spd:25
TBI: 0.41
LEFT Ankle
Amp:10
PPG RIGHT Great Toe
Gain: .50 Speed: 25 Amp:12
ABI INDEX
0.97 1.25 NORMAL
0.75 0.96 MILD
0.50 0.74 MODERATE
<0.50 SEVEREE
TBI (FBI) INDEX
>0.80 NORMAL
0.20 0.54 CLAUDICATION
<0.20 REST PAIN
PPG LEFT Great Toe
Gain:.50
Speed: 25 Amp:08
ÀüÀÚ¼­¸íÀÚ: ÇÑÇı¼ö
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
±â´É°Ë»ç°á°ú(I/FÇü)
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/66¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
2021-10-06
ÆÇµ¶ÀÇ(1Â÷)
À±¹ÎÀç
ÆÇµ¶ÀÇ(2Â÷)
¾ÈÃ¶¹Î
ÀüÀÚ¼­¸íÀÚ: ÇÑÇı¼ö
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
2/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/66¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
°­Àº¼®
BP(S)
164 mmHg
BP(D)
°æ°ú ¹× Plan
±â·ÏÀÚ¸í
°­Àº¼®
ÀüÀÚ¼­¸íÀÚ: °­Àº¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
70mmHg
HR
86/min
CAD(2vd+ LM)
s/p CAG (2018.04, ÀÏ»ê¹é)
s/p 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA) (2018-04-09)
Rt. ICA stenosis s/p stent insertion (2018.10.02)
PAD
s/p PTA c DCB at Rt. SFA (2019.01.28)
DM(11yrs)
Ex-smoker (30yr, 2³âÀü Áß´Ü)
Aorta to rPL with RA)
Glucose 114
Glycoalbumin 18.9
Glucose (¿¬¼Ó) - ½ÄÈÄ 2½Ã°£ 199
HbA1c 6.7
Cholesterol 112
Triglyceride 72
HDL-Cholesterol 48
LDL-Cholesterol (Friedewald) 49.6
½ÄÈÄ Ã¤Ç÷°Ë»ç½Ã Á× µå½Ã°í Ã¤Ç÷ÇÏ½É
> >
²ÙÁØÈ÷ »ıÈ°½À°ü °ü¸® ÇÊ¿äÇÕ´Ï´Ù.
actos D/C
3mo f/u
¿Ü·¡ÀçÁø±â·Ï
2021-06-22
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/66¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2021-10-06
Áø·á°ú
½ÉÀå³»°ú
ÁÖÄ¡ÀÇ
¾ÈÃ¶¹Î
BP(S)
139 mmHg
BP(D)
64mmHg
HR
84/min
Subjective
Objective
Assessment
Good/No interval change
ABI (Ankle / Brachial Index)
Non-HDL Cholesterol 62
-
Rt: 0.84/Lt: 0.82
LDL-Cholesterol (Friedewald) 49.6
PAD, S/p PTA 2019.1.28 - IVUS-DCB
Plan
Áø´Ü¸í
±¸ºĞ
È®Áø
ÁÖÁø´Ü È®Áø
±âÅ¸Áø´Ü È®Áø
|±âÅ¸Áø´Ü È®Áø
-
s/p PTA c DCB at Rt. SFA[2019-01-28]
ABI 1.04/1.09 <== 0.69/0.99
CAD(2vd+ LM)
s/pCAG(2018.04, ÀÏ»ê¹é)
s/p 2018-04-09 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA)
DM
herben ÀÏ³â Á¤µµ »ç¿ë- À¯°æÁ¾ ±³¼ö´Ô - radial graft
HTN_Q
Repeat med
6°³¿ù ÈÄ OPD
EKG/CXR/LAB/PVR/TMT
Unstable angina
Coronary artery disease (left main)
Coronary artery disease (2 vessel disease)
±â·ÏÀÚ¸í
¾ÈÃ¶¹Î
Áø´Ü¸í
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/67¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
°Ë»ç°á°ú
1. ABI (Ankle/ Brachial Index) Rt: 0.96 /Lt: 0.88
-
Impression
Name
Image 1
Name:
ID #:
Exam Date:
LEE K.W
8633158
03/30/2022 09:33 AM
Operator: J
±â´É°Ë»ç°á°ú(I/FÇü)
SEVERANCE HOSPITAL
Sex: M
MultiLab Series II
SEGMENTAL PRESSURE
AND PVR STUDY
Brachial
RIGHT LEFT
144
139
RIGHT
LEFT
0.96 138 PT 127 0.88
0.94 135 DP 127 0.88
0.59 85
PVR 67mmHg 196cc RIGHT Ankle
Gain: 2 Spd:25 Amp:08
ABI: 0.96
TBI: 0.59
57 0.40
PVR 64mmHg 156cc LEFT Ankle
ABI: 0.88 Gain: 2 Spd:25 Amp:10
TBI: 0.40
PPG RIGHT Great Toe
Gain: .50 Speed: 25 Amp: 17
ABI INDEX
0.97 1.25 NORMAL
0.75 0.96 MILD
0.50 0.74 MODERATE
<0.50 SEVEREE
TBI(FBI) INDEX
>0.80 NORMAL
0.20 0.54 CLAUDICATION
<0.20 REST PAIN
PPG LEFT Great Toe
Gain:.50
Speed: 25 Amp:15
2022-03-30
ÀüÀÚ¼­¸íÀÚ: ¸ğÇıÀÎ
1/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
±â´É°Ë»ç°á°ú(I/FÇü)
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/67¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
2022-03-30
ÆÇµ¶ÀÇ(1Â÷) ÀÌÂùÁÖ
ÆÇµ¶ÀÇ(2Â÷)
¾ÈÃ¶¹Î
ÀüÀÚ¼­¸íÀÚ: ¸ğÇıÀÎ
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
2/2
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/66¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
°­Àº¼®
BP(S)
139 mmHg
BP(D) 64 mmHg
HR 84/min
°æ°ú ¹× Plan
Áø´Ü¸í
±¸ºĞ
È®Áø
CAD(2vd+LM)
s/p CAG (2018.04, ÀÏ»ê¹é)
s/p_4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA
composite Y, Aorta to rPL with RA) (2018-04-09)
Rt. ICA stenosis s/p stent insertion (2018.10.02)
PAD
s/p PTA c DCB at Rt. SFA (2019.01.28)
DM(11yrs)
Ex-smoker (30yr, 2³âÀü Áß´Ü)
Aorta to rPL with RA)
Glucose
133
Glycoalbumin 20.9
Glucose (¿¬¼Ó) - ½ÄÈÄ 2½Ã°£ 199
HbA1c 7.3
Triglyceride 62
HDL-Cholesterol 41
Non-HDL Cholesterol
62
49.6
LDL-Cholesterol (Friedewald)
> >
Actos | add
4mthf/u (±è´ÙÇÔpf OPD ¸ÂÃß¾î ÀÏÁ¤ Á¶Àı)
ÁÖÁø´Ü È®Áø Diabetes mellitus type 2 with dyslipidemia
|±âÅ¸Áø´Ü È®Áø
Thyroid nodule
|±âÅ¸Áø´Ü È®Áø
Internal carotid artery stenosis
±â·ÏÀÚ¸í
°­Àº¼®
ÀüÀÚ¼­¸íÀÚ: °­Àº¼®
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
Áø´Ü¸í
¿Ü·¡ÀçÁø±â·Ï
2021-10-06
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/67¼¼
È¯ÀÚ¸í : ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
±è´ÙÇÔ
Progress
U/S °æºÎ(neck)(Doppler) 2022.01.18
Clinical information: Thyroid nodule
US examination was done with linear transducer> =10 MHz (central frequency).
Background echotexture: homogeneous
Both thyroid gland ¿¡ multiple probably benign nodules µéÀÌ °üÂûµÇ¸ç Å©±â°¡ ÀÛ¾Æ
Áø º´º¯µéµµ ÀÖÀ½.
°¡Àå Å« °ÍÀº Rt thyroid lower poleÀÇ 15mm Å©±âÀÇ nodule ÀÌ°í º¯È­ ¾øÀ½.
Both neck¿¡ pathologically enlarged LNs ¾øÀ½.
Doppler ultrasound images »ó Æ¯ÀÌ¼Ò°ß ¾øÀ½.
Imp: Multiple probably benign nodules in both thyroids(K-TIRADS: 3)
recommend follow up.
T3 0.89
Free T4 1.04
TSH2.58
Ãß°¡»çÇ× Thyroid nodule
Plan
2yf/u
Áø´Ü¸í
±¸ºĞ
È®Áø
ÁÖÁø´Ü È®Áø
|±âÅ¸Áø´Ü È®Áø
Diabetes mellitus type 2 with dyslipidemia
Thyroid nodule
|±âÅ¸Áø´Ü È®Áø
Internal carotid artery stenosis
Áø´Ü¸í
±â·ÏÀÚ¸í ±è´ÙÇÔ
¿Ü·¡ÀçÁø±â·Ï
2022-01-25
ÀüÀÚ¼­¸íÀÚ: ±è´ÙÇÔ
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/69¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿µ»ó°Ë»ç Æ¯¼öÃÔ¿µ - ÃÊÀ½ÆÄ
¿µ»ó°Ë»ç Æ¯¼öÃÔ¿µ-ÃÊÀ½ÆÄ
°Ë»ç¸í
U/S °æºÎ(neck)(Doppler)
°Ë»ç¹æ¹ı
°Ë»çÀÏÀÚ
ÆÇµ¶ÀÏÀÚ
2024.01.16 10:55
2024.01.16 11:17
Description
ÆÇµ¶ÀÇ/Àü¹®ÀÇ
ÀüÀÚ¼­¸íÀÚ: ÇÔÁÖÇö
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
ÃÔ¿µ½Ç
¾Ï)°©»ó¼±ÃÊÀ½ÆÄ 1°Ë»ç½Ç
Clinical information: Diabetes mellitus type 2 with dyslipidemia
US examination was done with linear transducer> =10 MHz (central frequency).
ÀÌÀü US¿Í ºñ±³ÇÔ
Both thyroid gland ¿¡ multiple probably benign nodules µéÀÌ °üÂûµÇ¸ç °¡Àå Å« °ÍÀº Rt
thyroid lower poleÀÇ 21mm Å©±âÀÇ nodule ÀÓ.
Background echotexture´Â subtle heterogeneous ÇÏ¸ç mild diffuse enlarge µÇ¾î ÀÖÀ½.
Both neck¿¡ pathologically enlarged LNs ¾øÀ½.
Doppler ultrasound images »ó Æ¯ÀÌ¼Ò°ß ¾øÀ½.
Imp: Multiple probably benign nodules in both thyroids (K-TIRADS: 3)
R/O Diffuse thyroid disease
recommend follow up.
ÇÔÁÖÇö/ÇÔÁÖÇö/ÇÔÁÖÇö
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ

|µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125**** ³²/67¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
Áø·á°ú
³»ºĞºñ³»°ú
ÁÖÄ¡ÀÇ
°­Àº¼®
BP(S)
mmHg
BP(D)
mmHg
HR /min
°æ°ú ¹× Plan
Áø´Ü¸í
±¸ºĞ
È®Áø
CAD(2vd+ LM)
s/p CAG (2018.04, ÀÏ»ê¹é)
s/p4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA
composite Y, Aorta to rPL with RA) (2018-04-09)
Rt. ICA stenosis s/p stent insertion (2018.10.02)
PAD
s/p PTA c DCB at Rt. SFA (2019.01.28)
DM(11yrs)
Ex-smoker (30yr, 2³âÀü Áß´Ü)
Aorta to rPL with RA)
T3 0.89
Free T4
1.04
TSH
2.58
Glucose 101
Glycoalbumin 20.4
Glucose (¿¬¼Ó) - ½ÄÈÄ 2½Ã°£ 294
HbA1c 6.7
Cholesterol 121
Triglyceride 43
HDL-Cholesterol
61
LDL-Cholesterol (Friedewald) 51.4
Urine Albumin-to-Creatinine Ratio 106.18
>>
repeat med
6mo f/u
ÁÖÁø´Ü È®Áø Diabetes mellitus type 2 with dyslipidemia
|±âÅ¸Áø´Ü È®Áø
Thyroid nodule
|±âÅ¸Áø´Ü È®Áø
Internal carotid artery stenosis
±â·ÏÀÚ¸í
°­Àº¼®
Áø´Ü¸í
¿Ü·¡ÀçÁø±â·Ï
2022-01-25
ÀüÀÚ¼­¸íÀÚ: °­Àº¼®
¼¼ºê¶õ½ºº´¿ø
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¿øº»´ëÁ¶ÇÊ
SEVERANCE HOSPITAL

µî·Ï¹øÈ£: 8633158
ÁÖ¹Îµî·Ï¹øÈ£: 550112-125****³²/67¼¼
È¯ÀÚ¸í: ÀÌ±¤¿í
¿Ü·¡ÀçÁø±â·Ï
2022-03-30
Áø·á°ú
½ÉÀå³»°ú
ÁÖÄ¡ÀÇ
¾ÈÃ¶¹Î
BP(S)
163 mmHg
BP(D)
74mmHg
HR
Subjective
Objective
Assessment
Plan
99/min
Good/No interval change
ABI (Ankle / Brachial Index) - Rt: 0.96 /Lt: 0.88 <==Rt: 0.84/Lt: 0.82
TMT negative
PAD, s/p PTA 2019.1.28 IVUS-DCB
s/p PTA DCB at Rt. SFA[2019-01-28]
ABI 1.04/1.09 <== 0.69/0.99
CAD(2vd+ LM)
s/p CAG(2018.04, ÀÏ»ê¹é)
s/p 2018-04-09 4OPCAB(LIMA to dLAD, to OM(seq) to DG with RIMA composite Y,
Aorta to rPL with RA)
DM
herben ÀÏ³â Á¤µµ »ç¿ë - À¯°æÁ¾ ±³¼ö´Ô - radial graft
HTN_Q
¾à°¨·®
6°³¿ù ÈÄ ÀÏ¹İ OPD
1³â EKG/CXR/LAB/PVR/TMT
Áø´Ü¸í
±¸ºĞ
È®Áø
ÁÖÁø´Ü
È®Áø
Unstable angina
±âÅ¸Áø´Ü È®Áø
Coronary artery disease (left main)
±âÅ¸Áø´Ü È®Áø
Coronary artery disease (2 vessel disease)
±â·ÏÀÚ¸í
¾ÈÃ¶¹Î
Áø´Ü¸í
ÀüÀÚ¼­¸íÀÚ: ¾ÈÃ¶¹Î
1/1
Ãâ·ÂÀÏ: 2025-04-11
Ãâ·ÂÀÚ: ±è°æ¹Ì
¼¼ºê¶õ½ºº´¿ø
SEVERANCE HOSPITAL
¿øº»´ëÁ¶ÇÊ

========== ÆÄÀÏ: i?¡şi??i?? i¡×?e¡Ì?e?¢¥i?¡©.pdf ==========

2025-04-16 19:09:54
G
ÇØ¿À¸§¼ÕÇØ»çÁ¤(ÁÖ)
REAL SUNRISE SURVEYORS & CLAIM ADJUSTERS CO., LTD.
½ÉÆò¿ø Áø·á³»¿ª
ÇÇº¸ÇèÀÚ
ÃÑ 1ºÎ
(Ç¥ÁöÁ¦¿Ü)
ºó°æÈ¯

2025-04-16 18:10:03
°³ÀÎÁø·áÁ¤º¸¿ä¾à
±âº»Áø·á³»¿ª
¼¼ºÎÁø·áÁ¤º¸
Ã³¹æÁ¶Á¦Á¤º¸
º´¡¤ÀÇ¿ø&¾à±¹º° °³ÀÎÁø·áÁ¤º¸¿ä¾à
Á¤º¸ÁÖÃ¼ : ÀÌ±¤¿í
¿­¶÷´ë»ó±â°£ : 2020-03-31~2024-10-08
ÀüÃ¼ ´Ù¿î·Îµå ¡é
º´¡¤ÀÇ¿ø&¾à±¹ ¿¬¼¼´ëÇĞ±³ÀÇ°ú´ëÇĞ¼¼ºê¶õ½ºº´¿ø
ÀÔ¿ø(¿Ü·¡)ÀÏ¼ö 0(13)
ÃÑÁø·áºñ(°Ç°­º¸ 2,488,930
ºó°æÈ¯
ÇèÀû¿ëºĞ)
°Ç°­º¸Çè µî ÇıÅÃ 970,830
¹ŞÀº ±İ¾×

2025-04-16 18:10:03
¿Ü·¡
ÄÚµå
ÀÏ¼ö (°Ç°­º¸Çè Àû¿ëºĞ) ÇıÅÃ¹ŞÀº ±İ¾×| (Áø·áºñ)
¿¬¼¼´ëÇĞ±³ÀÇ
1
2024-10-01 °ú´ëÇĞ¼¼ºê¶õ ½Å°æ°ú ¿Ü·¡ A1652 µ¿¸ÆÀÇ Æó 1
½ºº´¿ø
(¾ç¹æ)°æ
28,030
3,830
24,200
¼â ¹× ÇùÂø
(¾ç¹æ)°æ
2
2024-10-01
¼¼¿¬¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡ A1652 µ¿¸ÆÀÇ Æó
1
39,120
27,420
11,700
¼â ¹× ÇùÂø
¿¬¼¼´ëÇĞ±³ÀÇ
(¾ç¹æ)°æ
3
2024-09-12 °ú´ëÇĞ¼¼ºê¶õ ½Å°æ°ú ¿Ü·¡ A1652 µ¿¸ÆÀÇ Æó
½ºº´¿ø
1
778,260
311,360
466,900
¼â ¹× ÇùÂø
ÀÇ·á¹ıÀÎ ¼¼°æ
4 2024-08-20 ÀÇ·áÀç´Ü »õºû ¾È°ú ¿Ü·¡ AH400
¾È°úº´¿ø
(¾ç¹æ)³ì
145,440
³»Àå ÀÇ½É
87,340
58,100
5
2024-08-20
¹Ì¸£¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
$
ÇØ´ç¾øÀ½ 1
41,060
28,760
12,300
(¾ç¹æ)´Ş
¿¬¼¼´ëÇĞ±³ÀÇ
¸® ºĞ·ùµÇ
6
2024-07-16 °ú´ëÇĞ¼¼ºê¶õ ³»°ú ¿Ü·¡ AE1168Áö ¾ÊÀº ±â
½ºº´¿ø
25,640
3,840
21,800
Å¸ ¸í½ÃµÈ
ÇÕº´ÁõÀ»
7
2024-07-16 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
$
ÇØ´ç¾øÀ½ 1
267,830
187,530
80,300
(¾ç¹æ)´Ş
¿¬¼¼´ëÇĞ±³ÀÇ
¸® ºĞ·ùµÇ
8 2024-07-15 °ú´ëÇĞ¼¼ºê¶õ ³»°ú ¿Ü·¡ AE1168Áö ¾ÊÀº ±â
½ºº´¿ø
80,810
32,410
48,400
Å¸ ¸í½ÃµÈ
ÇÕº´ÁõÀ»
9
2024-07-15
ÀÏ»êÀÌ½ÊÀÏ¼¼ °¡Á¤ÀÇ
±âº´¿ø ÇĞ°ú
(¾ç¹æ)±â
Å¸ ¹× »ó¼¼
¿Ü·¡ Al109 ºÒ¸íÀÇ ¿ø
¹ß¼º °íÇ÷
¾Ğ
1
21,170
12,770
8,400
(¾ç¹æ)Áö
10 2024-07-15 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡ AE788 »çÀÇ ±âÅ¸
Áú´Ü¹é´ë
534,910
374,510
160,400
Àå¾Ö
(¾ç¹æ)¼Õ
11 2024-04-22
ÀÏ»êÀÌ½ÊÀÏ¼¼ ½Å°æ¿Ü
±âº´¿ø
¸ñÀÇ »ó¼¼
¿Ü·¡ AS6359 ºÒ¸í ºÎºĞ
ÀÇ ¿°ÁÂ
±äÀå
1
39,420
23,720
15,700
.
º» ÀÚ·á´Â º´¡¤ÀÇ¿ø&¾à±¹¿¡¼­ Ã»±¸ÇÑ ¿ä¾ç±Ş¿©ºñ¿ë ¸í¼¼¼­¸¦ ±âÁØÀ¸·Î ÀÛ¼ºµÈ ÀÚ·áÀÔ´Ï´Ù.
Áø·áºñ¿¡´Â ±¹¹Î°Ç°­º¸Çè¹ı Á¦41Á¶ÀÇ4¿¡ µû¸¥ ¼±º°±Ş¿© °ü·Ã ±İ¾×ÀÌ Æ÷ÇÔµÇ¾î ÀÖÁö ¾Ê½À´Ï´Ù.
ÀÌ¿¡ º» ÀÚ·á¸¦ ´Ü¼ø Âü°í°¡ ¾Æ´Ñ ÁõºùÀÚ·á·Î »ç¿ëÇÒ ¼ö ¾øÀ¸¸ç, ÀÌ¿ë¿¡ °üÇÑ Ã¥ÀÓÀº ÀÌ¿ëÀÚ¿¡°Ô ÀÖ½À´Ï´Ù.
1/10
ºó°æÈ¯

2025-04-16 18:10:03
TOOO
¿Ü·¡
RC
ÀÏ¼ö(°Ç°­º¸Çè Àû¿ëºĞ) ÇıÅÃ¹ŞÀº ±İ¾×|
(Áø·áºñ)
(¾ç¹æ)¼Õ
¸ñÀÇ »ó¼¼
12 2024-04-22
¼º½É¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡ AS6359 ºÒ¸í ºÎ
1
10,330
8,330
2,000
ÀÇ ¿°ÁÂ ¹×
±äÀå
13 2024-03-16
¾çÆòÇÁ¶óÀÚ¿Â
´©¸®¾à±¹
ÀÏ¹İÀÇ ¿Ü·¡ AJ069
(¾ç¹æ)»ó
¼¼ºÒ¸íÀÇ
±Ş¼º »ó±â
µµ°¨¿°
1
15,730
11,030
4,700
Æí¾ÈÇÑ³»°úÅë
(¾ç¹æ)»ó
14 2024-03-16 Ãş¿µ»óÀÇÇĞ°ú ³»°ú ¿Ü·¡ AJ069
ÀÇ¿ø
¼¼ºÒ¸íÀÇ
1
±Ş¼º »ó±â
µµ°¨¿°
24,130
19,330
4,800
(¾ç¹æ)´Ş
¸® ºĞ·ùµÇ
152024-01-16 °ú´ëÇĞ¼¼ºê¶õ ³»°ú ¿Ü·¡ AE1168Áö ¾ÊÀº ±â
¿¬¼¼´ëÇĞ±³ÀÇ
½ºº´¿ø
Å¸ ¸í½ÃµÈ
ÇÕº´ÁõÀ»
1
145,330
51,730
93,600
16 2024-01-16 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
$
ÇØ´ç¾øÀ½ 1
261,310
183,010
78,300
(¾ç¹æ)Áö
17 2024-01-16 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡ AE788 »çÀÇ ±âÅ¸
Ä¥´Ü¹é´ë
1
546,610
382,710
163,900
Àå¾Ö
18 2024-01-15
ÀÏ»êÀÌ½ÊÀÏ¼¼
±âº´¿ø
°¡Á¤ÀÇ
ÇĞ°ú
(¾ç¹æ)Á×
¿Ü·¡ A1251 »ó°æÈ­¼º
½ÉÀåº´
1
12,290
7,390
4,900
(¾ç¹æ)»ó
19 2024-01-04
¾çÆòº´¿ø
³»°ú
¿Ü·¡ AJ209
¼¼ºÒ¸íÀÇ
±Ş¼º ±â°ü
Áö¿°
16,960
11,060
5,900
(¾ç¹æ)±Ş
20 2024-01-04 ¾çÆò»õ±æ¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡ AJOO ¼ººñÀÎµÎ 1
11,910
9,610
2,300
¿°[°¨±â]
¿¬¼¼´ëÇĞ±³ÀÇ
(¾ç¹æ)´Ş
¸® ºĞ·ùµÇ
21 2023-07-18 °ú´ëÇĞ¼¼ºê¶õ ³»°ú ¿Ü·¡ AE1168Áö ¾ÊÀº ±â
½ºº´¿ø
1
113,930
39,330
74,600
Å¸ ¸í½ÃµÈ
ÇÕº´ÁõÀ»
(¾ç¹æ)»ó
22 2023-07-18
ÀÏ»êÀÌ½ÊÀÏ¼¼ °¡Á¤ÀÇ
±âº´¿ø
¼¼ºÒ¸í ºÎ
¿Ü·¡
ÇĞ°ú
AI213 À§ÀÇ ±Ş¼º
°æ»öÁõ
1
16,650
10,050
6,600
ÀüÃş½É±Ù
º» ÀÚ·á´Â º´¡¤ÀÇ¿ø&¾à±¹¿¡¼­ Ã»±¸ÇÑ ¿ä¾ç±Ş¿©ºñ¿ë ¸í¼¼¼­¸¦ ±âÁØÀ¸·Î ÀÛ¼ºµÈ ÀÚ·áÀÔ´Ï´Ù.
Áø·áºñ¿¡´Â ±¹¹Î°Ç°­º¸Çè¹ı Á¦41Á¶ÀÇ4¿¡ µû¸¥ ¼±º°±Ş¿© °ü·Ã ±İ¾×ÀÌ Æ÷ÇÔµÇ¾î ÀÖÁö ¾Ê½À´Ï´Ù.
.
.
ÀÌ¿¡ º» ÀÚ·á¸¦ ´Ü¼ø Âü°í°¡ ¾Æ´Ñ ÁõºùÀÚ·á·Î »ç¿ëÇÒ ¼ö ¾øÀ¸¸ç, ÀÌ¿ë¿¡ °üÇÑ Ã¥ÀÓÀº ÀÌ¿ëÀÚ¿¡°Ô ÀÖ½À´Ï´Ù.
ºó°æÈ¯
2/10

2025-04-16 18:10:03
¿Ü·¡
ÄÚµå
ÀÏ¼ö(°Ç°­º¸Çè Àû¿ëºĞ) ÇıÅÃ¹ŞÀº ±İ¾×|
(Áø·áºñ)
$
tA
ÇØ´ç¾øÀ½
1
264,400
185,100
79,300
232023-07-18 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
24-2023-07-18 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
$ ÇØ´ç¾øÀ½
546,280
382,480
163,800
ÀÇ·á¹ıÀÎ ¼¼°æ
25-2023-05-04 ÀÇ·áÀç´Ü »õºû ¾È°ú ¿Ü·¡ AH400
¾È°úº´¿ø
(¾ç¹æ)³ì
1
196,190
117,790
78,400
³»Àå ÀÇ½É
26 2023-05-04
¹Ì¸£¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
$
ÇØ´ç¾øÀ½
1
40,970
28,770
12,200
¿¬¼¼´ëÇĞ±³ÀÇ
27 2023-03-22 °ú´ëÇĞ¼¼ºê¶õ³»°ú ¿Ü·¡ A1200 ¾ÈÁ¤Çù½É 1
½ºº´¿ø
(¾ç¹æ)ºÒ
195,570
104,370
91,200
Áõ
28 2023-03-22 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
$
ÇØ´ç¾øÀ½ 1
282,820
198,020
84,800
ÀÇ·á¹ıÀÎ ¼¼°æ
<¡æ2023-02-02 ÀÇ·áÀç´Ü »õºû ¾È°ú ¿Ü·¡ AH400
¾È°úº´¿ø
(¾ç¹æ)³ì
23,890
³»Àå ÀÇ½É
14,390
9,500
30 2023-02-02
¹Ì¸£¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡ $
ÇØ´ç¾øÀ½
40,970
28,770
12,200
(¾ç¹æ)´Ş
¿¬¼¼´ëÇĞ±³ÀÇ
¸® ºĞ·ùµÇ
½ºº´¿ø
31 2023-01-17 °ú´ëÇĞ¼¼ºê¶õ³»°ú ¿Ü·¡ AE1168Áö ¾ÊÀº ±â
1
25,170
3,770
21,400
Å¸ ¸í½ÃµÈ
ÇÕº´ÁõÀ»
32 2023-01-17 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡ $
ÇØ´ç¾øÀ½ 1
151,900
106,400
45,500
(¾ç¹æ)´Ş
¿¬¼¼´ëÇĞ±³ÀÇ
¸® ºĞ·ùµÇ
332023-01-13 °ú´ëÇĞ¼¼ºê¶õ ³»°ú ¿Ü·¡ AE1168Áö ¾ÊÀº ±â
½ºº´¿ø
Å¸ ¸í½ÃµÈ
1
88,760
35,560
53,200
ÇÕº´ÁõÀ»
?º» ÀÚ·á´Â º´¡¤ÀÇ¿ø&¾à±¹¿¡¼­ Ã»±¸ÇÑ ¿ä¾ç±Ş¿©ºñ¿ë ¸í¼¼¼­¸¦ ±âÁØÀ¸·Î ÀÛ¼ºµÈ ÀÚ·áÀÔ´Ï´Ù.
Áø·áºñ¿¡´Â ±¹¹Î°Ç°­º¸Çè¹ı Á¦41Á¶ÀÇ4¿¡ µû¸¥ ¼±º°±Ş¿© °ü·Ã ±İ¾×ÀÌ Æ÷ÇÔµÇ¾î ÀÖÁö ¾Ê½À´Ï´Ù.
ÀÌ¿¡ º» ÀÚ·á¸¦ ´Ü¼ø Âü°í°¡ ¾Æ´Ñ ÁõºùÀÚ·á·Î »ç¿ëÇÒ ¼ö ¾øÀ¸¸ç, ÀÌ¿ë¿¡ °üÇÑ Ã¥ÀÓÀº ÀÌ¿ëÀÚ¿¡°Ô ÀÖ½À´Ï´Ù.
3/10
ºó°æÈ¯

2025-04-16 18:10:03
¿Ü·¡ ÄÚµå
ÀÏ¼ö (°Ç°­º¸Çè Àû¿ëºĞ) ÇıÅÃ¹ŞÀº ±İ¾×
(Áø·áºñ)
ÀÇ·á¹ıÀÎ ¼¼°æ
34 2022-12-01 ÀÇ·áÀç´Ü »õºû ¾È°ú ¿Ü·¡ AH400
¾È°úº´¿ø
(¾ç¹æ)³ì
³»Àå ÀÇ½É
23,050
13,850
9,200
35 2022-12-01
¹Ì¸£¾à±¹
ÀÏ¹İÀÇ ¿Ü·¡
$
ÇØ´ç¾øÀ½
40,760
28,560
12,200
¤Ó·á¹ıÀÎ ¼¼°æ
36 2022-11-03 ÀÇ·áÀç´Ü »õºû ¾È°ú ¿Ü·¡ AH400
¾È°úº´¿ø
(¾ç¹æ)³ì
1
³»Àå ÀÇ½É
131,150
78,750
52,400
37 2022-11-03
¹Ì¸£¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
$
ÇØ´ç¾øÀ½ 1
23,070
16,170
6,900
¿¬¼¼´ëÇĞ±³ÀÇ
(¾ç¹æ)ºÒ
38 2022-09-21 °ú´ëÇĞ¼¼ºê¶õ ³»°ú ¿Ü·¡ A1200 ¾ÈÁ¤Çù½É 1
½ºº´¿ø
24,760
3,760
21,000
¿¬¼¼´ëÇĞ±³ÀÇ
(¾ç¹æ)°æ
392022-09-21 °ú´ëÇĞ¼¼ºê¶õ ½Å°æ°ú ¿Ü·¡ A1652 µ¿¸ÆÀÇ Æó 1
½ºº´¿ø
24,760
3,760
21,000
¼â ¹× ÇùÂø
<2022-09-21
½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
59
$
ÇØ´ç¾øÀ½
546,490
382,590
163,900 >
¿¬¼¼´ëÇĞ±³ÀÇ
(¾ç¹æ)°æ
41 2022-09-14 °ú´ëÇĞ¼¼ºê¶õ ½Å°æ°ú ¿Ü·¡ A1652 µ¿¸ÆÀÇ Æó 1
½ºº´¿ø
845,790
338,390
507,400
¼â ¹× ÇùÂø
(¾ç¹æ)´Ş
¿¬¼¼´ëÇĞ±³ÀÇ
¸® ºĞ·ùµÇ
42 2022-07-19 °ú´ëÇĞ¼¼ºê¶õ ³»°ú ¿Ü·¡ AE1168Áö ¾ÊÀº ±â
1
112,120
38,720
73,400
½ºº´¿ø
Å¸ ¸í½ÃµÈ
ÇÕº´ÁõÀ»
43 2022-07-19 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
$
ÇØ´ç¾øÀ½ 1
155,350
108,750
46,600
ÀÇ·á¹ıÀÎ ¼¼°æ
(¾ç¹æ)±â
44 2022-07-14 ÀÇ·áÀç´Ü »õºû ¾È°ú ¿Ü·¡ AZ988
¾È°úº´¿ø
Å¸ ¸í½ÃµÈ
1
¼ö¼úÈÄ »ó
ÅÂ
46,540
27,940
18,600
.
.
ºó°æÈ¯
º» ÀÚ·á´Â º´¡¤ÀÇ¿ø&¾à±¹¿¡¼­ Ã»±¸ÇÑ ¿ä¾ç±Ş¿©ºñ¿ë ¸í¼¼¼­¸¦ ±âÁØÀ¸·Î ÀÛ¼ºµÈ ÀÚ·áÀÔ´Ï´Ù.
Áø·áºñ¿¡´Â ±¹¹Î°Ç°­º¸Çè¹ı Á¦41Á¶ÀÇ4¿¡ µû¸¥ ¼±º°±Ş¿© °ü·Ã ±İ¾×ÀÌ Æ÷ÇÔµÇ¾î ÀÖÁö ¾Ê½À´Ï´Ù.
ÀÌ¿¡ º» ÀÚ·á¸¦ ´Ü¼ø Âü°í°¡ ¾Æ´Ñ ÁõºùÀÚ·á·Î »ç¿ëÇÒ ¼ö ¾øÀ¸¸ç, ÀÌ¿ë¿¡ °üÇÑ Ã¥ÀÓÀº ÀÌ¿ëÀÚ¿¡°Ô ÀÖ½À´Ï´Ù.
4/10

2025-04-16 18:10:03
¤·¤¡¤¡¤¡
TOOO
¿Ü·¡
ÄÚµå
ÀÏ¼ö(°Ç°­º¸Çè Àû¿ëºĞ) ÇıÅÃ¹ŞÀº ±İ¾×|
(Áø·áºñ)
ÀÇ·á¹ıÀÎ ¼¼°æ
(¾ç¹æ)±â
45 2022-06-02 ÀÇ·áÀç´Ü »õºû ¾È°ú ¿Ü·¡ AZ988
¾È°úº´¿ø
Å¸ ¸í½ÃµÈ
1
¼ö¼úÈÄ »ó
ÅÂ
39,090
23,490
15,600
ÀÇ·á¹ıÀÎ ¼¼°æ
(¾ç¹æ)±â
46 2022-05-19 ÀÇ·áÀç´Ü »õºû ¾È°ú¿Ü·¡ AZ988
¾È°úº´¿ø
Å¸ ¸í½ÃµÈ
¼ö¼úÈÄ »ó
ÅÂ
1
39,090
23,490
15,600
47 2022-05-19
¹Ì¸£¾à±¹
ÀÏ¹İÀÇ ¿Ü·¡
$
ÇØ´ç¾øÀ½ 1
11,530
9,230
2,300
ÀÇ·á¹ıÀÎ ¼¼°æ
(¾ç¹æ)±â
482022-05-14 ÀÇ·áÀç´Ü »õºû ¾È°ú ¿Ü·¡ AH5228
¾È°úº´¿ø
Å¸ ¹× »ó¼¼
"ºÒ¸íÀÇ ³­
26,020
15,620
10,400
"½Ã"
ÀÇ·á¹ıÀÎ ¼¼°æ Áø·á°ú
(¾ç¹æ)±â
49 2022-05-13 ÀÇ·áÀç´Ü »õºû ¸ñÄÚµå ÀÔ¿ø AH2580
¾È°úº´¿ø
¿À·ù
Å¸ ³ë³â¹é
³»Àå, ¿À¸¥
ÂÊ
1
1,179,290
944,190
235,100
(¾ç¹æ)±â
ÀÇ·á¹ıÀÎ ¼¼°æ
Å¸ ÀÇ½ÉµÇ
502022-04-13 ÀÇ·áÀç´Ü »õºû ³»°ú ¿Ü·¡ AZ038 ´Â ÁúÈ¯ ¹×
190,260
114,160
76,100
¾È°úº´¿ø
<
2022-04-13
¹Ì¸£¾à±¹
ÀÏ¹İÀÇ ¿Ü·¡
º´ÅÂÀÇ °ü
Âû, ¹èÁ¦µÈ
tA
$
ÇØ´ç¾øÀ½
1
11,530
9,230
2,300
ÇĞ±³¹ıÀÎ¿¬¼¼
52 2022-03-30
´ëÇĞ±³ÀÇ°ú´ë
ÇĞ¼¼ºê¶õ½ºº´
¿ø
(¾ç¹æ)ºÒ
³»°ú ¿Ü·¡ AI200 ¾ÈÁ¤Çù½É 1
139,390
49,590
89,800
532022-03-30 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
$
ÇØ´ç¾øÀ½
1
546,490
382,590
163,900
ÀÇ·á¹ıÀÎ ¼¼°æ
(¾ç¹æ)±â
542022-03-29 ÀÇ·áÀç´Ü »õºû ¾È°ú ¿Ü·¡ AH2582 Å¸ ³ë³â¹é 1
¾È°úº´¿ø
99,460
59,760
39,700
³»Àå, ¾çÂÊ
ÀÇ·á¹ıÀÎ ¼¼°æ
(¾ç¹æ)±â
55 2022-02-11 ÀÇ·áÀç´Ü »õºû ¾È°ú ¿Ü·¡ AH5228 ºÒ¸íÀÇ ³­
¾È°úº´¿ø
Å¸ ¹× »ó¼¼
1
126,890
76,190
50,700
½Ã
º» ÀÚ·á´Â º´¡¤ÀÇ¿ø&¾à±¹¿¡¼­ Ã»±¸ÇÑ ¿ä¾ç±Ş¿©ºñ¿ë ¸í¼¼¼­¸¦ ±âÁØÀ¸·Î ÀÛ¼ºµÈ ÀÚ·áÀÔ´Ï´Ù.
.
Áø·áºñ¿¡´Â ±¹¹Î°Ç°­º¸Çè¹ı Á¦41Á¶ÀÇ4¿¡ µû¸¥ ¼±º°±Ş¿© °ü·Ã ±İ¾×ÀÌ Æ÷ÇÔµÇ¾î ÀÖÁö ¾Ê½À´Ï´Ù.
.
ºó°æÈ¯
ÀÌ¿¡ º» ÀÚ·á¸¦ ´Ü¼ø Âü°í°¡ ¾Æ´Ñ ÁõºùÀÚ·á·Î »ç¿ëÇÒ ¼ö ¾øÀ¸¸ç, ÀÌ¿ë¿¡ °üÇÑ Ã¥ÀÓÀº ÀÌ¿ëÀÚ¿¡°Ô ÀÖ½À´Ï´Ù.
5/10

2025-04-16 18:10:03
¤¡¤©
¤·¤¡¤¡¤¡
¿Ü·¡
TOOO
ÄÚµå
ÀÏ¼ö(°Ç°­º¸Çè Àû¿ëºĞ) ÇıÅÃ¹ŞÀº ±İ¾×
(Áø·áºñ)
56 2022-01-25
ÇĞ±³¹ıÀÎ¿¬¼¼
´ëÇĞ±³ÀÇ°ú´ë
ÇĞ¼¼ºê¶õ½ºº´
¿ø
(¾ç¹æ)´Ş
¸® ºĞ·ùµÇ
³»°ú
¿Ü·¡ AE1168Áö ¾ÊÀº ±â
Å¸ ¸í½ÃµÈ
ÇÕº´ÁõÀ»
1
24,760
3,760
21,000
57 2022-01-25 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡ $
ÇØ´ç¾øÀ½
1
155,350
108,750
46,600
ÇĞ±³¹ıÀÎ¿¬¼¼
(¾ç¹æ)´Ş
¸® ºĞ·ùµÇ
58 2022-01-18
´ëÇĞ±³ÀÇ°ú´ë
ÇĞ¼¼ºê¶õ½ºº´
¿ø
³»°ú ¿Ü·¡ AE1168Áö ¾ÊÀº ±â
Å¸ ¸í½ÃµÈ
129,400
51,800
77,600
ÇÕº´ÁõÀ»
(¾ç¹æ)´Ş
ÇĞ±³¹ıÀÎ¿¬¼¼
¸® ºĞ·ùµÇ
´ëÇĞ±³ÀÇ°ú´ë
59 2021-10-06
ÇĞ¼¼ºê¶õ½ºº´
³»°ú ¿Ü·¡ AE1168Áö ¾ÊÀº ±â
1
24,410
3,710
20,700
Å¸ ¸í½ÃµÈ
ÇÕº´ÁõÀ»
ÇĞ±³¹ıÀÎ¿¬¼¼
60 2021-10-06
´ëÇĞ±³ÀÇ°ú´ë
ÇĞ¼¼ºê¶õ½ºº´
¿ø
(¾ç¹æ)ºÒ
³»°ú ¿Ü·¡ A1200 ¾ÈÁ¤Çù½É 1
Áõ
24,410
3,710
20,700
tA
61-2021-10-06 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡ $
<
2021-10-06 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
ÇØ´ç¾øÀ½ 1
654,920
458,520
196,400
SA
$
ÇØ´ç¾øÀ½ 1
109,160
76,460
32,700
ÇĞ±³¹ıÀÎ¿¬¼¼
63 2021-10-05
´ëÇĞ±³ÀÇ°ú´ë
(¾ç¹æ)ºÒ
ÇĞ¼¼ºê¶õ½ºº´
¿ø
³»°ú ¿Ü·¡ A1200 ¾ÈÁ¤Çù½É
79,840
31,940
47,900
(¾ç¹æ)´Ş
64 2021-10-05
ÇĞ±³¹ıÀÎ¿¬¼¼
´ëÇĞ±³ÀÇ°ú´ë
ÇĞ¼¼ºê¶õ½ºº´
¿ø
¸® ºĞ·ùµÇ
³»°ú ¿Ü·¡ AE1168Áö ¾ÊÀº ±â
1
36,920
14,820
22,100
Å¸ ¸í½ÃµÈ
ÇÕº´ÁõÀ»
65 2021-06-22
ÇĞ±³¹ıÀÎ¿¬¼¼
´ëÇĞ±³ÀÇ°ú´ë
ÇĞ¼¼ºê¶õ½ºº´
¿ø
(¾ç¹æ)ºñ
³»°ú ¿Ü·¡AE041
µ¶¼º ´Ü¼ø
°©»ó¼± °á
Àı
1
110,530
38,130
72,400
66-2021-06-22 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡ $
ÇØ´ç¾øÀ½ 1
104,320
73,120
31,200
º» ÀÚ·á´Â º´¡¤ÀÇ¿ø&¾à±¹¿¡¼­ Ã»±¸ÇÑ ¿ä¾ç±Ş¿©ºñ¿ë ¸í¼¼¼­¸¦ ±âÁØÀ¸·Î ÀÛ¼ºµÈ ÀÚ·áÀÔ´Ï´Ù.
.
Áø·áºñ¿¡´Â ±¹¹Î°Ç°­º¸Çè¹ı Á¦41Á¶ÀÇ4¿¡ µû¸¥ ¼±º°±Ş¿© °ü·Ã ±İ¾×ÀÌ Æ÷ÇÔµÇ¾î ÀÖÁö ¾Ê½À´Ï´Ù.
?ÀÌ¿¡ º» ÀÚ·á¸¦ ´Ü¼ø Âü°í°¡ ¾Æ´Ñ ÁõºùÀÚ·á·Î »ç¿ëÇÒ ¼ö ¾øÀ¸¸ç, ÀÌ¿ë¿¡ °üÇÑ Ã¥ÀÓÀº ÀÌ¿ëÀÚ¿¡°Ô ÀÖ½À´Ï´Ù.
ºó°æÈ¯
6/10

2025-04-16 18:10:03
¿Ü·¡
ÄÚµå
ÀÏ¼ö(°Ç°­º¸Çè Àû¿ëºĞ) ÇıÅÃ¹ŞÀº ±İ¾×| (Áø·áºñ)
67 2021-05-04
ÀÏ»ê¿ÕÇÃ¶õÆ®
Ä¡°úÀÇ¿ø
(¾ç¹æ)¸¸
Ä¡ÁÖ°ú ¿Ü·¡ AK0530 ¼º ´Ü¼øÄ¡ 1
ÁÖ¿µ
53,340
37,340
16,000
68 2021-04-12
ÀÏ»êÀÌºñÀÎÈÄ
°úÀÇ¿ø
ÀÌºñÀÎ
ÈÄ°ú
¿Ü·¡ AH612
(¾ç¹æ)±Í
Áö¶±
1
52,650
36,950
15,700
692021-04-12 ´õ»ç¶û¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡ AH612
(¾ç¹æ)±Í
1
5,580
Áö¶±
4,580
1,000
ÇĞ±³¹ıÀÎ¿¬¼¼
70 2021-03-31
´ëÇĞ±³ÀÇ°ú´ë
ÇĞ¼¼ºê¶õ½ºº´
¿ø
(¾ç¹æ)ºÒ
³»°ú ¿Ü·¡ AI200 ¾ÈÁ¤Çù½É
13,830
5,630
8,200
ÇĞ±³¹ıÀÎ¿¬¼¼
71 2021-03-31
´ëÇĞ±³ÀÇ°ú´ë
ÇĞ¼¼ºê¶õ½ºº´
¿ø
(¾ç¹æ)ºÒ
³»°ú ¿Ü·¡ A1200 ¾ÈÁ¤Çù½É
Áõ
1
81,160
26,360
54,800
72 2021-03-31 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
$
tA
ÇØ´ç¾øÀ½
666,080
466,280
199,800
(¾ç¹æ)»ç
°í, ÃßÃâ
2021-02-02
ÀÏ»ê¿ÕÇÃ¶õÆ®
Ä¡°úÀÇ¿ø
Ä¡°úº¸
Ã¶°ú
¿Ü·¡ AK081 ¶Ç´Â ±¹ÇÑ
¼ºÄ¡ÁÖº´
¿¡ÀÇÇÑ Ä¡
1
564,010
394,810
169,200
74 2020-12-23 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
$
ÇØ´ç¾øÀ½ 1
285,400
199,800
85,600
ÇĞ±³¹ıÀÎ¿¬¼¼
(¾ç¹æ)ºñ
75 2020-12-22
´ëÇĞ±³ÀÇ°ú´ë
ÇĞ¼¼ºê¶õ½ºº´
³»°ú
¿Ü·¡ AE041
µ¶¼º ´Ü¼ø
°©»ó¼± °á
Àı
1
108,980
37,580
71,400
(¾ç¹æ)»ç
°í, ÃßÃâ
76 2020-12-09
ÀÏ»ê¿ÕÇÃ¶õÆ® Ä¡°úº¸
Ä¡°úÀÇ¿ø
Ã¶°ú
¿Ü·¡ AK081 ¶Ç´Â ±¹ÇÑ
¼ºÄ¡ÁÖº´
¿¡ ÀÇÇÑ
0
558,750
391,150
167,600
77 2020-12-09
ÀÏ»ê¿ÕÇÃ¶õÆ®
"Ä¡°úÀÇ¿ø
(¾ç¹æ)¸¸
Ä¡ÁÖ°ú ¿Ü·¡ AK0530 ¼º ´Ü¼øÄ¡ 1
ÁÖ¿°
37,990
26,690
11,300
º» ÀÚ·á´Â º´¡¤ÀÇ¿ø&¾à±¹¿¡¼­ Ã»±¸ÇÑ ¿ä¾ç±Ş¿©ºñ¿ë ¸í¼¼¼­¸¦ ±âÁØÀ¸·Î ÀÛ¼ºµÈ ÀÚ·áÀÔ´Ï´Ù.
Áø·áºñ¿¡´Â ±¹¹Î°Ç°­º¸Çè¹ı Á¦41Á¶ÀÇ4¿¡ µû¸¥ ¼±º°±Ş¿© °ü·Ã ±İ¾×ÀÌ Æ÷ÇÔµÇ¾î ÀÖÁö ¾Ê½À´Ï´Ù.
?ÀÌ¿¡ º» ÀÚ·á¸¦ ´Ü¼ø Âü°í°¡ ¾Æ´Ñ ÁõºùÀÚ·á·Î »ç¿ëÇÒ ¼ö ¾øÀ¸¸ç, ÀÌ¿ë¿¡ °üÇÑ Ã¥ÀÓÀº ÀÌ¿ëÀÚ¿¡°Ô ÀÖ½À´Ï´Ù.
7/10
ºó°æÈ¯

2025-04-16 18:10:03
¿Ü·¡
ÄÚµå
ÀÏ¼ö (°Ç°­º¸Çè Àû¿ëºĞ) ÇıÅÃ¹ŞÀº ±İ¾×
(Áø·áºñ)
(¾ç¹æ)»ç
°í, ÃßÃâ
78 2020-10-29
ÀÏ»ê¿ÕÇÃ¶õÆ®
Ä¡°úÀÇ¿ø
Ä¡°úº¸
Á¸°ú
¿Ü·¡ AK081 ¶Ç´Â ±¹ÇÑ
¼ºÄ¡ÁÖº´
¿¡ ÀÇÇÑ Ä¡
1
545,790
382,090
163,700
(¾ç¹æ)»ç
79 2020-10-29 ¸¶µÎÇÏ³ª¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡ AK081 ¶Ç´Â ±¹ÇÑ
°í, ÃßÃâ
¼ºÄ¡ÁÖº´
¿¡ ÀÇÇÑ
11,240
9,040
2,200
ÇĞ±³¹ıÀÎ¿¬¼¼
(¾ç¹æ)ºñ
80 2020-10-20
´ëÇĞ±³ÀÇ°ú´ë
ÇĞ¼¼ºê¶õ½ºº´
³»°ú
¿Ü·¡ AEO41
µ¶¼º ´Ü¼ø
°©»ó¼± °á
Àı
1
24,060
3,660
20,400
(¾ç¹æ)»ç
°í, ÃßÃâ
81 2020-10-15
ÀÏ»ê¿ÕÇÃ¶õÆ®
Ä¡°úÀÇ¿ø
Ä¡°úº¸
Ã¶°ú
¿Ü·¡ AK081 ¶Ç´Â ±¹ÇÑ
¼ºÄ¡ÁÖº´
¿¡ ÀÇÇÑ
116,800
81,800
35,000
82 2020-10-15 ¸¶µÎÇÏ³ª¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
$
ÇØ´ç¾øÀ½ 1
11,240
9,040
2,200
ÇĞ±³¹ıÀÎ¿¬¼¼
(¾ç¹æ)ºñ
83 2020-10-13
´ëÇĞ±³ÀÇ°ú´ë
ÇĞ¼¼ºê¶õ½ºº´
¿ø
³»°ú ¿Ü·¡ AE041
µ¶¼º ´Ü¼ø
°©»ó¼± °á
Àı
1
64,900
20,000
44,900
2020-10-08 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
$
|ÇØ´ç¾øÀ½ 1
665,500
465,900
199,600
ÇĞ±³¹ıÀÎ¿¬¼¼
85 2020-10-07
´ëÇĞ±³ÀÇ°ú´ë
ÇĞ¼¼ºê¶õ½ºº´
¿ø
(¾ç¹æ)ºÒ
³»°ú ¿Ü·¡ AI200 ¾ÈÁ¤Çù½É
93,670
31,470
62,200
ÇĞ±³¹ıÀÎ¿¬¼¼
86 2020-09-23
´ëÇĞ±³ÀÇ°ú´ë
ÇĞ¼¼ºê¶õ½ºº´
¿ø
(¾ç¹æ)°æ
½Å°æ°ú ¿Ü·¡ A1652 µ¿¸ÆÀÇ Æó
1
24,060
3,660
20,400
¼â ¹× ÇùÂø
87 2020-08-19
ÀÏ»ê¿ÕÇÃ¶õÆ®
Ä¡°úÀÇ¿ø
±¸°­¾Ç
(¾ç¹æ)¸¸
¾È¸é¿Ü ¿Ü·¡ AK0531 ¼º º¹ÇÕÄ¡ 1
°ú
ÁÖ¿µ
25,480
17,880
7,600
(¾ç¹æ)¸¸
882020-08-19 ¸¶µÎÇÏ³ª¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡ AK0531 ¼º º¹ÇÕÄ¡
9,270
8,270
1,000
ÁÖ¿°
?º» ÀÚ·á´Â º´¡¤ÀÇ¿ø&¾à±¹¿¡¼­ Ã»±¸ÇÑ ¿ä¾ç±Ş¿©ºñ¿ë ¸í¼¼¼­¸¦ ±âÁØÀ¸·Î ÀÛ¼ºµÈ ÀÚ·áÀÔ´Ï´Ù.
?Áø·áºñ¿¡´Â ±¹¹Î°Ç°­º¸Çè¹ı Á¦41Á¶ÀÇ4¿¡ µû¸¥ ¼±º°±Ş¿© °ü·Ã ±İ¾×ÀÌ Æ÷ÇÔµÇ¾î ÀÖÁö ¾Ê½À´Ï´Ù.
?ÀÌ¿¡ º» ÀÚ·á¸¦ ´Ü¼ø Âü°í°¡ ¾Æ´Ñ ÁõºùÀÚ·á·Î »ç¿ëÇÒ ¼ö ¾øÀ¸¸ç, ÀÌ¿ë¿¡ °üÇÑ Ã¥ÀÓÀº ÀÌ¿ëÀÚ¿¡°Ô ÀÖ½À´Ï´Ù.
8/10
ºó°æÈ¯

2025-04-16 18:10:03
¿Ü·¡ ÄÚµå
ÀÏ¼ö (°Ç°­º¸Çè Àû¿ëºĞ) ÇıÅÃ¹ŞÀº ±İ¾×
(Áø·áºñ)
89 2020-08-12
ÀÏ»ê¿ÕÇÃ¶õÆ®
Ä¡°úÀÇ¿ø
±¸°­¾Ç
(¾ç¹æ)¸¸
¾È¸é¿Ü ¿Ü·¡ AK0531 ¼º º¹ÇÕÄ¡ 1
°ú
ÁÖ¿°
13,720
12,220
1,500
(¾ç¹æ)¸¸
90 2020-08-12 ¸¶µÎÇÏ³ª¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡ AKO531 ¼º º¹ÇÕÄ¡
6,970
5,970
1,000
ÁÖ¿µ
91 2020-08-05
ÀÏ»ê¿ÕÇÃ¶õÆ®
Ä¡°úÀÇ¿ø
(¾ç¹æ)¸¸
Ä¡ÁÖ°ú ¿Ü·¡ AK0530 ¼º ´Ü¼øÄ¡
ÁÖ¿°
1
32,540
22,840
9,700
92 2020-08-03
ÀÏ»ê¿ÕÇÃ¶õÆ®
Ä¡°úÀÇ¿ø
Ä¡°úº¸
Á¸°ú
(¾ç¹æ)»ó
¿Ü·¡ AK074 ¼¼ºÒ¸íÀÇ
ºÎÁ¤±³ÇÕ
1
17,880
16,180
1,700
(¾ç¹æ)¸¸
93 2020-08-03 ¸¶µÎÇÏ³ª¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡ AK0530 ¼º ´Ü¼øÄ¡ 1
11,240
9,040
2,200
Ãß¿°
(¾ç¹æ)»ç
°í, ÃßÃâ
94 2020-07-09 ÀÏ»ê¿ÕÇÃ¶õÆ® Ä¡°úº¸
Ä¡°úÀÇ¿ø
Ã¶°ú
¿Ü·¡ AK081 ¶Ç´Â ±¹ÇÑ
116,800
81,800
35,000
¼º Ä¡ÁÖº´
¿¡ ÀÇÇÑ Ä¡
(¾ç¹æ)»ç
°í, ÃßÃâ
<
2020-07-09 ¸¶µÎÇÏ³ª¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡ AK081 ¶Ç´Â ±¹ÇÑ
11,690
9,390
2,300
¼ºÄ¡ÁÖº´
¿¡ ÀÇÇÑ Ä¡
96 2020-06-17 ½Åµµ½Ã¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
$
ÇØ´ç¾øÀ½ 1
285,400
199,800
85,600
ÇĞ±³¹ıÀÎ¿¬¼¼
´ëÇĞ±³ÀÇ°ú´ë
(¾ç¹æ)°æ
97 2020-06-16
ÇĞ¼¼ºê¶õ½ºº´
³»°ú ¿Ü·¡ A1652 µ¿¸ÆÀÇ Æó
¼â ¹× ÇùÂø
1
97,870
33,170
64,700
(¾ç¹æ)»ç
°í, ÃßÃâ
98 2020-05-27
ÀÏ»ê¿ÕÇÃ¶õÆ® Ä¡°úº¸
Ä¡°úÀÇ¿ø
Ã¶°ú
¿Ü·¡ AK081
¶Ç´Â ±¹ÇÑ
¼ºÄ¡ÁÖº´
¿¡ ÀÇÇÑ Ä¡
1
546,230
382,430
163,800
(¾ç¹æ)»ç
°í, ÃßÃâ
99 2020-05-20 ÀÏ»ê¿ÕÇÃ¶õÆ®
Ä¡°úÀÇ¿ø
Ä¡°úº¸
Ã¶°ú
¿Ü·¡ AK081 ¶Ç´Â ±¹ÇÑ
1
116,800
81,800
35,000
¼º Ä¡ÁÖº´
¿¡ ÀÇÇÑ Ä¡
º» ÀÚ·á´Â º´¡¤ÀÇ¿ø&¾à±¹¿¡¼­ Ã»±¸ÇÑ ¿ä¾ç±Ş¿©ºñ¿ë ¸í¼¼¼­¸¦ ±âÁØÀ¸·Î ÀÛ¼ºµÈ ÀÚ·áÀÔ´Ï´Ù.
.
Áø·áºñ¿¡´Â ±¹¹Î°Ç°­º¸Çè¹ı Á¦41Á¶ÀÇ4¿¡ µû¸¥ ¼±º°±Ş¿© °ü·Ã ±İ¾×ÀÌ Æ÷ÇÔµÇ¾î ÀÖÁö ¾Ê½À´Ï´Ù.
.
ÀÌ¿¡ º» ÀÚ·á¸¦ ´Ü¼ø Âü°í°¡ ¾Æ´Ñ ÁõºùÀÚ·á·Î »ç¿ëÇÒ ¼ö ¾øÀ¸¸ç, ÀÌ¿ë¿¡ °üÇÑ Ã¥ÀÓÀº ÀÌ¿ëÀÚ¿¡°Ô ÀÖ½À´Ï´Ù.
ºó°æÈ¯
9/10

¿Ü·¡
ÄÚµå
ÀÏ¼ö(°Ç°­º¸Çè Àû¿ëºĞ) ÇıÅÃ¹ŞÀº ±İ¾×|
(Áø·áºñ)
100 2020-04-08
ÇĞ±³¹ıÀÎ¿¬¼¼
´ëÇĞ±³ÀÇ°ú´ë
ÇĞ¼¼ºê¶õ½ºº´
¿ø
(¾ç¹æ)ºÒ
³»°ú ¿Ü·¡ A1200 ¾ÈÁ¤Çù½É 1
24,060
3,660
20,400
2025-04-16 18:10:03
101 2020-04-08 Çàº¹ÇÑ¾à±¹ ÀÏ¹İÀÇ ¿Ü·¡
$
ÇØ´ç¾øÀ½
665,500
465,900
199,600
ÇĞ±³¹ıÀÎ¿¬¼¼
102 2020-04-01
´ëÇĞ±³ÀÇ°ú´ë
ÇĞ¼¼ºê¶õ½ºº´
(¾ç¹æ)ºÒ
¿ø
³»°ú ¿Ü·¡ A1200 ¾ÈÁ¤Çù½É
Áõ
1
309,920
124,020
185,900
?º» ÀÚ·á´Â º´¡¤ÀÇ¿ø&¾à±¹¿¡¼­ Ã»±¸ÇÑ ¿ä¾ç±Ş¿©ºñ¿ë ¸í¼¼¼­¸¦ ±âÁØÀ¸·Î ÀÛ¼ºµÈ ÀÚ·áÀÔ´Ï´Ù.
Áø·áºñ¿¡´Â ±¹¹Î°Ç°­º¸Çè¹ı Á¦41Á¶ÀÇ4¿¡ µû¸¥ ¼±º°±Ş¿© °ü·Ã ±İ¾×ÀÌ Æ÷ÇÔµÇ¾î ÀÖÁö ¾Ê½À´Ï´Ù.
ÀÌ¿¡ º» ÀÚ·á¸¦ ´Ü¼ø Âü°í°¡ ¾Æ´Ñ ÁõºùÀÚ·á·Î »ç¿ëÇÒ ¼ö ¾øÀ¸¸ç, ÀÌ¿ë¿¡ °üÇÑ Ã¥ÀÓÀº ÀÌ¿ëÀÚ¿¡°Ô ÀÖ½À´Ï´Ù.